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Abstract 
 
Reported herein is a conceptually new synthetic route to 1’-aryl-C-ribofuranosides and 
their 2’,3’-didehydro-2’,3’-dideoxy (D4) analogues. We have successfully implemented a 
divergent synthetic route capable to reach two important, biologically significant groups of 
compounds. The first two strategic transformations are common for both families of target 
compounds (asymmetric allylic substitution, and ring-closing metathesis). D4 C-nucleoside 
analogues are synthesised in a three-step procedure, and 1’-aryl ribofuranoses are 
constructed in a four-step procedure.  
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The target compounds were prepared in an excellent enantio- and diastereopurity, in good 
overall yields. The yield in the synthesis of 1’-aryl-2’,3’-didehydro-
1’,2’,3’-trideoxyribofunanoses is up to 46% over all the reaction steps. The overall yield of 
the 1’-arylribofuranoses is up to 42%. 
 
All the strategic transformations rely on catalytic oranometallic reactions employing group 
8a transition metals. All the reactions have been optimized with a view of maximal atom 
efficiency and environmental impact.  
 
In summary, our new methodology is perfectly suitable for the synthesis of 
1’-arylribofuranoses, and their D4-analogues, bearing non-ortho-substituted aromatics and 
hereroaromatics, lacking coordinating (nitrogen) substituents or heteroatoms. In this point 
of view the most promising target application is the synthesis of lipophilic isosters of 
ribonucleosides for the RNA-studies.  
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Preface 
 
C-Nucleosides 1 are natural products (Ar: aryl, heteroaryl). They occur in functional RNA, 
like transfer-RNA. In spite of a very low content of these compounds in natural matrix, 
Cohn successfully isolated pseudouridine 1a in 1959, as the first C-nucleoside ever, in 
0.2-0.3% yield from yeast RNA.
1  
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The very low content in natural resources hindered any practical applications of these 
compounds. Methods of modern synthetic chemistry were utilised in the development of 
several synthetic approaches to the natural C-nucleosides. More interestingly, synthetic 
chemistry enabled introduction of various aryls and heterocycles as the artificial 
nucleobase moiety. 
 
Nucleosides bearing artificial or modified nucleobases can be used in chemical biology as 
tools for studying and the modulation of biological progresses,
2 as well as for the 
preparation of artificial bio-analogue systems.
3 Several Artificial Expanded Genetic 
Information Systems (AEGIS) were successfully developed.
4 A new scientific inter-
discipline has emerged: Synthetic Biology.
5 The ultimate goals of synthetic biology are 
systems where high-level behaviours of living systems are mimicked by artificial chemical 
systems.
6 Various artificial nucleobases were designed for these purposes. 
 
Among these compounds, C-nucleosides 1 play an important role.
7 They are characterized 
by replacement of a relatively unstable C-N glycosidic bond by a stable C-C bond and, 
therefore, exhibit in vivo stability against nucleosidase enzymes.
8 These improved 
properties, combined with high potential of versatility in the substitution patterns,
9 have the 
promise of far reaching applications in chemical biology
3 and medicinal chemistry.
10,11 
 
Herein we report on a principally novel synthetic method for artificial C-nucleosides.  
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1.  Artificial Nucleosides in Chemical Biology 
 
The structure of duplex DNA is based on the complementary Watson-Crick hydrogen 
bonding patterns of A-T and G-C pairs.
12 The replacement of the natural nucleobases by 
diverse surrogates has become very popular in recent years.
13 The original aim just to 
investigate the structure and function of nucleic acids (NA) was extended towards three 
main goals. (1) Formation of stabilized duplexes.
14 (2) Design of universal nucleobases not 
discriminating between the complementary bases.
15 (3) Extending the genetic alphabet.
16 
 
N
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Efforts to expand the genetic alphabet are focused on a stable and replicable third base-
pair.
17 Recent progress has resulted in the development of several candidates that are both 
stable in the DNA duplex and replicated by DNA polymerases with various degrees of 
efficiency and fidelity. The candidate base-pairs draw upon unnatural hydrogen-bonding 
topologies as well as upon shape complementarity,
18 hydrophobic forces,
19 metal-bridged
20 
base-pairs and even covalent cross-links.
21 
 
1.1.  Artificial Base-Pairs Based on Hydrogen-Bonding 
 
The concept of hydrogen bonding patterns and shape complementarity was introduced by 
Benner (e.g., isoguanosine, iso-G; isocytidine, iso-C).
18 
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N NH2
O NH2
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Rf Rf dd
iso-C iso-G   
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Further development led to the introduction of other donor-acceptor (D-A) purine-
pyrimidine (pu-py) pairs
22 and finally to a generalization of Watson-Crick nucleobases 
pairs.
23 In the most general form, the Watson-Crick base-pair joins a six-membered 
heterocyclic ring py (in nature, a pyrimidine) with a fused five/six-membered ring system 
pu (in nature, a purine) via three H-bonds. Two inter-base H-bonds are formed between 
exocyclic functional groups; one is formed between heteroatoms of the heterocycles. 
Donor hydrogen-bonding patterns are assigned D, whereas the acceptor hydrogen-bonding 
patterns are assigned A. With three H-bonds, eight (2
3) H-bonding patterns and sixteen 
independently replicable bases are conceivable within the Watson-Crick geometry. Only 
six of them are readily accessible (Table 1). 
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X X
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dRf
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X d
H
H
H
py pu
X = heteroatom
R
R: H, CH3
 
 
Dotted lines in the picture indicate the position of double bonds to complete the valence to 
the heteroatoms, and make the heterocycles aromatic. 
 
In practice, pyrimidine analogs presenting pyADD, pyDAD,  and  pyDDA H-bonding 
patterns are difficult to prepare.
24 In order of good stacking capabilities, they need to be 
aromatic, therefore the ring systems requires a junction to the carbohydrate as a 
C-glycoside, thus forming C-nucleoside. Several heterocycles might solve this problem. 
The 6-aminopyridin-2(1H)-one structure, which formally presents the correct H-bonding 
pattern, did not appear to be suitable, and is readily oxidized (Table 1, entries 5, and 6; Z = 
CH). Adding an N-atom to yield the 2-aminopyridin-4(3H)-one decreases the susceptibility 
to oxidation, but creates an unacceptable tautomeric ambiguity.
25  
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Table 1. Generalised Watson-Crick base-pairs 
(R = H, CH3; Z = N, CH) 
entry bonding 
pattern 
base-pair bonding 
pattern 
1 
pyDAA 
Donor 
Acceptor 
Acceptor 
N
NN
N
Rf
N
O
N
N
dRf
O
N d
R
H
H
H
H
H
 
puADD 
Acceptor 
Donor 
Donor 
2 
pyADA 
Acceptor 
Donor 
Acceptor 
N
NN
N
Rf
O
O
N
N
dRf
N
N d
R
H
H
H
H
H
 
puDAD 
Donor 
Acceptor 
Donor 
3 
pyAAD 
Acceptor 
Acceptor 
Donor 
N
NN
N
Rf
O
N
N
N
dRf
N
O d
R
H
H
H
H
H
 
puDDA 
Donor 
Donor 
Acceptor 
4 
pyDAD 
Donor 
Acceptor 
Donor 
N
NN
NH
Rf
N
N
N
N
dRf
O
O d
H
H
H
H
H
 
puADA 
Acceptor 
Donor 
Acceptor 
5 
pyDDA 
Donor 
Donor 
Acceptor  ZN N
N
N
Rf
N
O
N
dRf
O
N d
R
H
H
H
H
H
 
puAAD 
Acceptor 
Acceptor 
Donor 
6 
pyADD 
Acceptor 
Donor 
Donor  ZN N
N
N
Rf
O
N
N
dRf
N
O d
R
H
H
H
H
H
 
puDAA 
Donor 
Acceptor 
Acceptor 
 
Finally, the pyADD and pyDDA patterns were implemented in the pyrazine ring. Also the 
original purine ring has to be changed to pyrrolo[3,2-a]triazol ring (Table 1, entries 5, and 
6; Z = N). Although different heterocycles can support individual hydrogen-bonding 
patterns, only some representations of the same pattern are more suitable in artificial 
genetic systems than others (Figure 1).
26 
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Figure 1. C-glycosidic heterocycles able to implement the pyDAD hydrogen-bonding pattern
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The ability of NA polymerase enzymes to catalyse the template-directed synthesis of 
duplex oligonucleotides containing some of these artificial base-pairs has been 
investigated.
27,28 The most important result is that the C-nucleoside linkage itself has no 
influence on the enzymatic recognition of base-pairs with DNA polymerases.
29 The iso-G 
and iso-C base-pairs were successfully incorporated into DNA as self-complementary 
base-pairs with the Klenow fragment of DNA polymerase I (KF) from Escherichia coli.
30 
Furthermore, an additional set of codon-anticodon (iso-C):(iso-G) was introduced and 
successfully used to incorporate iodotyrosine (an unnatural amino acid) into a 
polypeptide.
31 These encouraging results have triggered a quest for replication of an 
AEGIS by Polymerase Chain Reaction (PCR). A polymerase suitable for amplifications of 
a six-letter genetic alphabet was found in HIV reverse transcriptase. One variant of the 
clinic mutant was found suitable (Y188L), and it has been engineered further. These 
improvements eliminated the “self-repair” exonuclease activity, and generated doubly-
changed HIV reverse transcriptase (Y188L-E478Q). This mutant was able to amplify a 
DNA containing a pyDAD-puADA pair in the PCR reaction. These artificial base-pairs 
were retained through multiple cycles of amplification. Longer PCR incubation times were 
needed to produce full-lenght strands than in the case of natural base-pairs. This successful 
PCR amplification was the first example of a six-letter genetic code replication.
32 A 
successful practical application was also developed, based on polymerase incorporation of 
AEGIS components. EraGen Biosciences (www.eragen.com) have developed a process, 
where a primer having a fluorescently tagged iso-C is targeted against a specific region of 
the SARS-virus DNA sequence. In a real time PCR a polymerase incorporates a 
fluorescence-quencher-tagged iso-G opposite iso-C, thus quenching fluorescence in the 
case when SARS virus is present.  
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The above stated studies have shown a very important result. An incorporation of 
C-nucleosides into a DNA duplex does not determine the duplex stability.
33 Further 
progress in the field of artificial base-pairs with H-bonding patterns based on 
C-nucleosides is shown in a table (Table 2). 
 
The natural base-pair analogues in which the fusion of a benzo-ring increases their size by 
ca. 2.4 Ǻ (xA, xT, xC, xG) were reported three decades ago.
34 Kool introduced the idea of 
size-expanded genetic systems using these structures.
35,36 These linear expanded analogues 
form stable base-pairs and are selectively incorporated into DNA opposite the template 
strand.
37 More recently, a double helix of size-expanded DNA (xDNA) containing all the 
size-expanded base-pairs have been prepared.
38 This work has shown that a new, expanded 
helix adopts β-structure, the right-handed-twisting variant that is the most common natural 
form of DNA. In a similar manner, angular expanded analogues (yA, yT, yC) were 
introduced, which exhibit even better duplex stability when incorporated into DNA.
39 
 
Hirao introduced the nucleobase y,
40 and v.
41 The dyTP is incorporated into DNA more 
efficiently than any natural substrate opposite template dx.
42 Further optimization of the 
complementary base gave structure s. The dyTP was incorporated into DNA opposite 
template ds with higher efficiency and a threefold higher selectivity than the opposite 
template dx.
43 The efficiency and fidelity of y-v pairing were as high as in natural base-
pairs. The RNA transcript containing two consecutive y bases was successfully transcribed 
from DNA template containing two v bases. 
 
It is apparent that unnatural base-pairs that are paired using H-bonding patterns offer 
promising approaches to expanding the genetic alphabet. However, there are some inherent 
limitations to their selective replication in DNA, due to the range of tautomeric forms of 
the unnatural bases.
44   
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Table 2: Artificial base-pairs with H-bonding patterns 
  base-pair
a   
dxA 
N
N N
N
NH2
Rf d  
N
H
NH
O
O
Rf d  
dxT 
dxG 
N
N N
NH
O
NH2
Rf d  
N
H
N
NH2
O
Rf d  
dxC 
dyA 
N
N N
NH2
Rf d  
NH HN
O
O
Rf d  
dyT 
“dyG
45” 
N
NH N
O
Rf d
NH2
 
N HN
NH2
O
Rf d  
dyC 
dy 
NH
O
Rf d   N
N N
N NH2
Rf d
N
H3CC H 3
 
dx 
dy 
NH
O
Rf d   N
N N
N NH2
Rf d
S
 
ds 
dy 
NH
O
Rf d   N
N N
N NH2
Rf d
S N
 
dv 
aFor all the references see the text below  
 
16
1.2. Artificial  Base-Pairs  Based on Hydrophobic Interactions 
 
Kool observed that H-bonds are not absolutely necessary and introduced a new concept of 
hydrophobic interactions.
19 The first nucleoside analogue was difluorotoluene F, as an 
isostere of thymine.
46 Furthermore, corresponding thimidine isoster dF triphosphate 
(dFTP), lacking the functionality for H-bonding, was selectively incorporated by DNA 
polymerases into DNA, opposite dA in the template.
47 These results encouraged further 
research in this kind of base-pairs analogues. They are mainly C-nucleosides (Table 3). 
Also mechanistic aspects of DNA replications were intensively studied.
48  
 
Many other hydrophobic C-nucleosides were synthesised as molecular probes for NA 
structural and functional studies, as well as for extension of the genetic alphabet. The most 
significant contributions to this area were from the Berdis,
49 Hirao,
50 Kool,
51 Kuchta,
52 and 
Romesberg
53 labs.
54 These hydrophobic artificial nucleobases are expected to selectively 
pair with each other within a DNA duplex. The self-pairs are based on hydrophobic, and 
more dominantly on packing interactions. A very interesting example has been published, 
where non-hydrogen bonded, non-shape complementary, but stable and selective base-pair 
was formed. In this case only the interstrand packing interactions of pentafluorophenyl- 
and phenyl- pseudonucleobase
55 contributed to the observed stability.
56 Contributions of all 
these interactions were investigated in an extensive theoretical study.
57 The unwinding free 
energy of 128 DNA octamers was correlated with the sum of interaction energies among 
DNA bases and their solvation energies, utilizing advanced level of theory, high accurate 
calculations. The results shows the importance of inter- and more importantly 
intramolecular stacking energies for the DNA duplex stabilization. These interactions are 
diminished when pairing a hydrophobic base-pair with a natural nucleobase, due to forced 
desolvation of a hydrophilic natural nucleobase. This enhanced the selectivity and stability 
of a hydrophobic self-pair or different, but hydrophobic base-pair. 
 
Many nucleotides bearing these artificial nucleobases were successfully replicated.
64,65,67 
However, the utility was limited by insufficient rate of insertion of the next correct 
nucleobase, i.e. NA strand extension. More recently, significant improvements in this field 
were achieved, mainly utilising artificial nucleobases with a relatively small aromatic 
surface. The minor groove hydrogen bonds interactions are expected to be the main 
interaction for a successful polymerase-mediated extension in these cases.
58 
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Table 3. Artificial base-pairs with hydrophobic bonding patterns 
sign 
(pairs with) 
nucleoside sign 
(pairs with) 
nucleoside 
dF 
(dA, dZ, dQ)  F
Rf d
F
H3C
 
BFr
59 
self-pair  O
Rf d  
3FB
60 
self-pair 
Rf d
F
 
DM5
61 
self-pair 
Rf d
CH3
CH3
 
dH
62 
H
Rf d
H
H3C
 
BTp
59 
self-pair  S
Rf d  
dL
62 
(dI)  Cl
Rf d
Cl
H3C
 
IN
59 
self-pair  NH
Rf d  
dB
62 
(dI)  Br
Rf d
Br
H3C
 
dF
63 
(dA) 
Rf d
F
 
dI
62 
self-pair  I
Rf d
I
H3C
 
3MN
64,65 
self-pair 
Rf d
H3C
 
dZ
66 
(dF) 
N
N
Rf d
CH3
 
PICS
65,67 
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1.3.  Artificial Base-Pairs Based on Metal Bridges 
 
Unnatural nucleobases that have the ability to bind metal ions can replace their natural 
analogues in DNA.
20 Metal-containing base-pairs could be incorporated into DNAs at 
desired positions. When the bond energy of metal coordination is compared with that of 
H-bonding, one ligand-metal bond should compensate for two or three H-bonds. Metal 
ions incorporated in this way could serve at least five purposes. (1) They could regulate 
thermal stability of high-order structures of DNA (duplex, triplex, etc.). (2) They could 
allow one-dimensional metal arrays in direct-stacked contact along the DNA helix axis 
with interesting chemical and physical properties, with applications far beyond chemical 
biology, such as molecular wires
69 or single-molecule magnets.
70 (3) They could be used to 
generate metal-dependent functions such as redox or photochemical catalysts. (4) They 
could be able to assemble DNA duplexes at the junctions to form two- or three-
dimensional DNA networks. (5) Finally, DNA could be labelled with metal ions for 
genetic analytical use. 
 
Interactions of the DNA helix with various metal salts and complexes have been well 
known, as well as the effect of subsequent stability enhancement, presumably due to the 
metal coordination.
71 The first artificial metal ligand-type nucleoside 2 (so called 
“ligandoside”) was described in 1999 by Shionoya.
72 Since then, other nucleosides having 
mono- to tri-dentate ligands for metal-mediated base-pairing have been reported. The 
C-glycosidic connection is the preferred feature in this class of artificial nucleosides. To 
date, C-nucleosides 2-8 and N-nucleoside 9 and 10 have been reported. A salen-based 
C-nucleoside was recently developed. This new “ligandoside” 5 features an interesting 
combination of metal coordinating groups, and a covalent cross-link.
73  
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The pseudonucleobase moiety can form a stable metal complex in a linear, trigonal-planar, 
square-planar, tetrahedral or octahedral geometry. Among these geometries, a linear, 
trigonal-planar and square-planar mimic a flat, H-bonded natural base-pair geometry, and 
just square-planar 11, linear 12 and tetrahedral 13 have been synthesized. To date, 
complexes of Ag(I),
74 B(III),
75 Co(II),
76 Cu(II),
77 Fe(III),
78 Hg(II),
79 Mn(III),
78 Ni(II),
76,78 
and Pd(II)
72,80 have been reported. 
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1.4. Artificial  Base-Pairs  Based on Covalent Cross-Linking 
 
The concept of covalently cross-linked DNA with molecular architecture similar to the 
Watson-Crick H-bonded base-pairs was introduced by Leonard in 1986.
81 Since then, 
several papers with this unique structural motif have appeared.
21,82  
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These base-pairs were incorporated into the DNA as cross-linked structures 14 from the 
very beginning
21a or formed the crosslink sequence-selectively inside the DNA. As an 
example, the dG-dC pair analogue 15 is formed after the attack of vinyl functionality by 
the deoxycytidine amino group (Scheme 1).
21b 
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Scheme 1. Formation of sequence selective cross-link inside the DNA
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2.  Artificial Nucleosides in Medicinal Chemistry 
 
The nucleoside analogues have also an important impact on medicinal chemistry as 
antineoplastics and virostatic drugs.
83,84 
 
The current stock pile for the chemotherapy of viral infections consists of 37 licensed 
antiviral drugs. Among them are seven inhibitors of nucleoside reverse transcriptase 
(NRTIs), mainly for treatment of retroviral HIV infection. There are zidovudine 16, 
didanosine 17, zalcitabine 18, stavudine 19, abacavir 20 and L-nucleosides lamivudine 21 
and emtricitabine 22.  
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The mode of action of these drugs has been extensively studied, and comprehensive 
reviews have been published.
85 In general, after the transport of the parent drug inside the 
cell, all NRTIs are transformed into the corresponding 5’-mono-, di- and tri-phosphate, 
using cellular/viral phosphokinase enzymes. The 5’-triphosphate itself is the active drug. In 
the case of DNA viruses (human herpes virus, varicella-zoster virus, cytomegalovirus), the 
virus-encoded nucleoside kinase accomplished the formation of the antiviral drug 
monophosphate that is metabolised further to the corresponding di- and tri-phosphate by 
cellular kinase enzymes. The monophosphorylation step is the rate-limiting step in this 
case, and thus contributes significantly to the overall antiviral activity. On the other hand, 
retroviruses (human immunodeficiency virus 1, human immunodeficiency virus 2, simian 
immunodeficiency virus, feline immunodeficiency virus) do not encode their own 
nucleoside kinase and antiretroviral drugs are phosphorylated, diphosphorylated, and 
triphosphorylated directly by cellular kinase enzymes. 
 
The mechanism of action of these drugs is based on the substrate competition of the natural 
nucleoside triphosphate and the drug triphosphate and subsequent inhibition of viral 
reverse transcriptase (for RNA viruses) or viral DNA-polymerase (for DNA viruses) 
catalysed viral DNA polymerization reaction. The termination of the viral DNA-chain 
elongation is due to the lack of 3’-hydroxy group functionality, required for the connection 
of the next nucleoside triphosphate. The evolution difference between eukaryotic and viral 
DNA-polymerase (or viral reverse transcriptase) is one of the most important principles  
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enabling chemotherapy of a viral infection. The antiviral activity is the result of a higher 
affinity of the drug-triphosphate to viral DNA polymerase (reverse transcriptase) than to 
the cellular DNA polymerases α, β, γ, δ and ε.  
 
This affinity ratio means that there is always certain inhibition of the cellular polymerases. 
The most sensitive is the mitochondrial polymerase γ. The result is a mitochondrial toxicity 
with various adverse effects. The most important are peripheral neuropathy (sensory 
disorders, itching, and pain), bone marrow suppression, liver failure, and myopathy.
86 
 
There are also several NRTIs drugs in current clinical trials. Amdoxovir 23, dOTC 24, 
FdOTC 25, reverset 26 and alovudine 27. Various combinations of these and/or already 
licensed drugs are also being investigated.
11a 
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Intensive research in this area promises further development in terms of high activity, 
selectivity and low toxicity.
87 The use of C-nucleosides could improve the stability, i.e., the 
halftime of decomposition inside the cells. 
 
The C-nucleosides themselves have become important among modern antineoplastics.
88 
This series is dominated by the ribose structural pattern as a carbohydrate part; 
representative examples are pseudouridine 1a,
89 showdomycin 1b,
90 pyrazofurin 1c
91 and 
thiazofurin 1d.
92 
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The mechanism of action of these drugs is very similar to the antivirals. The difference is 
in targeting the modified human DNA polymerase of tumour cells, instead of the viral 
polymerase. Obviously this is far more challenging and intensive research in this field is 
highly desirable.
93 
 
3.  Synthetic Routes to C-Nucleosides 
 
Since the Cohn discovery of the first C-nucleoside pseudouridine 1a, these natural 
products and their artificial analogues became an important part of research. The low 
natural abundance of C-nucleosides together with a high desire for their analogues led to a 
focused interest in this class of compounds. Many synthetic strategies have been developed 
and summarised in excellent reviews.
94 Different approaches may be employed to classify 
these strategies. We would like to present the following scheme in this chapter, regarding 
the structural features of C-nucleosides. 
 
(1) Connection of an appropriate functional group to an anomeric position of a preformed 
carbohydrate moiety, followed by a construction of the aglycon unit. (2) Connection of an 
appropriate functional group to a preformed aglycon, followed by a construction of the 
carbohydrate moiety. (3) A direct coupling of a preformed carbohydrate moiety with an 
aglycon. (4) Chemical modification of an existing C-nucleoside.  
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3.1.  Construction of an Aglycon Unit upon a Carbohydrate Moiety 
 
3.1.1.  Introduction of the CN Group 
The first synthetic strategy for the introduction of the appropriate functional group onto a 
preformed carbohydrate is often utilized to construct heterocycles.
95 A classical example is 
the introduction of the CN-group (Scheme  2). For example, Baldwin and co-workers 
introduced the CN group in the reaction of fully benzoylated carbohydrate 28 with 
trimethylsilyl cyanide.
96 The resulting mixture of nitrile anomers 29 was hydrolyzed to 
carboxylic acid 30. This precursor was converted into a chloroacetyl derivative 31 by 
reaction with α,α-dichloromethyl methyl ether, diazomethane, and HCl respectively. 
Subsequent cyclization with thioamide nucleophiles gave substituted thiazoles 32 in 
moderate to good yield. Cyclization with semithiocarbazide afforded aminothiadiazole 33 
as a mixture of anomers in good yield. Acid 30 can be converted into amide 34 whose 
reaction with lithium acetylide afforded acetylene 35. Treatment of the latter derivative 
with amidoimidates produced pyrimidines 36 as a 1:1 mixture of anomers in good yield.
97  
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The above presented cyano-group introduction is a non-stereoselective reaction, affording 
an equimolar mixture of both anomers. However, the carboxylic acid 30 is suitable for a 
chromatographic separation of the anomers. Thus, there is a possibility to carry out the 
subsequent reactions with pure diastereoisomers.  
 
Protected 1-cyano-β-D-ribofuranose 37 was employed in the synthesis of pyrimidines by 
Veronse et al (Scheme 3).
98 To the nitrile group was added the Reformatsky organozinc 
reagent to form β-iminoester 38.
99 After hydrolysis, the resulting unstable β-ketoester 39 
was immediately treated with methyl cyanoformate is the presence of copper(II) catalyst to 
afford diester 40 in good overall yield. Subsequent cyclization of 40 with amidoimidates or 
benzylhydrazine furnished the protected pyrimidine- 41 and pyrazole- C-nucleoside 42, 
respectively. 
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Al-Masoudi et al reported a procedure employing β-cyano functionality in a cycloaddition 
reaction.
100 Protected 1-cyano-β-D-ribofuranose 37 was treated with various hydrazonyl 
chlorides 43 in the presence of Lewis acids to afford 1,2,4-triazoles 44 in good yields when 
ytterbium triflate was used (Scheme 4).  
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Benhida et al reported a similar approach employing the tolylated acid 45 in the reaction 
with a variety of diamines using MuKaiyama reagent (chloromethylpyridinium iodide) in 
dichloromethane.
101 The resulting amides 46 were cyclized under acidic conditions to the 
corresponding benzo- and pyrido-imidazoles 47. Basic deprotection with sodium 
methanolate afforded C-nucleosides 48 in moderate overall yields (Scheme 5). 
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The diastereoselectivity of the above reactions fully depends on the initial cyano group 
introduction. Benhida at al reported a moderate diastereoselectivity (50% de) when 
α-chlorodeoxyribose 49 was used as a starting material. The resulting mixture of anomers  
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proved to be separable, and the desired 1-cyano-β-deoxyribofuranose 50β was employed in 
the subsequent reaction sequences (Scheme 6).
101 
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This strategy was also employed in the synthesis of dideoxynucleosides. Jung et al 
reported the synthesis utilising the purified β-anomer of protected acid 51, readily available 
from glucosamine 52 in seven steps and 37% overall yield.
102 The acid 51 was converted 
into the common intermediate, cyanoester 53 by a cyanation reaction, followed by the 
Wittig-type reaction with the appropriate triphenylphosphorane. Various ester 
functionalities were utilised in the cyanoester 53. Cyanoester 53 was either cyclised and 
deprotected to afford dideoxyshowdomycin 54 in the way of Ohno’s synthesis of 
showdomycin,
103 or submitted to cyclization reaction with ethyl diazoacetate to give 
pyrazol diester 55. Dideoxyformycin B 56 was finalised and deprotected in five following 
steps (Scheme 7). 
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Scheme 7. Construction of dideoxyshowdomycin 54 and dideoxyformycin B 56
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More recently Gold et al. reported a procedure employing the purified β-anomer of 
protected acid 30.
104 The acid 30β was converted to the corresponding acid chloride 57 and 
submitted to palladium-catalysed Stille coupling reaction with 2-trimethylstannyl aniline 
58. Removal of the protecting group gave aniline 59 in high yield. The cyclization with 
cyanamide, followed by deprotection, furnished the benzopyrimidine 2’-deoxyriboside 60 
(Scheme 8). 
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3.1.2. Wittig-Type  Reaction 
Another important approach within the aglycon building-up strategy is the Wittig-type 
reaction.
105 This approach is based on the reaction of a phosphorus ylide with an aldehyde 
function on the carbohydrate moiety. The reaction of ylide 63 with D-ribose 64 in boiling 
tetrahydrofuran produced compound 65 in 75% yield. Selenoetherification, followed by 
oxidative elimination, yielded showdomycine 1bβ and epishowdomycine 1bα as a 1:3 
mixture (Scheme 9).
106 
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The classical synthesis of 9-deazaadenosine 1e commenced with the functionality 
introduction via Horner-Wadsworth-Emmons reaction (Scheme 10).
107 Protected ribose 66 
produced ribosylacetonitril 67 on reaction with diethyl methylencyanophosphonate. The 
subsequent reaction with tert-butoxy bis(dimethylamino)methane in DMF gave enamine 
68. Acidic hydrolysis and alkylation of enol 69 with aminoacetonitrile hydrochloride in an 
acetate buffer produced bis-nitrile 70 in good yield over two steps. Protection of the 
secondary amino function with ethylchloroformate afforded intermediate 71 and 
subsequent cyclization with an excess of base produced the functionalized pyrrole 72 in 
good yield. After deprotection, the pyrrole-anomers 73 were separated using column 
chromatography. Pure β-D-anomer 73β was cyclized with formamide acetate in boiling 
ethanol to produce the protected adenosine 74. Deprotection afforded the C-analogue of 
adenosine 1e in 22% overall yield, after 10 steps from protected ribose 66. 
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Wittig-type chemistry was used by Townsend et al to construct polyhalogenated quinolines 
as potential antiviral agents (Scheme 11).
108 Phosphonium bromide 75 was treated with 
sodium hydroxide and then directly coupled with protected ribose 76 to afford alkene 77 in 
a good combined yield of two isomers (85%, Z:E = 12:1). This mixture was elaborated in 
seven steps to the desired C-nucleosides 1f, and 1g bearing bromodichloroquinoline, and 
trichloroquinoline aglycon, respectively. However, the overall yield was low.  
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Scheme 11. Construction of polyhalogenated quinoline 1f-g
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3.1.3. Cycloaddition 
Cycloaddition reactions have become an important strategy to be considered in the 
construction of aglycons. The first attempts were related to the total synthesis of 
showdomycin, where Diels-Alder cycloaddition reaction was used to construct the 
carbohydrate moiety with an appropriate functional group in the anomeric position.
103 In 
the same year (1984) Kozikowski et al employed a 1,3-dipolar cycloaddition reaction in 
the synthesis of artificial nucleoside analogues bearing an isooxazoline ring instead of 
ribose, and in the total synthesis of (±)-blastomycinone.
109  
 
With this experience in hand, Kozikowski et al soon reported the first example of 
1,3-dipolar cycloaddition in the synthesis of dimethoxynaphthyl C-nucleoside  79.
110 
Starting with the nitromethylene derivative 80, conversion to the nitrile oxide 81 was 
achieved as shown, and cycloadition with the substituted allyl benzene afforded 
isooxazoline 82. Reduction of the latter product with Raney nickel then gave ketoalcohol 
83 that was cyclized to the aryl C-nucleoside 79 on treatment with trimethylsilyl triflate 
(Scheme 12).  
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More recent procedures employ reactions involving an alkynyl glycoside, either as an 
intermediate or directly for the cycloaddition reaction. Vasella et al reported a procedure of 
exo-glycals (Scheme  13).
111 The triple bond was introduced directly to the hemiacetal 
carbon of the protected carbohydrate 85. The proposed Corey-Fuchs’s procedure of 
alkynylation failed and Ohira’s method was used instead, utilizing phosphonate 86. The 
resulting alkyne 87 was submitted to palladium-catalysed cross-coupling reaction with 
2-bromopyridine and (bromoethynyl)benzene under the Sonogashira reaction condition to 
afford alkynes 88a and 88b in good yield. Base-catalysed cyclization gave desired 
protected exo-glycals 89a and 89b in good yield. 
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Scheme 13. Cycloaddition in construction of exo-glycals
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Other procedures have utilised an ethynyl group connected to the anomeric C-atom. The 
key intermediate, ribofuranosylethyne 90 may be prepared with various degrees of 
stereoselectivity. Unfortunately, the α-anomer is the predominant product in all the 
procedures. Wamhoff et al reported synthesis of pyridazine- and triazole- C-nucleosides 
(Scheme 14).
112 An alpha anomer of chlororibose 49 was reacted with ethynylmagnesium 
bromide to afford tolylated ribofuranosylethyne 90 as a mixture of anomers. A strong 
influence of the protecting groups was expected. The ester-based protecting groups (Ac, 
Bz, Tol) were responsible for a strong neighbouring effect during ethenyl group 
introduction. The anomeric mixture of 90 was submitted to the Diels-Alder cycloaddition 
reaction. In the presence of dimethyl [1,2,4,5]-tetrazine-3,6-dikaboxylate, the cycloadduct 
was formed and spontaneously decomposed under the Diels-Alder reaction conditions and 
gave pyridazine 91. The anomeric mixture of 90 was reacted with azides in [3+2] 
cycloaddition reaction to afford practically equimolar (
1H-NMR) mixtures of two possible 
regioisomers  92Aa-b and 92Ba-b in moderate yield. The regioselectivity was not 
influenced by steric effects as shown in the case of azidoacridine. 
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Scheme 14. Cycloaddition in construction of pyridazines 91 and triazoles 92
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Kaliappan  et al reported a very efficient procedure leading to C-aryl glycosides 
(Scheme 15).
113 Application of this method to the ribofuranosides was also investigated. 
The synthetic strategy is based on a cross-enyne metathesis followed by Diels-Alder 
cycloaddition reaction. Protected ribofuranosylethyne 93 was reacted with ethylene in the 
means of cross-enyne metathesis catalysed by Grubbs 2
nd generation catalyst C2. The 
expected product 94 was isolated in high yield and reacted either with dimethyl 
ethynyldicarboxylate or benzoquinone to afford α-C-nucleosides 95 and 96, respectively. 
Both the cross-metathesis and the cycloaddition were carried out in toluene at 80 °C and a 
two-reactions-one-pot procedure was effected, without any significant difference in the 
isolated yield. 
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Scheme 15. Cross-enyne metathesis followed by Diels-Alder cycloaddition
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Another atom efficient method was recently published by Yamamoto et al (Scheme 16),
114 
according to which spirocyclic C-nucleosides are formed in a cyclotrimerization reaction. 
The main advantage here is the presence of three flexible substitution sites upon the newly 
formed benzene or pyridine ring. The synthesis of predominantly β-anomer of di-alkyne 97 
was optimized and the latter derivative was cyclized: (1) under ethyne atmosphere to 
afford unsubstituted benzene (R
1 = H) derivative 98, with hexyne to produce disubstituted 
benzene 99 (R
1 = Me), or with chloroacetonitrile to furnish the corresponding pyridine 
100. Iodination, followed by cyclotrimerization, gave intermediate 101 with the third 
position suitable for further functionalization. The products of Heck 102a, Sonogashira 
102b, and Suzuki-Miyaura 102c coupling reaction were prepared in good yield. 
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Scheme 16. Cyclotrimerization in construction of spirocyclic C-arylribosides 102
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Cyclotrimerization leading to standard C-nucleosides was reported by Kotora et al 
(Scheme 17).
115 The anomeric mixture of tolylated ribofuranosylethyne 90 was reacted 
with a range of diynes to afford the expected products of cyclotrimerization 105a-f. 
Various transition metal complexes were investigated to promote the reaction. As the 
authors were aware of the practical importance of β-C-nucleosides, HPLC separation of the 
desired anomer 90 was carried out. The pure β-anomer 90β gave in cyclotrimerization 
comparable or improved yields of cycloadducts 105aβ-105fβ. 
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Scheme 17. Cyclotrimerization in construction of spirocyclic C-arylribosides 105
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3.1.4.  Other Methods of Construction of an Aglycon Unit  
Other procedures leading to structures fulfilling the definition of C-nucleoside have been 
developed. However, the practical utility of these procedures is low, as their versatility is 
low and/or the compounds produced are of a very limited use. Only a brief selection of 
these methods is presented herein.  
 
Trost et al reported the palladium-catalysed asymmetric allylic substitution-based synthesis 
of  L-showdomycin  L-1b (Scheme 18).
116 This synthesis relies on desymetrization of the 
enantiopure benzylated dihydrofuran 107, upon which were constructed both the 
hydroxymethyl and maleimide moieties. The hydroxymethyl part was introduced in the 
form of the activated maleic diester 108, whereas the maleimide moiety in the form of 
sulfonylsuccinimide 109. In theory, either part, 108 or 109, can be introduced in either 
order. However, the hydroxymethyl precursor 108 was introduced first, followed by the 
introduction of imide 109 due to the side-products and poor enantioselectivity in the case 
of the reverse order. The unnatural L-configuration of the final product resulted from the 
enantioselectivity of the introduction of precursor 108. Whereas the presented L-configured 
intermediate  L-110 was obtained in high enantioselectivity of 90% ee, the natural 
D-configured intermediate D-110 was attained in more than 76% ee on average. Only the  
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highly advanced “Trost-design” ligands were utilised in this study.
117 Once the building 
blocks had been attached to the dihydrofurane ring, they were elaborated further to the 
final target of L-showdomycin  L-1b in ten steps and 10% overall yield. Although the 
authors claimed this method to be “a versatile route to the preparation of biologically 
interesting natural and unnatural C-nucleosides”, this has not been utilised since published 
in 1999. The main disadvantage is the long elaboration of suitable precursors towards 
desired structures, combined with the highly complex, commercially unavailable ligands 
for the palladium-catalysed allylic substitution. 
 
N
SO2Ph
PMB
O
O
O OBz BzO
H CO2Bn
CO2Bn CbzO
O
CO2Et
CbzO
CO2Et
N
O
O PMB
PhO2S
O
CO2Et
CbzO
CO2Et
N
O
O PMB
PhO2S
OO
O
HO OH
HN
OH O
O
Scheme 18. Allylic substitution in the synthesis of L-Showdomycin
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Fully unprotected 2’-deoxyribose 113 was reacted in a two-step-one-pot reaction protocol 
to give an equimolar mixture of anomers of C-nucleoside 114. The reaction itself consists 
of four consecutive steps involving Horner-Wadsworth-Emmons olefination, followed by 
cyclization, tandem bromination, and Ramberg-Bäcklund reaction (Scheme 19).
118 
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Scheme 19. HWE/cyclization-tandem-halogenation/Ramberg-Backlund reaction
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O
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..
 
 
Protected ribonolactone 115 was functionalized by carbenoid chemistry: Reaction with 
tris(dimethylamino)phosphine, dibromodifluoromethane and zinc dust in refluxing 
tetrahydrofuran produced the difluoro enol ether 116. Hydrogenation then afforded the 
desired difluormethyl analogue 117 (Scheme 20).
119 
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Scheme 20. Functionalization of protected ribonolactone with difluorocarbene
 
 
The thionucleoside 118 was reacted with the rhodium-based carbene to yield intermediate 
119, which then underwent a rearrangement to produce 120, which was elaborated further 
to afforded Showdomycin 1b (Scheme 21).
120 
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Scheme 21. Functialization of protected thioribose via carbene insertion
 
 
Stork et al has used his intramolecular radical cyclization method for the silicon-tethered 
alkynes to stereoselectively synthesize C-ribofuranosides. Owing to the mechanism of the 
reaction, the diastereoselectivity strictly depends on the alkyne position: with the ribose 
substrate 121, the α-anomer 122 becomes the only product of the reaction (Scheme 22).
121 
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Scheme 22. The radical cyclization in the aglycon unit construction
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3.2.  Construction of a Carbohydrate Moiety upon an Aglycon Unit 
 
The logical complement to the synthetic strategy based on construction of an aglycon unit 
upon a carbohydrate moiety is the construction of a carbohydrate moiety upon an aglycon, 
or the synthesis of a carbohydrate moiety followed by aglycon construction. These 
strategies are not common as they require constructing up to four stereogenic centres. 
 
This strategy includes several total syntheses of C-nucleosides, as these always start with 
the carbohydrate moiety containing all the stereochemistry required.
122 Vogel et al reported 
synthesis of the C-nucleoside intermediate 123, containing all the structural features and  
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stereochemistry required in the biologically attractive 3’-azido-2’,3’-dideoxy-
C-nucleosides (Scheme 23).
123 The enantiopure cyanoacetate 124 was transformed in six 
steps to azidochloride 125. Ozonolysis of the bicyclic structure 125 followed by an 
aldehyde function protection furnished azidoester 123. The ester functionality of this 
common intermediate was elaborated further into a range of C-nucleosides. 
 
Scheme 23. Total synthesis of a carbohydrate part of 3'-azido-2',3'-dideoxy C-nucleosides
O
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OAc O N3
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MeO
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1. O3, MeOH
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3. HC(OMe)3
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124 125 (83%) 123 (93%)  
 
2’,3’-Dideoxy-C-nucleosides should receive a special attention among C-nucleosides 
analogues. They possess a structural feature of 2,5-disubstituted tetrahydrofuran, and thus 
they share synthetic methodology with a variety of natural compounds.
124 Non-
stereoselective synthesis of racemic diastereoisomers was reported (Scheme  14).
125 
Unsaturated alcohol 126 was submitted to the epoxidation, followed by an in-situ non-
stereoselective oxirane-ring opening cyclization to give 2,5-disubstituted tetrahydrofuran 
127. 
 
MeO
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O
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18 h
126
127 (29%)
Scheme 24. Non-stereoselective synthesis of 2,5-disubstituted tetrahydrofurane
mixture of racemic diastereoisomers  
 
A stereoselective synthesis of tetrahydrofurans (and tetrahydropyrans) was developed by 
Carreño et al (Scheme 25).
126 Succinic anhydride 128 was reacted with a lithium salt of the 
enantiopure (R)- or (S)- methyl p-tolylsulfoxide 129. The resulting acid was reacted with 
dimethy sulfate to give ester of β-ketosulfoxide 130. Highly diastereoselective reduction of 
β-ketosulfoxide 130 was achieved using diisobutylaluminium hydride (DIBAL-H) with (or 
without) an addition of ZnBr2 as a Lewis acid. The reported diastereoselectivity exceeded 
98%  de for both anomers. Hydroxysulfinyl ester 131 was transformed into the 
corresponding Weinreb amide as a versatile intermediate suitable for reactions with a  
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variety of arylmagnesium bromides to afford hydroxysulfinyl ketones 132. The reductive 
cyclization gave tetrahydrofurans 133a-b. The diastereoselectivity of the cyclization was 
determined in the crude reaction mixture only in the case of phenyl substituent (72% de). 
Only the major diastereoisomers 133a-b were isolated. The Pummerer reaction, followed 
by reduction, released the 5’-hydroxyl functionality of the desired 
2’,3’-dideoxy-C-nucleosides 134a-b. 
 
128
130 (69%)
Scheme 25. Hydroxysulfinyl ketones in stereoselective synthesis of
2,5-disubstituted tetrahydrofurans
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The classical route of construction of the carbohydrate moiety upon an aglycon was 
reported by Townsend et al (Scheme  26).
127 The 2,6-dichloro-
3-formylimidazo[1,2-a]pyridine  135 bearing a formyl functionality was reacted with 
phosphonium iodide 136 in Wittig olefination reaction and deprotected to afford diol 137. 
Iodocyclization of diol 137 was extensively optimized to yield a procedure where desired 
iodotetrahydrofuran  138 was in majority. Elimination of iodine, followed by standard 
stereoselective oxidation of dihydrofuran 139, gave ribofuranose 1h in 17% yield over all 
four reaction steps. 
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Scheme 26. Construction of a carbohydrate moiety upon an aglycon unit
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The last course within this strategy employs carbene chemistry. The first attempts have 
been reported by Calter et al.
128 Aldol reaction of 142 with arylaldehyde 143a was 
employed as the key step followed by Rh-catalysed cyclization of the resulting 144 via the 
corresponding metallocarbene (Scheme 27). Full reduction of ketoester 145 can, a priori, 
afford racemic diastereoisomers 146-149, but the configuration of the natural 
2’-deoxy-β-D-ribofuranoside 146 was not observed under any reduction conditions. The 
cis-ketoester 145 was also isolated as a single diastereoisomer prior to reduction, but this 
compound is configurationally unstable.  
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Scheme 27. Carbene in carbohydrate moiety construction, non-specific reduction
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The sequential reduction of 145 was also investigated (Scheme 28). Ketoester 145 was 
transformed into the corresponding silyl enol ether 150 and the ester function was reduced 
with DIBAL-H to afford the primary alcohol 151. Diastereoselective cleavage of the 
silylenolether group in 151 was performed using triethylammonium fluoride to produce 
ketone 152 in moderate yield and good diatereoselectivity (77% de). Final reduction of 152 
with sodium triacetoxyborohydride afforded racemic diol 153 with the configuration of 
natural 2’-deoxy-β-D-ribofuranose. 
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Scheme 28. Carbene in carbohydrate moiety construction, two subsequent reductions
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There have been several attempts to follow this strategy, however only with modest 
success, prohibiting practical use.
129 Carbene cycloaddition approach was developed very 
recently by Fu et al (Scheme 29).
130 The principal difference here is the disconnection of 
the resulting dihydrofuran (145 vs. 154). Copper-catalysed cycloaddition of enone 155 
with diazoester 156 is the key-reaction. Dihydrofuran 154 is then stereoselectively 
hydrogenated to tetrahydrofuran (>90% de), followed by reduction of the ester function to 
primary hydroxyl functionality and deprotection, to afford the desired 
2’-deoxy-C-nucleoside  L-153 in good overall yield (66%, 4 steps) and good 
stereoselectivity. However, the practical utility of this efficient procedure is limited by the 
availability of the ligand (-)-bpy* used in the copper-catalysed cycloaddition.  
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Scheme 29.  Copper-catalyzed asymmetric [4+1] cycloaddition of enones with
diazo compounds to form 2'-deoxy-C-nucleoside L-153
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3.3.  Direct Coupling of a Carbohydrate Moiety with a Preformed Aglycon Unit 
 
The synthetic strategy of the direct coupling of a protected carbohydrate moiety with a 
preformed aglycon nucleophile represents the most common synthetic approach to the 
construction of C-nucleoside backbone.
94d There are six different reaction tactics within 
this synthetic approach of direct coupling. (1) Nucleophilic addition to an aldehyde 
function of a carbohydrate; (2) Nucleophilic addition to 1,2-anhydrofuranoses; (3) 
Nucleophilic addition to halogenoses; (4) Nucleophilic addition to furanolactones; (5) 
Heck coupling; (6) Coupling mediated by Lewis acids.   
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3.3.1.  Nucleophilic Addition to an Aldehyde Function of a Carbohydrate 
Addition of organometallic reagents to the aldehyde functionality in the carbohydrate 
moiety leads to a mixture of diastereoisomeric diols in good yields. Subsequent cyclization 
proceeds under acidic conditions in a non-diastereoselective fashion (Scheme 30).
131 
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Scheme 30. Coupling of protected ribofuranose 85 and organolithium derivate
with acid-catalysed cyclization
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The intermediate diol 160 has been cyclized diastereoselectively under Mitsunobu 
conditions to produce 161. The subsequent deprotection afforded the 
2’-deoxyribofuranoside  162 in 50% overall yield, and 66%  de  (Scheme 31).
132 An 
optimized Mitsunobu-based cyclization procedure was published recently. The 
corresponding pyrazole derivatives were prepared with up to 92% de.
133 
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Scheme 31. Coupling of protected 2'-deoxyribofuranose and organolithium nucleophile
with cyclization under Mitsunobu conditions.
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Yadav  et al recently communicated on an interesting one-step procedure leading to 
benzoxazinone  C-nucleosides (Scheme  32).
134 The dehydrazinative
134 glycosilation of 
unprotected ribose with intermediate 165 in aqueous media features of atom-efficient, 
environmentally bening process. However, the limited range of aglycons possessing 
activated benzyl functionality together with the absence of some experimental details 
(isolated yields) may hinder the possible practical applications of this method. 
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Scheme 32.  Dehydrazinative glycosylation to benzoxazinone C-nucleosides
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3.3.2.  Nucleophilic Addition to 1,2-Anhydrofuranoses 
A very innovative method was recently published by Seitz et al (Scheme 33).
135 Furanose 
glycal  167 was epoxidized by dimethyldioxirane to furnish anhydrofuranose 168. The 
oxirane ring was stereoselectively opened by various triarylalanes to afford 
arabinofuranoses 169. The using of triarylalanes is preferred over aryldimethylalanes, as it 
gives substantially better isolated yield. Arabinofuranose 169 was deoxygenated in 
2’-position using the Barton two-step procedure. Final deprotection gave 
2’-deoxyribofuranose-C-nucleosides  170 in moderate overall yields and excellent 
diastereoselectivity. The need of three equivalents of the aryl building block (Ar3Al) may 
be prohibitive in the case of more complex aryl moieties. 
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Scheme 33.  Nucleophilic addition to the protected 1,2-anhydrofuranose
O
TBSO
TBSO
O
TBSO
TBSO
O
O
TBSO
TBSO OH
Ar
O
TBSO
TBSO OC(S)Im
Ar O
TBSO
TBSO
Ar O
HO
HO
Ar
O
O
Me
Me
TBAF
THF
(Me3Si)3SiH
AIBN
DCM
0 oC
TCDI
Ar3Al
THF
DCM
167 168 169a-d (40-63%)
170a-d (69-90%) 172a-d (68-91%) 171a-d (98-99%)
R
Me
Ar:
(b)
Ar:
(a) R = H
(c) R = Me
(d) R = Ph
 
 
3.3.3.  Nucleophilic Addition to Halogenoses 
A coupling reaction of protected carbohydrate with a soft organometallic reagent is the 
oldest method for the C-glycoside bond construction.
136 Naturally it has become an 
important method for C-nucleosides synthesis. Both protected ribosyl, and 2-deoxyribosyl 
bromides or chlorides may be used as starting materials. Among them, Hoffer’s 
chlorosugar (1-chloro-2-deoxy-3,5-bis[O-(p-toluoyl)]-α-D-ribofuranose 49)
137 became one 
of the most widely used building blocks. The typical reaction procedure features of a 
coupling reaction of halogenose and an organometallic reagent based on cadmium, zinc, 
mercury, magnesium, and even lithium. Yields are generally low, determined by the nature 
of the organometallic reagent (Scheme 34).
138,139 
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Scheme 34. Coupling of Hoffer's chlorosugar with various organometallic reagents
aOnly one diastereoisomer was isolated.
49 173-178
α : β = 3.5 : 1
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α : β = 1 : 3.9
 
 
The α-anomer is the major product in all the cases, regardless on any variation of metal, 
solvent, temperature or other possible reaction conditions. The acid-catalysed 
epimerization is required as an additional step in order to obtain the more often desired, 
naturally configured β-anomer (Scheme 35).
140 Furanylmercury chloride was reacted with 
bromo ribose 179 to give separable anomeric mixture with predominant α-anomer 180α, 
which was isolated and submitted to the acid-catalysed epimerization to afford β-anomer in 
80% de purity. 
 
Scheme 35.  Furanylmercury-bromose coupling followed by epimerization
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In spite of the unfavourable stereochemical outcome, the synthetic approach utilizing the 
halogenose-coupling reaction has been optimized further. Seitz et al  reported an 
environmentally friendly organometallic reagent based on mixed magnesium-cuprate 
(Normant cuprate). This organometallic reagent substantially improved the isolated yield 
of the anomeric mixture, which again in combination with subsequent epimerization has 
made this method competitive (Scheme 36).
141,142 
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Scheme 36. Coupling of Hoffer's chlorosugar with Normant reagent
181α/β (81%) 49
 
 
3.3.4.  Nucleophilic Addition to Furanolactones 
Addition of aglycon organometallic nucleophilic reagent accros the lactone functionality is 
the most frequent synthetic tactic to construct a new C-C anomeric bond in the case of 
C-ribonucleosides, and one of the most frequent approaches to the synthesis of 
2’-deoxy-C-ribonucleosides (together with Heck coupling). 
 
Protected lactone 182 is reacted with aryl (heteroaryl) lithium reagent at low temperature 
to give hemiketal 183. Subsequent reduction of the hemiketal function to afford the desired 
C-nucleoside 184 was developed in two possible reaction pathways (Scheme 37). 
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Scheme 37. Coupling of ribonolactones with organometallic reagents
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The older method features deoxygenation of hemiketal 183 by Lewis acid, followed by 
reduction of the oxonium intermediate 185 (Scheme 38).
143 The most common Lewis acid 
is boron trifluoride etherate. Reduction of the planar intermediate 185 utilises triethylsilane 
in most cases. The reduction prceeds in a non-stereoselective fashion yielding equimolar 
mixtures of anomers, though various degrees of stereoselectivity, based on nature of the 
aglycon unit, were reported.
144 
 
α : β = 0 : 1
O Lewis
acid
Scheme 38. Lewis acid mediated deoxygenation followed by silane reduction
OH
Ar
RO
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N
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Ar =
RO R1 RO R1 RO R1
183a-e 185a-e 184a-e
184aα/β (43%) 184bα/β (50%) 184cα/β (42%) 184dα/β (82%) 184eα/β (85%)
α : β = 1 : 10 α : β = 1 : 6.5 α : β = 1 : 1 α : β = 10 : 1
R = protecting group
R1 = H, OR
 
 
Nucleophile addition to lactones proved to be a favourite method for the C-nucleosides 
construction, utilising easily accessible building blocks, but having unsatisfactory 
stereoselectivity. To overcome this particular problem, an alternative sequence of 
hemiketal 183 transformation has been developed. Hemiketal 183 is reduced by complex 
hydride to afford diol 186 that is cyclised under Mitsunobu conditions to the desired 
nucleoside analogue 184 (Scheme 39).
145,146 
 
O
RO
Scheme 39. Reduction followed by Mitsunobu-type cyclization
OH
Ar
R1
RO
O
RO R1
RO
Ar
OH
R1 RO
RO
Ar
OH
DEAD
Ph3P reduction
R = protecting group
R1 = H, OR
183 186 184
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Stereoselectivity of the above reaction sequence can be controlled in different ways. 
Benhida  et al reported stereoselective reduction of hemiketals 183f-g  and Mitsunobu 
cyclization of diols 186f-g bearing indole, imidazole, and benzimidazole heteroaryl 
moiety.
145 The stereoselectivity was controlled by the presence and the nature of the 
N-protecting group on heterocycle. They observed that the choice of an appropriate 
protecting group on the heterocyle moiety resulted in a highly stereoselective (up to 80% 
de) borohydride reduction of the hemiketal 183g to the corresponding diol 186g in 
quantitative yield, which upon Mitsunobu cyclization gave the α-anomer. On the other 
hand, removal of the protecting group allowed the total stereocontrol during the Mitsunobu 
cyclization step, leading to the β-anomer 184f exclusively. 
 
NH N
SO2NMe2
α : β = 0 : 100 α : β = 100 : 0
fg
 
 
A more general stereocontrol was reported by Hanessian et al (Scheme  40).
146 
Stereoselective reduction of hemiketal 183h was performed using L-selectride alone or 
with an addition of zinc chloride. The neighbouring effect of the protecting groups was 
also the essential part of the successful stereocontrol. The stereoselective reduction was 
followed by standard Mitsunobu-type cyclization. This methodology was applied to the 
synthesis of the α- and β-anomers of pseudouridin 1a. Starting from unprotected 
ribonolactone, the target structures were prepared in five steps as single diastereoisomers 
in good overall yield 1aα (65%), and 1aβ (46%). 
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Scheme 40.  L-selectride stereoselective reduction followed by Mitsunobu-type cyclization
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-78 oC to 20 oC
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1) L-selectride
184hα (79%)
184hβ (60%)
183h
2) DIAD, PPh3
THF
2) DIAD, PPh3
THF
 
 
3.3.5. Heck  Coupling 
Heck-type coupling reaction between the anomeric carbon of carbohydrate derivatives and 
(hetero)aromatics is the most important method for the synthesis of 
2’-deoxy-C-nucleosides in the last 30 years.
94f Daves et al reported the utility of the 
palladium-catalysed Heck coupling reaction for the synthesis of C-nucleosides for the first 
time.
147 Heck reaction is highly regioselective and stereoselective in the formation of C-C 
bonds. New C-glycosidic bond is formed on the least sterically hindered face of the glycal 
ring. An appropriate protecting group at the 3-hydroxyl function of the glycal controls the 
anomeric configuration of the resulting C-nucleoside. Such a protection results in an 
exclusive formation of β-anomer. A free, unprotected 3-hydroxyl function drives the attack 
of the organopalladium species to occur from the opposite direction to give α-anomer 
exclusively (Scheme 41).
148 
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R1O
NN
OTMS
X
OTMS
O
R2O
R1O N
N OTMS
TMSO
+
X = HgOAc, I, Sn(nBu)3
Pd(OAc)2
AsPh3
Scheme 41. Heck-type coupling reaction of furanoid glycals with aglycon precursor
base
R1 = H, DMPS, TBDPS, TBS, TIPS
R2 = DMPS, TBDPS, TBS, TIPS
187 188 189
O
HO
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NN
OTMS
X
OTMS
O
O
R1O N
N OTMS
TMSO
+
Pd(OAc)2
AsPh3
base
190 188 191
 
 
The carbonyl functionality is then restored in the Heck-type coupling product 189 by 
fluoride mediated desilylation of the corresponding silyl enol ether, and subsequently 
reduced by sodium triacetoxyborohydride with high stereoselectivity to afford the desired 
2’-deoxy-C-nucleoside 192 (Scheme 42).
149 
 
Scheme 42. Heck-enol deprotection followed by stereoselective reduction
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Furthermore, the Heck reaction was used in the stereoselective synthesis of 2’,3’-dideoxy-
C-nucleosides (Scheme  43).
150 Enantiopure 2,3-dihydrofurane 194 was reacted with 
iodopyrimidine to give a mixture of 2,3- and 2,5-dihydrofurans 195α, and 196, 
respectively. Although the major product 196 lost its original chiral centre, this was 
restored in a stereoselective hydrogenation that occurred from the least hindered face of the 
dihydrofuran ring. However, the restored chirality was of the opposite configuration, thus 
leading to L-unnatural configuration of the carbohydrate moiety in L-197β. The reaction  
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sequence gave a comparable yield of the naturally configurated D-197β in the reaction with 
the opposite enantiomer of the tritylated hydroxymethyldihydrofurane 194. 
 
Scheme 43. Heck-type coupling in the synthesis of 2',3'-dideoxy C-nucleosides
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O
TrtO N
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MeO
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N OMe
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O
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N
MeO
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+
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AsPh3
MeCN
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+
195α (20%)
194 198
L-197β (87%)
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Several general observations have been made for the Heck-type coupling reaction of the 
glycal to the aglycon.
151 Palladium acetate and Pd2(dba)3 are the most widely used sources 
of palladium and AsPh3 is the most frequent ligand of choice. Standard solvents for Heck 
reaction (DMF, MeCN, THF) have been employed in most of the cases. The most frequent 
bases are Bu3N, Et3N, iPr2NEt. Inorganic bases, like sodium bicarbonate (NaHCO3) have 
been used only in several cases.  
 
3.3.6.  Coupling Mediated by Lewis Acids 
Coupling reactions of a preformed carbohydrate and a (hetero)aryl catalysed by Lewis 
acids provide a simple method for the formation of C-nucleosides. The method was 
developed in the synthesis of C-glycosides of hexopyranoses.
152,153 Šorm et al utilised the 
Lewis-acid-mediated coupling reaction in the synthesis of showdomycin (vide infra, page 
63). Condensation of benzylated bromose 179 with sym-trimethoxybenzene in the presence 
of zinc chloride gave C-nucleoside 199 (Scheme 44).
154  
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O
BzO
BzO
179
OBz
199
Scheme 44. Lewis acid catalysed condensation used in the first
synthesis of showdomycin 1b
Br
O
BzO
BzO
OBz
MeO
OMe
OMe
ZnO
20 oC
200: 1,3,5-trimethoxybenzene
200
 
 
The authors applied this protocol to a broad range of electron-rich benzenes to afford 
equimolar mixtures of anomers of the products.
155 
 
The simplicity of the process is balanced with poor regioselectivity of the aglycon attack 
and with non- or low stereoselectivity of new anomeric C-C bond formation. Reactions are 
fully controlled by the nature of the aglycon unit. Some reference examples are shown in 
the reaction of protected ribofuranose 201 with a range of aglycon units 202a-202f 
(Scheme 45).
156,157 
 
Scheme 45. Coupling reaction of aglycon and preformed carbohydrate catalysed by Lewis acid
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Tellurides are known as useful building blocks reactive toward electrophiles, nucleophiles, 
and radicals.
158 Togo and Yokoyama reported a procedure based on coupling reaction of 
carbohydrate anomeric radical, anion, and cation with aglycon unit (Scheme  46).
159 
Ribofuranose derivatives 85 and 163 were transformed to the corresponding anisyl 
tellurides and directly treated with either triethylborane, buthyllithium, or boron trifluoride, 
respectively, and reacted with appropriate aryl- or heterocyclic- aglycon unit. No 
stereoselective reaction was observed. The reactions of a mixtures of anomers (route A) 
gave essentially the same results as in the cases where pure α- and β-anomer of telluride 
203a, and 203b had been separated and employed in the reaction. The reactions of radical 
cation (route C) resulted in certain degree of stereoselectivity. However, these were of the 
same value as were the thermodynamic equilibrium ratio of epimerization mediated by 
boron trifluoride itself. 
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Scheme 46. Tellurides in C-nucleosides synthesis
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3.4.  Chemical Modification of Existing C-Nucleosides 
 
The last synthetic strategy is based on modification of functional groups in the naturally 
occurring or synthetic C-nucleosides. The modification(s) may include either aromatic part 
or carbohydrate part of the C-nucleoside, or both. The C-C bond between an aglycon and a 
carbohydrate moiety is kept intact during all the transformations.
160 
 
This strategy was employed in the syntheses of analogues of the naturally occurring 
pseudouridine (Scheme  47).
161 Protected pseudouridine 211 was transformed into 
thiatriazolon  212, which was hydrolyzed to 6-aza analogue of pseudouridine 1j. This 
approach faded as the natural sources were very limited, both in quantity and structural 
diversity. 
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NH HN
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O
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1. O3 / MeOH
2. Me2S
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HCO2H, H2O
4. NaOH / H2O O
Scheme 47. Modification of protected pseudouridine 211
MeI
H2O
 
 
Šorm  at al reported the first synthesis of showdomycin (Scheme  48).
154 The parent 
C-nucleoside structure 213 was obtained by Lewis acid catalysed condensation (vide 
supra, page 59) followed by separation of β-anomer (by crystallization). The protected 
C-nucleosides 213 was ozonolyzed in ethyl acetate at -25 °C with reductive workup. The 
resulting ketoester 214 was directly treated with phosphoran 215 in refluxing benzene, 
yielding the unsaturated ester 216. The cis to trans isomers ratio on the new double bond 
was 10:1. After alkaline hydrolysis the desired cis isomer was separated by ion-exchange 
chromatography. Diacid 217 was treated with hydrazine dihydrochloride to give pyridazine 
1k. The conversion of diacid 217 to showdomycin 1b was accomplished in four steps and 
14% yield as follows: diacid 217 was dehydrated to afford anhydride 218, followed by 
ammonolysis to produce maleamic acid 219, dehydration by ethyl polyphosphate in 
dimethylformamide, and final deprotection by 2% HCl in methanol. 
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213
Scheme 48. First synthesis of showdomycin 1b and its pyridazine analogue 1k
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Renaissance of this method has begun in late 1990’s. Many stereoselective methods were 
developed to construct C-nucleosides as shown in previous paragraphs of this chapter. 
C-Nucleosides possessing a structure of a common intermediate can be stereoselectively 
synthesized and then transformed into a plethora of final structures. 
 
Townsend  et al reported preparation and subsequent derivatization of pyrazinoic ester 
221.
162 Protected pyrazine C-nucleoside  222 was selectively lithiated by lithium 
2,2,6,6-tetramethylpiperidide at low temperature and carboxylated using ethyl 
cyanoformate. This was an optimized procedure as many of standard carboxylation 
procedures failed. The resulting ester 221 was debenzylated and the resulting ribose 1l was 
submitted to a variety of functionalization. A range of potential chemotherapeutics 
1ma-1me was prepared in three steps (Scheme 49). 
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Scheme 49. Pyrazinoic-ester C-Nucleosides 1m
O
BnO
BnO OBn
N
N Cl
Cl
O
RO
RO OR
N
N Cl
Cl
CO2Et
O
HO
HO OH
N
N Cl
X
CO2R
LTMP
-94 oC
NCCO2Et
221: R = Bn (78%)
1l: R = H (89%)
1ma: (A)   OEt     NH2       59%
1mb: (B)   OEt     NHMe   57%
1mc: (C)   NH2     NH2      35%
1md: (D)   NH2     OMe     30%
1me: (E)   NH2     OEt      12%
RX yield
Conditionsa
aConditions: (A) 2 equiv of NH3 / 1,4-dioxane, 40 oC, 42 h;
                    (B) 2 equiv of MeNH2 / THF, 20 oC, 30 h;
                    (C) sat. NH3 / EtOH, 4 oC, 48 h;
                    (D) sat. NH3 / MeOH, 20 oC, 48 h;
                    (E) sat. NH3 / EtOH,  20 oC, 70 h;
a
BCl3
-70 oC
1ma-e
222
 
 
Epimerization plays an important role among possible modifications of C-nucleosides. 
Many presented procedures constructing the anomeric C-C bond are not perfectly 
stereoselective, thus controlled epimerization would be highly desirable. Optimized 
procedures were reported for C-nucleosides bearing both, electron-donating-group (EDG) 
and electron-withdrawing-group (EWG).
9,163  
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Scheme 50. Epimerization of C-nucleosides 223
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Stivers at al have presented two procedures either for EDG or EWG substituted aglycon.
163 
Epimerization is possible just by using a catalytic amount of TFA (5%) in the case of EDG 
groups. Stronger acidic conditions are required for EWG substituted aglycons. A catalytic 
amount of a mixture of TFA and benzensulfonic acid proved to be optimal (Scheme 50). 
Examples of thermodynamic equilibrium distribution of an epimerization are shown in 
table (Table 4).  
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Table 4. Epimerization of α-C-nucleosides (Scheme 50) 
compound 
Ar 
conditions  α-isomer
a 
(%) 
β-isomer
a 
(%) 
223a 
F
F
 
20 mol % catalyst 
40 °C, 40 h 
37 58 
223b 
F
F
Me
 
12 mol % catalyst 
40 °C, 20 h 
35 54 
223c 
 
12 mol % catalyst 
40 °C, 20 h 
38 54 
223d 
F
 
12 mol % catalyst 
40 °C, 20 h 
27 65 
223e 
Me
 
5 mol % catalyst 
40 °C, 20 h 
30 64 
223f 
OMe
 
5 mol % catalyst 
23 °C, 2 h 
20 78 
223g 
Me
 
5 mol % catalyst 
40 °C, 20 h 
32 63 
aIsolated yield 
 
Recently, the strategy of C-nucleoside modification was employed in the syntheses of the 
artificial DNA-nucleoside analogue dxC from dxT.
37c Starting dxT was transformed into 
its 4-thia analogue 224, subsequent amonolysis afforded dxC in 74% overall yield. 
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Scheme 51. Synthesis of dxC
 
 
The carbohydrate-moiety modification procedures were also important since the discovery 
of  C-nucleosides.
164 Modification of the carbohydrate part of an easily accessible 
C-nucleoside remains the major way to compounds possessing modified (artificial) 
carbohydrate, such as the D4 modification. Sartorelli et al reported a preparation of 
D4-9-deazaguanosine.
165 9-Deazaguanosine 1na was treated with bis(trimethylsilyl)azane 
in anhydrous DMF, followed by pyridine and isobutyranhydride to afford the N-protected 
9-deazaguanosine  1nb. Standard protection of the primary hydroxyl function with 
tert-butyldimethylsilyl was followed by formation of the cyclic thiocarbonate 225 using 
thiocarbonyl diimidazole in dichloromethane. Deoxygenation with triethyl phosphite, 
followed by two consequent deprotection steps, yielded D4 9-deazaguanosine 226. 
 
O
HO
Scheme 52. Modification of the carbohydrate moiety, synthesis of D4 9-deazaguanosine 226
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A very innovative approach to C-nucleosides modifications has been published by Hocek 
et al.
166 Protected 2’-deoxy-C-nucleoside  229 bearing a bromopyridine nucleobase was 
submitted to a wide range of palladium catalysed reactions. These involved simple 
hydrogenolysis (a), cross-coupling reactions with trimethylalane (b), and triethylalane (c), 
Suzuki-Miyaura coupling with phenylboronic acid (d), Negishi coupling with benzylzinc 
chloride (e), and Hartwig-Buchwald aminations with lithium bis(trimethylsilyl)amide (f), 
methylamine (g), and dimethylamine (h). The subsequent deprotection of 230a-h gave 
2’-deoxyribonucleosides 231a-h with a broad range of substitution patterns. This modular 
approach is a good example of modern trends in synthetic approach to the modification of 
existing C-nucleosides (Scheme 52).
167 
 
Scheme 52. Modification of the sugar moiety
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4.  Novel Synthetic Approach to C-Nucleosides 
 
In the previous chapter, we have discussed several powerful synthetic methods commonly 
used in C-nucleoside synthesis. Nevertheless, any synthetic methodology has certain 
restrictions, and therefore new synthetic approaches are highly desirable. Any new, 
practically useful concept proposal has to be competitive with any of the state-of-the-art 
methods frequently used. 
 
4.1. General  Considerations 
 
We have reanalysed the general structure of C-nucleosides. C-Nucleosides are compounds 
featuring two parts; (1) the polysubstituted tetrahydrofuran ring bearing up to four 
stereogenic centres (carbohydrate part). The most important one is that on the carbon 4’- 
bearing the hydroxymethyl substituent. The absolute configuration at this carbon directs 
the structure either to D- (4’-R) or L- (4’-S) family of carbohydrates, with the principal 
consequence to the biological relevance of the compound. The second most important 
centre is at the carbon 1’-bearing the aglycon unit. Here the relative configuration of the 
aglycon-connecting C-C bond to the position of hydroxymethyl group in 4’-position 
directs the structure either to α- (trans) or β- (cis) anomer of C-nucleoside. Positions 2’,3’- 
may be free or mono- and di- hydroxylated. Hydroxyl group(s) is(are) in the (deoxy)ribo 
relative configuration in all the relevant cases.  
 
 
 
O
OH HO
HO
aglycon
unit
 
 
 
 
(2) The second part is the aglycon unit (pseudonucleobase). This has to be an aromatic, 
mono- to poly- cyclic structure, bearing substituents of varying nature and number, may 
α or β  D or L 
dihydroxyl function (ribo)  
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include a range of heteroatoms in the core cycle except the position where connected to the 
1’-carbon of carbohydrate part. 
 
4.2. Retrosynthetic  Analysis 
 
We have considered C-ribofuranosides 1 as our primary target structure. The retrosynthetic 
analysis was designed with all the aspects of modern and viable synthetic methodology 
(Scheme 54).
168 
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Scheme 54. Novel (retro)synthetic analysis of C-nucleosides 1
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The retrosynthesis starts with introducing a 5’-OH protecting group to form 232. The 
second retrosynthetic step, and the first of the strategic ones, is cis-vicinal dihydroxyl 
functionality removal to form a double bond in dihydrofuran 233. The stereochemical 
outcome of the reaction is perfectly directed by the relative configuration of the 
substituents in the positions 2’- and 5’- of the dihydrofuran ring 233. Moreover, 
dihydrofuran 233 features the structure of D4 nucleoside analogues, and thus forms an 
important target in itself. This highly enhances the utility of the proposed reaction  
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sequence. Dihydrofuran 233 is then disconnected in ring-closing metathesis (RCM) to 
form diallyl ether 234. The key-step of the proposed synthesis is the disconnection of the 
diallyl ether 234 in the way of asymmetric allylic substitution (AAS). Extensive 
optimization of this reaction had been expected. We have finished the retrosynthetic 
analysis with commercially available butenediol 235  (R = H)  and  readily  available 
arylpropenols  236 in four steps. Furthermore, we envisaged an extensive comparative 
study on the starting arylpropenols 236, in order to obtain these in as short synthesis as 
possible in the cases where they are not commercial. 
 
4.3.  Metal-Catalysed Asymmetric Allylic Substitution 
 
Asymmetric allylic substitution is a versatile method for the construction of a new chiral 
centre, starting with achiral allylic substrates, such as 242 (Scheme  55). This 
transformation is catalysed by chiral complexes of transition metals, such as 
palladium,
169,170 molybdenum,
171 tungsten,
171b,172 ruthenium,
173 rhodium,
174 iridium,
175 
nickel,
176 platinum,
177 iron,
178 and copper,
179 and typically proceeds through the π-allyl 
intermediate 243. To date, asymmetric allylic substitution has evolved into a powerful 
synthetic tool for the enantioselective formation of C-C, C-N, and C-O bonds.
169-179 
Among the leaving groups, esters (242, R
2 = alkyl), carbonates (242, R
2 = OR’) and, in 
particular, tert-butyl carbonates (242, R
2 = Ot-Bu), have an important position.  
 
R1 O R2
O
R1
Nu
ML*
Scheme 55.  Metal-catalysed asymmetric allylic substitution.
242 244
*
Nu
R1
243
ML*
 
 
Aliphatic alkoxides are generally difficult to be successfully reacted in AAS reaction. 
Evans et al reported rhodium-catalysed allylic etherification using copper(I) alkoxides.
174a 
This approach proved to be beneficial, avoiding a range of side-reactions when usual hard 
alkali alkoxides were used. The transmetallation of an alkali-metal alkoxide diminished the 
nucleophile basicity, thus promoting the etherification on a soft allylic electrophile.
180 The 
reaction exhibited excellent regioselectivity, using phosphite-modified Wilkinson catalyst 
(Scheme 56). 
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Scheme 56. Regioselectivity of Rh-catalysed allylic substitution
OBoc
Bn
OBn
Bn Bn
OBn + Rh(PPh)3Cl (10 mol %)
P(OMe)3 (40 mol %)
THF, 20 oC
BnOLi (1.9 equiv)
CuI (2.0 equiv)
246a 246b
246a : 246b = 99 : 1 (96%)
245
Bn
RhLn
Bn
RhLn
Bn
LnRh
245i 245ii 245iii  
 
Evans and co-workers employed their new catalytic system in the enantioselective 
synthesis of guaric acid 247 (Scheme  57).
181 Formation of strongly coordinated σ-π 
complex of rhodium species and the allyl system was proposed. A double-inversion 
mechanism has been expected in this case but not rigorously proven. In general, the 
reaction can proceed through either an enyl complex 248i or (distorted) π-allyl complexes 
248ii and 248iii. Stereocontrol of the reaction through control of dynamic equilibrium of 
the intermediates 248i-iii was not successful due to complexity of these reactions. 
Considerably easier approach was applied. The reaction conditions were optimised in order 
to perform an allylation of the nucleophile faster than racemisation of the rhodium 
complexes occurs (i.e. knuc >> k3, knuc >> k1·k4). Enantiopure branched carbonate 248 
together with configurational stability of the catalyst-substrate complex resulted in 
excellent stereoselectivity of the reaction. 
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Scheme 57. Stereoselectivity of Rh-catalysed allylic substitution
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The first regioselective allylic etherification of aliphatic Zn-alkoxides catalysed by iridium 
species was reported by Lee et al (Scheme 58).
182 Carbonate 251 was reacted with a model 
substrate (benzyl alcohol) in the presence of diethylzinc. A fast reaction gave the expected 
products 252a and 252b in excellent regioselectivity in favour of the branched product 
252a. 
 
Scheme 58. Regioselectivity of Ir-catalysed allylic substitution of Zn-alkoxides
OBoc
+
[Ir(COD)Cl]2 / L
Et2Zn (0.55 equiv)
NH4I (1.0 equiv)
THF, 25 oC
251
(1.0 equiv)
OBn
OBn
+
252a : 252b = 98 : 1 (96%)
252a
252b
15 min
BnOH (1.1 equiv)
L = Pyridine
Ir : L = 1 : 1
5 mol % Ir  
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The extensive work of Hartwig et al proved Cu(I)-alkoxides superior over the 
Zn-alkoxides.
183 Linear carbonates 236 were used as the allylating agent in all cases. 
Stereoselective formation of an enyl catalyst-substrate complex was based on chiral 
ligands, thus forming a chiral iridium catalyst. This is the key difference when compared 
with branched carbonates such as 248. Chiral σ-π complex of matal species and the allyl 
system bears the chirality induced either by starting non-racemic carbonate in the case of 
branched carbonates (e.g. 248) or by chiral catalyst in the case of linear carbonates (e.g. 
236). 
 
Primary and secondary alkoxides were successfully reacted in iridium-catalysed reaction 
utilising phosphoramidites ligands L1 and L2. Reactions with tertiary alkoxides exhibited 
high regioselectivities and good yields, however enantioselectivites were comparatively 
lower than in the case of primary or secondary alkoxides (Scheme 59). 
 
Scheme 59. Stereoselectivity of Ir-catalysed allylic substitution of Cu-alkoxides
Ph OBoc +
0 oC to 25 oC
THF, 12 h
236a
(0.5 equiv)
(L1)
 253a : 253b = 95 : 5
68%, 93% ee
(L2)
253a : 253b = 99 : 1
92%, 94% ee
253a 253b
Ph OBn Ph
OBn
(Ra,Rc,Rc)
PN
Ar
Ar
O
O
L1: Ar = Ph
L2: Ar = 1-Np
[Ir(COD)Cl]2 / L BnOLi (1.0 equiv)
CuI (1.05 equiv)
2 mol % Ir
Ir : L = 1 : 1
+
O[Cu] N Boc O[Cu] O[Cu]
(L2)
 b : l = 99 : 1
96% ee (86%)
(L2)
 b : l = 98 : 2
95% ee (70%)
(L2)
 b : l = 96 : 4
63% ee (80%)  
 
Several catalytically active species can be expected in the reaction.
175a Complex K1 was 
generally considered to be the active catalyst in the cases when [Ir(COD)Cl]2 was used as a 
precatalyst.   
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Ir
Cl
L
K1  
An interesting observation was made in an attempt to isolate a catalyticaly active species or 
its complex with a substrate. In the allylation reaction of dimethyl malonate, catalysed by 
[Ir(COD)Cl]2 – P(OPh)3 was isolated metalacycle K2 arising from the reaction of the 
corresponding complex K1 with sodium malonate nucleophile. 
Ir
P(OPh)3
K2
O
(PhO)2P
 
In this point of view, any Ir-catalysed allylic substitution requires close attention to the 
reaction conditions. The following two general procedures were developed (THF, rt): (1) 
The catalyst is prepared by mixing [Ir(COD)Cl]2 and ligand in a 1:2 ratio. A simple 
complex K1 is formed by ligand exchange and consecutive breaking of chloro bridges. (2) 
Treatment the former mixture with a base in order to induce the C-H activation and 
metalacycle formation (a type of K2 complex). Hartwig et al reported preparation of the 
metalacyclic complex K3 based on the opposite enantiomer of the phosphoramidite ligand 
L1. Its structure was confirmed by X-ray diffraction. Initial kinetic study showed roughly 
one order of magnitude increase in reaction rate when metalacyclic catalyst was used.
184  
Ir
Ph
N H3C
Ph
P O
O
L
K3  
Effects of such catalyst activation and ligand steric properties on the enantioselective 
allylation of amines and phenoxides were then further investigated.
185  
 
The only synthesis based on the iridium-catalysed allylation of aliphatic alkoxides reported 
to date is a very innovative stereoselective synthesis of the tetrahydropyranic antibiotic 
centrolobine 254 (Scheme 60).
186 The synthesis started with reaction of carbonate 236b  
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with 3-cyclopentenol. The allylation product was obtained in good yield (87%) and 
excellent enantioselectivity of more than 98% ee. Phosphoramidite ligand L2 was utilised 
in this reaction. Subsequent ring rearrangement metathesis, followed by isomerization of a 
terminal double bond and then by a one-pot cross-metathesis/catalytic hydrogenation gave 
centrolobine 254 in three preparative steps in good overall yield  
 
Scheme 60. Stereoselective synthesis of Centrolobine
255 (87%)
>98% ee
(Sa,Sc,Sc)-L2
MeO
OBoc
OH
MeO
O
O
OH MeO
254
overall (24%)
nBuLi, CuI
[Ir(COD)Cl]2
236b
3 steps
28%
 
 
4.4.  Ring-Closing Metathesis (RCM) 
 
Ring-closing metathesis is a powerful method for the construction of unsaturated rings.
187 
The reaction proposed in our synthetic scheme starts with diallyl ether 234 to afford 
dihydrofuran 233. Protected dihydrofuran 233 features all the key structural motifs of the 
target C-nucleoside; i.e. defined stereocentres in positions 1 and 5 (Scheme 61).  
 
O
RO
Ar O
RO
Ar
Scheme 61. Ring-closing metathesis in the proposed C-nucleosides synthesis
233 234
Grubbs
catalyst
 
 
Only Grubbs ruthenium-based catalysts were considered during retrosynthetic analysis. 
This simplification was based on the fact that our system is one of the most common 
systems employed in RCM with a range of successful examples. Commercially available  
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ruthenium-based Grubbs 1
st generation C1, and Grubbs 2
nd generation catalyst C2 have 
been used in this study. 
Ru
Ph
Cl
Cl
NMes MesN
PCy3
C2
Ru
Ph
Cl
Cl
PCy3
PCy3
C1  
 
4.5. Vicinal  Dihydroxylation 
 
The transition-metal-catalysed dihydroxylation of olefins represents a powerful synthetic 
tool for generation of two C-O bonds with precisely defined relative configuration. The 
reaction proceeds with high degree of stereospecificity. Vicinal dihydroxyl function is 
introduced from the least stericaly hindered face of the double bond. Metal tetroxide is 
used in a catalytic amount with a reoxidant such as metal chlorates, potassium ferricyanide, 
hydrogen peroxide, tert-butyl peroxide, or the most common, N-methylmorpholine 
N-oxide (NMO). Osmium tetroxide is one of the most reliable reagents for this catalytic 
transformation.
188 All these features fulfilled our requirements for the proposed 
transformation in our C-nucleoside synthesis (Scheme 62).  
 
O
RO
Ar O
RO
Ar
Scheme 62. cis-Vicinal dihydroxylation in the proposed C-nucleoside synthesis
234 233
HO OH
OsO4 or RuO4
 
 
Osmium tetroxide has been successfully applied in many dihydroxylations reactions in the 
past century. However, OsO4 is an expensive, highly toxic, non-polar volatile solid, which 
prevents its use on a large scale considering environmental issues. Kobayashi et al reported 
one successful solution of these particular problems, using microencaptulation process to 
capture this reagent, and form a recoverable and reusable polymer-supported catalyst.
189 
 
The second alternative has emerged in use of an isoelectronic, less expensive and much 
less toxic ruthenium tetroxide (RuO4) as the dihydroxylation catalyst.
190 RuO4 exhibits a 
dramatically higher reactivity compared to OsO4. Reactions catalysed by RuO4 were  
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considered as non-selective for a long time. Sica et al reported the first successful 
application of RuO4 as a selective catalyst in vicinal dihydroxylation of olefins.
191 Several 
further improvements of the Sica’s original procedure have then followed.
192 
 
Ruthenium tetroxide successfully competes with osmium tetroxide in dihydroxylation 
reactions since this discovery. Hudlický et al employed RuO4-catalysed dihydroxylation 
reaction in the synthesis of complex natural products (Scheme 63).
193 Olefins 256, and 257 
were stereoselectively dihydroxylated, using  10 mol %,  and  7 mol %  of  ruthenium 
respectively. Due to its reactivity and very short reaction times, these reactions are called 
flash dihydroxylation. 
 
Scheme 63. Ruthenium-catalysed cis-vicinal dihydroxylation reaction
258 (85%)
TsN
O
O
TsN
O
O HO
OH RuCl3.6H2O
NaIO4
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0 oC
256
NHAc
O
O
O
O
NHAc
O
O
O
O HO
OH
259 (75%)
RuCl3.6H2O
NaIO4
AcOEt, MeCN
H2O, 3 min
0 oC
AcOEt, H2O
257  
 
Further improvement of the RuO4-catalysed dihydroxylation was reported be Plietker 
et al.
194 Combination of RuO4 with a Lewis acid generated a new bimetallic catalytic 
system, which not only further enhanced the reaction selectivity, but also surpassed the 
OsO4. A redox-active Lewis acid, such as CeCl3, aids both the Ru-catalyst reoxidation and 
the subsequent hydrolysis of the Ru(VI) ester, together with a deceleration of the undesired 
scission reaction of the resulting diol. The use of a catalytic amount of CeCl3 (10%) 
broadened the reaction scope together with the further decreasing of Ru-loading to 0.25 
mol %. Tetrasubstituted, electron-deficient double bonds were successfully dihydroxylated 
in high yields under these conditions (Scheme 64). 
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Scheme 64. Ru-Ce bimetallic cis-vicinal dihydroxylation reaction
260 (89%)
AcOEt, MeCN
H2O, 10 min
0 oC
N Bn
O
O
N Bn
O
O
HO
HO [Ru] cat.
[Ru] cat.:
12 mol % Ru (0.1M RuCl3 in water)
10 mol % CeCl3.7H2O
1.5 equiv NaIO4  
 
A very innovative combination of metathesis and Ru-catalysed dihydroxylation was 
recently reported by Blechert et al (Scheme  65).
195 The presented reaction protocol 
features two reactions catalysed by Ru-species, which increases the synthetic efficiency 
and economy, together with lowering the negative environmental impact. Diene 261 was 
submitted to the ring-closing metathesis to afford the expected cyclohexene product. The 
reaction solvent was then evaporated, since dichloromethane, the usual metathesis solvent 
proved to be incompatible with the subsequent dihydroxylation protocol. The resulting 
residue, containing the metathesis product together with the residues of the metathesis 
catalyst, was then dissolved in a mixture of acetonitrile and ethyl acetate, cooled to 0 °C, 
and a cold solution of a mixture of NaIO4 and a catalytic amount (10%) of Lewis acid in 
water was added. The authors claimed better results when YbCl3 was used instead of 
CeCl3. The reaction gave a product of vicinal dihydroxylation 262 in good yield. However, 
the reaction yields varied in a wide range, even for relatively similar substrates 
(Scheme 65). 
 
Scheme 65. Two-step-one-pot procedure of RCM-cis-vicinal dihydroxylation reaction
N
Ts N
Ts
OH
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HO OH
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Cl
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1) Grubbs 1st gen.
DCM, reflux
2) NaIO4, YbCl3.6H2O
MeCN:AcOEt:H2O 1:1:1
0 oC
262a (88%)
261
  
 
81
5.  Results and Discussion 
 
5.1. Linear  Carbonates 
 
Conversion of an alcohol to the corresponding Boc derivative is well established synthetic 
transformation.
196 Expedient synthesis of even a small library of desirable carbonates may 
actually become considerably more cumbersome than expected. With 3-aryl allyl alcohols, 
in particular, there is little choice in diversity with a view of matching the portfolio of the 
commercially available aryl building blocks with a suitable methodology.  
 
We have now developed two new methods for the construction of tert-butyl 
(E)-3-arylprop-2-en-1-ol carbonates 236 from commercially available starting materials 
that are suitable for parallel synthesis techniques (routes a and b; Scheme  66). For 
comparison, some of the materials have been synthesized via an optimized conventional 
approach to these compounds, based on the Horner-Wadsworth-Emmons reaction (HWE; 
route c). 
 
Ar
OBoc
Ar OH
Ar Hal
Ar OEt
O
Ar O
(EtO)2P
OEt
O O
Ar O O
O
Scheme 66.  Retrosynthetic analysis of tert-butyl 3-arylprop-2-en-1-yl carbonates. 
                     For Ar, see the following Schemes
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Our retrosynthetic analysis of the target carbonates 236 was based upon the desire to 
develop a one-step synthetic protocol suitable for parallel synthesis (Scheme 66). The main 
interest was laid upon the disconnection (a) employing the commercially available aryl 
halides 237 and the common building block 263. Route (b) is based on the (E)-double bond 
disconnection via a cross-metathesis reaction of the commercially available styrenes 239 
and the Boc-protected allyl alcohol 240 as common building blocks. The last part of our 
investigation was focused on the optimization of the Boc derivatization of the 
cinnamyl-type alcohols 264 (c). Some of these alcohols are commercially available or easy 
to make from the corresponding cinnamic acids. Others can be synthesized using the 
Horner-Wadsworth-Emmons reaction. Optimization of the latter sequence, starting with 
the commercially available aldehydes 143 and the phoshonate reagent 241, into a 
three-step-one-purification protocol (c-e) is also reported.  
 
5.1.1.  Boc Derivatization 
The Boc-derivatization of cinnamyl alcohol 264a was investigated under various 
conditions (Scheme 67).
196 The procedure employing Boc anhydride and NaOH with a 
phase-transfer catalyst failed,
196a whereas reactions with Boc anhydride in dichloromethane 
catalysed by V(O)(OTf)2
196b gave only the symmetric carbonate (PhCH=CHCH2O)2CO in 
high yield. On the other hand, by following the procedure, in which Boc anhydride is 
added to a solution of the corresponding alkoxide in THF,
196c,d we were able to isolate the 
desired product 236a in about 40% yield along with the symmetric carbonate 
(PhCH=CHCH2O)2CO. A modified protocol, in which the alcoholate solution was 
transferred to an excess of the solution of Boc anhydride, afforded 236a in high yield and 
was then employed throughout this study (Scheme 67). 
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Scheme 67.  Formation of tert-butyl carbonates 236.
R OH R O
THF
1.  NaH
2.  Boc2O
O
O
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OBoc OBoc
266a (82%)
236a (73%)
240 (50%)
236b (62%)
236c (52%)
 
 
5.1.2.  Suzuki-Miyaura Coupling 
The preparation of the building block 238a was based upon the procedure for the 
preparation of boronic acid 238b (Scheme 68).
197 In our hands, the established protocol 
was successful only for propargyl alcohol 266b to produce 238b (Table 5, entry 1), and 
failed in the case of the Boc derivative 266a (entries 2, and 3). Alternative hydroboration 
conditions were also investigated:
198 thus, for instance, treatment of alkyne 266a with 
boron dibromide proved fruitless (entry  4) and an attempted reaction with 
dicyclohexylborane, followed by addition of trimethylammonium N-oxide, gave only 
moderate yield (entry 5). On the other hand, employing dicyclohexylborane as catalyst,
199 
with a stoichiometric amount of catecholborane, furnished the desired product 238a in 
good yield (entry  6).
200 Finally, the reaction of 266a with pinacolborane, catalysed by 
dicyclohexylborane, afforded vinyl boronate 263 in an excellent isolated yield (entry 7). In 
the latter protocol, the high purity of the hydroborating reagents proved to be crucial for 
attaining high yields.   
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Scheme 68.  Hydroboration; for conditions, see Table 5.
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Table 5. Hydroboration of 266a and 266b. 
entry conditions alkyne  product  yield  (%)
a
1  Catecholborane (2 equiv) 
neat, 70 °C, 1 h 
266b 238b  40 
2 Catecholborane,  THF 
70 °C, 12 h 
266a 238a  0 
3 Catecholborane,  neat 
70 °C, 12 h 
266a 238a  0 
4 Br2BH·Me2S, DCM 
0 °C to 20 °C, 6 h 
266a 238a  0 
5 cHx2BH, TMANO, THF 
0 °C to 20 °C, 1.5 h 
266a 238a  40 
6 Catecholborane,  cHx2BH (10%), neat 
20 °C, 12 h 
266a 238a  62 
7 Pinacolborane,  cHx2BH (10%), neat 
20 °C, 12 h 
266a 263  95 
aIsolated yields. 
 
The procedure, published for the Suzuki-type coupling reactions of hydroxy boronic acid 
238b in the presence of thallium ethoxide in aqueous medium,
201 was applied to the 
coupling of the Boc-protected acid 238a with p-iodotoluene but gave only traces of the 
desired product 236d (Scheme  69; Table  6, entry  1). By contrast, simple standard 
conditions for the aqueous Suzuki-Miyaura coupling reactions, employing K2CO3 as a 
base, resulted in the formation of 236d in good yield (entry 2).
202  
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A considerable drawback of the latter protocol is the behavior of the acid 238a: when 
freshly prepared, it is a white solid, which in the air (moisture) melts to a very viscous oil, 
containing variable amount of the corresponding oligomers; upon prolonged standing, both 
forms (oil or solid) become a sticky brown-grey solid, containing products of 
decomposition. These features, in conjunction with the lower yield of the hydroboration, 
drew our attention to boronate 263, a colourless, bench stable liquid that can be distilled.
203 
 
Initially, we chose alkali carbonates in aqueous 1,2-dimethoxyethane (DME) as the 
reaction medium for the 237d + 263 coupling. An overnight heating with alkali carbonates 
gave the product 236d in about 10% yield (Table 6, entries 3 and 4). Higher loading of the 
iodide 237d and the base led to an improvement (entries 5 and 6), whereas a significant 
decrease of the yield was observed when potassium tert-butoxide was employed (entry 7), 
although the use of a toluene-water two-phase system resulted in some improvement 
(entry 8). The reaction failed when higher amount of water (>80%) was used in the solvent 
mixture, or when thallium ethoxide was used as a base, or when DMF was chosen as a 
solvent. Best results were attained when the reaction time was kept short (entry 9). Other 
published conditions did not lead to any further improvement.
204 Furthermore, the 
recyclable microencapsulated palladium
205 gave lower yields along with a relatively high 
amount of unidentified side-products (entries 10 and 11), whereas the use of an advanced 
ligand,
206 such as S-Phos (2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl), resulted in 
no reaction or gave just traces of product 236d (entry 12). 
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O
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Scheme 69.  Suzuki-Miyaura coupling.
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Table 6. Suzuki-Miyaura coupling optimization.
a 
entry  237d 
(equiv)
allyl 
carbonate 
catalyst 
(mol %) 
base 
(equiv) 
solvent conditions  yield
b
(%) 
1 2.0  238a  (Ph3P)4Pd 
(5) 
EtOTl 
(2.1) 
DME - H2O 
(7:3) 
20 °C, 1 h  traces
c
2 0.7  238a  (Ph3P)4Pd 
(10) 
K2CO3 
(1.8) 
DME - H2O 
(20:3) 
85 °C, 20 h  61 
3 1.0  263  (Ph3P)4Pd 
(10) 
Na2CO3 
(5.3) 
DME - H2O 
(7:5) 
100 °C, 15 h 8 
4 1.0  263  (Ph3P)4Pd 
(10) 
K2CO3 
(2.5) 
DME - H2O 
(20:3) 
80 °C, 18 h  12 
5 1.8  263  (Ph3P)4Pd 
(9) 
K2CO3 
(7.8) 
DME - H2O 
(20:3) 
85 °C, 18 h  33 
6 3.3  263  (Ph3P)4Pd 
(5) 
K2CO3 
(5.5) 
DME - H2O 
(4:1) 
100 °C, 20 h 40 
7 1.9  263  (Ph3P)4Pd 
(5) 
t-BuOK 
(4.8) 
DME - H2O 
(4:1) 
100 °C, 20 h 6 
8 2.2  263  (Ph3P)4Pd 
(5) 
t-BuOK 
(5.2) 
Toluene - H2O 
(4:1) 
100 °C, 20 h 26 
9 5.0  263  (Ph3P)4Pd 
(5) 
K2CO3 
(4.0) 
DME - H2O 
(1:1) 
80 °C, 2 h  42 
10 1.4  263  Pd(0) EnCat
TM 
(5)
 
K2CO3 
(3.3) 
DME - H2O 
(1:1) 
80 °C, 14.5 h 25 
11 0.9  263  Pd(0) EnCat
TM
(4) 
K2CO3 
(2.7) 
DME - H2O 
(1:1) 
80 °C, 2 h   16 
12 0.9  263  (Ph3P)4Pd (5) 
S-Phos (5) 
K2CO3 
(2.0) 
DME - H2O 
(1:1) 
20 °C, 1 h  5 
aReactions were performed on 1 mmol scale, using 10 mL of the solvent mixture; all the 
equivalents are based on the boronate (boronic acid). 
bIsolated yield. 
cThe
  yield was 
determined by 
1H-NMR spectroscopy in the reaction mixture after the work up. 
 
Having identified potassium carbonate as the optimal base, a DME-water mixture (1:1) as 
the optimal solvent system, and (Ph3P)4Pd as the most suitable pre-catalyst (entry 2), we 
then investigated the role of the reaction time in the range of 1-32 h at 40 °C (Chart 1). The 
acquired data clearly show an increase in yield of 236d with a maximum reached in 8 h.  
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Our data suggest that both the product 236d and the starting boronate 263 are unstable 
under the reaction conditions. 
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a Reactions were performed on 1 mmol scale; conditions: aryl iodide (0.9 equiv), 
  K2CO3 (3 equiv), DME / H2O (1:1, 10 mL), 40 °C, (PPh3)4Pd; isolated yields.
Chart 1. Suzuki-Miyaura coupling of 237d with 263; isolated yields vs reaction time.
a
 
A deeper insight was obtained via monitoring the reaction by 
1H-NMR spectroscopy. The 
coupling was performed at a higher temperature (80  °C), with sampling every 20  min 
(Chart 2). The spectra plot showed an increasing amount of the product 236d, reaching the 
maximum in about 2 h. After this point, both signals begun to slowly disappear in the 
baseline noise. We concluded that, at the temperatures ranging from 40  °C to 80  °C, 
boronate 263 is sufficiently reactive to form a significant amount of the product 236d, 
whose formation is estimated to be one order of magnitude faster than the rate of its 
decomposition. These results also show that 80 °C for 2 h are optimal reaction parameters 
for this process. 
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Chart 2: 
1H-NMR spectra plot based on Scheme 5. The reaction was performed on a 
1  mmol scale; conditions: aryl iodide (0.9  equiv), K2CO3 (2.5  equiv), 
DME-H2O(1:1, 10 mL), 80 °C, (PPh3)4Pd (5.4 mol %). 
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The last sets of parameters to be optimized were the ratios of the starting iodide and the 
base employed (Table 7). We also proved the need for higher amounts of water (50%), 
combined with higher dilution. Under these conditions, the reactions were homogeneous 
(compare entries 2 vs 3). The other results show the highest yields when either excess of 
boronate 263 (entry 4) or iodide 237d (entry 6) were used along with an excess of base. 
Further increased loading of the base (entries 6 and 7) had a more negative effect than 
further increase in the loading of the iodide (entries 5 and 6). 
 
Table 7. The influence of the molar ratios on the Suzuki-Miyaura 
Coupling of 237d with 263.
a 
entry iodide 
(equiv) 
base 
(equiv)
solvent Pd(0) 
(mol%) 
yield
b 
(%) 
1 1.4 2.9  2  mL,  DME  /  H2O (9:1)
  5.2 11
c 
2 0.8 1.7  2  mL,  DME  /  H2O (9:1)
  5.2 9
c 
3  0.8  2.3  10 mL, DME / H2O (1:1)  4.0  20 
4  0.6  1.7  10 mL, DME / H2O (1:1)  3.1  36 
5  4.7  2.9  10 mL, DME / H2O (1:1)  5.6  33 
6  3.1  3.0  10 mL, DME / H2O (1:1)  6.0  36 
7  4.6  4.6  10 mL, DME / H2O (1:1)  4.8  24 
aReactions were performed on 1  mmol scale; conditions: 2  h, 80  °C, 
(PPh3)4Pd; all equivalents are based on the boronate. 
bIsolated yield. 
cThe 
yield was determined by 
1H-NMR spectroscopy in the reaction mixture 
after the work up. 
 
The optimized reaction protocol was employed in the synthesis of a series of various 
carbonates  236d-r (Scheme  70).
207 The results fully correspond to the previous 
observations as well as to the common reactivity of aryl halides in the Suzuki-Miyaura 
coupling reaction. The highest yields were attained with electron-poor aryl iodides lacking 
ortho substituents. Aryl bromides did not successfully react in any variation of the reaction 
conditions. This effect can be utilized in the distinguishing of the reaction site of 
polyhalogenated substrates; thus, for example, 4-bromoiodobenzene (237f) was selectively 
reacted at the C-I bond to produce 236f. In some cases, the excess of aryl iodide was 
successfully recovered (236e,  236j,  236l, and 236n). 3-Iodopyridine (237q) was also 
successfully reacted to afford 236q. Despite the low to moderate yields, the main synthetic 
utility of this method is in the fast reaction and mild reaction conditions. An aqueous work  
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up procedure gave generally mixtures containing mainly the unreacted starting iodide (in 
excess) and the desired product. With the subsequent simple chromatography, the whole 
reaction-purification procedure did not exceed 3  h, which is very convenient for 
automation. These advantages were demonstrated in the reaction of salicylate 237r
208 that 
afforded the highly substituted carbonate 236r. 
 
263
O
B
O
OBoc
Scheme 70. Suzuki-Miyaura coupling of aryl and heteroaryl halides 237 with vinyl        
boronate 263.
Ar OBoc
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OBoc
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F
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5.1.3.  Alkene Cross Metathesis 
Alkene cross metathesis reaction
209 was investigated as an alternative synthetic approach to 
the carbonates 236 (Scheme  71). Many of the starting vinyl aromatics 239 are 
commercially available or are readily accessible in one step by the well-developed 
vinylation of aryl halides 237,
210 which renders this approach attractive. 
 
Employing styrene (239a) and allyl t-butyl carbonate (240) as model substrates, a brief 
screening of the reaction conditions has been conducted to find an optimal protocol. The 
second-generation Grubbs catalyst C2 gave generally twice as high yields as the Grubbs 
first-generation catalyst C1, along with the full conversion of allyl carbonate 240 (Table 8, 
entries 1 and 2).  
 
Ru
Ph
Cl
Cl
NMes MesN
PCy3
C2
Ru
Ph
Cl
Cl
PCy3
PCy3
C1  
 
In both cases trans-stilbene was isolated as the major product as a result of self-metathesis 
of 239a. On the other hand, self-metathesis of allyl carbonate 240 was observed only as a 
very minor side reaction. Higher yields of the desired product 236a were attained by 
increasing the excess of styrene (entries 6 and 7), which is an acceptable scenario in the 
case of cheap, commercially available vinyl aromatics.  
 
Various vinyl aromatics were then submitted to the optimized cross metathesis protocol 
(Scheme 72).
207 The reaction showed reversed electronic demands to the Suzuki-Miyaura 
coupling and did not work for electronically poor substrates, such as nitrostyrene or 
pentafluorostyrene, and for vinyl pyridines. On the other hand, the reaction proceeded 
successfully with ortho-substituted styrenes to produce 236e and 236g. 
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Scheme 71. Synthesis of carbonates 236 via cross-coupling metathesis.
240
OBoc
239a
+ OBoc
236a
Ph Ph
 
 
Table 8. Screening of the cross-metathesis reaction.
a 
entry  239a 
(equiv) 
catalyst (mol %) time (h)  yield (%)
b 
1 2.0  Grubbs  1
st (5.6)  12  17 
2 2.0  Grubbs  2
nd (2.7)    2  36 
3 0.5  Grubbs  2
nd (0.7)    2  21 
4 0.4  Grubbs  2
nd (0.8)    2  23 
5 0.2  Grubbs  2
nd (0.4)    2  16 
6 5.0  Grubbs  2
nd (2.4)    2  37 
7 10.0  Grubbs  2
nd (2.7)    2  43 
aReactions were performed on 1  mmol scale; conditions: 
DCM (2 mL), 40 °C; all the equivalents are based on allyl 
carbonate. 
bIsolated yields. 
 
OBoc
236e  (52%)
OBoc
236g  (29%)
F
OBoc
236i  (27%)
F
OBoc
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OBoc
236t  (36%)
MeO
Ar OBoc
Scheme 72.  Ru-Catalyzed cross metathesis of styrenes 239 with allyl carbonate 240.
240
OBoc
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+
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Me Me
AcO
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5.1.4.  Horner-Wadsworth-Emmons Reaction 
Optimization of the conventional synthetic approach
211 to carbonates 236 was also 
investigated (Schemes  66 and  73). Commercially available aryl aldehydes 143 were 
reacted with phosphonate 241 to afford the corresponding ethyl acrylates 265 (see 
Scheme  66, page  81). The reaction proved to be clean and highly stereoselective; no 
(Z)-isomers were detected by 
1H-NMR spectroscopy. The acrylates 265 were then reduced 
with DIBAL-H directly after the aqueous work-up without further purification. The 
resulting aryl propenols 264 were obtained again in sufficient purity and were directly 
transformed into the desired Boc derivatives 236, using our optimized protocol (vide supra, 
page  82); the crude products were then subjected to the only purification (by 
chromatography) required in this sequence. 
 
This classical synthetic approach proved to be very robust for a number of structural 
patterns (Scheme 73). The only difficulties were observed in the reaction sequences of 
aldehydes 143v and 143w. Pyridine aldehyde 143v reacted well in the HWE reaction but 
the subsequent reduction at room temperature resulted in the formation of intractable 
products only. Reduction at low temperature (-80 °C) gave propenol 264v in about 40% 
yield (over two steps) but additional purification of the propenol 264v was necessary. 
Carbonate 236v was obtained from the latter product (48%) by using the standard Boc 
derivatisation procedure. Pyrrole carbonate 236w was prepared by the standard reaction 
sequence. The problematic part was the final purification, due to the low stability of the 
pyrrole moiety.
212 Even if the chromatography was carried out on a column of neutral 
alumina and with triethylamine as co-eluent, the blue colour of pyrrole-based oligomers 
was observed upon the stationary phase. Also the final pyrrole carbonate 236w proved 
unstable at room temperature, as it underwent spontaneous polymerization. Despite these 
particular problems, this optimized HWE approach proved to be a very convenient method 
for a gram scale (all reactions were carried out on 20 mmol scale) synthesis of carbonates 
236 bearing various structural patterns including the ortho-substituents and 
aromatic/heteroaromatic moieties with diverse electronic properties. 
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236e  (68%)
OBoc
236i  (65%)
OBoc
236j (80%)
F Me Me
Ar OBoc
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+
236
Ar O
1.  (EtO)2P(O)CH2CO2Et
     n-BuLi
2.  DIBAL-H
3.  NaH
4.  Boc2O
Scheme 73.  Horner-Wadsworth-Emmons approach to carbonates 236.
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5.1.5. Conclusions 
We have systematically investigated new synthetic routes to tert-butyl 
(E)-3-arylprop-2-enol carbonates (236a-w) based on Suzuki-Miyaura reaction and alkene 
cross metathesis and compared them with an optimized conventional approach based on 
HWE reaction. All these three approaches were shown to be complementary. The 
Suzuki-Miyaura coupling reaction is a versatile method for aryls lacking an ortho 
substituent and for non-coordinating heterocycles, bearing preferentially electron-
withdrawing functionalities. This method employs a wide range of commercially available 
aryl iodides and its main advantage relates to polyfunctional substrates, such as methyl 
acetylsalicylate (237r → 236r). The cross metathesis is a universal method with preference 
for electronically neutral or electron-donating groups, highlighted by the tolerance to ortho 
substituents.
213 Both these methods give moderate and reproducible yields within the 
limitations spelt out here. These one-step reactions are fast and atom-economic, yielding 
relatively clean products that are easy to purify, which makes this approach amenable to 
the use in parallel synthesis of large sets of derivatives with diverse functionality. The  
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HWE-based reaction sequence, optimized to a three-step-one-purification protocol, 
represents a robust method for the standard preparation of carbonates 236 that can be easily 
scaled up. Comparing the three methods shows that each has its merit so that they are 
complementary and none is a clear, general winner. Thus, for instance, the synthesis of 
236r would be rather difficult via the classical HWE approach in view of the required 
protection-deprotections step, selective reactivity, etc. On the other hand, some of the low 
yields obtained via the Suzuki-Miyaura coupling (e.g., 236e) would direct the strategy 
either toward cross-metathesis or HWE approach. 
 
5.2. Branched  Carbonates 
 
5.2.1.  Racemic Branched Carbonates 
The branched carbonates 267 were prepared by a published, one-pot procedure.
214 Aryl 
aldehyde was treated with vinylmagnesium bromide, and the resulting magnesium 
alkoxide was directly transferred to a solution of an excess of Boc anhydride (Scheme 74). 
Various aryl aldehydes 143 were employed in the reaction (Scheme  74, Table  9). The 
unexpected product 236 was obtained as a side- or main product in several cases. These 
linear carbonates 236 were most likely formed via [3,3] sigmatropic rearrangement 
(Scheme 75).  
 
The second unexpected product 268 was identified by means of elemental analysis; its 
formation pathway was not investigated. None of these side-products (236 or 268) were 
mentioned in the original procedure. The amount of the side-products can be correlated 
with the electronic properties of the aryl substituent (Table 9).  
 
Ar
267
Scheme 74. Synthesis of the carbonates 267
143
1. CH2=CHMgBr
2. Boc2O
Ar
OBoc
O
H
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Ar
267
Scheme 75. Rearrangement of the carbonates 267
143
1. CH2=CHMgBr
2. Boc2O
Ar
O
O
O Ar O O
O
236
Ar O O
O
268
O
H
 
 
In some cases, the desired product 267 was not formed and only the products 236 and 268 
were detected (entries  6, and  9). Only aldehyde 143q gave carbonate 267q selectively 
(entry 7). The mixtures of all the possible carbonates are not convenient for the preparative 
synthesis due to the difficult separation (physical properties of the compounds 267 and 236 
are essentially the same). 
 
Table 9. Synthesis of the tert-butyl 1-arylprop-2-en-1-ol 
carbonates.
a 
entry aryl  aldehyde  ratio
b 
267:236:268 (%) 
1 
CHO
Me
 
143d  67.0 : 26.5 : 6.5
c 
2 
CHO
Me Me
 
143e  29.2 : 63.5 : 7.3
c 
3 
CHO
Br
 
143f  39.4 : 0.0 : 60.6 
4 
CHO F  
143h  50.5 : 0.0 : 49.5  
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Table 9. Synthesis of the tert-butyl 1-arylprop-2-en-1-ol 
carbonates.
a 
entry aryl  aldehyde  ratio
b 
267:236:268 (%) 
5 
CHO
F F
 
143j  23.8 : 0.0 : 76.2 
6 
S CHO 
143o  0.0 : 74.1 : 25.9 
7 
N
CHO 
143q  100 : 0.0 : 0.0 
8 
CHO MeO  
143x  68.0 : 0.0 : 32.0 
9 
O CHO 
143y  0.0 : 97.1 : 2.9 
aReaction was performed on 50  mmol scale. 
bRatio based on 
isolated yields. 
cRatio based on the 
1H-NMR spectroscopy of the 
crude reaction mixture. 
 
The preparation of carbonates 267 proved to be optimal in two subsequent steps, with 
isolation of the intermediate 1-arylpropenol 269  (Scheme 76,  and 77).  Several 
1-arylpropenols 269 were prepared in sufficient yield (74-78%; Scheme 76, entries 1, 2, 
and 3). These results were in contrast with our expectation for such a simple 
transformation. The lower yield was caused by collecting of only the most intensive 
(UV-light) fractions during the chromatography separation of the desired product. During 
the reaction-yield-investigation we have realised, only the aqueous work-up is a sufficient 
purification procedure when small (5-7%) excess of vinylmagnesium bromide is used 
during the reaction with an aldehyde 143. The resulting 1-arylpropenols 269 were isolated 
in high yield (95-98%; Scheme 76, entries 4, and 5), and in a good quality (no detectable 
impurity in 
1H/
13C-NMR spectra), fully compatible with the further proposed chemical 
transformations. The only notable difference is the intensive colour of the products isolated 
without the chromatography separation step.  
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Scheme 76. Synthesis of the allyl alcohols 269
143
1. CH2=CHMgBr
Ar
OH
O
H
1) 269c (78%)
OH
MeO
2) 269f (74%)
OH
Br
4) 269f (95%)
OH
5) 269h (98%)
OH
3) 269i (77%)
OH
F
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MeO
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F
 
 
Using neat sodium hydride instead of its suspension in mineral oil further improved the 
isolated yields of carbonates 267 up to 95% (Scheme 77). 
 
269
Scheme 77. Synthesis of carbonates 267
Ar
OH
267
Ar
OBoc 1. NaH
2. Boc2O
267f (85%)
OBoc
Br
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F
THF
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5.2.1.  Non-Racemic Branched Carbonates. 
The non-racemic 1-arylpropenols 269 were prepared by means of enzymatic resolution.
215 
The highly active, acrylic resin supported recombinant lipase formulation Novozyme™ 
435 was added to a suspension of the corresponding 1-arylpropenol 269, isopropenyl 
acetate, and 4 Å molecular sieves in dry toluene (Scheme 78). The enantioselectivity of the 
lipase-catalysed reaction can be described by enantiomeric ratio, the E-value. The E-value  
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is defined as the ratio of specificity constant for the two enantiomers and can be expressed 
in terms of eeS and eeR only (Equation 1).
215a  
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The E-values of the Novozyme™ 435 was rather high in all the resolution reactions. The 
observed values of E>1000 indicate a very good selectivity of the lipase formulation 
Novozyme™ 435 for the resolution of 1-arylpropenols 269. The reactions yielded mixtures 
of (S)-alcohol and (R)-acetate in all cases. These were separated by column 
chromatography. The acetates were hydrolysed in aqueous methanolic solution of 
potassium hydroxide in practically quantitative yields. The enantiopurities of the 
(S)-alcohols and (R)-ester-liberated alcohols were determined by GC and/or HPLC. The 
absolute configuration was determined by comparison (chiral GC) with the commercially 
available enantiopure standard ((S)-1-phenylpropenol (S)-269a). The absolute 
configurations of the other 1-arylpropenols 269 were correlated to the known 
1-phenylpropenol, by comparison of the absolute sign of the optical rotation value, by the 
HPLC behaviour, and by the chemical correlation of the diastereoisomers produced in the 
later reactions.  
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Scheme 78. Resolution of 1-arylpropenols 269
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The synthesis of the corresponding non-racemic carbonates 267 was further optimized. 
n-Buthyllithium was used as a base instead of sodium hydride. High yields and excellent 
purities of the desired products were attained without chromatography separation 
(Scheme  79). The main advantage of this procedure is that it allows an accurate base 
addition (1.05 equiv), together with the use of a very small excess of Boc anhydride (1.01 
to 1.02 equiv). The high purities of the resolved starting 1-arylpropenols 269 were also of a 
key importance for the high purity of the resulting carbonates 267. 
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Scheme 79. Synthesis of the non-racemic carbonates 267
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5.2.3. Conclusions 
We have successfully prepared various non-racemic 1-arylpropenols 269 and their 
carbonates  267. Several published procedures
214,215 were tested and optimized. We 
presented a very robust synthetic procedure leading to enantiopure carbonates 267. 
Carbonates 267 bring the wealth of aryl moieties of commercially available aryl aldehydes, 
together with the chirality source easily available in any of the required absolute 
configuration. Thus carbonates 267 are the key group of starting materials for our novel 
C-nucleosides synthetic methodology development.  
 
5.3. Iridium-Catalysed  Asymmetric Allylic Substitution (AAS) 
 
5.3.1.  Synthesis of Protected Butenediols for AAS 
One of the main advantages of the proposed synthetic strategy leading to C-nucleosides is 
the common building block of the nucleophilic part in the AAS reaction. Any synthetic 
sequence always starts with protected 3-buten-1,2-diol 235. Diol 235 is protected at the  
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primary hydroxyl in order to enable only the secondary hydroxyl function to react in AAS 
reaction. Various protecting groups were investigated. Standard synthetic procedures were 
employed for the introduction of the protecting groups (Scheme 80).
216 Either racemic, or 
enantiopure, commercially available diol 235a was used. In the proposed C-nucleoside 
synthetic scheme the (R)-enantiomer will give rise to the unnatural L-C-nucleosides, 
whereas the (S)-enantiomer will produce the natural configuration of D-C-nucleosides. The 
protection of the enantiopure diol 235a proceeded without any loss of enantiopurity. The 
cheaper racemic diol 235a is suitable for the AAS reaction condition optimization. The 
protecting groups were selected in order to achieve high selectivity in the primary hydroxyl 
function protection. These were pivaloyl, trityl, tert-butyldiphenylsilyl, and 
tert-butyldimethylsilyl. During the course of the AAS reaction investigation we have 
realised that only the tert-butyldimethylsilyl was suitable for all the proposed synthetic 
sequence (vide infra, page 116). 
 
235a
Scheme 80. Synthesis of the protected butenediols 235b-e
235b-e
Et3N (4-5 equiv)
DMAP (10 mol %)
(S)-235c (86%)
THF
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TBSO
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The carbonates 272 and (R)-272 were prepared for the complete AAS reaction 
investigation (Scheme 81). The optimized procedure for the Boc function introduction was 
employed (vide supra, page 100). 
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235c
Scheme 81. Synthesis of the carbonates 272
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5.3.2.  Synthesis of Ligands for AAS 
Several Feringa’s type phosphoramidite ligands were used through the AAS reaction 
investigation and optimisation. Some of them were prepared by published procedures.
217,218 
The required amine (R,R)-273 was prepared by reductive amination of ketone 274 using 
the commercially available enantiopure amine (R)-275 and sodium borohydride at room 
temperature (Scheme  82), followed by separation of the resulting diastereoisomers by 
column chromatography on silica gel.
219 
 
H2N
O
HN HN (R)-275
274 (R,R)-273 (R,S)-273
1. NaHCO3
benzene
2. NaBH4
THF
+
+
Scheme 82. Synthesis of naphthylethylamines 273
 
 
Attempted synthesis of the phosphoramidite ligand L4, using Feringa’s method, failed.
217 
The reason was the use of chromatography on silica gel (as described in the reference) 
which, in our hands, proved to be incompatible with this class of compounds. Using 
chromatography on Al2O3, as reported by Alexakis, gave the desired product.
220 
Phosphoramidite L4 was prepared by adding amine 276 and diol 277 consecutively to 
phosphoric tribromide (Scheme 83). Ligands (R,R)-L3 and (Ra,Rc,Rc)-L2 were synthesized  
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in the same way, starting from amine (R,R)-273 and the respective phenols 277 and 
(R)-278. The yields correspond with the published results
217 and were not optimized.  
 
(R,R)-273: R = 1-Np
276:           R = Me
Scheme 83. Synthesis of the phosphoramidites L2-L4
277: Biphenol
(R)-278: BINOL
(Ra,Rc,Rc)-L2 (39%)
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5.3.3.  Optimization of the AAS Conditions  
Initial conditions for the iridium-catalysed intermolecular allylic etherification were 
published by Hartwig.
183 According to the original procedure, solid aliphatic lithium 
alkoxide and copper(I) iodide are mixed, followed by addition of a solvent at 0  °C; a 
solution of a mixture of the catalyst and the ligand is then added at 0 °C, finally followed 
by the addition of the allyl carbonate at 0 °C. The reaction temperature profile is a gradient 
from 0  °C to 20  °C during 16  h. All these procedures need to be carried out under 
inert/anhydrous conditions. 
 
Our reaction system required further development and optimization in order to improve the 
reaction of our more complex allylic, secondary and sterically hindered alcohol 235c. This 
optimization included finding the right conditions for the deprotonation of the alcohol and 
optimizing the source of the metal for the alkoxide formation, the time to the alkoxide  
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formation, the reaction temperature profile, as well as identifying the influence of the 
ligand, various additives, and the activation of the metal catalyst and its loading. 
 
Various methods for the formation of alkoxide from 235c were investigated, namely 
deprotonation by n-butyllithium, vinylmagnesium bromide, phenylmagnesium bromide, 
and phenylzinc bromide. The solution of alkoxide from 235c thus generated was then 
directly transferred (via cannula) to the suspension of a Cu(I) salt in THF at 0 °C or at 
20 °C, with CuI and CuBr·Me2S, employed as the source of Cu(I), respectively. For the 
formation of the alkoxide from 235c, the protocol using n-butyllithium at 0 °C for 10 min, 
followed by transmetallation with CuI at 20  °C for 30  min, proved to be optimal. 
Appearance of a bright yellow solution of the corresponding copper alkoxide is indicative 
of the successful transmetallation. The quality of the CuI also proved to be of the key 
importance. The optimized CuI treatment includes drying of the perfectly ground CuI in 
the reaction flask at 140 °C overnight, and until the reaction is set up. No difference was 
noticed when non-degassed solvent was used.  
 
With the successful procedure for the copper alkoxide formation, we started to optimize 
the rest of the reaction conditions (Scheme  84, Table  10). These included the reaction 
temperature profile, and the protecting group in racemic butenediol 235. These initial 
optimisations were monitored only by 
1H-NMR spectroscopic analysis of the worked-up 
reaction mixture. In conflict with the original procedure,
183 we have found at least ambient 
temperature (20 °C) necessary for the reaction to proceed to full conversion. The observed 
de dropped down to 40% de as a consequence of this temperature change, when the most 
complex ligand (Ra,Rc,Rc)-L2 was used (entry  20). No significant improvement was 
observed when the “activated” catalyst was used.
185 The catalyst was “activated” by 
heating [Ir(COD)Cl]2 and ligand L4 or (Ra,Rc,Rc)-L2 with propylamine at 50 °C for 20 min 
to generate the metalacyclic structure K3 (vide supra, page 76), followed by evaporation of 
the volatile materials before the addition of the reaction solvent and the two reagents. The 
reaction was tested in the case when only the ligand was added without the metal source 
(entry 19). Only small conversion up to 10% was observed in this case. TBDPS protecting 
group showed the best performance under the same reaction conditions (entries 20, 21, 
and 22). The conversion dropped dramatically when trityl protecting group was used (entry 
21), followed by further significant decresing in the case of pivaloyl protecting group 
(entry 22). 
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Scheme 84. The initial screening of diallylic ether 234 formation
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Table 10. Allylic substitution reaction, Scheme 84.
a 
entry allyl 
alcohol 
ligand 
(mol %) 
pre-cat.
b
(mol % Ir)
cond.
c temperature 
profile 
conv. 
(%)
d 
1  235c L4 
2.2% 
2.0%  S  0 °C/4 h 
0 °C to 20 °C/12 h 
10 
2  235c L4 
2.2% 
2.0%  S  0 °C/1 h 
0 °C to 20 °C/15 h 
49 
3  235c L4 
4.4% 
3.0%  A  20 °C/5 h  5 
4  235c L4 
4.4% 
3.0%  A  0 °C/15 min 
20 °C/4 h 45 min 
6 
5  235c L4 
4.4% 
3.0%  A  0 °C/30 min 
20 °C/4 h 30 min 
8 
6  235c L4 
4.4% 
3.0%  A  0 °C/1 h 
20 °C/4 h 
11 
7  235c L4 
4.4% 
3.0%  A  0 °C/5 h  30 
8  235c L4 
2.2% 
2.0%  S  20 °C/16 h  18  
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Table 10. Allylic substitution reaction, Scheme 84.
a 
entry allyl 
alcohol 
ligand 
(mol %) 
pre-cat.
b
(mol % Ir)
cond.
c temperature 
profile 
conv. 
(%)
d 
9  235c L4 
2.2% 
2.0%  S  0 °C/15 min 
20 °C/15 h 45 min 
22 
10  235c L4 
2.2% 
2.0%  S  0 °C/30 min 
20 °C/15 h 30 min 
26 
11  235c L4 
2.2% 
2.0%  S  0 °C/1 h 
20 °C/15 h 
32 
12  235c L4 
2.2% 
2.0%  S  0 °C/4 h 
0 °C to 20 °C/15 h 
25 
13  235c  (Ra,Rc,Rc)-L2 
4.1% 
4.2%  A  0 °C/5 h  5 
14  235c  (Ra,Rc,Rc)-L2 
4.0% 
4.0%  A  20 °C/5 h  83 
15  235c  (Ra,Rc,Rc)-L2 
4.1% 
4.2%  S  0 °C/4 h 
0 °C to 20 °C/15 h 
56 
16  235c  (Ra,Rc,Rc)-L2 
4.1% 
4.2%  S  20 °C/16 h  98 
(93)
e 
17  235c  (Ra,Rc,Rc)-L2 
1.0% 
1.0%  S  20 °C/16 h  49 
18  235c  (R,R)-L3 
1.0% 
1.0%  S  20 °C/16 h  74 
19  235c  (Ra,Rc,Rc)-L2 
2.0% 
n.a.  S  20 °C/16 h  10 
20  235c  (Ra,Rc,Rc)-L2 
2.0% 
2.0%  S  20 °C/16 h  95 
40% de 
21  235d  (Ra,Rc,Rc)-L2 
2.0% 
2.0%  S  20 °C/16 h  25 
22  235e  (Ra,Rc,Rc)-L2 
2.0% 
2.0%  S  20 °C/16 h  12 
aReactions were performed on 1 mmol scale, conditions: 1 equiv CuI, 1 equiv n-BuLi, 
0.55 equiv carbonate, THF. 
b[Ir(COD)Cl]2 was used as a pre-catalyst. 
cConditions “S” 
(= standard), conditions “A” (= activated). The catalyst was activated by heating 
[Ir(COD)Cl]2 and an appropriate ligand with propylamine at 50 °C for 20 min, followed 
by evaporation of the volatile materials. 
dConversion based on the 
 1 H-NMR 
spectroscopy integrals of the worked-up reaction mixture (based on the carbonate). 
eIsolated yield (%), average from 2 independent runs. 
 
We decided to investigate most of the possible catalytic systems for the AAS reaction, as a 
consequence of the above stated initial results (Scheme 85). Rhodium can be employed as 
an alternative catalyst. A simple rhodium catalyst was described in the allylic ether 
formation.
181 The advantage of this method resides in the formation of the ether from 
carbonates  267, 272 and alcohols 235,  269 with retention of configuration at both 
stereocentres. Surprisingly, formation of alkene 279 was observed in the cases when 
rhodium was used. Selectivity of the formation of 279 was found to strongly depend on the 
ligand employed. We have investigated the influence of the additional commercial ligands  
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such as (S)-BINAP, (Sa,Sc,Sc)-L1, (R,R)-L5, (t-BuO)2PN(iPr)2  L6, and (MeO)3P  L7. 
Conditions without any additional ligand were also investigated. 
 
The difference between rhodium and iridium was demonstrated in the reaction in the 
reaction with the branched carbonate 267a without any additional ligand. Whereas 
rhodium catalysed reaction gave preferentially alkene 279a (Scheme  85, Table  11, 
entry 1), iridium catalysed reaction gave only the expected product of allylic substitution 
234ca (entry  2). Also the reactivity of the linear and branched carbonate significantly 
differs in the reaction without any additional ligand. Whereas the branched carbonate 267a 
gave a significant amount of product 234ca (entry 4), the linear carbonate 236a proved to 
be unreactive under these conditions (entry  3). Moreover, the successful recovery of 
starting 236a (88%) indicates that no iridium complex of 236a was formed. The phosphine 
ligand ((S)-BINAP) significantly enhanced the amount of the undesired product 279a, 
whereas the amount of the product 234ca was decreased or entirely eliminated (compare 
entries 1 vs. 9 and 2 vs. 10). No enrichment in any diastereoisomer was observed in these 
cases. The reactions with silane 235c were successfully promoted by using (Sa,Sc,Sc)-L1 as 
the catalyst (entries  7, and  8). Only trace of the excess of one diastereoisomer was 
observed in the later case. This is a significant difference to compare with the less 
sterically hindered silane 235b, where only modest amount of the product was isolated 
along with recovered starting material (Scheme 86, Table 12, entries 11, and 12). The non-
sterically hindered phosphoramidite (R,R)-L5 decreased the reaction rate. In the case of the 
linear carbonate 236a the reaction did not proceed and only the starting material was 
recovered (entry  11). The reaction rate of the branched carbonate 267a  decreased 
(entry 12). Also in these two cases, no enrichment in any diastereoisomer was observed. 
The non-chiral, relatively bulky ligand L6 improved the reaction. In the case of the linear 
carbonate 236a, only the starting 236a (98%) was recovered. In the case of the branched 
carbonate 267a the isolated yield of 234ca increased (compare entries 3 vs. 13 and 4 vs. 
14). Trimethylphosphite ligand L7 promoted formation of the undesired product 279a 
(entries 17, and 18). The alkene 279a was formed exclusively in these cases, and it was 
isolated along with a substantial amount of the unreacted branched carbonate 267a. 
 
The 4’-fluoro analogue 267i gave the results consistent with the previous observations for 
the non-fluorinated carbonate 267a for both rhodium and iridium catalysed reaction 
(entries 5 and 6), but generally with 20% increase in yields.  
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Scheme 85. Diallylic ether 234 formation investigation I.
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Table 11. Allylic substitution reaction, Scheme 85.
a 
entry allyl 
alcohol 
carbonate conditions com-
pound 
yield
b 
(%) 
re-
covered
b 
(%) 
1  235c 267a  [Rh(COD)Cl]2, 9.5% Rh 
20 °C 
234ca 
279a 
12 
23 
- 
- 
2  235c 267a  [Ir(COD)Cl]2, 4.2% Ir 
20 °C 
234ca  52 - 
3 (R)-235c  236a  [Ir(COD)Cl]2, 3.0% Ir 
20 °C 
236a  - 88 
4 (R)-235c  267a  [Ir(COD)Cl]2, 3.0% Ir 
20 °C 
234ca  54 - 
5 (R)-235c  267i  [Rh(COD)Cl]2, 4.0% Rh 
20 °C 
279i 
234ci 
43 
31 
- 
- 
6 (R)-235c  267i  [Ir(COD)Cl]2, 3.7% Ir 
20 °C 
234ci  77 -  
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Table 11. Allylic substitution reaction, Scheme 85.
a 
entry allyl 
alcohol 
carbonate conditions com-
pound 
yield
b 
(%) 
re-
covered
b 
(%) 
7  235c 236a  [Ir(COD)Cl]2, 2.1% Ir 
(Sa,Sc,Sc)-L1 1.8% 
20 °C 
234ca  73 
0% 
de 
- 
8  235c 267a  [Ir(COD)Cl]2, 2.1% Ir 
(Sa,Sc,Sc)-L1 1.8% 
20 °C 
234ca  66 
6.3% 
de 
- 
9 (R)-235c  267a  [Rh(COD)Cl]2, 3.7%Rh 
S-BINAP 3.2% 
20 °C 
279a  18 - 
10 (R)-235c  267a  [Ir(COD)Cl]2, 2.6% Ir 
S-BINAP 2.4 % 
20 °C 
234ca 
279a 
5 
33 
- 
- 
11 (R)-235c  236a  [Ir(COD)Cl]2, 1.8% Ir 
(R,R)-L5 2.9% 
20 °C 
236a  - 99
c 
12 (R)-235c  267a  [Ir(COD)Cl]2, 1.8% Ir 
(R,R)-L5 2.9% 
20 °C 
267a 
234ca 
- 
19 
57 
- 
13  235c 236a  [Ir(COD)Cl]2, 1.9% Ir 
L6 2.0% 
20 °C 
236a  - 98 
14  235c 267a  [Ir(COD)Cl]2, 1.9% Ir 
L6 2.0% 
20 °C 
234ca  62 - 
15  235c  267a  Rh(PPh3)3Cl, 4.9% Rh 
L7 20% 
0 °C  
267a  - 77 
16  235c 267a  Rh(PPh3)3Cl, 4.8% Rh 
L7 120% 
0 °C 
267a  - 41 
17  235c 267a  Rh(PPh3)3Cl, 6.2% Rh 
L7 20% 
20 °C  
267a 
279a 
- 
46 
(77)
d 
40 
- 
18  235c 267a  Rh(PPh3)3Cl, 6.2% Rh 
L7 120% 
20 °C 
267a 
279a 
- 
20 
(40)
d 
51 
- 
aReactions were performed on 1  mmol scale, conditions: CuI (1 equiv), n-BuLi 
(1 equiv),  carbonate (0.55  equiv), THF. 
bIsolated yield. 
cYield based on the 
 
1H-NMR spectroscopy integrals of the crude reaction mixture. 
 dYield based on the 
starting carbonate recovered. 
 
The reactions of the tert-butyldimethylsilyl protected butenediol 235b were investigated 
(Scheme  86, Table  12). The reactions without any additional ligand were investigated. 
These gave generally higher yields to compare with reactions of butenediol 235c (entries 1 
to 10). The phosphoramidite (Sa,Sc,Sc)-L1 promoted the reaction in the case of the linear  
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carbonate 236a (entry 11) but a substantial part of the starting material was also recovered. 
The reaction rate of the branched carbonate 267a decreased (entry 12). In both cases, any 
enrichment of any diastereoisomer was below experimental error of the measurement. This 
is a significant difference to compare with the more sterically hindered silane 235c, where 
practically doubled yield of the product was isolated without any recovered starting 
material (Scheme 85, Table 11, entries 7, and 8). The phosphoramidite (R,R)-L5 decreased 
the reaction rate. In the case of the linear carbonate 236a, the reaction did not proceed and 
only the starting material was recovered (entry  13). The reaction rate of the branched 
carbonate  267a  decreased (entry  14). Also in these two cases, no enrichment in any 
diastereoisomer was observed. The non-chiral, relatively bulky ligand (t-BuO)2PN(iPr)2 
L6 improved the reaction (entries 15, and 16). All these observations were consistent with 
previously recorded data for 235c.  
 
 
TBSO
OH +
Scheme 86. Diallylic ether 234 formation investigation II.
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Table 12. Allylic substitution reaction, Scheme 86.
a 
entry allyl 
alcohol 
carbonate conditions com-
pound 
yield
b 
(%) 
re-
covered
b 
(%) 
1  235b 236a  [Rh(COD)Cl]2, 2.3% Rh 
20 °C 
236a  - 99
c 
2  235b 267a  [Rh(COD)Cl]2, 2.3% Rh 
20 °C 
267a  - 99
c 
3  235b 236a  [Ir(COD)Cl]2, 1.9% Ir 
20 °C 
236a  - 99 
4  235b 267a  [Ir(COD)Cl]2, 1.9% Ir 
20 °C 
234ba  84 - 
5  235b 267a 
0.7 eq 
[Ir(COD)Cl]2, 2.0% Ir 
20 °C 
234ba  76 - 
6  235b 267a 
0.8 eq 
[Ir(COD)Cl]2, 2.0% Ir 
20 °C 
234ba  74 - 
7  235b 267i 
0.9 eq 
[Ir(COD)Cl]2, 2.0% Ir 
20 °C 
234bi  74 - 
8  235b 267i 
1.0 eq 
[Ir(COD)Cl]2, 2.0% Ir 
20 °C 
234bi  65 - 
9 (R)-235b  (S)-
267a 
[Ir(COD)Cl]2, 2.8% Ir 
20 °C 
234ba  79 - 
10 (R)-235b  267f  [Ir(COD)Cl]2, 1.8% Ir 
20 °C 
234bf  75 - 
11  235b 236a  [Ir(COD)Cl]2, 2.1% Ir 
(Sa,Sc,Sc)-L1 1.8% 
20 °C 
236a 
234ba 
- 
38 
0% de 
31 
- 
 
12  235b 267a  [Ir(COD)Cl]2, 2.1% Ir 
(Sa,Sc,Sc)-L1 1.8% 
20 °C 
234ba  41 
2.8% de 
- 
13  235b 236a  [Ir(COD)Cl]2, 2.0% Ir 
(R,R)-L5 2.2% 
20 °C 
236a  - 86 
14  235b 267a  [Ir(COD)Cl]2, 2.0% Ir 
(R,R)-L5 2.2% 
20 °C 
234ba  75 
0% de 
- 
15  235b 236a  [Ir(COD)Cl]2, 2.2% Ir 
L6 2.1% 
20 °C 
236a  - 93 
16  235b 267a  [Ir(COD)Cl]2, 2.2% Ir 
L6 2.1% 
20 °C 
234ba  84 - 
aReactions were performed on 1  mmol scale, conditions: CuI (1 equiv), n-BuLi 
(1 equiv), carbonate (0.55 equiv), THF. 
bIsolated yield. 
cYield based on the 
 1H-NMR 
spectroscopy integrals of the crude reaction mixture. 
 
The reactions employing slightly different retrosynthetic disconnection of the target diallyl 
ether were also investigated during the extensive allylic substitution investigation 
sumarised in the previous schemes and tables  (Scheme 85, 86  and  Table 11, 12).  The 
difference is based on disconnecting the 4’-O bond of the target ribofuranose ring rather  
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than the 1’-O bond. The reaction was investigated under various conditions, employing 
allyl alcohol 269a and branched carbonate 272 (Scheme  87, Table  13). No expected 
product was either isolated or detected in the crude reaction mixture. Various amount of 
the starting carbonate 272 was recovered in all cases  
 
O
TBDPSO
Ar
TBDPSO
OBoc +
Scheme 87. Diallylic ether 234 formation investigation III.
Ph
269a
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Conditions
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Table 13. Allylic substitution reaction, Scheme 87.
a 
entry conditions  isolated 
compound
re-covered
b 
(%) 
1 Rh(PPh3)3Cl, 4.6% Rh 
L7 20% 
0 °C  
272  32 
2 Rh(PPh3)3Cl, 4.6% Rh 
L7 120% 
0 °C 
272  66 
3 Rh(PPh3)3Cl, 5.2% Rh 
L7 20% 
20 °C 
272  28 
4 Rh(PPh3)3Cl, 5.2% Rh 
L7 120% 
20 °C 
272  94 
5 [Rh(COD)Cl]2, 4.0% Rh 
20 °C 
272  16 
6 [Ir(COD)Cl]2, 3.6% Ir 
20 °C 
272  34 
aReactions were performed on 1  mmol scale, conditions: 
CuI (1  equiv), n-BuLi (1  equiv), carbonate (0.55  equiv), 
THF. 
bIsolated yield.  
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5.3.4. Conclusions 
In summary, the optimal procedure for the formation of the diallyl ether 234 utilises only 
the metal source ([Ir(COD)Cl]2), adding 2 mol % of iridium, without any additional ligand. 
The successful procedure requires reaction temperature of 20 °C for at least 16 h. The 
reaction employs enantiopure allyl alcohol 235 and branched allyl carbonate 267 as the 
sources of chirality. The best reaction conditions were tested with a range of substrates and 
carbonate equivalence ratio. All the reactions performed have shown very consistent 
performance. The optimal equivalence ratio of the carbonate for efficient reaction should 
be in the range of 0.8-0.9 equiv. 
 
5.4.  Optimization of the Final Reaction-Sequence Steps and Completion of the 
Synthesis of Artificial C-Nucleosides and Their Analogues 
 
5.4.1.  Proof of the Synthetic Concept Using Diastereoisomeric Mixtures 
The diallyl ethers obtained in the AAS investigation were submitted to the standard RCM 
reaction procedure (Scheme  88).
187 The reaction was briefly screened for optimal 
conditions. Grubbs 1
st generation C1 and Grubbs 2
nd generation C2 catalysts were used in 
the reaction. No significant difference was noticed in the performance of these catalysts in 
our simple RCM to construct the five-membered ring. Therefore, Grubbs 1
st generation 
catalyst C1 was chosen as an optimal catalyst, in loadings as low as 1%. Diastereoisomeric 
mixtures of racemic D4 1’-arylribofuranose analogues 233 were produced in good yields.  
 
O Ar
RO
234
O Ar
RO
233
Scheme 88. Preliminary RCM reaction of diallyl ethers 234
RCM
R: TBDPS; TBS
85-90%
 
 
These diastereoisomeric mixtures of D4 analogues were used for the optimization of the 
5’-OH deprotection conditions (Scheme 89, Table 14). The initial reaction conditions using 
TBAF gave the expected product in 40-50% yield along with a number of decomposition 
products, which made the separation tedious. Therefore, milder reaction conditions were 
investigated, employing various complex salts of hydrogen fluoride (entries 2 to 5). The 
pyridine-hydrogen fluoride complex gave no reaction, unless used in high excess (entry 2,  
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and 3). The best results were obtained with the Et3N·3HF complex (entry 4, and 5). Only 
this reaction procedure enabled a recovery of the starting material, but the amount 
recovered (1.8%) indicated that also in this case decomposition took place. This is an 
important issue in the D4 nucleoside analogues preparation. The higher sensitivity of 
dihydrofuranes is known, and it has to be considered in the synthetic strategy planing.
221 
 
O Ar
TBDPSO
233c
O Ar
HO
233a
Scheme 89. Deprotection of the D4 C-nucleosides analogues
Conditions
 
 
Table 14. Deprotection of the intermediates 233c, Scheme 89.
a 
entry Ar  reagent  (equiv) conditions  yield  (%)
b 
1  Ph  TBAF (3.5)  20 °C, 16 h  44 
2  Ph  Py·HF (2.8)  20 °C, 20 h  0 
3  Ph  Py·HF (11)  20 °C, 16 h  52 
4 Ph  Et3N.3HF (3.2)  20 °C, 16 h  56 
5 4-F-Ph  Et3N.3HF (3.0)  20 °C, 16 h  58 
aReactions were performed on 0.5 mmol scale. 
bIsolated yield of an 
equimolar mixture of racemic diastereoisomers. 
 
The mixture of diastereoisomers could be separated by column chromatography after the 
deprotection step. The deprotected D4 nucleoside analogue 233aa was successfully 
isolated as two separated diasteroisomers. Configuration of one was assigned as cis-233aa 
by NOE-NMR experiments. However, because of the very low intensity of the NOE 
enhancement (1-2%), this should be considered just as a preliminary method for the 
stereochemistry assignment. No NOE enhancement was recorded for any of the 
1H-NMR 
signals of the second diastereoisomer. 
 
O Ph
H H HO
NOE: 1-2%  
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We decided to change the protecting group of the primary hydroxyl functionality of 
butene-1,2-diol to tert-butyldimethylsilyl (TBS) group. This proved to be beneficial in the 
allylic substitution and, most importantly, in the deprotection step. The introduction of 
TBS proved selective in favour of the primary hydroxyl function (vide supra, page 102). 
The utility of TBS was confirmed in the deprotection of D4 analogue 233ba (Scheme 90). 
The isolated yield was roughly 20% higher than in the case of TBDPS.  
 
O Ph
TBSO
233ba
O Ph
HO
233aa (71%)
Scheme 88. Final deprotection of the D4 C-nucleosides analogues
THF
20 oC, 16 h
Et3N.3HF
 
 
5.4.2.  Synthesis of Diallylethers 
The best conditions developed for AAS (vide supra, page  114) were utilised in the 
synthesis of various diallyl ethers 234 (Scheme  91). All the carbonates 267 bearing 
substituted benzene ring gave the expected products in comparable yields; however, 
pyridine-derived and ortho-substituted carbonates 267 did not successfully react. The 
corresponding carbonates decomposed and only small amounts of the starting silyl 
protected butenediol were recovered in these cases. 
 
The AAS reaction proved to be very robust within these limitations. All the reactions 
performed showed practically the same yield. Racemic starting materials were used in 
some cases. Protected, enantiopure diols 235b were reacted with enantiopure carbonates 
267 to give enantiopure diallyl ethers with high diastereoselectivity. The diastereopurity of 
the diallyl ether produced was determined by 
1H-NMR spectroscopy only. The de purity 
can be claimed up to 90% de due to this method. Very weak, or entirely no 
1H-NMR 
integral intensities of the second diastereoisomer were recorded. 
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Scheme 91. Optimised AAS: Formation of diallyl ethers 234
TBSO
OH Ar
OBoc
235b 234b a,c,f,h
>99% ee >99% ee
267a,c,f,h
+
>99% ee
>90% de
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234ba (72%) (2S,1'S)-234ba (79%) (2S,1'R)-234ba (82%)
(2R,1'R)-234ba (83%) (2R,1'S)-234ba (77%) (2S,1'S)-234bh (78%)
(2S,1'R)-234bh (74%) (2R,1'R)-234bh (72%) (2R,1'S)-234bh (73%)
234bf (75%) (2R,1'S)-234bf (85%) (2R,1'S)-234bc (70%)
BuLi, CuI
[Ir(COD)Cl]2
20 oC, 16 h
THF
 
 
5.4.3.  Synthesis of Artificial 2’,3’-Didehydro-2’,3’-Dideoxy-C-Nucleosides 
Diallyl ethers 234 were submitted to the optimized RCM reaction conditions (Scheme 92). 
Diallyl ether 234 was dissolved in degassed dichloromethane, and a catalytic amount 
(1-2%) of Grubbs 1
st generation catalyst C1 was added under a stream of argon. 
Ru
Ph
Cl
Cl
PCy3
PCy3
C1   
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The reaction mixture was heated at 50 °C for 3 hours. Conversion of the starting material 
was monitored by TLC in a couple of the first runs. The optimal reaction time of 3 hours 
proved to be sufficient for all the diallyl ethers 234 employed. All reactions furnished 
protected D4 C-nucleosides analogues 233 in good yield. 
 
234b a,f,h
O Ar
TBSO
233b a,f,h
Scheme 92. RCM and D4 analogues 233 formation
Grubbs 1st gen. O Ar
TBSO DCM
O Ph
TBSO
O Ph
TBSO
O
TBSO
O
TBSO
O
OTBS
Ph
O
OTBS
Ph
F F
O
OTBS
O
OTBS F F
O
OTBS
Br
D-233baα (56%) D-233baβ (78%) L-233baα (91%)
L-233baβ (86%) L-233bfα/β (84%)
D-233bhα (95%) D-233bhβ (96%)
L-233bhα (97%) L-233bhβ (95%)  
 
The protected D4 nucleosides analogues 233 are not only the key intermediates for the 
synthesis of target ribofuranosides, but also represent protected final product of significant 
biological importance (see the Chapter  1). The 5’-O-protected enantiopure 
2’,3’-didehydro-1’,2’,3’-triideoxy-1’-aryl ribofuranoses were deprotected using the 
optimized reaction conditions (Scheme  93). All the possible combinations of the 
enantiopure D4 C-nucleosides analogues bearing phenyl and 3-fluorophenyl moiety were 
successfully prepared and isolated in good yields. 
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233b a,h
O Ar
HO
233a a,h
Scheme 93. D4 analogues 233 deprotection
Et3N.3HF O Ar
TBSO
O Ph
HO
O Ph
HO
O
HO
O
HO
O
OH
Ph O
OH
Ph
F F
O
OH
O
OH F F
D-233aaα (66%) D-233aaβ (68%)
L-233aaα (71%) L-233aaβ (54%)
D-233ahα (88%) D-233ahβ (61%)
L-233ahα (76%) L-233ahβ (66%)
THF
 
 
This deprotection step represents not only the possible divergent route broadening the 
synthetic utility of our new C-nucleosides synthetic approach, but also provides a tool to 
determine the enantiopurity of our products. Both the previous intermediates, diallyl ethers 
234 and ring-closed metathesis products 233 were not suitable for HPLC or GC analysis, 
either for stability reasons or no resolution. All four diastereoisomers of 1’-phenyl 
substituted D4 nucleoside analogue were submitted to the GC analysis. The results we 
obtained were compared with the chromatograms recorded for racemic mixture of 
diastereoisomers and with the chromatograms recorded for each racemic diastereoisomer. 
All the samples showed high diastereopurity and enantiopurity in values of >99% ee, and 
>99% de. Based on these values we could propose the diastereoselectivity of the first step, 
the AAS reaction, was higher than the 
1H-NMR spectroscopy-estimated 90% de. But in 
this case we have to keep in mind that deprotected D4 C-nucleosides analogues are as far 
as three chromatography separations from the diastereoselective reaction step, and a 
various de enhancement may occur.  
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5.4.4.  Synthesis of Artificial Ribofuranosides and Completion of the Synthesis 
The vicinal dihydroxylation of the double bond was the last strategic transformation to be 
investigated in our novel synthetic route to C-nucleosides. There are two possible tactics to 
construct the target structure of 5’-O-protected ribofuranose (Scheme 94). The first one, 
the route (a) is a more conventional way of direct vicinal dihydroxylation of the double 
bond in D4 C-nucleoside analogues 233.
187,193 This transformation can be performed by 
catalytic oxidation either by more common osmium tetroxide, or by less toxic and far more 
reactive ruthenium tetroxide.
190,193 The second possibility, route (b), is a novel method 
recently developed by Blechert.
195 This innovative procedure employs ruthenium catalyst 
for both, the RCM reaction step, and then in the oxidation step as a two-reaction-one-pot 
procedure. 
 
Scheme 94. Formation of protected ribofuranose 232
D-233β
O Ar
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O Ar
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OH HO
Conditions
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O Ar
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Conditions
O Ar O Ar
OH HO
O Ar
OTBS OTBS OTBS
D-232β D-234β
L-233β L-232β L-234β
 
 
All the above stated reaction tactics were investigated in various combinations of the 
reaction conditions. The vicinal dihydroxylation (a) utilising osmium tetroxide in catalytic 
amount, and N-methyl morpholine N-oxide as a stoichiometric oxidant in a mixture of 
THF-water (9:1) gave the expected product D-232 (Table  15, entry 1). Although the 
reaction yield was lower than expected, the reaction conditions were not optimized in this 
particular case.  
 
Our main interest was laid upon the optimization of a less toxic, environmentally friendly 
ruthenium tetroxide oxidation. This was optimized in a number of experiments with model 
compounds (e.g., 2-cyclohexenone). Basically, two different reaction protocols were 
reported: (1) Plietker’s procedure utilises catalytic amount of a ruthenium source together 
with certain amount of Lewis acid (CeCl3) and a stoichiometric amount of various 
inorganic oxidants, most frequently NaIO4.
194 A minor modification of this procedure was  
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recently reported. Blechert at al reported a RCM reaction procedure with a subsequent 
utilising of the ruthenium metathesis catalyst as a ruthenium source for the Plietker’s 
procedure of vicinal dihydroxylation in a two-reaction-one-pot procedure.
195 Neither of 
these two modifications were successful in our hands at the level claimed by the authors. 
We are aware that the practical success in heterogeneous reaction is determined by the 
efficiency of the phase transfer. This parameter is of key importance, and may be difficult 
to keep, especially in a variety of reaction scales. (2) Hudlicky’s procedure does not utilise 
any Lewis acid additive, and runs the reaction with a higher ruthenium catalyst loading 
(10%).
193 
 
Table 15. Formation of the protected ribofuranoses 232,  
Scheme 94, sumarised in Schemes 95 and 96.
a 
entry Ar 
(config.)
route oxidation  catalyst 
(mol %) 
conditions yield 
(%)
b 
1 Ph 
(D-) 
a  OsO4 (9.0)  20 °C, 19 h  34 
2 Ph 
(D-) 
b  C1 (5.0) 
RuCl3·H2O (5.0) 
50 °C, 3 h 
0 °C, 20 s 
25 
3 Ph 
(L-) 
a  RuCl3·H2O (10.3)  0 °C, 40 s  27 
(88)
c 
4 3-F-Ph 
(D-) 
a  RuCl3·H2O (12.2)  0 °C, 45 s  61 
5 3-F-Ph 
(D-) 
a  RuCl3·H2O (12.0)  0 °C, 80 s  16 
6 3-F-Ph 
(L-) 
b  C1 (1.5) 
RuCl3·H2O (10) 
50 °C, 3 h 
0 °C, 15 s 
34 
7 4-Br-Ph 
(L-) 
b  C1 (1.4) 
RuCl3·H2O (10.7) 
50 °C, 3 h 
0 °C, 10 s 
31 
aReactions were performed on 1.0 mmol scale. NaIO4 1.5 equiv. 
bIsolated yield. 
cYield based on the starting alkene recovered. 
 
Furthermore, in this procedure the results were very much dependent on the level of 
homogeneity. Finally, a combination of these two protocols proved to be optimal. The 
optimized reaction procedure starts as proposed by Blechert and after the RCM reaction 
step the solvent was changed, but the oxidation was performed via Hudlicky’s procedure, 
without any Lewis acid, and with an additional ruthenium source in the form of RuCl3·H2O 
(up to 10% Ru in total), using NaIO4 as the stoichiometric (re)oxidant (Table  15, 
Schemes 95, 96). 
  
 
122
233b a,h
O Ar
TBSO
232b a,h
Scheme 95. Oxidation of dihydrofurans 233, formation of ribofuranisides 232b
O Ar
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O
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O
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OH HO
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Any other reaction conditions, such as the Hudlicky procedure with a Lewis acid added, 
different reaction solvents, reaction time, reaction temperature, and various combinations 
of them did not lead to any improvement. We suggest a high potential for possible 
optimization of the oxidation step, but only in terms of improved homogeneity control. 
Remarkable results were recorded in the case when the unreacted starting material was 
successfully recovered (Table 15, entry 3), or in the case of an improved homogeneity 
(entry 4). Note the high reaction rate of the ruthenium oxidation and the significant drop in 
the isolated yield once the reaction time was prolonged (entry 4 vs. 5). 
 
Scheme 96. Tandem RCM-oxidation, formation of ribofuranisides 232b
234b a,f,h
O Ar
TBSO
232o a,f,h
1. C1 O Ar
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O Ph
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O
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L-232bhβ (34%)
OH HO
HO OH
HO OH
F
O
OTBS
L-232bfβ (31%)
HO OH
Br
2. RuCl3.H2O
NaIO4
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A synthesis of deprotected ribofuranose 1oc via a 5’-O-protected ribofuranose L-232bc in a 
three-step-one-pot reaction protocol was attempted (Scheme 97). Diallyl ether 234bc was 
dissolved in degassed dichloromethane and a catalytic amount (2%) of Grubbs 1
st 
generation catalyst C1 was added in a stream of argon. Once the RCM reaction was 
completed, the solvent was removed. The residue was dissolved in a mixture of ethyl 
acetate and acetonitrile (1:1), and the oxidation step was performed as stated in the above 
paragraph. The reaction solvent was changed for the third time (THF) and a complex 
Et3N·3HF was added according to the optimized deprotection procedure. However, the 
resulting reaction mixture was far too complex to isolate the target structure.  
 
Scheme 97. Attempted synthesis of ribofuranose 1oc
232bc
O
OH HO
1. Grubbs 1st
2. RuCl3/NaIO4
234bc
O
Et3N.3HF
OTBS OTBS MeO
MeO MeO
MeO
n.a.  
 
This is one of the practical limitations of our new synthetic procedure. We suggest to 
isolate the 5’-O-protected intermediate, as the oxidation step introduces side-products, 
which cannot be taken further through the ribofuranose synthesis. 
 
The enantiopure 1’-aryl ribofuranoses 1o were obtained in the deprotection step, utilising 
an optimized reaction protocol (vide supra, page  116). Both enantiomers of D-, and 
L-ribofuranoses bearing phenyl, and 3-fluorophenyl aromatic moiety were prepared in 
good yields (Scheme 98). 
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232b a,h
O Ar
HO
1o a,h
Scheme 98. Deprotection of ribofuranisides 232b
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Both enantiomers of β-1’-phenyl ribofuranose 1oa were isolated as crystalline compounds 
suitable for X-ray diffraction analysis (Figure  2, and 3). In this very last stage of the 
successful synthesis the absolute stereochemistry of the products was thus confirmed. 
Knowing the configuration of the 4’-carbon brought from the starting butenediol 235 
configuration on all the remaining stereocentres can be assigned. The observed 
configuration fully corresponds to our initial expectations and to the chirality brought from 
the starting branched carbonates 267. 
 
5.4.5. Conclusions 
D4  C-nucleoside analogues were synthesised in a three-step procedure, and 1’-aryl 
ribofuranoses were constructed in a fourth-step procedure. The enantiopurity and 
diastereopurity of all the products is based on the enantiopurity of the starting materials, 
and a conservation of this chirality throughout all the transformations employed. The target 
compounds were prepared in excellent enantio- and diastereopurity, in good overall yields. 
The yield in the synthesis of 1’-aryl-2’,3’-didehydro-1’,2’,3’-trideoxyribofunanoses 233a 
is up to 46% over all the reaction steps. The yield of 1’-arylribofuranoses 1o is up to 42%.  
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5.5. Conclusions 
 
We have systematically investigated a conceptually new synthetic route to C-nucleosides. 
This synthetic concept is based on a divergent reaction sequence containing three strategic 
steps and, as the very last step, the deprotection. 
 
All the strategic reactions are catalytic oranometallic reactions employing group 8a. 
transition metals. All the reactions were, from the beginning, optimized with a view of 
maximal atom efficiency. The point of an environmental impact was strongly considered 
through all the optimization processes, and only the reaction variations with the lowest 
toxicity and with the lowest environmental impact were chosen, and optimized further.  
 
The successful implementation of a divergent synthetic route enabled us to access two 
important, biologically significant groups of compounds. The two first strategic 
transformations are common for both target families of compounds (AAS, and RCM 
reactions). D4 C-nucleoside analogues were synthesised in a three-step procedure, and 
1’-aryl ribofuranoses were constructed in a fourth-step procedure.  
 
The enantiopurity and diastereopurity of all the products is based on the enantiopurity of 
the starting materials, and a conservation of this chirality throughout all the 
transformations employed. From this point of view, the most important is the first strategic 
connection, utilizing an excellent memory effect of the iridium catalyst in the allylic 
substitution. The right choice of the right enantiomer of the starting material is very 
straightforward. For example in the case of 1’-aryl ribofuranose, there are fourth 
stereocentres at carbons 1’, 2’, 3’, and 4’. The configuration of the centres 2’, and 3’ (syn) 
is introduced in the last strategic step, and fully depends on the configuration of the centres 
1’, and 4’. These later ones are based on the configuration in the two starting materials. 
Thus full chirality control can be easily achieved.  
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Scheme 99. Chirality source retention in novel ribofuranisides 1o synthesis
O Ph
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In summary, diol (S)-235 leads to the D-ribofuranoses and diol (R)-235 leads to the 
L-ribofuranoses. The combinations of enantiomers of the diol and the carbonate (S)-,(S)-, 
and (R)-, (R)- led to the alpha ribofuranoses, whereas mixed configuration of (S)-,(R)-, and 
(R)-, (S)- led to the beta ribofuranoses (Scheme 99). 
 
We have successfully developed new synthetic methodology enabling to prepare two 
important classes of biologically significant compounds, utilising one common 
(retro)synthetic concept (Scheme 100). The target compounds were prepared in excellent 
enantio- and diastereopurity, in good overall yields. The yield in the synthesis of 1’-aryl-
2’,3’-didehydro-1’,2’,3’-trideoxyribofunanoses is up to 46% over all the reaction steps. 
The yield of 1’-arylribofuranoses depends in particular on successful undertaking of the 
oxidation step. In the first attempt we can predict about 15% overall yield, about 30% 
overall yield in the case the phase transfer in a heterogeneous reaction mixture was well 
managed, and finally the overall yield up to roughly 42%, in the case of good phase 
transfer control and a recovery of an unreacted starting material (kinetic control). 
 
All the reaction steps were investigated in detail and optimized. We were aware of the key 
importance of the starting materials resources, and an extensive account on all the starting 
materials was reported herein. All the starting materials utilised are either commercially 
available or easy to prepare in high yields and excellent stereoselectivity. 
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Scheme 100. Total overall preparative yields of C-nucleosides and their analogues
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Our new synthetic methodology is fully comparable with current state-of-the-art synthetic 
routes to C-nucleosides. This is particularly interesting in the term of a small number of 
reaction steps and a good overall yield. Our synthetic protocol enables to produce 
C-nucleosides with any stereochemistry required, with a variety of structural features in the 
aglycon unit, thus providing unprecedented synthetic tool. Despite not fully optimised 
oxidation step, the overall yield is fully comparable with the most common synthetic 
methods. Future work of our research will be focused on the optimisation of the oxidation 
step as it could enhance the overall yield of the synthesis up to 70%.  
 
Every synthetic methodology has its limitations. In summary of all the above results, our 
new methodology is perfectly suitable for the synthesis of 1’-arylribofuranoses, and their 
D4-analogues, bearing non-ortho-substituted aromatics and heteroaromatics, lacking 
coordinating (nitrogen) substituents or (ring)heteroatoms. From this point of view the most 
promising target application is the synthesis of lipophilic isosters of ribonucleosides for the 
RNA-studies. 
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6. Experimental 
 
6.1. General  Methods 
 
Melting points were determined on a Kofler block and are uncorrected. Optical rotations 
were recorded in CHCl3 at 25 °C unless otherwise indicated with an error of <±0.1 on an 
Autopol IV (Rudolph Research Analytical) polarimeter. The [α]D values are given in 
10
-1 deg cm
2 g
-1. The NMR spectra were measured in chloroform-d1. Residual solvent 
peaks (δ 7.26, 
1H; δ 77.00, 
13C) and CCl3F (δ 0.00, 
19F) were used as internal standards 
unless otherwise indicated. Chemical shifts are given in ppm (δ-scale), coupling constants 
(J) in Hz. Complete assignment of all NMR signals was performed using a combination of 
H,H-COSY, H,C-HSQC and H,C-HMBC experiments. IR spectra were recorded for a thin 
film between NaCl plates or for CHCl3 solutions. Mass spectra (EI or CI-isobutane, unless 
otherwise specified) were measured on a dual sector mass spectrometer using direct inlet 
and the lowest temperature enabling evaporation. All reactions were performed under an 
atmosphere of dry, oxygen-free argon in oven-dried glassware three times evacuated and 
backfilled with the argon three times. Reaction temperature -83 °C refers to the cooling 
bath filled with an ethyl acetate – liquid nitrogen mixture. Solvents and solutions were 
transferred by syringe-septum and cannula techniques. All solvents for the reactions were 
of reagent grade and were dried and distilled immediately before use as follows: 
tetrahydrofuran (THF) from sodium/benzophenone; dichloromethane from calcium 
hydride. Solvents for the palladium- and ruthenium-catalysed reactions were degassed in 
vacuo and stored over molecular sieves (4 Å) under argon atmosphere. Yields are given for 
isolated products showing one spot on a TLC plate and no impurities detectable in the 
NMR spectrum. The identity of the products prepared by different methods was checked 
by comparison of their 
1H-NMR spectra, and ultimate elemental composition 
(microanalysis). 
 
6.2. General  Procedures 
 
General Procedure A: tert-Butyloxycarbonylation of Alcohols to Produce Carbonates 
236. An alcohol (100.0 mmol, neat or 5M solution in THF if solid) was added slowly to a 
suspension of sodium hydride (6.0 g, 150 mmol, 60% suspension in mineral oil, 3× washed 
with dry THF) in THF (100 mL) at room temperature and the mixture was stirred for 1 h.  
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The resulting solution was added slowly to a solution of tert-butoxy-
(tert-butoxycarbonyloxy)methanone (Boc anhydride, 25.0 g, 115 mmol) in THF (400 mL) 
at room temperature and the mixture was stirred at room temperature overnight. The 
reaction was quenched with brine (100  mL) and the product was extracted into ether 
(500 mL). The organic layer was dried (Na2SO4) and evaporated. 
 
General Procedure B: Suzuki-Miyaura Coupling Reaction to Produce Carbonates 
236. A flask containing aryl iodide 237 (3.00 mmol), K2CO3 (415 mg, 3.00 mmol) and 
(Ph3P)4Pd (60.0 mg, 0.052 mmol) was sealed and three times evacuated and backfilled 
with argon. Boronate 263 (neat, 280 mg, 1.00 mmol), DME (5 mL), and water (5 mL) were 
added and the mixture was stirred at 80 °C for 2 h. The resulting solution was cooled to 
room temperature, diluted with Et2O (80  mL), washed with brine (3 × 50  mL), dried 
(Na2SO4) and evaporated. 
 
General Procedure C: Suzuki-Miyaura Coupling Reaction to Produce Carbonates 
236.  A flask containing K2CO3 (415  mg, 3.00  mmol) and (Ph3P)4Pd (60.0  mg, 
0.052 mmol) was sealed and three times evacuated and backfilled with argon. Aryl halide 
237 (3.00  mmol), boronate 263  (neat, 285  mg, 1.00  mmol), DME (5  mL), and water 
(5 mL) were added and the mixture was stirred at 80 °C for 2 h. The resulting solution was 
cooled to room temperature, diluted with Et2O (80 mL), washed with brine (3 × 50 mL), 
dried (Na2SO4) and evaporated. 
 
General Procedure D: Cross Metathesis Reaction to Carbonates 236. A flask 
containing benzylidene[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(tri-
cyclohexylphosphine)ruthenium (2
nd generation Grubbs catalyst; C2; 23.9  mg, 
0.028  mmol) was sealed and three times evacuated and backfilled with argon. 
Dichloromethane (2.0 mL), neat allyl carbonate 240 (1.00 mmol), and neat vinyl aromate 
239 (0.40 to 5.00 mmol) were added and the mixture was stirred at 40 °C for 2 h. The 
resulting solution was cooled to room temperature and evaporated. 
 
General Procedure E: Horner-Wadsworth-Emmons Based Reaction Sequence to 
Carbonates 236. n-Butyllithium (11 mL, 22 mmol, 2.0M solution in pentane) was added 
slowly to a solution of triethylphosphonoacetate 241 (4.49 g, 20.0 mmol) in THF (20 mL) 
at –83 °C. After 5 min, aldehyde 143 (20.0 mmol) was added slowly and the resulting 
mixture was stirred at -83 °C for 10 min and then at room temperature for 2 h. The reaction  
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was quenched with brine (10 mL), the mixture was diluted with ether (100 mL), washed 
with brine (3 × 50 mL), dried (Na2SO4), and evaporated. The crude ethyl ester 265 was 
dissolved in THF (20 mL), cooled to 0 °C, and DIBAL-H (40 mL, 60 mmol, 1.5M solution 
in toluene) was added slowly at this temperature. The resulting mixture was stirred at room 
temperature for an additional 2 h and than the reaction was quenched with a saturated 
aqueous solution of potassium-sodium tartrate (50 mL). The resulting solution was stirred 
at 40 °C and a solid potassium-sodium tartrate (approximately 15 g) was added in portions, 
until the solution became homogeneous. The resulting mixture was diluted with ether 
(300  mL), washed with a saturated aqueous solution of potassium-sodium tartrate 
(3 × 100 mL), dried (Na2SO4), and evaporated. The crude allyl alcohol 264 was dissolved 
in THF (20 mL) and slowly added to a suspension of sodium hydride (1.21 g, 30.3 mmol, 
60% suspension in mineral oil, 3  ×  washed with dry THF) in THF (20  mL) at room 
temperature and the mixture was stirred for 1 h. The resulting solution was added slowly to 
a solution of Boc anhydride (4.84 g, 22.2 mmol) in THF (50 mL) at room temperature and 
the mixture was stirred at room temperature overnight. The reaction was quenched with 
brine (10  mL) and the mixture was diluted with ether (250  mL), washed with brine 
(3 × 50 mL), dried (Na2SO4), and evaporated.  
 
6.3.  Synthesis of Linear Carbonates 
 
Ph OBoc
236a
 
tert-Butyl (E)-3-Phenylprop-2-en-1-yl Carbonate (236a). Fractional distillation of the 
crude product obtained by procedure A produced 236a as a colourless oil (34.07 g, 73%): 
bp 114 °C at 270 Pa; 
1H-NMR (400.1 MHz, CDCl3) δ 1.54 (s, 9H, t-Bu), 4.76 (dd, 
3J1-H,2-H 
= 6.5 Hz, 
4J1-H,3-H = 1.1 Hz, 2H, 1-H), 6.33 (dt, 
3J = 15.9 Hz, 
3J2-H,1-H = 6.5 Hz, 1H, 2-H), 
6.71(dt, 
3J3-H,2-H = 15.9 Hz, 
4J3-H,1-H = 1.1 Hz, 1H, 3-H), 7.27-7.32 (m, 1H, H-arom), 
7.33-7.38 (m, 2H, H-arom), 7.43 (dd, JH,H = 7.2 and 1.5 Hz, 2H, H-arom); 
13C-NMR 
(100.6 MHz, CDCl3) δ 27.65 (C(CH3)3), 67.32 (CH2-1), 82.03 (C(CH3)3), 122.74 (CH-2), 
126.51, 127.94 and 128.46 (CH-arom), 134.25 (CH-3), 136.03 (C-arom), 153.21 (CO 
carbonate); MS (CI-NH3) m/z (%) 252 (M+NH4
+, 2), 151 (1), 134 (3), 117 (2), 88 (3); IR 
(CHCl3): ν 2980 (m), 1740 (s), 1449 (w), 1369 (m), 1275 (s), 1254 (s), 1163 (s), 1117 (m), 
1085 (w), 967 (m) cm
-1. Anal. Calcd. for C14H18O3: C, 71.77; H, 7.74. Found: C, 71.93; H, 
7.78.  
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OBoc
236b
OMe
MeO
 
tert-Butyl (E)-3-(2’,3’-Dimethoxyphenyl)prop-2-en-1-yl Carbonate (236b). The crude 
product obtained by procedure A was chromatographed on a column of silica gel 
(5 × 10 cm) with a mixture of hexanes and ethyl acetate (90:10) to afford 236b as a yellow 
oil (1.064 g, 49%, 62% based on the recovered allylic alcohol). Continued elution with a 
mixture of hexanes and ethyl acetate (80:20) gave the starting allylic alcohol 264b 
(272 mg, 19% recovered). 236b: 
1H-NMR (400.1 MHz, CDCl3) δ 1.49 (s, 9H, t-Bu), 3.79 
(s, 3H, CH3O-2’), 3.84 (s, 3H, CH3O-3’), 4.73 (dd, 
3J1-H,2-H = 6.5 Hz, 
4J1-H,3-H = 1.2 Hz, 2H, 
1-H), 6.31 (dt, 
3J2-H,3-H = 16.1 Hz, 
3J2-H,1-H = 6.5 Hz, 1H, 2-H), 6.82 (dd, 
3J4’-H,5’-H = 8.0 Hz, 
4J4’-H,6’-H = 1.4 Hz, 1H, 4’-H), 6.98 (dt, 
3J3-H,2-H = 16.1 Hz, 
4J3-H,1-H = 1.2 Hz, 1H, 3-H), 7.00 
(t, 
3J5’-H,4’-H = 8.0 Hz, 
3J5’-H,6’-H = 8.0 Hz, 1H, 5’-H), 7.07 (dd, 
3J6’-H,5’-H = 8.0 Hz, 
4J6’-H,4’-H 
= 1.4 Hz, 1H, 6’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.71 (C(CH3)3), 55.70 (CH3O-3’), 
60.87 (CH3O-2’), 67.75 (CH2-1), 82.05 (C(CH3)3), 111.74 (CH-4’), 118.26 (CH-6’), 
123.96 (CH-5’), 124.19 (CH-2), 128.72 (CH-3), 130.29 (C-1’), 146.84 (C-2’), 152.89 
(C-3’), 153.27 (CO carbonate); IR (neat) ν 2979 (w), 2835 (w), 1740 (s, CO carbonate), 
1478 (m), 1369 (m), 1272 (s), 1255 (s), 1161 (s), 1117 (m), 1090 (m), 1070 (m), 1008 
(m) cm
-1; MS (EI, 150  °C) m/z (%) 294 (M
+, 15), 238 (M
+-(CH3)2C=CH2, 100), 194 
(M
+-(CH3)2C=CH2-CO2, 5), 177 (MH
+-(CH3)2C=CH2-CO2-H2O, 85); HRMS (EI) 
294.1469 [C16H22O5 (M
+) requires 294.1467]. Anal. Calcd. for C16H22O5: C, 65.29; H, 
7.53. Found: C, 65.14; H, 7.66. 
OBoc
236c
MeO
MeO
 
tert-Butyl (E)-3-(3’,4’-Dimethoxyphenyl)prop-2-en-1-yl Carbonate (236c). The crude 
product obtained by procedure  A was chromatographed on a column of silica gel 
(5 × 10 cm) with a mixture of hexanes and ethyl acetate (90:10) to furnish 236c as a yellow 
oil (638 mg, 33%, 52% based on the recovered allylic alcohol). Continued elution with a 
mixture of hexanes and ethyl acetate (75:25) gave the starting allylic alcohol 264c 
(440 mg, 35% recovered). 236c: 
1H-NMR (400.1 MHz, CDCl3) δ 1.49 (s, 9H, t-Bu), 3.86 
(s, 3H, CH3O), 3.87 (s, 3H, CH3O), 4.69 (dd, 
3J1-H,2-H = 6.6 Hz, 
4J1-H,3-H = 1.1 Hz, 2H,  
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1-H), 6.15 (dt, 
3J2-H,3-H = 15.8 Hz, 
3J2-H,1-H = 6.6 Hz, 1H, 2-H), 6.59 (dt, 
3J3-H,2-H = 15.8 Hz, 
4J3-H,1-H = 1.1 Hz, 1H, 3-H), 6.80 (d, 
3J5’-H,6’-H = 8.1 Hz, 1H, 5’-H), 6.91 (dd, 
3J6’-H,5’-H = 8.1 
Hz, 
4J6’-H,2’-H = 1.9 Hz, 1H, 6’-H), 6.93 (d, 
4J2’-H,6’-H = 1.9 Hz, 1H, 2’-H); 
13C-NMR (100.6 
MHz, CDCl3)  δ 27.71 (C(CH3)3), 55.73 and 55.81 (CH3O), 67.56 (CH2-1), 82.07 
(C(CH3)3), 108.81 (CH-2’), 110.94 (CH-5’), 119.97 (CH-6’), 120.78 (CH-2), 129.16 
(C-1’), 134.39 (CH-3), 148.93 and 149.12 (C-arom), 153.30 (CO carbonate); IR (neat) ν 
2979 (w), 1739 (s, CO carbonate), 1515 (m), 1369 (m), 1269 (s), 1256 (s), 1160 (s), 1027 
(m), 966 (m), 856 (m) cm
-1; MS (EI, 150 °C) m/z (%) 295 (MH
+, 10), 294 (M
+, 50), 238 
(M
+-(CH3)2C=CH2, 100), 224 (32), 193 (MH
+-(CH3)2C=CH2-CO2, 15), 177 
(MH
+-(CH3)2C=CH2-CO2-H2O, 100); HRMS (EI) 294.1466 [C16H22O5 (M
+) requires 
294.1467]. Anal. Calcd. for C16H22O5: C, 65.29; H, 7.53. Found: C, 65.14; H, 7.67. 
Me
OBoc
236d
 
tert-Butyl (E)-3-(4’-Methylphenyl)prop-2-en-1-yl Carbonate (236d). A flask containing 
4-iodotoluene (109  mg, 0.50  mmol), boronic acid 238a (151  mg, 0.75  mmol), K2CO3 
(187  mg, 1.35  mmol) and (PPh3)4Pd (57.0  mg, 0.049  mmol) was sealed, three times 
evacuated and backfilled with argon. DME (5 mL) and water (0.7 mL) were then added 
and the reaction mixture was stirred at 85 °C for 20 h. The resulting solution was 
co-distilled three times with toluene and the residue was chromatographed on a column of 
silica gel (3 × 10 cm) with a mixture of hexanes and ethyl acetate (100:0 to 97:3) to afford 
236d as a colourless oil (76 mg, 61%): 
A crude product obtained using procedure B was chromatographed on a column of 
silica gel (3 × 10 cm) with a mixture of hexanes and ethyl acetate (100:0 to 97:3) to furnish 
236d as a colourless oil (89 mg, 36%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.51 (s, 9H, t-Bu), 
2.34 (s, 3H, CH3), 4.71 (dd, 
3J1-H,2-H = 6.6 Hz, 
4J1-H,3-H = 1.3 Hz, 2H, 1-H), 6.25 (dt, 
3J2-H,3-H 
= 15.9 Hz, 
3J2-H,1-H = 6.6 Hz, 1H, 2-H), 6.64 (dt, 
3J3-H,2-H = 15.9 Hz, 
4J3-H,1-H = 1.3 Hz, 1H, 
3-H), 7.13 (d, 
3J3’-H,2’-H = 8.1 Hz, 2H, 3’-H), 7.29 (d, 
3J2’-H,3’-H = 8.1 Hz, 2H, 2’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 21.22 (CH3), 27.76 (C(CH3)3), 67.63 (CH2-1), 82.16 
(C(CH3)3), 121.73 (CH-2), 126.54 (CH-2’), 129.26 (CH-3’), 133.36 (C-1’), 134.48 (CH-3), 
137.97 (C-4’), 153.33 (CO carbonate); IR (neat) ν 2979 (m), 1736 (s, CO carbonate), 1453 
(m), 1368 (m), 1273 (s), 1155 (s) cm
-1; MS (CI-NH3, 150 °C) m/z (%) 266 (M+NH4
+, 35), 
165 ([M+NH4
+]-Boc, 30), 148 (M+H
+-Boc, 45), 131 (40), 52 (100). Anal. Calcd. for 
C15H20O3: C, 72.55; H, 8.12. Found: C, 72.25; H, 7.98.  
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Me
OBoc
236e
Me
 
tert-Butyl (E)-3-(2’,4’-Dimethylphenyl)prop-2-en-1-yl Carbonate (236e). The crude 
product obtained by procedure  C was chromatographed on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (95:5) to give 236e as a yellowish 
oil (27 mg, 11%). 
The crude product obtained by procedure D was chromatographed on a column of 
silica gel (3 × 10 cm) with hexanes to yield the corresponding stilbene derivative (123 mg); 
continued elution with a mixture of hexanes and ethyl acetate (98.5:1.5) gave 236e as a 
colourless oil (150 mg, 52%). 
The crude product obtained by procedure E was chromatographed on a column of 
silica gel (5 × 15 cm) with a mixture of hexanes and ethyl acetate (98.5:1.5) to produce 
236e as a colourless oil (3.60 g, 68%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, t-Bu), 
2.30 (s, 3H, CH3), 2.31 (s, 3H, CH3), 4.72 (dd, 
3J1-H,2-H = 6.6 Hz, 
4J1-H,3-H = 1.2 Hz, 2H, 
1-H), 6.14 (dt, 
3J2-H,3-H = 15.7 Hz, 
3J2-H,1-H = 6.6 Hz, 1H, 2-H), 6.85 (dt, 
3J3-H,2-H = 15.7 Hz, 
4J3-H,1-H = 1.2 Hz, 1H, 3-H), 6.97 (s, 1H, 3’-H), 6.98 (d, JHH = 7.6 Hz, H-arom), 7.34 (d, 
JHH = 7.6 Hz, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 19.63 (CH3), 21.06 (CH3), 27.78 
(C(CH3)3), 67.84 (CH2-1), 82.12 (C(CH3)3), 123.19 (CH-2), 125.79 and 126.83 (CH-arom), 
131.04 (CH-3’), 132.41 (CH-3), 132.44, 135.53 and 137.74 (C-arom), 153.35 (CO 
carbonate); IR (neat) ν 2980 (m), 2932 (m), 1742 (s, CO carbonate), 1613 (w), 1369 (s), 
1276 (s), 1254 (s), 1162 (s), 1089 (m), 858 (m) cm
-1; MS (CI-NH3, 150 °C) m/z (%) 508 
(2), 468 ([2M+NH4
+]-tBuOH, 5), 386 ([2M+NH4
+]-tBuOH-CO2, 4), 280 ([M+NH4
+], 3), 
179 ([M+NH4
+]-Boc, 3), 162 (MH
+-Boc, 5), 145 (MH
+-Boc-OH, 42), 52 (100). Anal. 
Calcd. for C16H22O3: C, 73.25; H, 8.45. Found: C, 73.18; H, 8.48. 
OBoc
236f
Br
 
tert-Butyl (E)-3-(4’-Bromophenyl)prop-2-en-1-yl Carbonate (236f). The crude product 
obtained by procedure B was chromatographed on a column of silica gel (3 × 10 cm) with 
a mixture of hexanes and ethyl acetate (99:1) to afford 236f as white crystals (113 mg, 
33%): mp 57-58 °C; 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, t-Bu), 4.70 (dd, 
3J1-H,2-H 
= 6.4 Hz, 
4J1-H,3-H = 1.3 Hz, 2H, 1-H), 6.28 (dt, 
3J2-H,3-H = 15.9 Hz, 
3J2-H,1-H = 6.4 Hz, 1H,  
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2-H), 6.60 (dt, 
3J3-H,2-H = 15.9 Hz, 
4J3-H,1-H = 1.3 Hz, 1H, 3-H), 7.24 (d, 
3Ja-H,b-H = 8.4 Hz, 
2H, Ha-arom), 7.44 (d, 
3Jb-H,a-H = 8.4 Hz, 2H, Hb-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 
27.75 (C(CH3)3), 67.13 (CH2-1), 82.30 (C(CH3)3), 121.88 (C-4’), 123.73 (CH-2), 128.10 
(CaH-arom), 131.68 (CbH-arom), 132.98 (CH-3), 135.10 (C-1’), 153.24 (CO carbonate); 
IR (CHCl3) ν 2983 (m), 1740 (s, CO carbonate), 1487 (m), 1370 (m), 1277 (s), 1256 (s), 
1216 (s), 1157 (s), 1073 (m), 845 (m), 755 (s)  cm
-1; MS (CI-NH3, 150  °C) m/z (%) 
642/644/646 ([2M+NH4
+], 10), 524/526/528 ([2M+NH4
+]-tBuOH-CO2, 65), 330/332 
([M+NH4
+], 100), 229/231 ([M+NH4
+]-Boc, 35), 212/214 (MH
+-Boc, 15), 195/197 
(MH
+-Boc-OH, 4), 52 (43). Anal. Calcd. for C14H17BrO3: C, 53.69; H, 5.47. Found: C, 
53.60; H, 5.47. 
OBoc
236g
F
 
tert-Butyl (E)-3-(2’-Fluorophenyl)prop-2-en-1-yl Carbonate (236g). The crude product 
obtained by procedure C was chromatographed on a column of silica gel (3 × 10 cm) with 
a mixture of hexanes and ethyl acetate (100:00 to 98.5:1.5) to give 236g as a colourless oil 
(25 mg, 10%). 
The crude product obtained by procedure D was chromatographed on a column of 
silica gel (3 × 10 cm) with hexanes to yield the corresponding stilbene derivative (17 mg); 
continued elution with a mixture of hexanes and ethyl acetate (98.5:1.5) provided 236g as a 
colourless oil (70 mg, 29%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.51 (s, 9H, t-Bu), 4.74 (dd, 
3J1-H,2-H = 6.3 Hz, 
4J1-H,3-H = 1.4 Hz, 2H, 1-H), 6.38 (dt, 
3J2-H,3-H = 16.1 Hz, 
3J2-H,1-H = 6.3 
Hz, 1H, 2-H), 6.82 (dt, 
3J3-H,2-H = 16.1 Hz, 
4J3-H,1-H = 1.4 Hz, 1H, 3-H), 7.03 (ddd, 
3JHF = 
10.7 Hz, 
3J3’-H,4’-H = 8.2 Hz, 
4J3’-H,5’-H = 1.2 Hz, 1H, 3’-H), 7.10 (dt, 
3J5’-H,4’-H = 7.6 Hz, 
3J5’-
H,6’-H = 7.6 Hz, 
4J5’-H,3’-H = 1.2 Hz, 1H, 5’-H), 7.22 (ddd, 
3J4’-H,3’-H = 8.2 Hz, 
3J4’-H,5’-H = 7.6 
Hz, 
4J4’-H,6’-H = 1.8 Hz, 1H, 4’-H), 7.45 (dd, 
3J6’-H,5’-H = 7.6 Hz, 
4J6’-H,4’-H = 1.8 Hz, 1H, 
6’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.76 (C(CH3)3), 67.47 (CH2-1), 82.30 (C(CH3)3), 
115.75 (d, 
2JCF = 22.1 Hz CH-3’), 123.97 (d, 
2JCF = 12.1 Hz, C-1’), 124.10 (d, 
4JCF = 3.6 
Hz, CH-5’), 125.55 (d, 
4JCF = 5.1 Hz, CH-2), 126.63 (d, 
3JCF = 3.6 Hz, CH-3), 127.61 (d, 
3JCF = 3.6 Hz, CH-6’), 129.34 (d, 
3JCF = 8.8 Hz, CH-4’), 153.28 (CO carbonate), 160.34 (d, 
1JCF = 250.3 Hz, CF-2’); 
19F-NMR (376.5 MHz, CDCl3) δ –118.21; IR (CHCl3) ν 2979 
(m), 1743 (s, CO carbonate), 1489 (m), 1457 (m), 1370 (m), 1256 (s), 1163 (s), 969 (m), 
858 (m), 755 (m)  cm
-1; MS (CI-NH3, 150  °C) m/z (%) 522 ([2M-NH4
+], 1), 404 
([2M+NH4
+]-tBuOH-CO2, 3), 270 ([M+NH4
+], 95), 214 ([M+NH4
+]-CH2=C(CH3)2, 20),  
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169 ([M+NH4
+]-Boc, 20), 152 (MH
+-Boc, 22), 135 (MH
+-Boc-OH, 5), 52 (100). Anal. 
Calcd. for C14H17FO3: C, 66.65; H, 6.79. Found: C, 66.77; H, 6.91. 
OBoc
236h
F
 
tert-Butyl (E)-3-(3’-Fluorophenyl)prop-2-en-1-yl Carbonate (236h). The crude product 
obtained by procedure C was chromatographed on a column of silica gel (3 × 10 cm) with 
a mixture of hexanes and ethyl acetate (99.2:0.8) to furnish 236h as a yellowish oil 
(103 mg, 40%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, t-Bu), 4.72 (dd, 
3J1-H,2-H = 6.3 
Hz, 
4J1-H,3-H = 1.3 Hz, 2H, 1-H), 6.29 (dt, 
3J2-H,3-H = 15.9 Hz, 
3J2-H,1-H = 6.3 Hz, 1H, 2-H), 
6.63 (dt, 
3J3-H,2-H = 15.9 Hz, 
4J3-H,1-H = 1.3 Hz, 1H, 3-H), 6.94 (dddd, 
3JHF = 8.5 Hz, 
3J4’-H,5’-
H = 8.4 Hz, 
4J4’-H,6’-H = 2.5 Hz, 
4J4’-H,2’-H = 0.9 Hz, 1H, 4’-H), 7.08 (ddd, 
3J2’-H,F = 10.1 Hz, 
4J2’-H,4’-H = 2.5 Hz, 
4J2’-H,6’-H = 1.9 Hz, 1H, 2’-H), 7.14 (ddd, 
3J6’-H,5’-H = 7.8 Hz, 
4J6’-H,2’-H = 
1.9 Hz, 
4J6’-H,4’-H = 0.9 Hz, 1H, 6’-H), 7.27 (ddd, 
3J5’-H,4’-H = 8.4 Hz, 
3J5’-H,6’-H = 7.8 Hz, 
4J5’-
H,F = 6.0 Hz, 1H, 5’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.75 (C(CH3)3), 67.02 (CH2-1), 
82.35 (C(CH3)3), 113.06 (d, 
2JCF = 21.8 Hz CH-2’), 114.84 (d, 
2JCF = 21.4 Hz, CH-4’), 
122.50 (d, 
4JCF = 2.8 Hz, CH-6’), 124.38 (CH-2), 130.02 (d, 
3JCF = 8.5 Hz, CH-5’), 132.93 
(d, 
4JCF = 2.5 Hz, CH-3), 138.51 (d, 
3JCF = 7.8 Hz, C-1’), 153.25 (CO carbonate), 163.00 
(d, 
1JCF = 245.4 Hz, CF-3’); 
19F-NMR (376.5 MHz, CDCl3) δ –113.84; IR (CHCl3) ν 2980 
(m), 1741 (s, CO carbonate), 1584 (m), 1370 (m), 1276 (s), 1255 (s), 1161 (s), 1117 (m), 
966 (m), 859 (m)  cm
-1; MS (CI-NH3, 150  °C) m/z (%) 522 ([2M+NH4
+], 15), 404 
([2M+NH4
+]-tBuOH-CO2, 25), 386 (10), 310 (10), 270 ([M+NH4
+], 100), 169 
([M+NH4
+]-Boc, 5), 152 (MH
+-Boc, 5), 135 (MH
+-Boc-OH, 2), 52 (5). Anal. Calcd. for 
C14H17FO3: C, 66.65; H, 6.79. Found: C, 66.49; H, 6.81. 
OBoc
236i
F
 
tert-Butyl (E)-3-(4’-Fluorophenyl)prop-2-en-1-yl Carbonate (236i). The crude product 
obtained by procedure C was chromatographed on a column of silica gel (3 × 10 cm) with 
a mixture of hexanes and ethyl acetate (99:1) to give 236i as a yellowish oil (72 mg, 29%). 
The crude product obtained by procedure E was chromatographed on a column of 
silica gel (5 × 15 cm) with a mixture of hexanes and ethyl acetate (100:0 to 98.5:1.5) to  
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afford 236i as a colourless oil (3.273 g, 65%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, 
t-Bu), 4.70 (dd, 
3J1-H,2-H = 6.5 Hz, 
4J1-H,3-H = 1.2 Hz, 2H, 1-H), 6.21 (dt, 
3J2-H,3-H = 15.9 Hz, 
3J2-H,1-H = 6.5 Hz, 1H, 2-H), 6.63 (dt, 
3J3-H,2-H = 15.9 Hz, 
4J3-H,1-H = 1.2 Hz, 1H, 3-H), 6.94 
(dd, 
3J3’-H,2’-H = 8.8 Hz, 
3J3’-H,F = 8.7 Hz, 2H, 3’-H and 5’-H), 7.28 (dd, 
4J2’-H,F = 5.4 Hz, 
3J2’-H,3’-H = 8.8 Hz, 2H, 2’-H and 6’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.76 (C(CH3)3), 
67.32 (CH2-1), 82.26 (C(CH3)3), 115.51 (d, 
2JCF = 21.7 Hz, CH-3’), 122.64 (d, 
6JCF = 2.2 
Hz, CH-2), 128.19 (d, 
3JCF = 8.1 Hz, CH-2’), 132.34 (d, 
4JCF = 3.2 Hz, C-1’), 133.23 
(CH-3), 153.30 (CO carbonate), 162.56 (d, 
1JCF = 247.6 Hz, CF-4’); 
19F-NMR (376.5 
MHz, CDCl3) δ –114.15; IR (neat) ν 2981 (m), 2936 (w), 1740 (s, CO carbonate), 1601 
(m), 1510 (s, CF), 1370 (m), 1275 (s), 1255 (s), 1159 (s), 850 (m) cm
-1; MS (CI-NH3, 
150 °C) m/z (%) 522 ([2M+NH4
+], 10), 404 ([2M+NH4
+]-tBuOH-CO2, 100), 348 (10), 270 
([M+NH4
+], 40), 169 ([M+NH4
+]-Boc, 7), 152 (MH
+-Boc, 9), 135 (MH
+-Boc-OH, 8), 52 
(1). Anal. Calcd. for C14H17FO3: C, 66.65; H, 6.79. Found: C, 66.39; H, 6.95. 
The crude product obtained by procedure D was chromatographed on a column of 
silica gel (3 × 10 cm) with hexanes to yield the corresponding stilbene derivative (73 mg); 
continued elution with a mixture of hexanes and ethyl acetate (100:0 to 98.5:1.5) gave 236i 
as a colourless oil (65 mg, 27%). 
OBoc
236j
F F
 
tert-Butyl (E)-3-(2’,4’-Difluorophenyl)prop-2-en-1-yl Carbonate (236j). The crude 
product obtained by procedure  C was chromatographed on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (99:1 to 98.5:1.5) to afford 236j as 
a yellowish oil (31 mg, 11%). 
The crude product obtained by procedure E was chromatographed on a column of 
silica gel (5 × 15 cm) with a mixture of hexanes and ethyl acetate (100:0 to 98.5:1.5) to 
furnish 236j as a colourless oil (4.32 g, 80%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, 
t-Bu), 4.72 (dd, 
3J1-H,2-H = 6.3 Hz, 
4J1-H,3-H = 1.1 Hz, 2H, 1-H), 6.31 (dt, 
3J2-H,3-H = 16.1 Hz, 
3J2-H,1-H = 6.3 Hz, 1H, 2-H), 6.74 (dt, 
3J3-H,2-H = 16.1 Hz, 
4J3-H,1-H = 1.1 Hz, 1H, 3-H), 6.79 
(ddd, 
3JHF = 11.4 and 10.8 Hz, 
4J3’-H,5’-H = 2.4 Hz, 1H, 3’-H), 6.84 (dddd, 
3JHF = 11.3 Hz, 
3J5’-H,6’-H = 8.7 Hz, 
4J5’-H,3’-H = 2.4 Hz, 
5JHF = 1.0 Hz, 1H, 5’-H), 7.41 (ddd, 
3J6’-H,5’-H = 8.7 
Hz, 
4JHF = 8.5 and 6.4 Hz, 1H, 6’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.77 (C(CH3)3), 
67.35 (CH2-1), 82.37 (C(CH3)3), 104.09 (t, 
2JCF = 25.6 Hz, CH-3’), 111.52 (dd, 
2JCF = 21.5 
Hz, 
4JCF = 3.6 Hz, CH-5’), 125.23 (dd, 
4JCF = 5.1 Hz, 
6JCF = 2.1 Hz, CH-2), 125.74 (dd,  
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3JCF = 2.9 Hz, 
5JCF = 1.5 Hz, C-3), 128.48 (dd, 
3JCF = 9.5 and 5.2 Hz, CH-6’), 137.50 (d, 
2JCF = 25.6 Hz, C-1’), 153.26 (CO carbonate), 162.40 (d, 
1JCF = 250.1 Hz, CF), 162.52 (d, 
1JCF 250.2 Hz, CF); 
19F-NMR (376.5 MHz, CDCl3) δ –110.66 (d, 
4JFF = 7.9 Hz), -113.92 
(d, 
4JFF = 7.9 Hz); IR (neat) ν 2981 (m), 2934 (m), 1742 (s, CO carbonate), 1615 (m), 1503 
(s, CF), 1370 (m), 1275 (s), 1255 (s), 1161 (s), 966 (m), 853 (m) cm
-1; MS (CI-NH3, 
150 °C)  m/z (%) 288 ([M+NH4
+], 30), 187 ([M+NH4
+]-Boc, 5), 170 
([M+NH4
+]-tBuOH-CO2, 5), 153 ([M+NH4
+]-tBuOH-CO2-NH3, 5), 52 (100). Anal. Calcd. 
for C14H16F2O3: C, 62.22; H, 5.97. Found: C, 62.35; H, 6.15. 
OBoc
236k
MeO
 
tert-Butyl (E)-3-(3’-Methoxyphenyl)prop-2-en-1-yl Carbonate (236k). The crude 
product obtained by procedure  C was chromatographed on a column of silica gel 
(3  ×  10  cm) with a mixture of hexanes and ethyl acetate (99.2:0.8) to give 
iodo-3-methoxybenzene 237k (366 mg, 51% recovered). Continued elution with a mixture 
of hexanes and ethyl acetate (98.5:1.5) furnished 236k as a yellowish oil (73 mg, 25%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, t-Bu), 3.81(s, 3H, CH3O), 4.72 (dd, 
3J1-H,2-H = 
6.4 Hz, 
4J1-H,3-H = 1.3 Hz, 2H, 1-H), 6.29 (dt, 
3J2-H,3-H = 15.9 Hz, 
3J2-H,1-H = 6.4 Hz, 1H, 
2-H), 6.64 (d, 
3J3-H,2-H = 15.9 Hz, 1H, 3-H), 6.82 (ddd, 
3J4’-H,5’-H = 8.1 Hz, 
4J4’-H,2’-H = 2.5 
Hz, 
4J4’-H,6’-H = 0.9 Hz, 1H, 4’-H), 6.92 (dd, 
4J2’-H,4’-H = 2.5 Hz, 
4J2’-H,6’-H = 1.7 Hz, 1H, 
2’-H), 6.98 (ddd, 
3J6’-H,5’-H = 7.9 Hz, 
4J6’-H,2’-H = 1.7 Hz, 
4J6’-H,4’-H = 0.9 Hz, 1H, 6’-H), 7.24 
(dd, 
3J5’-H,4’-H = 8.1 Hz, 
3J5’-H,6’-H = 7.9 Hz, 1H, 5’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 
27.77 (C(CH3)3), 55.18 (CH3O), 67.35 (CH2-1), 82.22 (C(CH3)3), 111.83 (CH-2’), 113.77 
(CH-4’), 119.30 (CH-6’), 123.22 (CH-2), 129.54 (CH-5’), 134.22 (CH-3), 137.62 (C-1’), 
153.31 (CO carbonate), 159.76 (CH-3’); IR (neat) ν 2979 (m), 2938 (m), 1740 (s, CO 
carbonate), 1598 (m), 1580 (m), 1369 (m), 1275 (s), 1255 (s), 1159 (s), 857 (m) cm
-1; MS 
(CI-NH3, 150 °C) m/z (%) 546 ([2M+NH4
+], 18), 428 ([2M+NH4
+]-tBuOH-CO2, 63), 282 
([M+NH4
+], 100), 181 ([M+NH4
+]-Boc, 45), 164 (MH
+-Boc, 40), 147 (MH
+-Boc-OH, 10), 
52 (25). Anal. Calcd. for C15H20O4: C, 68.16; H, 7.63. Found: C, 68.03; H, 7.80.  
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OBoc
236l
O2N
 
tert-Butyl (E)-3-(3’-Nitrophenyl)prop-2-en-1-yl Carbonate (236l). The crude product 
obtained by procedure B was chromatographed on a column of silica gel (3 × 10 cm) with 
a mixture of hexanes and ethyl acetate (98.5:1.5) to afford iodo-3-nitrobenzene 237l 
(562 mg, 73% recovered). Continued elution with a mixture of hexanes and ethyl acetate 
(97.5:2.5) furnished 236l as a yellowish oil (134 mg, 43% of theory, 57% based on the 
recovered iodide): 
1H-NMR (400.1 MHz, CDCl3) δ 1.49 (s, 9H, t-Bu), 4.74 (dd, 
3J1-H,2-H = 
6.0 Hz, 
4J1-H,3-H = 1.4 Hz, 2H, 1-H), 6.42 (dt, 
3J2-H,3-H = 16.0 Hz, 
3J2-H,1-H = 6.0 Hz, 1H, 
2-H), 6.70 (dt, 
3J3-H,2-H = 16.0 Hz, 
4J3-H,1-H = 1.4 Hz, 1H, 3-H), 7.48 (dd, 
3J5’-H,4’-H = 8.1 Hz, 
3J5’-H,6’-H = 7.8 Hz, 1H, 5’-H), 7.67 (ddd, 
3J6’-H,5’-H = 7.8 Hz, 
4J6’-H,2’-H = 1.8 Hz, 
4J6’-H,4’-H = 
0.9 Hz, 1H, 6’-H), 8.08 (ddd, 
3J4’-H,5’-H = 8.1 Hz, 
4J4’-H,2’-H = 2.2 Hz, 
4J4’-H,6’-H = 0.9 Hz, 1H, 
4’-H), 8.21 (dd, 
4J2’-H,4’-H = 2.2 Hz, 
4J2’-H,6’-H = 1.8 Hz, 1H, 2’-H); 
13C-NMR (100.6 MHz, 
CDCl3)  δ 27.69 (C(CH3)3), 66.53 (CH2-1), 82.45 (C(CH3)3), 121.14 (CH-2’), 122.49 
(CH-4’), 126.40 (CH-2), 129.48 (C-5’), 131.23 (CH-3), 132.27 (C-6’), 137.93 (C-1’), 
148.52 (C-3’), 153.13 (CO carbonate); IR (neat) ν 2981 (m), 2935 (m), 1742 (s, CO 
carbonate), 1531 (s, C-N), 1369 (m, N-O), 1351 (s, N-O), 1276 (s), 1255 (s), 1160 (s), 966 
(m), 859 (m), 732 (m)  cm
-1; MS (CI-NH3, 150  °C) m/z (%) 576 ([2M+NH4
+], 5), 458 
([2M+NH4
+]-tBuOH-CO2, 1), 297 ([M+NH4
+], 100), 241 (3), 52 (23). Anal. Calcd. for 
C14H17NO5: C, 60.21; H, 6.14; N, 5.02. Found: C, 60.13; H, 6.15; N, 4.88. 
OBoc
236m
Me
Me
 
tert-Butyl (E)-3-(3’,5’-Dimethylphenyl)prop-2-en-1-yl Carbonate (236m). The crude 
product obtained by procedure  C was chromatographed on a column of silica gel 
(3  ×  10  cm) with a mixture of hexanes and ethyl acetate (99:1) to yield 
3,5-dimethyliodobenzene  237m (252  mg, 35% recovered). Continued elution with a 
mixture of hexanes and ethyl acetate (99:1) afforded 236m as a yellowish oil (87 mg, 
33%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.51 (s, 9H, t-Bu), 2.31 (s, 6H, CH3), 4.71 (dd, 
3J1-
H,2-H = 6.5 Hz, 
4J1-H,3-H = 1.2 Hz, 2H, 1-H), 6.27 (dt, 
3J2-H,3-H = 15.9 Hz, 
3J2-H,1-H = 6.5 Hz, 
1H, 2-H), 6.61 (dt, 
3J3-H,2-H = 15.9 Hz, 
4J3-H,1-H = 1.2 Hz, 1H, 3-H), 6.91 (s, 1H, 4’-H), 7.02  
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(s, 2H, 2’-H and 6’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 21.19 (CH3), 27.76 (C(CH3)3), 
67.55 (CH2-1), 82.09 (C(CH3)3), 122.44 (CH-2’), 124.52 (CH-2’ and CH-6’), 129.77 
(CH-4’), 134.64 (CH-3), 136.08 (C-1’), 137.98 (C-3’ and C-5’), 153.35 (CO carbonate); IR 
(neat) ν 2979 (m), 2920 (w), 1740 (s, CO carbonate), 1602 (w), 1369 (m), 1274 (s), 1254 
(s), 1163 (s), 853 (m) cm
-1; MS (CI-NH3, 150 °C) m/z (%) 542 ([2M+NH4
+], 15), 424 
([2M+NH4
+]-tBuOH-CO2, 100), 280 ([M+NH4
+], 42), 179 ([M+NH4
+]-Boc, 40), 162 
(MH
+-Boc, 52), 145 (MH
+-Boc-OH, 30), 52 (30). Anal. Calcd. for C16H22O3: C, 73.25; H, 
8.45. Found: C, 73.06; H, 8.39. 
OBoc
236n
 
tert-Butyl (E)-3-(Naphthalen-1’-yl)prop-2-en-1-yl Carbonate (236n). The crude product 
obtained by procedure C was chromatographed on a column of silica gel (3 × 10 cm) with 
a mixture of hexanes and ethyl acetate (99:1) to give 1-iodonaphthalene 237n (629 mg, 
81% recovered). Continued elution with a mixture of hexanes and ethyl acetate (98.5:1.5) 
afforded 236n as a yellowish oil (93 mg, 32%, 56% based on recovered iodide): 
1H-NMR 
(400.1 MHz, CDCl3) δ 1.54 (s, 9H, t-Bu), 4.85 (dd, 
3J1-H,2-H = 6.4 Hz, 
4J1-H,3-H = 1.3 Hz, 
2H, 1-H), 6.34 (dt, 
3J2-H,3-H = 15.6 Hz, 
3J2-H,1-H = 6.4 Hz, 1H, 2-H), 7.44 (dt, 
3J3-H,2-H = 15.6 
Hz, 
4J3-H,1-H = 1.3 Hz, 1H, 3-H), 7.46 (m, 1H, 3’-H), 7.50 (m, 1H, 6’-H), 7.52 (m, 1H, 
8’-H), 7.61 (d, JHH = 7.2 Hz, 1H, 4’-H), 7.81 (d, JHH = 8.2 Hz, 1H, 2’-H), 7.86 (dd, JHH = 
7.71 Hz, 
4J6’-H,8’-H = 2.0 Hz, 1H, 6’-H), 8.11 (dd, JHH = 7.2 Hz, 
4J8’-H,6’-H = 2.0 Hz, 1H, 
8’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.77 (C(CH3)3), 67.52 (CH2-1), 82.23 (C(CH3)3), 
123.68 (CH-7’), 124.12 (CH-4’), 125.51 (CH-2), 125.79 (CH-8’), 126.11 and 126.12 
(CH-3’/6’), 128.33 (CH-2’), 128.47 (CH-5’), 131.07 (C-10’), 131.64 (CH-3), 133.50 
(C-1’), 133.95 (C-9’), 153.35 (CO carbonate); IR (neat) ν 2979 (m), 1740 (s, CO 
carbonate), 1369 (m), 1276 (s), 1254 (s), 1160 (s), 857 (m), 791 (m), 777 (m) cm
-1; MS 
(CI-NH3, 150 °C) m/z (%) 586 ([2M+NH4
+], 10), 468 ([2M+NH4
+]-tBuOH-CO2, 65), 302 
([M+NH4
+], 30), 201 ([M+NH4
+]-Boc, 25), 184 (MH
+-Boc, 25), 167 (MH
+-Boc-OH, 100), 
52 (10). Anal. Calcd. for C18H20O3: C, 76.03; H, 7.09. Found: C, 76.16; H, 6.92.  
 
141
OBoc
236o
S
 
tert-Butyl (E)-3-(Thiophen-2’-yl)prop-2-en-1-yl Carbonate (236o). The crude product 
obtained by procedure C was chromatographed on a column of silica gel (3 × 10 cm) with 
a mixture of hexanes and ethyl acetate (99:1) to yield 236o as a yellowish oil (77 mg, 
31%). 
The crude product obtained by procedure E was chromatographed on a column of 
silica gel (5  ×  15  cm) with a mixture of hexanes and ethyl acetate (100:0 to 99:1) to 
produce 236o as a colourless oil (3.07 g, 64%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 
9H, t-Bu), 4.67 (dd, 
3J1-H,2-H = 6.5 Hz, 
4J1-H,3-H = 1.3 Hz, 2H, 1-H), 6.12 (dt, 
3J2-H,3-H = 15.7 
Hz, 
3J2-H,1-H = 6.5 Hz, 1H, 2-H), 6.79 (dt, 
3J3-H,2-H = 15.7 Hz, 
4J3-H,1-H = 1.3 Hz, 1H, 3-H), 
6.96 (dd, 
3J4’-H,5’-H = 5.0 Hz, 
3J4-H,3’-H = 3.6 Hz, 1H, 4’-H), 6.99 (dd, 
3J3’-H,4’-H = 3.6 Hz, 
4J3’-
H,5’-H = 1.1 Hz, 1H, 3’-H), 7.18(dd, 
3J5’-H,4’-H = 5.0 Hz, 
4J5’-H,3’-H = 1.1 Hz, 1H, 5’-H); 
13C-NMR (100.6 MHz, CDCl3)  δ 27.75 (C(CH3)3), 67.08 (CH2-1), 82.23 (C(CH3)3), 
122.29 (CH-2), 124.94 (CH-5’), 126.50 (CH-3’), 127.34 (CH-4’), 127.53 (CH-3), 141.13 
(C-1’), 153.26 (CO carbonate); IR (neat) ν 2980 (m), 2933 (w), 1741 (s, CO carbonate), 
1650 (w), 1369 (m), 1274 (s), 1254 (s), 1161 (s), 956 (m), 857 (m), 700 (m) cm
-1; MS 
(CI-NH3, 150  °C) m/z (%) 380 ([2M+NH4
+]-tBuOH-CO2, 1), 258 ([M+NH4
+], 5), 157 
([M+NH4
+]-Boc, 5), 140 (MH
+-Boc, 5), 123 (MH
+-Boc-OH, 25), 52 (100). Anal. Calcd. 
for C12H16O3S: C, 59.97; H, 6.71. Found: C, 59.75; H, 6.96. 
OBoc
236p
S
 
tert-Butyl (E)-3-(Thiophen-3’-yl)prop-2-en-1-yl Carbonate (236p). The crude product 
obtained by procedure C was chromatographed on a column of silica gel (3 × 10 cm) with 
a mixture of hexanes and ethyl acetate (99:1) to afford 236p as a yellowish oil (110 mg, 
44%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, t-Bu), 4.68 (dd, 
3J1-H,2-H = 6.6 Hz, 
4J1-
H,3-H = 1.3 Hz, 2H, 1-H), 6.14 (dt, 
3J2-H,3-H = 15.8 Hz, 
3J2-H,1-H = 6.6 Hz, 1H, 2-H), 6.67 (ddt, 
3J3-H,2-H = 15.8 Hz, 
4J3-H,1-H = 1.3 Hz, 
4J3-H,4’-H = 0.6 Hz, 1H, 3-H), 7.19 (dd, 
4J2’-H,4’-H = 2.9 
Hz, 
4J2’-H,5’-H = 1.3 Hz, 1H, 2’-H), 7.20 (dd, 
3J5’-H,4’-H = 5.1 Hz, 
4J5’-H,2’-H = 1.3 Hz, 1H, 
5’-H), 7.27 (ddd, 
3J4’-H,5’-H = 5.1 Hz, 
4J4’-H,2’-H = 2.9 Hz, 
4J4’-H,3-H = 0.6 Hz, 1H, 4’-H); 
13C-NMR (100.6 MHz, CDCl3)  δ 27.73 (C(CH3)3), 67.40 (CH2-1), 82.15 (C(CH3)3),  
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122.59 (CH-2), 123.10 (CH-2’), 124.91 (CH-5’), 126.13 (CH-4’), 128.62 (CH-3), 138.78 
(C-3’), 153.27 (CO carbonate); IR (neat) ν 2981 (m), 1741 (s, CO carbonate), 1369 (m), 
1275 (s), 1254 (s), 1163 (s) cm
-1; MS (EI, 150 °C) m/z (%) 240 (M
+, 5), 205 (20), 184 
(M
+-(CH3)2C=CH2, 50), 166 (M
+-tBuOH, 100), 140 (M
+-(CH3)2C=CH2-CO2, 20), 123 
(30), 121 (40), 119 (25), 83 (40); HRMS (EI) 240.0822 [C12H16O3S (M
+) requires 
240.0820]. 
N OBoc
236q
 
tert-Butyl (E)-3-(Pyridne-3’-yl)prop-2-en-1-yl Carbonate (236q). The crude product 
obtained by procedure C was chromatographed on a column of silica gel (3 × 10 cm) with 
a mixture of hexanes and ethyl acetate (60:40) to furnish 236q as a brown oil (44 mg, 
18%). 
The crude product obtained by procedure E was chromatographed on a column of 
silica gel (5 × 15 cm) with ethyl acetate to afford 236q as a brown oil (2.22 g, 48%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.45 (s, 9H, t-Bu), 4.68 (dd, 
3J1-H,2-H = 6.2 Hz, 
4J1-H,3-H = 
1.4 Hz, 2H, 1-H), 6.31 (dt, 
3J2-H,3-H = 16.0 Hz, 
3J2-H,1-H = 6.2 Hz, 1H, 2-H), 6.60 (dt, 
3J3-H,2-
H = 16.0 Hz, 
4J3-H,1-H = 1.4 Hz, 1H, 3-H), 7.19 (dd, 
3J5’-H,4’-H = 8.0 Hz, 
3J5’-H,6’-H = 4.8 Hz, 
1H, 5’-H), 7.64 (ddd, 
3J4’-H,5’-H = 8.0 Hz, 
4J4’-H,2’-H = 2.1 Hz, 
4J4’-H,6’-H = 1.6 Hz, 1H, 4’-H), 
8.43 (dd, 
3J6’-H,5’-H = 4.8 Hz, 
4J6’-H,4’-H = 1.6 Hz, 1H, 6’-H), 8.55 (d, 
4J2’-H,4’-H = 2.1 Hz, 1H, 
2’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.62 (C(CH3)3), 66.77 (CH2-1), 82.26 (C(CH3)3), 
123.31 (CH-5’), 125.26 (CH-2), 130.20 (CH-3), 131.68 (C-3’), 132.87 (CH-4’), 148.34 
(CH-2’), 148.93 (CH-6’), 153.08 (CO carbonate); IR (neat) ν 2980 (w), 1744 (s, CO 
carbonate), 1280 (s), 1255 (m), 1161 (m) cm
-1; MS (EI, 150 °C) m/z (%) 236 (MH
+, 100), 
180 (MH
+-(CH3)2C=CH2, 20), 120 (10), 118 (MH
+-(CH3)2C=CH2-H2O, 10); HRMS (EI) 
236.1289 [C13H18O3N (MH
+) requires 236.1287]. Anal. Calcd. for C13H17NO3: C, 66.36; 
H, 7.28; N, 5.95. Found: C, 66.03; H, 7.35; N, 5.89. 
OBoc
236r
CO2Me
AcO
 
Methyl 2-Acetoxy-5-(E)-3’-tert-butoxycarbonyloxy-prop-1’-en-1’-yl Benzoate (236r). 
The crude product obtained by procedure B was chromatographed on a column of silica gel  
 
143
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (98.5:1.5) to yield the deacetylated 
iodide (192  mg); continued elution with a 95:5 mixture gave the starting iodide 237r 
(195 mg, 20% recovered). Finally, elution with a 90:10 mixture afforded 236r (84 mg, 
22%) as a yellow oil: 
1H-NMR (400.1 MHz, CDCl3) δ 1.48 (s, 9H, t-Bu), 2.32 (s, 3H, 
CH3CO), 3.85 (s, 3H, CH3O), 4.70 (dd, 
3J3’-H,2’-H = 6.2 Hz, 
4J3’-H,1’-H = 1.0 Hz, 2H, 3’-H), 
6.29 (dt, 
3J2’-H,1’-H = 15.9 Hz, 
3J2’-H,3’-H = 6.2 Hz, 1H, 2’-H), 6.64 (dt, 
3J1’-H,2’-H = 15.9 Hz, 
4J1’-H,3’-H = 1.0 Hz, 1H, 1’-H), 7.04 (d, 
3J3-H,4-H = 8.4 Hz, 1H, 3-H), 7.54 (dd, 
3J4-H,3-H = 8.4 
Hz, 
4J4-H,6-H = 2.2 Hz, 1H, 4-H), 8.01 (d, 
4J6-H,4-H = 2.2 Hz, 1H, 6-H); 
13C-NMR (100.6 
MHz, CDCl3) δ 20.86 (CH3CO), 27.67 (C(CH3)3), 52.15 (CH3O), 66.88 (CH2-3), 82.26 
(C(CH3)3), 123.12 (C-1), 123.19 (CH-3), 124.53 (CH-2’), 129.79 (CH-6), 131.46 (CH-4), 
132.00 (CH-1’), 134.28 (C-5), 150.07 (C-2), 153.16 (CO carbonate), 164.54 (CO 
benzoate), 169.55 (CO acetate); IR (CHCl3) ν 2980 (m), 1740 (s), 1731 (s), 1369 (s), 1275 
(s), 1187 (s), 1081 (s)  cm
-1; MS (EI, 150  °C) m/z (%) 350 (M
+, 1), 319 (4), 294 
(M
+-(CH3)2C=CH2, 14), 252 (100), 220 (30), 191 (30), 159 (25), 158 (18), 103 (15); 
HRMS (EI) 350.1367 [C18H22O7 (M
+) requires 350.1366]. Anal. Calcd. for C17H22O7: C, 
61.71; H, 6.33. Found: C, 61.53; H, 6.47. 
OBoc
236s
MeO
 
tert-Butyl (E)-3-(4’-Methoxyphenyl)prop-2-en-1-yl Carbonate (236s). The crude 
product obtained by procedure  D was chromatographed on a column of silica gel 
(3  ×  10  cm) with a mixture of hexanes and ethyl acetate (98.5:1.5) to give 236s as a 
colourless oil (88 mg, 35%), followed by corresponding stilbene derivative (21 mg). 236s: 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, t-Bu), 3.81 (s, 3H, CH3O), 4.70 (dd, 
3J1-H,2-H 
= 6.7 Hz, 
4J1-H,3-H = 1.2 Hz, 2H, 1-H), 6.16 (dt, 
3J2-H,3-H = 15.8 Hz, 
3J2-H,1-H = 6.7 Hz, 1H, 
2-H), 6.62 (dt, 
3J3-H,2-H = 15.8 Hz, 
4J3-H,1-H = 1.2 Hz, 1H, 3-H), 6.85 (d, 
3J3’-H,2’-H = 8.8 Hz, 
2H, 3’-H), 7.33 (d, 
3J2’-H,3’-H = 8.8 Hz, 2H, 2’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.78 
(C(CH3)3), 55.26 (CH3O), 67.74 (CH2-1), 82.11 (C(CH3)3), 113.97 (CH-3’), 120.54 
(CH-2), 127.88 (CH-2’), 128.93 (C-1’), 134.25 (CH-3), 153.37 (CO carbonate), 159.56 
(C-4’); IR (neat) ν 2979 (m), 1742 (s, CO carbonate), 1610 (m), 1514 (m), 1370 (m), 1275 
(s), 1253 (s), 1164 (s), 1034 (m), 849 (m)  cm
-1; MS (CI-NH3, 150  °C) m/z (%) 282 
([M+NH4
+], 0.5), 264 (M
+, 1), 208 (5), 175 (20), 147 ([M+NH4
+]-NH3-tBuOH-CO2, 100). 
Anal. Calcd. for C15H20O4: C, 68.16; H, 7.63. Found: C, 68.32; H, 7.89.  
 
144
OBoc
236t
AcO
 
tert-Butyl (E)-3-(4’-Acetyloxyphenyl)prop-2-en-1-yl Carbonate (236t). The crude 
product obtained by procedure  D was chromatographed on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (98.5:1.5) to yield the starting 
acetate 239t (46 mg, 28% recovered). Continued elution with a 92.5:7.5 mixture afforded 
236t (75  mg, 36% based on recovered starting acetate) as a colourless oil; the 
corresponding stilbene derivative (8 mg) was eluted with an 85:15 mixture. 236t: 
1H-NMR 
(400.1 MHz, CDCl3) δ 1.50 (s, 9H, t-Bu), 2.29 (s, 3H, CH3CO), 4.70 (dd, 
3J1-H,2-H = 6.4 
Hz, 
4J1-H,3-H = 1.2 Hz, 2H, 1-H), 6.24 (dt, 
3J2-H,3-H = 15.9 Hz, 
3J2-H,1-H = 6.4 Hz, 1H, 2-H), 
6.64 (dt, 
3J3-H,2-H = 15.9 Hz, 
4J3-H,1-H = 1.2 Hz, 1H, 3-H), 7.04 (d, 
3J3’-H,2’-H = 8.6 Hz, 2H, 
3’-H), 7.39 (d, 
3J2’-H,3’-H = 8.6 Hz, 2H, 2’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 21.06 
(CH3CO), 27.73 (C(CH3)3), 67.25 (CH2-1), 82.19 (C(CH3)3), 121.67 (CH-3’), 123.13 
(CH-2), 127.57 (CH-2’), 133.27 (CH-3), 133.94 (C-1’), 150.34 (C-4’), 153.26 (CO 
carbonate), 169.28 (CO acetate); IR (neat) ν 2981 (m), 1740 (s, CO carbonate), 1507 (m), 
1370 (m), 1275 (s), 1255 (s), 1194 (s), 1164 (s) cm
-1; MS (CI-NH3, 150 °C) m/z (%) 602 
([2M+NH4
+], 1), 484 ([2M+NH4
+]-tBuOH-CO2, 2), 310 ([M+NH4
+], 10), 175 
([M+NH4
+]-NH3-tBuOH-CO2, 100). Anal. Calcd. for C16H20O5: C, 65.74; H, 6.90. Found: 
C, 65.60; H, 7.02. 
N
OBoc
236u
 
tert-Butyl (E)-3-(Pyridine-2’-yl)prop-2-en-1-yl Carbonate (236u). The crude product 
obtained by procedure E was chromatographed on a column of silica gel (5 × 15 cm) with 
ethyl acetate to afford 236u as a brown oil: 
1H-NMR (400.1 MHz, CDCl3) δ 1.46 (s, 9H, 
t-Bu), 4.74 (d, 
3J1-H,2-H = 4.7 Hz, 2H, 1-H), 6.69 (d, 
3J3-H,2-H = 15.8 Hz, 1H, 3-H), 6.75 (dt, 
3J2-H,3-H = 15.8 Hz, 
3J2-H,1-H = 4.7 Hz, 1H, 2-H), 7.09 (ddd, 
3J5’-H,4’-H = 7.6 Hz, 
3J5’-H,6’-H = 
4.8 Hz, 
4J5’-H,3’-H = 1.0 Hz, 1H, 5’-H), 7.24 (ddd, 
3J3’-H,4’-H = 7.8 Hz, 
4J3’-H,5’-H = 1.0 Hz, 
5J3’-
H,6’-H = 0.9 Hz, 1H, 3’-H), 7.58 (ddd, 
3J4’-H,3’-H = 7.8 Hz, 
3J4’-H,5’-H = 7.6 Hz, 
4J4’-H,6’-H = 1.8 
Hz, 1H, 4’-H), 8.51 (ddd, 
3J6’-H,5’-H = 4.8 Hz, 
4J6’-H,4’-H = 1.8 Hz, 
5J6’-H,3’-H = 0.9 Hz, 1H, 
6’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.66 (C(CH3)3), 66.57 (CH2-1), 82.13 (C(CH3)3), 
121.74 (CH-3’), 122.37 (CH-5’), 127.49 (CH-3), 132.66 (CH-2), 136.37 (CH-4’), 149.46  
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(CH-6’), 153.15 (CO carbonate), 154.48 (C-2’); IR (neat) ν 2980 (w), 1741 (s, CO 
carbonate), 1278 (s), 1254 (s), 1161 (s)  cm
-1; MS (CI-isobutane, 150  °C) m/z (%) 236 
(MH
+, 100), 180 (MH
+-(CH3)2C=CH2, 20), 120 (MH
+-(CH3)2C=CH2-H2O, 40); HRMS 
(CI-isobutane) 236.1289 [C13H18O3N (MH
+) requires 236.1287). Anal. Calcd. for 
C13H17NO3: C, 66.36; H, 7.28; N, 5.95. Found: C, 66.22; H, 7.27; N, 6.07. 
N
OBoc
236v
 
tert-Butyl (E)-3-(Pyridine-4’-yl)prop-2-en-1-yl Carbonate (236v). A solution of the allyl 
alcohol 264v (60 mg, 0.44 mmol) in THF (2 mL) was added slowly to a suspension of 
sodium hydride (54 mg, 1.30 mmol, 60% suspension in mineral oil, 3 × washed with dry 
THF) in THF (3  mL) at room temperature and the mixture was stirred for 1 h. The 
resulting solution was added slowly to a solution of Boc anhydride (226 mg, 1.04 mmol) in 
THF (7  mL) at room temperature and the mixture was stirred at room temperature 
overnight. The reaction was quenched with brine (5 mL), the mixture was diluted with 
ether (100  mL), washed with brine (3  ×  50  mL), dried (Na2SO4), and evaporated. The 
residue was chromatographed on a column of silica gel (3 × 10 cm) with a mixture of 
hexanes and ethyl acetate (60:40) to furnish 236v as a yellow oil (50 mg, 48%): 
1H-NMR 
(400.1 MHz, CDCl3) δ 1.49 (s, 9H, t-Bu), 4.73 (dd, 
3J1-H,2-H = 5.7 Hz, 
4J1-H,3-H = 1.2 Hz, 
2H, 1-H), 6.48 (dt, 
3J2-H,3-H = 16.0 Hz, 
3J2-H,1-H = 5.7 Hz, 1H, 2-H), 6.59 (dt, 
3J3-H,2-H = 16.0 
Hz, 
4J3-H,1-H = 1.2 Hz, 1H, 3-H), 7.22 (d, 
3J3’-H,2’-H = 6.0 Hz, 2H, 3’-H and 5’-H), 8.54 (d, 
3J2’-H,3’-H = 6.0 Hz, 2H, 2’-H and 6’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.71 (C(CH3)3), 
66.47 (CH2-1), 82.53 (C(CH3)3), 120.96 (CH-3’ and CH-5’), 127.94 (CH-2), 131.01 
(CH-3), 143.47 (C-4’), 150.16 (CH-2’ and CH-6’), 153.11 (CO carbonate); IR (neat) ν 
2980 (m), 1742 (s, CO carbonate), 1596 (m), 1369 (m), 1277 (s), 1255 (s), 1162 (s), 1119 
(m), 849 (m) cm
-1; MS (EI, 150 °C) m/z (%) 235 (M
+, 10), 179 (M
+-(CH3)2C=CH2, 45), 
135 (M
+-(CH3)2C=CH2-CO2, 10), 118 (MH
+-(CH3)2C=CH2-CO2-H2O, 30), 28 (100); 
HRMS (EI) 235.1207 [C13H17NO3 (M
+) requires 235.1208]. Anal. Calcd. for C13H17NO3: 
C, 66.36; H, 7.28; N, 5.95. Found: C, 66.20; H, 7.34; N, 5.81. 
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OBoc
236w
N
Me
 
tert-Butyl (E)-3-(N-Methylpyrrol-2’-yl)prop-2-en-1-yl Carbonate (236w). The crude 
product obtained by procedure E was chromatographed on a column of neutral alumina 
(3 × 15 cm) with a mixture of hexanes, ethyl acetate and Et3N (74:25:1) to give 236w as a 
brown oil (200 mg, 31%): 
1H-NMR (400.1 MHz, C6D6) δ 1.35 (s, 9H, t-Bu), 2.72 (s, 3H, 
CH3), 4.60 (dd, 
3J1-H,2-H = 6.6 Hz, 
4J1-H,3-H = 1.2 Hz, 2H, 1-H), 5.94 (dt, 
3J2-H,3-H = 15.7 Hz, 
3J2-H,1-H = 6.6 Hz, 1H, 2-H), 6.16 (dd, 
3J4’-H,3’-H = 3.7 Hz, 
3J4’-H,5’-H = 2.6 Hz, 1H, 4’-H) 6.20 
(dd, 
3J5’-H,4’-H = 2.6 Hz, 
4J5’-H,3’-H = 1.6 Hz, 1H, 5’-H), 6.31 (dt, 
3J3-H,2-H = 15.7 Hz, 
4J3-H,1-H 
= 1.2 Hz, 1H, 3-H), 6.41 (dd, 
3J3’-H,4’-H = 3.7 Hz, 
4J3’-H,5’-H = 1.6 Hz, 1H, 3’-H); 
13C-NMR 
(100.6 MHz, C6D6)  δ 27.76 (C(CH3)3), 33.32 (CH3), 67.92 (CH2-1), 81.16 (C(CH3)3), 
108.30 (CH-3’), 108.47 (CH-4’), 119.72 (CH-2), 123.58 (CH-5’), 123.85 (CH-3), 130.53 
(C-2’), 154.17 (CO carbonate); MS (EI, 150  °C) m/z (%) 237 (M
+, 80), 181 
(M
+-(CH3)2C=CH2, 80), 137 (M
+-(CH3)2C=CH2-CO2, 52), 120 (80), 57 (100); HRMS (EI) 
237.1362 [C13H19NO3 (M
+) requires 237.1365]. 
I
237r
CO2Me
AcO
 
Methyl 2-Acetoxy-5-iodobenzoate (237r).
208 Concentrated H2SO4 (10 drops) was added 
to a solution of 5-iodosalicylic acid (1.515 g, 5.73 mmol) in methanol (10 mL) and the 
resulting mixture was heated at 80 °C for 8 h. The mixture was cooled and poured slowly 
into an ice-water mixture (100 mL). White crystals which precipitated were collected by 
filtration and washed to neutral pH with 5% aqueous sodium hydrogencarbonate and 
distilled water, consecutively. The crude crystals were dissolved in acetic anhydride (3 mL, 
31 mmol), concentrated H2SO4 (5 drops) was added, and the reaction mixture was stirred at 
room temperature for three days. The reaction mixture was then diluted with CHCl3 
(40  mL) and the resulting solution was washed with 5% aqueous sodium 
hydrogencarbonate three times. The organic layer was dried (Na2SO4) and evaporated and 
the residue was chromatographed on a column of silica gel (3 × 10 cm) with a mixture of 
hexanes and ethyl acetate (92:8) to give 237r as a white solid (1.544 g, 84%): 
1H-NMR 
(400.1 MHz, CDCl3) δ 2.34 (s, 3H, CH3CO), 3.87 (s, 3H, CH3O), 6.86 (d, 
3J3-H,4-H = 8.5  
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Hz, 1H, 3-H), 7.85 (dd, 
3J4-H,3-H = 8.5 Hz, 
4J4-H,6-H = 2.2 Hz, 1H, 4-H), 8.32 (d, 
4J6-H,4-H = 
2.2 Hz, 1H, 6-H); consistent with the literature data.
208 
B OBoc
HO
HO
238a
 
1-(tert-Butyloxycarbonyl)prop-2-en-1-ol-3-yl Boronic acid (238a). Cyclohexene 
(165  mg, 2.01  mmol) was added to a mixture of a 1.0M solution of borane in THF 
(1.0 mL, 1.0 mmol) and THF (1 mL) at 0 °C and the mixture was stirred for 1.5 h. The 
resulting solution was evaporated in vacuum to form a white solid, to which were added 
neat catecholborane (1.34 g, 11.2 mmol) and then carbonate 266a (1.50 g, 9.6 mmol) at 
room temperature (spontaneous heating is desired for high yield) and the resulting mixture 
was stirred at room temperature overnight. The reaction was quenched with water (10 mL) 
and the mixture was stirred for 2 h. The resulting suspension was filtered off, yielding 
238a as a white solid (710  mg, 36%). The filtrate was extracted with ethyl acetate 
(3  ×  20  mL) and combined organic layers were dried (Na2SO4) and evaporated. The 
residue was chromatographed on a column of silica gel (5  ×  5  cm) with a mixture of 
hexanes and ethyl acetate (80:20), which eluted catechol. Continued elution with ethyl 
acetate afforded boronic acid 238a as a white foam 504 mg, 26%). The combined yield of 
boronic acid 238a was 1.210 g (62%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.48 (s, 9H, t-Bu), 
4.69 (dd, 
3J1-H,2-H = 4.5 Hz, 
4J1-H,3-H = 1.7 Hz, 2H, 1-H), 5.76 (dt, 
3J3-H,2-H = 17.9 Hz, 
4J3-H,1-
H = 1.7 Hz, 1H, 3-H), 6.91 (dt, 
3J2-H,3-H = 17.9 Hz, 
3J2-H,1-H = 4.5 Hz, 1H, 2-H); 
13C-NMR 
(100.6 MHz, CDCl3): δ 27.70 (C(CH3)3), 67.49 (CH2-1), 82.40 (C(CH3)3), 122.45 (CH-3), 
149.18 (CH-2), 153.15 (CO carbonate); MS (EI) m/z (%) 384 (3(M+H
+-H2O-tBu), 20), 322 
(3(M+H
+-H2O-tBu-H2O.CO2), 10), 278 (3(M+H
+-H2O-tBu-H2O.CO2-CO2), 10), 216 (7), 
177 (8); HRMS (EI) 384.0844 [C12H15O12B3 trimer (M+H
+-H2O-tBu) requires 384.0842]; 
IR (CHCl3) ν 3328 (m), 2977 (w), 1748 (s), 1645 (w), 1394 (m), 1349 (m), 1279 (m), 1248 
(m), 1159 (m), 1138 (m), 1113 (m), 1074 (m) cm
-1. Anal. Calcd. for C8H15BO5: C, 47.56; 
H, 7.48. Found: C, 47.68; H, 7.34.   
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B OH
HO
HO
238b
 
Prop-2-en-1-ol-3-yl Boronic acid (238b).
197 Neat catecholborane (13.25 g, 110.5 mmol) 
was added slowly to neat propargyl alcohol (2.76 g, 50.8 mmol) at room temperature over 
a period of 15 min. After the addition has been completed, the mixture was heated at 70 °C 
for 1 h. White precipitate that was formed during the course of the reaction was dissolved 
in a small amount of a mixture of MeOH and CH2Cl2 (1:1) and chromatographed on a 
column of silica gel (5 × 5 cm): a mixture of hexanes and ethyl acetate (50:50) eluted 
catechol; continued elution with a mixture of CH2Cl2 and MeOH (90:10) furnished boronic 
acid 238b as a white foam (2.08 g, 40%): 
1H-NMR (400.1 MHz, CD3OD) δ 4.10 (dd, 
3J1-
H,2-H = 4.2 Hz, 
4J1-H,3-H = 1.9 Hz, 2H, 1-H), 5.80 (dt, 
3J3-H,2-H = 17.8 Hz, 
4J3-H,1-H = 1.9 Hz, 
1H, 3-H), 6.60 (dt, 
3J2-H,3-H = 17.8 Hz, 
3J2-H,1-H = 4.2 Hz, 1H, 2-H); 
13C-NMR (100.6 MHz, 
CD3OD) δ 64.78 (CH2-1), 123.10 (CH-3), 151.75 (CH-2). 
OBoc
240
 
tert-Butyl Prop-2-en-1-yl Carbonate (240).
222 Fraction distillation of the crude product 
obtained by procedure A yielded 240 as a colourless oil (7.89 g, 50%): bp 40 °C at 270 Pa; 
1H-NMR (400.1 MHz, CDCl3) δ 1.46 (s, 9H, t-Bu), 4.53 (ddd, 
3J1-H,2-H = 5.8 Hz, 
4J1-H,3-Ha = 
1.4 Hz, 
4J1-H,3-Hb = 1.3 Hz, 2H, 1-H), 5.22 (ddd, 
3J3-Hb,2-H = 10.5 Hz, 
2J3-Hb,3-Ha = 2.8 Hz, 
4J3-Hb,1-H = 1.3 Hz, 1H, 3-Hb), 5.31 (ddd, 
3J3-Ha,2-H = 17.2 Hz, 
2J3-Ha,3-Hb = 2.8 Hz, 
4J3-Ha,1-H = 
1.4 Hz, 1H, 3-Ha), 5.90 (ddt, 
3J2-H,3-Ha = 17.2 Hz, 
3J2-H,3-Hb = 10.5 Hz, 
3J2-H,1-H = 5.8 Hz, 
1H, 2-H). Anal. Calcd. for C8H14O3: C, 60.74; H, 8.92. Found: C, 60.70; H, 8.96. 
263
O
B
O
OBoc
 
Pinacolyl 1-(tert-Butyloxycarbonyl)prop-2-en-1-ol-3-yl Boronate (263). Cyclohexene 
(164  mg, 2.00  mmol) was added to a mixture of a 1.0M solution of borane in THF 
(1.0 mL, 1.0 mmol) and THF (1 mL) at 0 °C and the mixture was stirred for 1.5 h. The 
resulting solution was evaporated in vacuum to form a white solid, to which was added 
neat pinacolborane (1.41  g, 11.0  mmol). Carbonate 266a (1.56  g, 10.0  mmol) was then  
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slowly added and the reaction mixture heated spontaneously. The resulting mixture was 
stirred at room temperature overnight, the reaction was quenched with water (2 mL) and 
the mixture was stirred for 1 h. The resulting suspension was extracted with ethyl acetate 
(3 × 20 mL), and the combined organic layers were dried (Na2SO4) and evaporated to yield 
boronate 263 (2.70 g, 95%): bp 110-111 °C at 270 Pa; 
1H-NMR (400.1 MHz, CDCl3) δ 
1.20 (s, 12H, CH3), 1.42 (s, 9H, t-Bu), 4.58 (dd, 
3J1-H,2-H = 4.8 Hz, 
4J1-H,3-H = 1.8 Hz, 2H, 
1-H), 5.63 (dt, 
3J3-H,2-H = 18.1 Hz, 
4J3-H,1-H = 1.8 Hz, 1H, 3-H), 6.55 (dt, 
3J2-H,3-H = 18.1 Hz, 
3J2-H,1-H = 4.8 Hz, 1H, 2-H); 
13C-NMR (100.6 MHz, CDCl3) δ 24.65 (C(CH3)2), 27.65 
(C(CH3)3), 67.76 (CH2-1), 82.03 (C(CH3)3) , 83.27 (C(CH3)2), 120.25 (CH-3), 145.66 
(CH-2), 153.13 (CO carbonate); MS (CI) m/z (%) 285 (9, M+H
+), 284 (2, M+), 229 (100, 
M+H
+-tBu), 228 (25, M
+-tBu), 185 (7, M+H
+-tBu-CO2), 119 (20), 101 (35);HRMS (CI) 
285.1871 [C14H26BO5 (M+H)
+ requires 285.1873]; IR (CHCl3) 2980 (s), 1744 (s), 1648 
(m), 1458 (w), 1370 (m), 1350 (m), 1329 (m), 1278 (s), 1255 (s), 1165 (m), 1145 (s), 1118 
(m) cm
-1; Anal. Calcd. for C14H25BO5: C, 59.18; H, 8.87. Found: C, 59.32; H, 8.83. 
N
OH
264v
 
(E)-3-(Pyridine-4’-yl)prop-2-en-1-ol (264v).  n-Butyllithium (1.1  mL, 2.2  mmol, 2.0M 
solution in pentane) was added slowly to a solution of triethylphosphonoacetate 241 
(450 mg, 2.01 mmol) in THF (5 mL) at –83 °C and the mixture was stirred for 5 min. 
Pyridine-4-carbaldehyde  143v (214  mg, 2.00  mmol) was then slowly added and the 
resulting mixture was stirred at –83  °C for an additional 10  min and then at room 
temperature for 2 h. The reaction was quenched with brine (5 mL), the mixture was diluted 
with ether (100 mL) and washed with brine (3 × 50 mL), dried (Na2SO4), and evaporated. 
The crude ethyl ester 265v was dissolved in THF (5 mL), cooled to -83 °C, DIBAL-H 
(3.2 mL, 4.8 mmol, 1.5M solution in toluene) was added slowly, and the resulting mixture 
was stirred for an additional 2  h at this temperature. The reaction was quenched with 
MeOH (5 mL) and then a saturated aqueous solution of potassium-sodium tartrate (10 mL) 
was added. The resulting mixture was stirred at 40  °C and a solid potassium-sodium 
tartrate (approximately 2  g) was added in portions, until the solution became 
homogeneous. The resulting mixture was diluted with ether (100 mL), washed with an 
aqueous saturated solution of potassium-sodium tartrate (3 × 50 mL), dried (Na2SO4), and 
evaporated. The residue was chromatographed on a column of silica gel (3 × 10 cm) with 
ethyl acetate to afford 264v as a white solid (105  mg, 39%): mp 90-91  °C (CHCl3);  
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1H-NMR (400.1 MHz, CDCl3) δ 2.52 (s, 1H, OH), 4.39 (m, 2H, 1-H), 6.58-6.60 (m, 2H, 
2-H and 3-H), 7.24 (d, 
3J3’-H,2’-H = 6.2 Hz, 2H, 3’-H and 5’-H), 8.52 (d, 
3J2’-H,3’-H = 6.2 Hz, 
2H, 2’-H and 6’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 62.86 (CH2-1), 120.95 (CH-3’ and 
CH-5’), 127.66 and 133.94 (CH-2 and CH-3), 144.30 (C-4’), 149.99 (CH-6’); IR (CHCl3) 
3019 (m), 1220 (m), 1211 (m), 784 (m) cm
-1; MS (EI, 150 °C) m/z (%) 135 (M
+, 75), 117 
(M
+-H2O, 20), 106 (85), 93 (100); HRMS (EI) 135.0686 [C8H9NO (M
+) requires 
135.0684]. 
OBoc
266a
 
tert-Butyl Prop-2-yn-1-yl Carbonate (266a). Fraction distillation of the crude product 
obtained by procedure A gave 266a as a colourless liquid (25.60 g, 82%): bp 47-49 °C at 
270 Pa 
1H-NMR (400.1 MHz, CDCl3) δ 1.47 (s, 9H, t-Bu), 2.50 (t, 
4J3-H,1-H = 2.5 Hz, 1H, 
3-H), 4.64 (d, 
4J1-H,3-H = 2.5 Hz, 2H, 1-H); 
13C-NMR (100.6 MHz, CDCl3)  δ 27.6 
(C(CH3)3), 54.2 (CH2-1), 75.2 (CH-3), 77.2 (C-2), 82.9 (C(CH3)3), 152.6 (CO carbonate); 
MS (CI) m/z (%) 157 (M+H
+, 100), 139 (5), 119 (5), 101 (20), 81 (22); HRMS (CI) 
157.0862 [C8H13O3 (M+H)
+ requires 157.0865]; IR (CHCl3): ν 3296 (m), 2983 (w), 1747 
(s), 1395 (m), 1371 (m), 1280 (m), 1256 (m), 1158 (m), 1097 (m) cm
-1; Anal. Calcd. for 
C8H12O3: C, 61.52; H, 7.74. Found: C, 61.54; H, 7.80. 
 
6.4. Synthesis  of  Branched Carbonates 
 
267a
Ph
OBoc
 
(±)-tert-Butyl 1-Phenylprop-2-en-1-yl Carbonate (267a). Phenylpropenol (±)-269a 
(3.405  g, 25.37  mmol) was added slowly to a suspension of sodium hydride (1.6  g, 
40 mmol, 60% suspension in mineral oil, 3 × washed with dry THF) in THF (35 mL) at 
room temperature and the mixture was stirred for 1 h. The resulting solution was added 
slowly to a solution of Boc anhydride (6.024 g, 27.60 mmol) in THF (100 mL) at room 
temperature and the mixture was stirred at room temperature overnight. The reaction was 
quenched with brine (15 mL), diluted with ether (300 mL), washed with brine (3 × 50 mL), 
dried (Na2SO4), and evaporated. Chromatography on a column of silica gel (5 × 10 cm) 
with a mixture of hexanes and ethyl acetate (98.5:1.5) gave (±)-267a as a colourless oil  
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(5.672 g, 95%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.48 (s, 9H, t-Bu), 5.26-5.33 (m, 2H, 
3-H), 6.00-6.09 (m, 2H, 1-H and 2-H), 7.29-7.40 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, 
CDCl3)  δ 27.76 (C(CH3)3), 79.18 (CH-1), 82.28 (C(CH3)3), 117.10 (CH2-3), 126.97 
(CH-2’), 128.14 (CH-4’), 128.51 (CH-3’), 136.18 (CH-2), 138.69 (C-1’), 152.71 (CO 
carbonate); MS (EI, 150 °C) m/z (%) 234 (M
+, 80), 178 (M
+-(CH3)2C=CH2, 98), 177 (100); 
HRMS (EI) 234.1258 [C14H18O3 (M
+) requires 234.1256]. Anal. Calcd. for C14H18O3: C, 
71.77; H, 7.74. Found: C, 71.64; H, 7.72. 
(R)-267a
Ph
OBoc
 
(R)-tert-Butyl 1-Phenylprop-2-en-1-yl Carbonate (R)-(267a).  n-Butyllithium (6.5  mL, 
13.0  mmol, 2.0M solution in pentane) was added to a cold (0  °C) solution of 
phenylpropenol (R)-269a (1.742 g, 12.98 mmol) in THF (15 mL). The resulting solution 
was stirred at 0 °C for 10 min and then transferred (via cannula) to a solution of Boc 
anhydride (2.974 mg, 13.63 mmol) in THF (30 mL) at 20 °C, and the mixture was stirred 
at this temperature for 3  h (TLC monitoring). The reaction was quenched with brine 
(20 mL), the mixture was diluted with ether (200 mL), washed with brine (3 × 100 mL), 
dried (Na2SO4), and evaporated. Chromatography on a column of silica gel (3 × 10 cm) 
with a mixture of hexanes and ethyl acetate (98.5:1.5) gave (R)-267a as a colourless oil 
(2.804  g, 92%): [α]D  +29.2 (c 0.94, CHCl3), >99% ee, chiral HPLC (Chiracel OJ-H, 
hexane/2-propanol 99:1, 0.500  mL.min
-1)  tR  = 14.59  min ((R)-267a),  tR = 19.13  min 
((S)-267a). 
(S)-267a
Ph
OBoc
 
(S)-tert-Butyl 1-Phenylprop-2-en-1-yl Carbonate (S)-(267a).  n-Butyllithium (2.5  mL, 
5.0  mmol, 2.0M solution in pentane) was added to a cold (0  °C) solution of 
phenylpropenol (S)-269a (675 mg, 5.03 mmol) in THF (5 mL). The resulting solution was 
stirred at 0 °C for 10 min and then transferred (via cannula) to a solution of Boc anhydride 
(1.221  mg, 5.59  mmol) in THF (25  mL) at 20  °C, and the mixture was stirred at this 
temperature for 3 h (TLC monitoring). The reaction was quenched with brine (15 mL), the 
mixture was diluted with ether (50 mL), washed with brine (3 × 50 mL), dried (Na2SO4), 
and evaporated. Chromatography on a column of silica gel (3 × 10 cm) with a mixture of 
hexanes and ethyl acetate (98.5:1.5) gave (S)-267a as a colourless oil (1.132 g, 96%): [α]D  
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-25.6 (c 0.99, CHCl3), >99% ee, chiral HPLC (Chiracel OJ-H, hexane/2-propanol 99:1, 
0.500 mL.min
-1) tR = 14.59 min ((R)-267a), tR = 19.13 min ((S)-267a). 
(S)-267c
OBoc
MeO
MeO
 
(S)-tert-Butyl 1-(3’,4’-dimethoxyphenyl)prop-2-en-1-yl Carbonate (S)-(267c). 
n-Butyllithium (7.3 mL, 14.6 mmol, 2.0M solution in pentane) was added to a cold (0 °C) 
solution of 1-(3,4-dimethoxyphenyl)prop-2-en-1-ol (S)-269c (2.837  g, 14.60  mmol) in 
THF (15 mL). The resulting solution was stirred at 0 °C for 10 min and then transferred 
(via cannula) to a solution of Boc anhydride (3.20 g, 14.7 mmol) in THF (70 mL) at 20 °C, 
and stirred at this temperature for 3 h (TLC monitoring). The reaction was quenched with 
brine (20 mL), diluted with ethyl acetate (200 mL), washed with brine (3 × 80 mL), and 
dried (Na2SO4). Evaporation of the organic phase gave (S)-267c as a light yellow oil 
(4.26 g, 99%): [α]D -42.2 (c 1.66, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 1.45 (s, 9H, 
t-Bu), 3.84 (CH3O), 3.86 (CH3O), 5.22 (ddd, 
3J3-Ha,2-H = 10.4 Hz, JHH = 1.7 Hz, JHH = 1.3 
Hz, 1H, 3-Ha), 5.29 (ddd, 
3J3-Hb,2-H = 17.1 Hz, JHH = 1.5 Hz, JHH = 1.2 Hz, 1H, 3-Hb), 
5.94-5.96 (m, 1H, 1-H), 6.01 (ddd, 
3J2-H,3-Hb = 17.1 Hz, 
3J2-H,3-Ha = 10.4 Hz, 
3J2-H,1-H = 5.9 
Hz, 1H, 2-H), 6.82 (d, 
3J5’-H,6’-H = 8.2 Hz, 1H, 5’-H), 6.87 (d, 
4J2’-H,6’-H = 2.0 Hz, 1H, 2’-H), 
6.91 (dd, 
3J6’-H,5’-H = 8.2 Hz, 
4J6’-H,2’-H = 2.0Hz, 1H, 6’-H); 
13C-NMR (100.6 MHz, CDCl3) 
δ 27.67 (C(CH3)3), 55.75 (2 × CH3O), 78.96 (CH-1), 82.17 (C(CH3)3), 110.02 (CH-2’), 
110.78 (CH-5’), 116.67 (CH2-3), 119.69 (CH-6’), 131.04 (CH-1’), 136.10 (CH-2), 148.85, 
and 148.86 (C-3’, and C-4’), 152.62 (CO carbonate); MS (CI) m/z (%) 295 ([M+H
+], 90), 
177 (100); HRMS (CI) 295.1537 [C16H23O5 (M+H
+) requires 295.1545]. 
267f
OBoc
Br
 
(±)-1-(4’-Bromophenyl)prop-2-en-1-yl tert-Butyl Carbonate (±)-(267f). 
1-(4’-Bromophenyl)prop-2-en-1-ol (±)-269f (13.94 g, 65.4 mmol) was added slowly to a 
suspension of sodium hydride (2.51  g, 104.6  mmol, neat) in THF (70  mL) at room 
temperature and the mixture was stirred for 10  min. The resulting solution was added 
slowly to a solution of Boc anhydride (16.24 g, 74.4 mmol) in THF (100 mL) at room  
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temperature and the mixture was stirred at room temperature overnight. The reaction was 
quenched with brine (20  mL), diluted with ether (300  mL), washed with brine 
(3 × 100 mL), dried (Na2SO4), and evaporated. Gradient chromatography on a column of 
silica gel (10 × 10 cm) with a mixture of hexanes and ethyl acetate (100:0 to 98:2) gave 
(±)-267f as a yellowish oil (17.44 g, 85%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, 
t-Bu), 5.27-5.36 (m, 2H, 3-H), 5.97-6.06 (m, 2H, 1-H and 2-H), 7.28 (d, 
3JHH = 8.6 Hz, 2H, 
H-arom), 7.52 (d, 
3JHH = 8.6 Hz, 2H, H-arom); MS (CI-NH3, 145 °C) m/z (%) 642/644/646 
([2M+NH4
+], 3), 524/526/528 ([2M+NH4
+]-tBuOH-CO2, 25), 330/332 ([M+NH4
+], 30), 
229/231 ([M+NH4
+]-Boc, 35), 212/214 (MH
+-Boc, 100), 195/197 (MH
+-Boc-OH, 85). 
Anal. Calcd. for C14H17BrO3: C, 53.69; H, 5.47. Found: C, 53.72; H, 5.51. 
(S)-267f
OBoc
Br
 
(S)-1-(4’-Bromophenyl)prop-2-en-1-yl tert-Butyl Carbonate (S)-(267f). n-Butyllithium 
(6.0 mL, 12.0 mmol, 2.0M solution in pentane) was added to a cold (0 °C) solution of 
1-(4-bromophenyl)prop-2-en-1-ol (S)-269f (2.575  g, 12.08  mmol) in THF (15  mL). The 
resulting solution was stirred at 0 °C for 10 min and then transferred (via cannula) to a 
solution of Boc anhydride (2.65 g, 12.1 mmol) in THF (60 mL) at 20 °C, and stirred at this 
temperature for 3 h (TLC monitoring). The reaction was quenched with brine (20 mL), 
diluted with ethyl acetate (200 mL), washed with brine (3 × 80 mL), and dried (Na2SO4). 
Evaporation of the organic phase gave (S)-267f as a light yellow oil (3.45 g, 91%): [α]D 
-22.6 (c 1.99, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 1.50 (s, 9H, t-Bu), 5.27-5.36 (m, 
2H, 3-H), 5.97-6.06 (m, 2H, 1-H and 2-H), 7.28 (d, 
3JHH = 8.6 Hz, 2H, H-arom), 7.52 (d, 
3JHH = 8.6 Hz, 2H, H-arom); MS (CI-NH3, 145 °C) m/z (%) 642/644/646 ([2M+NH4
+], 3), 
524/526/528 ([2M+NH4
+]-tBuOH-CO2, 25), 330/332 ([M+NH4
+], 30), 229/231 
([M+NH4
+]-Boc, 35), 212/214 (MH
+-Boc, 100), 195/197 (MH
+-Boc-OH, 85). Anal. Calcd. 
for C14H17BrO3: C, 53.69; H, 5.47. Found: C, 53.72; H, 5.51.  
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(R)-267h
OBoc
F
 
(R)-tert-Butyl 1-(3’-fluorophenyl)prop-2-en-1-yl Carbonate (R)-(267h). n-Butyllithium 
(16  mL, 32  mmol, 2.0M solution in pentane) was added to a cold (0  °C) solution of 
1-(3-fluorophenyl)prop-2-en-1-ol (R)-269h (4.679 g, 30.74 mmol) in THF (30 mL). The 
resulting solution was stirred at 0 °C for 10 min and then transferred (via cannula) to a 
solution of Boc anhydride (7.10 g, 32.5 mmol) in THF (100 mL) at 20 °C, and stirred at 
this temperature for 3 h (TLC monitoring). The reaction was quenched with brine (20 mL), 
diluted with ether (300  mL), washed with brine (3  ×  100  mL), and dried (Na2SO4). 
Evaporation of the organic phase gave (R)-267h as a light yellow oil (7.60 g, 98%): [α]D 
+14.2 (c 4.43, CHCl3), >99% ee, chiral HPLC (Chiracel OJ-H, hexane/2-propanol 99:1, 
0.500 mL.min
-1) tR = 10.20 min ((R)-267h), tR = 12.06 min ((S)-267h); 
1H-NMR (400.1 
MHz, CDCl3) δ 1.48 (s, 9H, t-Bu), 5.25-5.36 (m, 2H, 3-H), 5.99 (ddd, 
3J2-H,3-Ha = 16.1 Hz, 
3J2-H,3-Hb = 10.7 Hz, 
3J2-H,1-H = 6.2 Hz, 1H, 2-H), 6.05 (m, 1H, 1-H), 6.98 (dddd, 
3J4’-H,F = 
8.5 Hz, 
3J4’-H,5’-H  = 8.5 Hz, 
4J4’-H,2’-H = 2.6 Hz, 
4J4’-H,6’-H = 1.0 Hz, 1H, 4’-H), 7.08 (ddd, 
3J2’-H,F = 9.6 Hz, 
4J2’-H,4’-H = 2.6 Hz, 
4J2’-H,6’-H = 1.0 Hz, 1H, 2’-H), 7.14 (dddd, 
3J6’-H,5’-H = 
7.6 Hz, 
4J6’-H,2’-H = 1.0 Hz, 
4J6’-H,4’-H = 1.0 Hz, 
5J6’-H,F = 0.4 Hz, 1H, 6’-H), 7.31 (ddd, 
3J5’-
H,4’-H = 8.5 Hz, 
3J5’-H,6’-H = 7.6 Hz, 
4J5’-H,F = 5.8 Hz, 1H, 5’-H); 
13C-NMR (100.6 MHz, 
CDCl3) δ 27.74 (C(CH3)3), 78.37 (d, 
4JCF = 1.9 Hz, CH-1), 82.59 (C(CH3)3), 113.89 (d, 
2JCF = 22.4 Hz, CH-2’), 115.05 (d, 
2JCF = 21.2 Hz, CH-4’), 117.65 (CH2-3), 122.52 (d, 
4JCF 
= 3.0 Hz, CH-6’), 130.07 (d, 
3JCF = 8.2 Hz, CH-5’), 135.71 (CH-2), 141.35 (d, 
3JCF = 7.1 
Hz, C-1’), 152.60 (CO carbonate), 162.89 (d, 
1JCF = 246.4 Hz, CF-3’); 
19F-NMR (376.5 
MHz, CDCl3) δ –113.06. 
(S)-267h
OBoc
F
 
(S)-tert-Butyl 1-(3’-fluorophenyl)prop-2-en-1-yl Carbonate (S)-(267h). n-Butyllithium 
(15  mL, 30  mmol, 2.0M solution in pentane) was added to a cold (0  °C) solution of 
1-(3-fluorophenyl)prop-2-en-1-ol (S)-269h (4.50  g, 29.6  mmol) in THF (30  mL). The 
resulting solution was stirred at 0 °C for 10 min and then transferred (via cannula) to a 
solution of Boc anhydride (6.92 g, 31.7 mmol) in THF (100 mL) at 20 °C, and stirred at  
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this temperature for 3 h (TLC monitoring). The reaction was quenched with brine (20 mL), 
the mixture was diluted with ether (300 mL), washed with brine (3 × 100 mL), and dried 
(Na2SO4). Evaporation of the organic phase gave (S)-267h as a light yellow oil (7.24 g, 
97%): [α]D  -14.1 (c 3.58, CHCl3), >99% ee, chiral HPLC (Chiracel OJ-H, 
hexane/2-propanol 99:1, 0.500  mL.min
-1)  tR  = 10.20  min ((R)-267h),  tR = 12.06  min 
((S)-267h); 
1H-NMR (400.1 MHz, CDCl3) δ 1.48 (s, 9H, t-Bu), 5.25-5.36 (m, 2H, 3-H), 
5.99 (ddd, 
3J2-H,3-Ha = 16.1 Hz, 
3J2-H,3-Hb = 10.7 Hz, 
3J2-H,1-H = 6.2 Hz, 1H, 2-H), 6.05 (m, 
1H, 1-H), 6.98 (dddd, 
3J4’-H,F = 8.5 Hz, 
3J4’-H,5’-H  = 8.5 Hz, 
4J4’-H,2’-H = 2.6 Hz, 
4J4’-H,6’-H = 
1.0 Hz, 1H, 4’-H), 7.08 (ddd, 
3J2’-H,F = 9.6 Hz, 
4J2’-H,4’-H = 2.6 Hz, 
4J2’-H,6’-H = 1.0 Hz, 1H, 
2’-H), 7.14 (dddd, 
3J6’-H,5’-H = 7.6 Hz, 
4J6’-H,2’-H = 1.0 Hz, 
4J6’-H,4’-H = 1.0 Hz, 
5J6’-H,F = 0.4 
Hz, 1H, 6’-H), 7.31 (ddd, 
3J5’-H,4’-H = 8.5 Hz, 
3J5’-H,6’-H = 7.6 Hz, 
4J5’-H,F = 5.8 Hz, 1H, 
5’-H); 
13C-NMR (100.6 MHz, CDCl3) δ 27.74 (C(CH3)3), 78.37 (d, 
4JCF = 1.9 Hz, CH-1), 
82.59 (C(CH3)3), 113.89 (d, 
2JCF = 22.4 Hz, CH-2’), 115.05 (d, 
2JCF = 21.2 Hz, CH-4’), 
117.65 (CH2-3), 122.52 (d, 
4JCF = 3.0 Hz, CH-6’), 130.07 (d, 
3JCF = 8.2 Hz, CH-5’), 135.71 
(CH-2), 141.35 (d, 
3JCF = 7.1 Hz, C-1’), 152.60 (CO carbonate), 162.89 (d, 
1JCF = 246.4 
Hz, CF-3’); 
19F-NMR (376.5 MHz, CDCl3) δ –113.06. 
267i
OBoc
F
 
(±)-tert-Butyl 1-(4’-Fluorophenyl)prop-2-en-1-yl Carbonate (±)-(267i). 
1-(4’-Fluorophenyl)prop-2-en-1-ol (3.030  g, 20.00  mmol) was added slowly to a 
suspension of sodium hydride (1.6 g, 40 mmol, 60% suspension in mineral oil, 3 × washed 
with dry THF) in THF (40 mL) at room temperature and the mixture was stirred for 1 h. 
The resulting solution was added slowly to a solution of Boc anhydride (4.810  g, 
22.04 mmol) in THF (70 mL) at room temperature and the mixture was stirred at room 
temperature overnight. The reaction was quenched with brine (15 mL), diluted with ether 
(200 mL),  washed  with  brine  (3 × 50 mL),  dried  (Na2SO4), and evaporated. 
Chromatography on a column of silica gel (5 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave (±)-267i as a colourless oil (4.146 g, 82%): 
1H-NMR (400.1 MHz, 
CDCl3) δ 1.47 (s, 9H, t-Bu), 5.26 (dd, JHH = 9.1 Hz, 
2J3-Ha,3-Hb = 1.2 Hz, 1H, 3-Ha), 5.30 
(dd, JHH = 15.7 Hz, 
2J3-Hb,3-Ha = 1.2 Hz, 1H, 3-Hb), 6.01 (m, 2H, 1-H and 2-H), 7.04 (t, 
3J3’-
H,F = 8.7 Hz, 
3J3’-H,2’-H = 8.7 Hz, 2H, 3’-H), 7.35 (dd, 
3J2’-H,3’-H = 8.7 Hz, 
4J2’-H,F = 5.3 Hz, 
2H, 2’-H); 
13C-NMR (100.6 MHz, CDCl3)  δ 27.74 (C(CH3)3), 78.39 (CH-1), 82.42  
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(C(CH3)3), 115.41 (d, 
2JCF = 21.6 Hz, CH-3’), 117.24 (CH2-3), 128.91 (d, 
3JCF = 8.3 Hz, 
CH-2’), 134.53 (d, 
4JCF = 3.2 Hz, C-1’), 135.97 (CH-2), 152.62 (CO carbonate), 162.53 (d, 
1JCF = 246.7 Hz, CF-4’); IR (NaCl, neat) ν 2982 (m), 1742 (s, CO carbonate), 1511 (s), 
1276 (s), 1254 (s), 1157 (s)  cm
-1; MS (EI, 150  °C) m/z (%) 252 (M
+, 5), 196 
(M
+-(CH3)2C=CH2, 45), 135 (90), 57 (100); HRMS (EI) 252.1163 [C14H17O3F (M
+) 
requires 252.1162]. Anal. Calcd. for C14H17O3F: C, 66.65; H, 6.79. Found: C, 66.60; H, 
6.74. 
  Procedure utilising neat sodium hydride: 1-(4’-Fluorophenyl)prop-2-en-1-ol 
(1.135  g, 7.45  mmol) was added slowly to a suspension of sodium hydride (350  mg, 
14.58 mmol, neat) in THF (20 mL) at room temperature and the mixture was stirred for 
15 min. The resulting solution was added slowly to a solution of Boc anhydride (1.880 g, 
8.61 mmol) in THF (50 mL) at room temperature and the mixture was stirred at room 
temperature overnight. The reaction was quenched with brine (15 mL), diluted with ether 
(200 mL),  washed  with  brine  (3 × 50 mL),  dried  (Na2SO4), and evaporated. 
Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave (±)-267i as a colourless oil (1.674 g, 89%). 
267q
OBoc
N
 
(±)-tert-Butyl 1-(Pyridin-3’-yl)prop-2-en-1-yl Carbonate (±)-(267q). Vinylmagnesium 
bromide (70  mL, 70  mmol, 1.0M solution in THF) was added slowly to a solution of 
pyridine-3-carbaldehyde (6.830 g, 63.77 mmol) in THF (60 mL), and the resulting solution 
was stirred at 0 °C for 1 h. Then the solution was added slowly (via cannula) to a solution 
of Boc anhydride (15.454 g, 70.81 mmol) in THF (100 mL) at 0 °C and the mixture was 
stirred at room temperature overnight. The reaction was quenched with brine (15 mL), 
diluted with ether (200  mL), washed with brine (3  ×  50  mL), dried (Na2SO4) and 
evaporated. Chromatography on a column of silica gel (5  ×  10  cm) with a mixture of 
hexanes and ethyl acetate (85:15) gave (±)-267q as a brown oil (3.94 g, 26%): 
1H-NMR 
(400.1 MHz, CDCl3) δ 1.41 (s, 9H, t-Bu), 5.25 (dd, 
3J3-Ha,2-H = 10.3 Hz, 
2J3-Ha,3-Hb = 1.0 Hz, 
1H, 3-Ha), 5.29 (dd, 
3J3-Hb,2-H = 16.8 Hz, 
2J3-Hb,3-Ha = 1.0 Hz, 1H, 3-Hb), 5.97 (ddd, 
3J2-H,3-
Hb = 16.8 Hz, 
3J2-H,3-Ha = 10.3 Hz, 
3J2-H,1-H = 6.0 Hz, 1H, 2-H), 6.00 (m, 1H, 1-H), 7.23(ddd, 
3J5’-H,4’-H = 7.9 Hz, 
3J5’-H,6’-H = 4.8 Hz, JHH = 0.8 Hz, 1H, 5’-H), 7.63 (dddd, 
3J4’-H,5’-H = 7.9 
Hz, 
4J4’-H,2’-H = 2.2 Hz, 
4J4’-H,6’-H = 1.7 Hz, JHH = 0.4 Hz, 1H, 4’-H), 8.50 (dd, 
3J6’-H,5’-H =  
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4.8 Hz, 
4J6’-H,4’-H = 1.7 Hz, 1H, 6’-H), 8.57 (d, 
4J2’-H,4’-H = 2.2 Hz, 1H, 2’-H); 
13C-NMR 
(100.6 MHz, CDCl3) δ 27.60 (C(CH3)3), 76.72 (CH-1), 82.60 (C(CH3)3), 117.94 (CH2-3), 
123.27 (CH-5’), 134.17 (C-3’), 134.53 (CH-4’), 135.16 (CH-2), 148.66 (CH-2’), 149.47 
(CH-6’), 152.35 (CO carbonate); IR (NaCl, neat) ν 2982 (m), 1743 (s, CO carbonate), 1370 
(s), 1274 (s), 1254 (s), 1161 (s)  cm
-1; MS (EI, 150  °C) m/z (%) 235 (M
+, 2), 179 
(M
+-(CH3)2C=CH2, 80), 134 (50), 118 (90), 57 (100); HRMS (EI) 235.1211 [C13H17NO3 
(M
+) requires 235.1208]. Anal. Calcd. for C13H17NO3: C, 66.36; H, 7.28; N, 5.95. Found: 
C, 65.91; H, 7.29; N, 5.87.  
(S)-269a
OH OH
(R)-269a
 
(R)-1-Phenylprop-2-en-1-ol (R)-(269a); (S)-1-Phenylprop-2-en-1-ol (S)-(269a) . 
Novozyme
® 435 (1  g) was added to a mixture of 1-phenylprop-2-en-1-ol (5.02  g, 
37.4 mmol), isoprenyl acetate (14.78 g, 147.6 mmol), and activated 4Å molecular sieves 
powder (5.0 g) in dry toluene (300 mL) and the resulting suspension was stirred at 40 °C 
for 16 h. The suspension was then cooled to ambient temperature, filtered, and evaporated. 
Chromatography on a column of silica gel (5 × 10 cm) with a mixture of hexanes and ethyl 
acetate (95:5) gave corresponding acetate (R)-270a as a colourless liquid (3.104  g), 
followed by (S)-269a (2.247 g, 45%, >99% ee (Chiral GC)) as a colourless liquid. The 
acetate (R)-270a (2.910 g, 16.51 mmol) was placed in a 25 mL flask and cooled to 0 °C. A 
solution of KOH (1.085 g, 19.27 mmol) in water (1.0 mL) was added dropwise, the cooling 
bath was removed, and the solution was heated at 60 °C for 2 h. The mixture was then 
cooled to ambient temperature, water (40 mL) was added, the product was extracted with 
ethyl acetate (3 × 50 mL), and the organic solution was dried (Na2SO4), and evaporated to 
furnish (R)-269a as a colourless liquid (2.195  g, 43%, >99% ee (Chiral GC)). The 
combined yield of both enantiomers was 88% and the chemical purity >99% (GC). Chiral 
GC (Supelco β-DEX 120 column, oven 110 °C isothermal) tR = 23.75 min ((R)-269a), tR = 
25.07 min ((S)-269a). 
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(S)-269c
OH OH
(R)-269c
MeO
MeO
MeO
MeO
 
(R)-1-(3’,4’-Dimethoxyphenyl)prop-2-en-1-ol (R)-(269c) and 
(S)-1-(3’,4’-Dimethoxyphenyl)prop-2-en-1-ol (S)-(269c). Vinylmagnesium bromide 
(122 mL, 122 mmol, 1.0M solution in THF) was added slowly to a cold (-83 °C) solution 
of 3,4-dimethoxybenzaldehyde (20.02  g, 120.5  mmol) in THF (100  mL). The reaction 
mixture was stirred for an additional 2 h (while the cooling bath was allowed to warm up 
to 0  °C), quenched with saturated aqueous solution of ammonium chloride (50  mL), 
diluted with ethyl acetate (400 mL), washed with brine (3 × 100 mL), and dried (Na2SO4). 
Evaporation of the organic phase gave crude (±)-269c as a yellow oil (22.46 g, 96%): 
1H-NMR (400.1 MHz, CDCl3) δ 2.12 (d, JHH = 3.2 Hz, 1H, OH), 3.86 (s, 3H, CH3O), 3.87 
(s, 3H, CH3O), 5.12-5.14 (m, 1H, 1-H), 5.18 (ddd, 
3J3-Ha,2-H = 10.3 Hz, 
4J3-Ha,1-H = 1.4 Hz, 
2J3-Ha,3-Hb = 1.4 Hz, 1H, 3-Ha), 5.33 (ddd, 
3J3-Hb,2-H = 17.1 Hz, 
4J3-Hb,1-H = 1.5 Hz, 
2J3-Hb,3-Ha 
= 1.4 Hz, 1H, 3-Hb), 6.03 (ddd, 
3J2-H,3-Hb = 17.1 Hz, 
3J2-H,3-Ha = 10.3 Hz, 
3J2-H,1-H = 5.9 Hz, 
1H, 2-H), 6.82 (d, 
3J5’-H,6’-H = 8.1 Hz, 1H, 5’-H), 6.89 (dd, 
3J6’-H,5’-H = 8.1 Hz, 
4J6’-H,2’-H = 
1.9 Hz, 1H, 6’-H), 6.90 (d, 
4J2’-H,6’-H = 1.9 Hz, 1H, 2’-H). 
Novozyme
® 435 (2 g) was added to a mixture of a crude (±)-269c (14.86 g, 76.5 mmol), 
isoprenyl acetate (35 mL, 317 mmol), and activated 4Å molecular sieves powder (10 g) in 
dry toluene (650  mL) and the resulting suspension was stirred at 40  °C for 18  h. The 
suspension was then cooled to ambient temperature, filtered, and evaporated. Gradient 
chromatography of the residue on a column of silica gel (8 × 10 cm) with a mixture of 
hexanes and ethyl acetate (80:20 to 62:38) gave the corresponding acetate (R)-270c as a 
colourless liquid (8.28 g), followed by (S)-269c (3.27 g, 22%) as a colourless liquid. The 
acetate (R)-270c (8.28 g, 35.0 mmol) was placed in a 100 mL flask and cooled to 0 °C and 
a solution of KOH (2.26  g, 40.3  mmol) in MeOH (3.0  mL) was added dropwise. The 
cooling bath was removed and the solution was heated at 50 °C for 2 h. The mixture was 
then cooled to ambient temperature, brine (50 mL) was added, and the resulting solution 
was extracted with ethyl acetate (3 × 80 mL), dried (Na2SO4), and filtered. Evaporation of 
the filtrate furnished (R)-269c as a colourless liquid (6.72 g, 45%). The combined yield of 
both enantiomers was 67%. (R)-269c: [α]D +10.8 (c 3.69, PhH). (S)-269c: [α]D -10.8 (c 
2.78, PhH).   
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(S)-269f
OH OH
(R)-269f
Br Br
 
(R)-1-(4’-Bromophenyl)prop-2-en-1-ol (R)-(269f) and 
(S)-1-(4’-Bromophenyl)prop-2-en-1-ol (S)-(269f). Vinylmagnesium bromide (105  mL, 
105  mmol, 1.0M solution in THF) was added slowly to a cold (-83  °C) solution of 
4-bromobenzaldehyde (18.54 g, 100.2 mmol) in THF (100 mL). The reaction mixture was 
stirred for an additional 2 h (while the cooling bath was allowed to warm up to 0 °C), the 
reaction was quenched with saturated aqueous solution of ammonium chloride (50 mL), 
diluted with ethyl acetate (400 mL), washed with brine (3 × 100 mL), and dried (Na2SO4). 
Evaporation of the organic phase gave crude (±)-269f as a yellow oil (20.43 g, 95%): 
1H-NMR (400.1 MHz, CDCl3) δ 2.36 (d, JHH = 3.1 Hz, 1H, OH), 5.12-5.13 (m, 1H, 1-H), 
5.20 (ddd, 
3J3-Ha,2-H = 10.3 Hz, 
4J3-Ha,1-H = 1.3 Hz, 
2J3-Ha,3-Hb = 1.3 Hz, 1H, 3-Ha), 5.32 (ddd, 
3J3-Hb,2-H = 17.1 Hz, 
4J3-Hb,1-H = 1.3 Hz, 
2J3-Hb,3-Ha = 1.3 Hz, 1H, 3-Hb), 5.97 (ddd, 
3J2-H,3-Hb 
= 17.1 Hz, 
3J2-H,3-Ha = 10.3 Hz, 
3J2-H,1-H = 6.1 Hz, 1H, 2-H), 7.22 (d, 
3JHH = 8.5 Hz, 2H, 
2’-H, and 6’-H), 7.47 (d, 
3JHH = 8.5 Hz, 2H, 3’-H, and 5’-H). 
Novozyme
® 435 (2 g) was added to a mixture of a crude (±)-269f (14.98 g, 70.3 mmol), 
isoprenyl acetate (35 mL, 317 mmol), and activated 4Å molecular sieves powder (10 g) in 
dry toluene (650  mL) and the resulting suspension was stirred at 40  °C for 18  h. The 
resulting suspension was then cooled to ambient temperature, filtered, and evaporated. 
Gradient chromatography of the residue on a column of silica gel (8  ×  10  cm) with a 
mixture of hexanes and ethyl acetate (98:2 to 94:6) gave corresponding acetate (R)-270f as 
a colourless liquid (8.16 g), followed by (S)-269f (3.28 g, 22%) as a colourless liquid. The 
acetate (R)-270f (7.47 g, 29.3 mmol) was placed in a 100 mL flask and cooled to 0 °C and 
a solution of KOH (1.89  g, 33.7  mmol) in MeOH (2.0  mL) was added dropwise. The 
cooling bath was removed and the solution was heated at 50 °C for 2 h. The mixture was 
then cooled to ambient temperature, brine (50 mL) was added, and the resulting solution 
was extracted with ethyl acetate (3 × 80 mL), dried (Na2SO4), and filtered. Evaporation of 
the filtrate furnished (R)-269f as a colourless liquid (6.24 g, 41%). The combined yield of 
both enantiomers was 63%. (R)-269f: [α]D -12.2 (c 3.69, PhH). (S)-269f: [α]D +11.59 (c 
3.28, PhH).   
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(S)-269h
OH OH
(R)-269h
F F
 
(R)-1-(3’-Fluorophenyl)prop-2-en-1-ol (R)-(269h) and 
(S)-1-(3’-Fluorophenyl)prop-2-en-1-ol (S)-(269h). Vinylmagnesium bromide (85  mL, 
85  mmol, 1.0M solution in THF) was added slowly to a cold (-83  °C) solution of 
3-fluorobenzaldehyde (9.85 g, 79.4 mmol) in THF (100 mL). The reaction mixture was 
stirred for an additional 2 h (while the cooling bath was allowed to warm up to 0 °C), the 
reaction was quenched with saturated aqueous solution of ammonium chloride (50 mL), 
diluted with ethyl acetate (400 mL), washed with brine (3 × 100 mL), and dried (Na2SO4). 
Evaporation of the organic phase gave crude (±)-269h as a yellow oil (11.93 g, 98%). 
Novozyme
® 435 (2 g) was added to a mixture of a crude (±)-269h (11.52 g, 75.7 mmol), 
isoprenyl acetate (35 mL, 317 mmol), and activated 4Å molecular sieves powder (10 g) in 
dry toluene (650  mL) and the resulting suspension was stirred at 40  °C for 20  h. The 
suspension was then cooled to ambient temperature, filtered, and evaporated. Gradient 
chromatography of the residue on a column of silica gel (8 × 10 cm) with a mixture of 
hexanes and ethyl acetate (98:2 to 96:4) gave the corresponding acetate (R)-270h as a 
colourless liquid (6.42 g, 80%), followed by (S)-269h (4.57 g, 40%) as a colourless liquid. 
The acetate (R)-270h (6.41 g, 33.0 mmol) was placed in a 100 mL flask and cooled to 0 °C 
and a solution of KOH (2.13 g, 38.0 mmol) in MeOH (3.0 mL) was added dropwise. The 
cooling bath was removed and the solution was heated at 50 °C for 2 h. The mixture was 
then cooled to ambient temperature, brine (50 mL) was added, and the resulting solution 
was extracted with ethyl acetate (3 × 80 mL), dried (Na2SO4), and filtered. Evaporation of 
the filtrate furnished (R)-269h as a colourless liquid (4.76 g, 41%). The combined yield of 
both enantiomers was 81%. (R)-269h: [α]D -12.25 (c 4.57, PhH). Anal. Calcd. for C9H9FO: 
C, 71.04; H, 5.96. Found: C, 70.98; H, 6.01. (S)-269h: [α]D +13.13 (c 4.53, PhH). Anal. 
Calcd. for C9H9FO: C, 71.04; H, 5.96. Found: C, 70.78; H, 5.91.  
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269q
OH
N
 
(±)-1-(Pyrid-3’-yl)prop-2-en-1-ol (±)-(269q). A solution of vinylmagnesium bromide 
(43  mL, 43  mmol, 1.0M in THF) was added slowly to a solution of 
pyridine-3-carboxaldehyde (4.50  g, 42.0  mmol) in THF (80  mL) at 0  °C. The resulting 
solution was stirred at room temperature overnight, then quenched with saturated aqueous 
solution of NH4Cl, diluted with Et2O (100  mL), washed with brine (3  ×  50  mL), dried 
(Na2SO4), and evaporated. Chromatography on a column of silica gel (5 × 15 cm) with 
ethyl acetate gave (±)-269q as a yellow oil (1.82 g, 32%): 
1H-NMR (400.1 MHz, CDCl3) δ 
5.15 (dt, 
3Jcis-3-H,2-H = 10.2 Hz, 
2J3-H,3-H = 1.3 Hz, 1H, 3-H), 5.17 (d, 
3J1-H,2-H = 6.2 Hz, 1H, 
H-1), 5.29 (dt, 
3Jtrans-3-H,2-H = 17.1 Hz, 
2J3-H,3-H = 1.3 Hz, 1H, 3-H), 5.67 (bs, 1H, OH), 5.96 
(ddd, 
3J2-H,trans-3-H = 17.1 Hz, 
3J2-H,cis-3-H = 10.2 Hz, 
3J2-H,1-H = 6.2 Hz, 1H, 2-H), 7.21 (ddd, 
3J5’-H,4’-H = 7.9 Hz, 
3J5’-H,6’-H = 4.9 Hz, JHH = 0.8 Hz, 1H, 5’-H), 7.69 (dddd,
3J4’-H,5’-H = 7.9 
Hz, 
4J4’-H,2’-H = 2.2 Hz, 
4J4’-H,6’-H = 1.7 Hz, JHH = 0.6 Hz, 1H, 4’-H), 8.30 (dd, 
3J6’-H,5’-H = 
4.9 Hz, 
4J6’-H,4’-H = 1.7 Hz, 1H, 6’-H), 8.41 (d, 
4J2’-H,4’-H = 2.2 Hz, 1H, 2’-H); 
13C-NMR 
(100.6 MHz, CDCl3) δ 72.44 (CH), 115.52 (CH2), 123.43 (CH), 134.46 (CH), 138.86 (C), 
139.82 (CH), 147.59 (CH), 147.91 (CH); MS (CI) m/z (%) 136 (M+H
+, 100), 118 (15); 
HRMS (CI) 136.0760 [C8H10ON (M+H
+) requires 136.0762]. Anal. Calcd. for C8H9NO: C, 
71.09; H, 6.71; N, 10.36. Found: C, 70.53; H, 6.73; N, 10.26. 
 
6.5.  Synthesis of Protected Butenediols and Their Carbonates 
 
235b
TBSO
OH
 
(±)-1-(tert-Butyldimethylsilyloxy)but-3-en-2-ol (±)-(235b). A solution of 
tert-butyl(chloro)dimethylsilane (4.600 g, 30.52 mmol) in THF (20 mL) was added slowly 
to a solution of butene-1,2-diol (±)-235a (2.721  g, 30.87  mmol) and DMAP (400  mg, 
3.27 mmol) in a mixture of Et3N (15 mL) and THF (60 mL) at 0 °C and the mixture was 
stirred overnight at 20 °C. The reaction was then quenched with water, diluted with Et2O 
(200  mL), three times washed with brine, dried (Na3SO4), and evaporated. 
Chromatography on a column of silica gel (5 × 10 cm) with a mixture of hexanes and ethyl  
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acetate (98:2) gave the butenol (±)-235b as a yellowish liquid (5.081 g, 81%): 
1H-NMR 
(400.1 MHz, CDCl3) δ 0.07 (s, 6H, CH3), 0.90 (s, 9H, t-Bu), 2.60 (d, 
3JOH,2-CH = 3.4 Hz, 
1H, OH), 3.44 (dd, 
2J1-Ha,1-Hb = 10.0 Hz, 
3J1-Ha,2-H = 7.6Hz, 1H, 1-Ha), 3.64 (dd, 
2J1-Hb,1-Ha = 
10.0 Hz, 
3J1-Hb,2-H = 3.8 Hz, 1H, 1-Hb), 4.15 (m, 1H, 2-H), 5.17 (ddd, 
3J4-Ha,3-H = 10.6 Hz, 
2J4-Ha,4-Hb = 1.5 Hz, 
4J4-Ha,2-H = 1.4 Hz, 1H, 4-Ha), 5.33 (ddd, 
3J4-Hb,3-H = 17.3 Hz, 
4J4-Hb,2-H = 
1.6 Hz, 
2J4-Hb,4-Ha = 1.5 Hz, 1H, 4-Hb), 5.80 (ddd, 
3J3-H,4-Hb = 17.3 Hz, 
3J3-H,4-Ha = 10.6 Hz, 
3J3-H,2-H = 5.7 Hz, 1H, 3-H); 
13C-NMR (100.6 MHz, CDCl3): δ -5.42 (CH3), -5.39 (CH3), 
18.27 (C(CH3)3), 25.83 (C(CH3)3), 66.94 (CH2-1), 72.96 (CH-2), 116.36 (CH2-4), 136.67 
(CH-3). Anal. Calcd. for C10H22O2Si: C, 59.35; H, 10.96. Found: C, 59.36; H, 11.07. 
(R)-235b
TBSO
OH
 
(R)-1-(tert-Butyldimethylsilyloxy)but-3-en-2-ol (R)-(235b). A solution of 
tert-butylchlorodimethylsilane (4.34 g, 28.8 mmol) in THF (20 mL) was added slowly to a 
cold solution (0 °C) of diol (R)-235a (2.53 g, 28.6 mmol) in a mixture  of THF (60 mL), 
Et3N (15 mL, 107 mmol), and DMAP (376 mg, 3.07 mmol). The cooling bath was then 
removed and the solution was stirred overnight. The reaction was quenched with water 
(20 mL), diluted with ether (100 mL), washed with brine (3 × 50 mL), dried (Na2SO4), and 
evaporated. Chromatography on a column of silica gel (5 × 10 cm) with hexanes (200 mL), 
followed by elution with a mixture of hexanes and ethyl acetate (98:2) gave (R)-235b as a 
colourless oil (3.83 g, 66%) with chemical purity >99% (GC) and >99% ee (chiral GC): 
1H-NMR (400.1 MHz, CDCl3) δ 0.05 (s, 6H, CH3), 0.88 (s, 9H, t-Bu), 2.65 (d, 
3J2-OH,2-H = 
3.6 Hz, 1H, 2-OH), 3.43 (dd, 
2J1-Ha,1-Hb = 9.9 Hz, 
3J1-Ha,2-H = 7.6 Hz, 1H, 1-Ha), 3.62 (dd, 
2J1-Hb,1-Ha = 9.9 Hz, 
3J1-Hb,2-H = 3.8 Hz, 1H, 1-Hb), 4.10-4.15 (m, 1H, 2-H), 5.15 (dd, 
3J4-Ha,3-
H = 10.6 Hz, 
2J4-Ha,4-Hb = 1.2 Hz, 1H, 4-Ha), 5.31 (dd, 
3J4-Hb,3-H = 17.3 Hz, 
2J4-Hb,4-Ha = 1.2 
Hz, 1H, 4-Hb), 5.78 (ddd, 
3J3-H,4-Hb = 17.3 Hz, 
3J3-H,4-Ha = 10.6 Hz, 
3J3-H,2-H = 5.7 Hz, 1H, 
3-H). Anal. Calcd. for C10H22O2Si: C, 59.35; H, 10.96. Found: C, 59.21; H, 11.13. Chiral 
GC showed >99% ee (Supelco β-DEX 120 column, oven 70 °C for 5 min then gradient 
1 °C.min
-1 to 105 °C) tR = 31.48 min ((S)-235b), tR = 32.68 min ((R)-235b). 
  Fraction distillation of the crude product obtained by the above procedure 
(131 mmol scale) gave (R)-235b as a colourless liquid (21.35 g, 80%): bp 43-45 °C at 
270 Pa.  
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(S)-235b
TBSO
OH
 
(S)-1-(tert-Butyldimethylsilyloxy)but-3-en-2-ol (S)-(235b). A solution of 
tert-butyl(chloro)dimethylsilane (9.26 g, 61.5 mmol) in THF (40 mL) was added slowly to 
a cold solution (0 °C) of diol (S)-235a (5.28 g, 59.9 mmol) in a mixture  of THF (120 mL), 
Et3N (30  mL, 215  mmol), and DMAP (640  mg, 5.23  mmol). The cooling bath was 
removed and the solution was stirred overnight. The reaction was quenched with water 
(20 mL), diluted with ether (200 mL), washed with brine (3 × 80 mL), dried (Na2SO4), and 
evaporated. Chromatography on a column of silica gel (5 × 10 cm) with hexanes (200 mL), 
followed by elution with a mixture of hexanes and ethyl acetate (98:2) gave (S)-235b as a 
colourless oil (9.29 g, 76%) with chemical purity >99% (GC) and >99% ee (chiral GC): 
1H-NMR (400.1 MHz, CDCl3) δ 0.05 (s, 6H, CH3), 0.88 (s, 9H, t-Bu), 2.65 (d, 
3J2-OH,2-H = 
3.6 Hz, 1H, 2-OH), 3.43 (dd, 
2J1-Ha,1-Hb = 9.9 Hz, 
3J1-Ha,2-H = 7.6 Hz, 1H, 1-Ha), 3.62 (dd, 
2J1-Hb,1-Ha = 9.9 Hz, 
3J1-Hb,2-H = 3.8 Hz, 1H, 1-Hb), 4.10-4.15 (m, 1H, 2-H), 5.15 (dd, 
3J4-Ha,3-
H = 10.6 Hz, 
2J4-Ha,4-Hb = 1.2 Hz, 1H, 4-Ha), 5.31 (dd, 
3J4-Hb,3-H = 17.3 Hz, 
2J4-Hb,4-Ha = 1.2 
Hz, 1H, 4-Hb), 5.78 (ddd, 
3J3-H,4-Hb = 17.3 Hz, 
3J3-H,4-Ha = 10.6 Hz, 
3J3-H,2-H = 5.7 Hz, 1H, 
3-H). Anal. Calcd. for C10H22O2Si: C, 59.35; H, 10.96. Found: C, 59.13; H, 11.13. Chiral 
GC showed >99% ee (Supelco β-DEX 120 column, oven 70 °C for 5 min then gradient 
1 °C.min
-1 to 105 °C) tR = 31.48 min ((S)-235b), tR = 32.68 min ((R)-235b). 
Fraction distillation of the crude product obtained by the above procedure 
(156 mmol  scale) gave (S)-235b as a colourless liquid (25.16 g, 80%): bp 46-48 °C at 
300 Pa. 
235c
TBDPSO
OH
 
(±)-1-(tert-Butyldiphenylsilyloxy)but-3-en-2-ol (±)- (235c).
223 
tert-Butyl(chloro)diphenylsilane (16.0 g, 58.2 mmol) was added slowly to a cold (0 °C) 
solution of diol (±)-235a (5.0  g, 56.8  mmol), Et3N (20  mL) and DMAP (488  mg, 
4.00 mmol) in THF (100 mL). The reaction mixture was stirred at room temperature for 
24  h and then quenched with saturated aqueous NaCl (50  mL), extracted with AcOEt 
(3 × 150 mL), dried (MgSO4), and evaporated. Chromatography on a column of silica gel 
(8 × 10  cm) with a mixture of hexanes and ethyl acetate (95:5) gave (±)-235c as a 
colourless oil (17.68 g, 95%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.14 (s, 9H, t-Bu), 2.73 (d,  
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3J2-OH,2-H = 3.9 Hz, 1H, 2-OH), 3.62 (dd, 
2J1-Ha,1-Hb = 10.2 Hz, 
3J1-Ha,2-H = 7.4 Hz, 1H, 
1-Ha), 3.76 (dd, 
2J1-Hb,1-Ha = 10.2 Hz, 
3J1-Hb,2-H = 3.9 Hz, 1H, 1-Hb), 4.27-4.32 (m, 1H, 
2-H), 5.21 (ddd, 
3J4-Ha,3-H = 10.6 Hz, 
2J4-Ha,4-Hb = 1.5 Hz, 
4J4-Ha,2-H = 1.5 Hz, 1H, 4-Ha), 5.37 
(ddd, 
3J4-Hb,3-H = 17.3 Hz, 
2J4-Hb,4-Ha = 1.5 Hz, 
4J4-Hb,2-H = 1.5 Hz,1H, 4-Hb), 5.89 (ddd, 
3J3-
H,4-Hb = 17.3 Hz, 
3J3-H,4-Ha = 10.6 Hz, 
3J3-H,2-H = 5.6 Hz, 1H, 3-H), 7.40-7.48 (m, 6H, 
H-arom), 7.72-7.74 (m, 4H, H-arom); 
13C-NMR (100.6 MHz, CDCl3): δ 19.21 (C(CH3)3), 
26.80 (C(CH3)3), 67.63 (CH2-1), 72.96 (CH-2), 116.41 (CH2-4), 127.73 (CH-arom), 129.78 
(CH-arom), 132.98 (CH-arom), 135.48 (C-arom), 136.59 (CH-3); consistent with the 
literature data.
223 
(R)-235c
TBDPSO
OH
 
(R)-1-(tert-Butyldiphenylsilyloxy)but-3-en-2-ol (R)-(235c).  
tert-Butyl(chloro)diphenylsilane (7.60 g, 27.7 mmol) was added slowly to a cold (0 °C) 
solution of diol (R)-235a (2.18  g, 24.7  mmol), Et3N (10  mL) and DMAP (288  mg, 
2.36 mmol) in THF (40 mL). The reaction mixture was stirred at room temperature for 
24  h and then quenched with saturated aqueous NaCl (50  mL), extracted with AcOEt 
(3 × 150 mL), dried (MgSO4), and evaporated. Chromatography on a column of silica gel 
(5 × 10  cm) with a mixture of hexanes and ethyl acetate (95:5) gave (R)-235c as a 
colourless oil (7.06 g, 88%). [α]D +5.2 (c 0.9, CHCl3). Anal. Calcd. for C20H26O2Si: C, 
73.57; H, 8.03. Found: C, 73.49; H, 8.13. 
(S)-235c
TBDPSO
OH
 
(S)-1-(tert-Butyldiphenylsilyloxy)but-3-en-2-ol (S)-(235c).
223  
tert-Butyl(chloro)diphenylsilane (7.50 g, 27.3 mmol) was added slowly to a cold (0 °C) 
solution of diol (S)-235a (2.20  g, 25.0  mmol), Et3N (10  mL) and DMAP (300  mg, 
2.46 mmol) in THF (50 mL). The reaction mixture was stirred at room temperature for 
24  h and then quenched with saturated aqueous NaCl (50  mL), extracted with AcOEt 
(3 × 150 mL), dried (MgSO4), and evaporated. Chromatography on a column of silica gel 
(5 × 10  cm) with a mixture of hexanes and ethyl acetate (95:5) gave (S)-235c as a 
colourless oil (7.02 g, 86%). [α]D -4.9 (c 1.2, CHCl3). Anal. Calcd. for C20H26O2Si: C, 
73.57; H, 8.03. Found: C, 73.31; H, 8.39. Consistent with the literature data.
223  
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235d
TrtO
OH
 
(±)-1-(Trityloxy)but-3-en-2-ol (235d).
224 A solution of chloro(triphenyl)methane (5.90 g, 
21.2 mmol) in dichloromethane (10 mL) was slowly added to a cold (0 °C) solution of diol 
(±)-235a (1.76  g, 20.0  mmol), Et3N (10  mL) and DMAP (100  mg, 0.82  mmol) in 
dichloromethane (20 mL). The reaction mixture was stirred at room temperature for 24 h 
and then quenched with saturated aqueous NaCl (20  mL), extracted with ethyl acetate 
(3 × 100 mL), dried (Na2SO4), and evaporated. Chromatography on a column of silica gel 
(5  ×  10  cm) with a mixture of hexanes and ethyl acetate (95:5) gave (±)-235d as a 
colourless oil (5.82 g, 88%): 
1H-NMR (400.1 MHz, CDCl3) δ 2.44 (d, 
3J2-OH,2-H = 3.9 Hz, 
1H, 2-OH), 3.14 (dd, 
2J1-Ha,1-Hb = 9.4 Hz, 
3J1-Ha,2-H = 7.5 Hz, 1H, 1-Ha), 3.24 (dd, 
2J1-Hb,1-Ha 
= 9.4 Hz, 
3J1-Hb,2-H = 3.7 Hz, 1H, 1-Hb), 4.27-4.33 (m, 1H, 2-H), 5.18 (ddd, 
3J4-Ha,3-H = 10.6 
Hz, 
2J4-Ha,4-Hb = 1.4 Hz, 
4J4-Ha,2-H = 1.4 Hz, 1H, 4-Ha), 5.32 (ddd, 
3J4-Hb,3-H = 17.2 Hz, 
2J4-
Hb,4-Ha = 1.4 Hz, 
4J4-Hb,2-H = 1.4 Hz, 1H, 4-Hb), 5.83 (ddd, 
3J3-H,4-Hb = 17.2 Hz, 
3J3-H,4-Ha = 
10.6 Hz, 
3J3-H,2-H = 5.7 Hz, 1H, 3-H), 7.25-7.29 (m, 3H, H-arom), 7.31-7.35 (m, 6H, 
H-arom), 7.44-7.48 (m, 6H, H-arom); 
13C-NMR (100.6 MHz, CDCl3): δ 67.37 (CH2-1), 
71.98 (CH-2), 86.72 (CPh3), 116.33 (CH2-4), 127.10 (CH-arom), 127.85 (CH-arom), 
128.61 (CH-arom), 136.92 (CH-3), 143.71 (C-arom); MS (EI) m/z (%) 330 (1, M
+) 243 
(100, Trt), 228 (15), 215 (15), 183 (22), 165 (90), 105 (40), 77 (25). Anal. Calcd. for 
C23H22O2: C,83.60; H, 6.71. Found: C, 81.43; H, 6.58. Consistent with the literature 
data.
224 
235e
PivO
OH
 
(±)-2-Hydroxybut-3-enyl Pivalate  (235e).
223 Pivaloylchloride (2.40  g, 19.9  mmol) was 
slowly added to a cold (0 °C) solution of diol (±)-235a (1.78 g, 20.2 mmol), Et3N (10 mL) 
and DMAP (100 mg, 0.82 mmol) in dichloromethane (20 mL) and the reaction mixture 
was stirred at room temperature for 24 h, and then quenched with saturated aqueous NaCl 
(50  mL), extracted with ethyl acetate (3  ×  100  mL), dried (Na2SO4), and evaporated. 
Gradient chromatography on a column of silica gel (5 × 10 cm) with a mixture of hexanes 
and ethyl acetate (95:5 to 80:20) gave (±)-235e as a colourless oil (1.81 g, 53%): 
1H-NMR 
(400.1 MHz, CDCl3) δ 1.13 (s, 9H, t-Bu), 2.94 (s, 1H, 2-OH), 3.99 (dd, 
2J1-Ha,1-Hb = 11.4 
Hz, 
3J1-Ha,2-H = 6.6 Hz, 1H, 1-Ha), 4.04 (dd, 
2J1-Hb,1-Ha = 11.4 Hz, 
3J1-Hb,2-H = 4.3 Hz, 1H,  
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1-Hb), 4.26-4.31 (m, 1H, 2-H), 5.14 (ddd, 
3J4-Ha,3-H = 10.6 Hz, 
2J4-Ha,4-Hb = 1.4 Hz, 
4J4-Ha,2-H 
= 1.4 Hz, 1H, 4-Ha), 5.29 (ddd, 
3J4-Hb,3-H = 17.2 Hz, 
2J4-Hb,4-Ha = 1.4 Hz, 
4J4-Hb,2-H = 1.4 
Hz,1H, 4-Hb), 5.78 (ddd, 
3J3-H,4-Hb = 17.2 Hz, 
3J3-H,4-Ha = 10.6 Hz, 
3J3-H,2-H = 5.6 Hz, 1H, 
3-H); 
13C-NMR (100.6 MHz, CDCl3): δ 26.97 (C(CH3)3), 38.64 (C(CH3)3), 67.34 (CH2-1), 
70.74 (CH-2), 116.56 (CH2-4), 136.36 (CH-3), 178.58 (CO carbonyl); MS (CI) m/z (%) 
173 (98, M+H
+), 155 (100, M
+-OH), 103 (22, M
+-tBu-H2O); HRMS (CI) 173.1180 
[C9H17O3 (M+H
+) requires 173.1178]; consistent with the literature data.
223  
272
TBDPSO
OBoc
 
(±)-tert-Butyl 1-(tert-Butyldiphenylsilyloxy)but-3-en-2-yl Carbonate (±)-(272). A 
solution of n-butyllithium (5.0 mL, 2.0M in pentane) was added slowly to a solution of 
silylated diol (±)-235c (3.260  g, 9.98  mmol) in THF (10  mL) at 0  °C. The resulting 
solution was stirred at 0  °C for 20 min and than transfered, at room temperature, (via 
canula), to a solution of Boc anhydride (2.45 g, 11.2 mmol) in THF (30 mL), and stirred at 
room temperature overnight. The reaction was quenched with brine (20 mL), diluted with 
ethyl acetate (100 mL), washed with brine (3 × 50 mL), dried (Na2SO4), and evaporated. 
Chromatography on a column of silica gel (5 × 15 cm) with a mixture of hexanes and ethyl 
acetate (95:5) gave (±)-272 as a yellowish oil (4.03  g, 94%): 
1H-NMR (400.1 MHz, 
CDCl3) δ 1.06 (s, 9H, t-Bu), 1.51 (s, 9H, t-Bu), 3.70 (dd, 
2J1-H,1-H = 10.9 Hz, 
3J1-H,2-H = 4.5 
Hz, 1H, 1-H), 3.77 (dd, 
2J1-H,1-H = 10.9 Hz, 
3J1-H,2-H = 7.3 Hz, 1H, 1-H), 5.23 (dt, 
3Jcis-4-H,3-H 
= 10.7 Hz, 
2J4-H,4-H = 1.2 Hz, 1H, 4-H), 5.26 (m, 1H, 2-H), 5.34 (dt, 
3Jtrans-4-H,3-H = 17.3 Hz, 
2J4-H,4-H = 1.2 Hz, 1H, 4-H), 5.81 (ddd, 
3J3-H,trans-4-H = 17.1 Hz, 
3J3-H,cis-4-H = 10.6 Hz, 
3J3-H,2-
H = 6.4 Hz, 1H, 3-H), 7.37-7.46 (m, 6H, H-arom), 7.68-7.72 (m, 4H, H-arom); 
13C-NMR 
(100.6 MHz, CDCl3) δ 19.20 (C(CH3)3), 26.71 (C(CH3)3), 27.81 (C(CH3)3), 65.41 (CH2-1), 
77.90 (CH-2), 81.89 (C(CH3)3), 118.22 (CH2-4), 127.64 (CH-arom), 129.65 (CH-arom), 
133.20 (CH-3), 133.29 (C-arom), 135.60 (CH-arom), 152.95 (CO carbonate); IR (neat) ν 
2932 (m), 2858 (m), 1743 (s, CO carbonate), 1428 (m), 1368 (m), 1276 (s), 1254 (s), 1165 
(s), 1113 (s), 702 (s)  cm
-1; MS (CI-NH3)  m/z (%) 444 (M+NH4
+, 100), 388 
([M+NH4
+]-C4H8, 15), 371 (5), 326 (5), 309 (MH
+-C4H8-CO2-H2O, 20), 216 (8). Anal. 
Calcd. for C25H34O4Si: C, 70.38; H, 8.03. Found: C, 70.31; H, 8.12. 
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(R)-272
TBDPSO
OBoc
 
(R)-tert-Butyl 1-(tert-Butyldiphenylsilyloxy)but-3-en-2-yl Carbonate (R)-(272). A 
solution of n-butyllithium (2.5 mL, 2.0M in pentane) was added slowly to a solution of 
silylated diol (R)-235c (1.630  g, 4.99  mmol) in THF (10  mL) at 0  °C. The resulting 
solution was stirred at 0 °C for 20 min and than transferred, at room temperature, (via 
canula) to a solution of Boc anhydride (1.230  g, 5.63  mmol) in THF (20  mL) and the 
mixture was stirred at room temperature overnight. The reaction was quenched with brine, 
diluted with ethyl acetate (100 mL), washed with brine (3 × 50 mL), dried (Na2SO4) and 
evaporated. Chromatography on a column of silica gel (5  ×  15  cm) with a mixture of 
hexanes and ethyl acetate (95:5) gave (R)-272 as a yellowish oil (2.02 g, 95%): [α]D +17.0 
(c 1.7, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 1.06 (s, 9H, t-Bu), 1.51 (s, 9H, t-Bu), 3.70 
(dd, 
2J1-H,1-H = 10.9 Hz, 
3J1-H,2-H = 4.5 Hz, 1H, 1-H), 3.77 (dd, 
2J1-H,1-H = 10.9 Hz, 
3J1-H,2-H = 
7.3 Hz, 1H, 1-H), 5.23 (dt, 
3Jcis-4-H,3-H = 10.7 Hz, 
2J4-H,4-H = 1.2 Hz, 1H, 4-H), 5.26 (m, 1H, 
2-H), 5.34 (dt, 
3Jtrans-4-H,3-H = 17.3 Hz, 
2J4-H,4-H = 1.2 Hz, 1H, 4-H), 5.81 (ddd, 
3J3-H,trans-4-H = 
17.1 Hz, 
3J3-H,cis-4-H = 10.6 Hz, 
3J3-H,2-H = 6.4 Hz, 1H, 3-H), 7.37-7.46 (m, 6H, H-arom), 
7.68-7.72 (m, 4H, H-arom); 
13C-NMR (100.6 MHz, CDCl3)  δ 19.20 (C(CH3)3), 26.71 
(C(CH3)3), 27.81 (C(CH3)3), 65.41 (CH2-1), 77.90 (CH-2), 81.89 (C(CH3)3), 118.22 
(CH2-4), 127.64 (CH-arom), 129.65 (CH-arom), 133.20 (CH-3), 133.29 (C-arom), 135.60 
(CH-arom), 152.95 (CO carbonate). Anal. Calcd. for C25H34O4Si: C, 70.38; H, 8.03. 
Found: C, 70.15; H, 8.10.  
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6.6.  Synthesis of Ligands for the Asymmetric Allylic Substitution 
 
HN HN
(R,R)-273 (R,S)-273
 
(R,S)-Bis[1-(1-naphthyl)ethyl]amine (R,S)-(273), and 
(R,R)-Bis[1-(1-naphthyl)ethyl]amine (R,R)-(273).
225  A mixture of 
(R)-(+)-(1-naphthyl)ethylamine (1.71  g, 10.0  mmol), 1-acetylnaphthalene (1.70  g, 
10.0  mmol), dry sodium hydrogencarbonate (4.20  g, 50.0  mmol), 4 Å  sieves  (7.0 g)  in 
benzene (5 mL) was heated at 80 °C for 20 h. The mixture was then filtered and the filtrate 
was evaporated. The crude imine thus obtained was stirred with sodium borohydride 
(1.52  g, 40.0  mmol) in THF (30  mL) at room temperature for 24  h. The reaction was 
quenched with 6M HCl, neutralised with saturated aqueous sodium carbonate, extracted 
with dichloromethane (3 × 50 mL), dried, and evaporated. Chromatography on a column of 
silica gel (20 × 5 cm) with a mixture of hexanes and ethyl acetate (90:10) gave (R,R)-273 
(480 mg, 15%) as the lipophilic component, followed by a mixture of (R,R)- and (R,S)-
diastereoisomers (857 mg, 26%), and finally by (R,S)-273 (241 mg, 8%) as a colourless oil: 
(R,R)-273: 
1H-NMR (400.1 MHz, CDCl3) δ 1.46 (d, 
3JHH = 6.7 Hz, 6H, CH3), 1.93 (brs, 
1H, NH), 4.51 (q, 
3JHH = 6.7 Hz, 2H, CH), 7.22 (ddd, JHH = 8.3 Hz, JHH = 6.8 Hz, JHH = 1.4 
Hz, 2H, CH-arom), 7.42 (ddd, JHH = 8.0 Hz, JHH = 6.8 Hz, JHH = 1.1 Hz, 2H, CH-arom), 
7.55 (t, JHH = 7.6 Hz, 2H, CH-arom), 7.75 – 7.82 (m, 6H, H-arom), 7.87 (dd, JHH = 8.3 Hz, 
JHH = 1.4 Hz, , 2H, CH-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 24.5, 51.2, 122.6, 123.1, 
125.2, 125.4, 125.6, 127.1, 128.7, 131.4, 133.9, 141.9; consistent with the literature data.
225 
(R,S)-273:
225 
1H-NMR (400.1 MHz, CDCl3) δ 1.53 (d, JHH = 6.6 Hz, 6H, CH3), 1.79 (brs, 
1H, NH), 4.76 (q, JHH = 6.6 Hz, 2H, CH), 7.41 – 7.50 (m, 6H), 7.64 (dd, JHH = 7.2 Hz, JHH 
= 1.0 Hz, 2H, CH-arom), 7.77 (d, JHH = 8.2 Hz, 2H, CH-arom); 7.88 (dd, JHH = 7.8 Hz, JHH 
= 1.7 Hz, 2H, CH-arom); 8.03 (d, JHH = 8.4 Hz, 2H, CH-arom); consistent with the 
literature data.
225 
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O
O
P N
(Ra,Rc,Rc)-L2
 
O,O’-(R)-(1,1’-Dinaphtyl-2,2’-diyl)-N,N-di-(R,R)-1-naphtylethylphosphoramidite 
(Ra,Rc,Rc)-(L2).
217 A solution of amine (R,R)-273 (357 mg, 1.10 mmol) in THF (2 mL) 
was added slowly to a mixture of Et3N (1.45 g, 14.3 mmol) and PBr3 (375 mg, 1.40 mmol) 
in THF (2 mL) at 0 °C and the resulting mixture was stirred at room temperature for 3 h. 
The mixture was than cooled to 0 °C and a solution of (R)-BINOL (320 mg, 1.10 mmol) in 
THF (1 mL) was added, and the mixture was stirred at room temperature overnight. The 
reaction was than diluted with toluene (20 mL), passed through a short path of alumina 
(3  ×  5  cm) and evaporated. Chromatography on a column of alumina (5  ×  5  cm) with 
toluene gave (Ra,Rc,Rc)-L2 as a white foam (285 mg, 39%): 
1H-NMR (400.1 MHz, CDCl3) 
δ 1.46 (d, JHH = 6.7 Hz, 6H, CH3), 5.56 (m, 2H, CH-arom); 6.73 (t, JHH = 7.7 Hz, 2H, CH); 
7.15-8.05 (m, 24H, CH-arom); 
13C-NMR (100.6 MHz, CDCl3)  δ 21.46 (CH3), 29.70 
(CH3), 49.57 (CH), 49.64 (CH), 121.81, 122.22, 122.77, 123.15, 124.27, 124.32, 124.41, 
124.54, 124.82, 124.90, 125.30, 126.13, 126.15, 126.91, 127.18, 127.21, 128.23, 128.37, 
129.73, and 130.50 (CH-arom), 131.51, 132.90, 133.08, 138.31, 149.53, 150.40, 150.39, 
and 150.46 (C-arom); consistent with the literature data.
217 
O
O
P N
(R,R)-L3
 
O,O’-(1,1’-Diphenyl-2,2’-diyl)-N,N-di-(R,R)-1-naphthylethylphosphoramidite
 
(R,R)-(L3).
226 A solution of amine (R,R)-273 (126 mg, 0.39 mmol) in THF (1 mL) was 
added slowly to a mixture of Et3N (1.0 g, 7 mmol) and PBr3 (120 mg, 0.44 mmol) in THF 
(1 mL) at 0 °C and the resulting mixture was stirred at room temperature for 3 h. The  
 
170
mixture was than cooled to 0 °C and a solution of biphenol 277 (80 mg, 0.43 mmol) in 
THF (1 mL) was added, and the mixture was stirred at room temperature overnight. The 
reaction was than diluted with toluene (10 mL), passed through a short path of alumina 
(3  ×  5  cm), and evaporated. Chromatography on a column of alumina (5  ×  5  cm) with 
toluene gave (R,R)-L3 as a white foam (159 mg, 34%): 
1H-NMR (400.1 MHz, CDCl3) δ 
1.54 (d, JHH = 7.7 Hz, 6H, CH3), 5.64 (p, JHH = 7.3 Hz, 2H, CH), 7.00 (d, JHH = 7.7Hz, 2H, 
H-arom), 7.01-7.19 (m, 4H, H-arom), 7.37 (ddd, JHH = 8.3 Hz, JHH = 6.8 Hz, JHH = 1.4, 2H, 
H-arom), 7.43-7.46 (m, 4H, H-arom), 7.61 (dd, JHH = 7.6 Hz, JHH = 7.4 Hz, 2H, H-arom), 
7.73 (d, JHH = 8.5 Hz, 2H, H-arom), 7.82 (d, JHH = 8.2 Hz, 2H, H-arom), 7.87 (d, JHH = 7.4 
Hz, 2H, H-arom), 8.02 (d, JHH = 7.2 Hz, 2H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 
23.2 (CH3), 23.3 (CH3), 51.9 (CH), 52.0 (CH), 122.0, 122.9, 123.6, 124.2, 125.4, 125.5, 
125.8, 127.4, 128.8, 128.9, 129.7 (CH-arom), 130.2, 130.5, 133.9, 142.0, 151.5, and 151.6 
(C-arom); consistent with the literature data.
226 
O
O
P N
L4
 
O,O’-(1,1’-Diphenyl-2,2’-diyl)-N,N-diisopropylphosphoramidite (L4).
220 A solution of 
i-Pr2NH (1.010 g, 9.98 mmol) in THF (10 mL) was added slowly to a mixture of Et3N 
(7.26  g, 71.7  mmol) and PBr3 (2.85  g, 10.5  mmol) in THF (40  mL) at 0  °C and the 
resulting mixture was stirred at room temperature for 3 h. The mixture was then cooled to 
0 °C and a solution of biphenol 277 (1.86 g, 10.0 mmol) in THF (10 mL) was added. This 
mixture was stirred at room temperature overnight, then diluted with toluene (20 mL) and 
passed through a short path of alumina (3 × 5 cm), and evaporated. Chromatography on a 
column of alumina (5  ×  5  cm) with toluene gave L4 as a white foam (1.51  g, 48%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.27 (d, J = 6.8 Hz, 12H, CH3), 3.50-3.63 (m, 2H, CH), 
7.21-7.28 (m, 4H, CH-arom), 7.37 (ddd, JHH = 7.7 Hz, JHH = 7.6 Hz, JHH = 1.5 Hz, 2H, 
CH-arom), 7.50 (dd, JHH = 7.7 Hz, JHH = 1.5 Hz, 2H, CH-arom); 
13C-NMR (100.6 MHz, 
CDCl3) δ 24.0(CH3), 44.5 (C), 44.6 (C), 122.1, 124.1, 128.9, 129.6 (CH-arom), 130.8, and 
151.9 (C-arom); MS (CI) 316 (100, M+H
+), 247 (8), 187 (10, Ph(OH)-Ph(OH)
+); HRMS 
(CI) 316.1468 [C18H23NO2P (M+H
+) requires 316.1466]; Anal. Calcd for C18H22NO2P: C, 
68.56; H, 7.03; N, 4.43. Found: C, 68.33; H, 7.16; N, 4.38; consistent with the literature 
data.
220  
 
171
6.7. Synthesis  of  C-Nucleosides and Their Analogues 
 
D-1oaβ
O Ph
HO
OH HO
 
1’-Deoxy-1’-phenyl-β-D-ribofuranose (D-1oaβ).
144b 
Complex Et3N.3HF (75 µL, 0.46  mmol) was added to a solution of silane D-232baβ 
(76 mg, 0.23 mmol) in THF (5 mL), the reaction mixture was stirred at 20 °C overnight, 
and then evaporated. Flash chromatography on a column of silica gel (3 × 10 cm) with 
ethyl acetate gave D-1oaβ (36 mg, 75%) as a white crystalline solid: mp 112 °C (ethyl 
acetate), (lit.
144b mp 121-122  °C); [α]D  -24.8 (c 0.44, MeOH); 
1H-NMR (400.1 MHz, 
CD3OD) δ 3.73 (dd, 
2J5’-Ha,5’-Hb = 12.1 Hz, 
3J5’-Ha,4’-H = 4.8 Hz, 1H, 5’-Ha), 3.79 (dd, 
2J5’-
Hb,5’-Ha = 12.1 Hz, 
3J5’-Hb,4’-H = 3.9 Hz, 1H, 5’-Hb), 3.88 (dd, 
3J2’-H,1’-H = 6.4 Hz, 
3J2’-H,3’-H = 
5.8 Hz, 1H, 2’-H), 3.95 (ddd, 
3J4’-H,3’-H = 4.8 Hz, 
3J4’-H,5’-Ha = 4.8 Hz, 
3J4’-H,5’-Hb = 3.9 Hz, 
1H, 4’-H), 4.03 (dd, 
3J3’-H,2’-H = 5.8 Hz, 
3J3’-H,4’-H = 4.8 Hz, 1H, 3’-H), 4.69 (d, 
3J1’-H,2’-H = 
6.4 Hz, 1H, 1’-H), 5.28 (s, 3H, OH), 7.22-7.32 (m, 3H, H-arom), 7.36-7.39 (m, 2H, 
H-arom); 
13C-NMR (100.6 MHz, CD3OD)  δ 62.66 (CH2-5’), 71.48 (CH-3’), 77.42 
(CH-2’), 84.78 (CH-4’), 84.81 (CH-1’), 126.33, 128.07, and 128.57 (CH-arom), 140.03 
(C-arom); MS (CI) m/z (%) 211 ([M+H
+], 25), 193 ([M+H
+]-H2O, 100); HRMS (CI) 
211.0973 [C11H15O4 (M+H
+) requires 211.0970]; consistent with the literature data.
144b 
L-1oaβ
O Ph
OH HO
OH
 
1’-Deoxy-1’-phenyl-β-L-ribofuranose (L-1oaβ).
144b 
Complex Et3N.3HF (0.2  mL, 1.2  mmol) was added to a solution of silane L-232baβ 
(77 mg, 0.24 mmol) in THF (5 mL), the reaction mixture was stirred at 20 °C overnight, 
and then evaporated. Flash chromatography on a column of silica gel (3 × 10 cm) with 
ethyl acetate gave L-1oaβ (36 mg, 72%) as a white crystalline solid: mp 112-113 °C (ethyl 
acetate), (lit.
144b mp 121-122  °C); [α]D  +25.0 (c 0.48, MeOH); 
1H-NMR (400.1 MHz, 
CD3OD) δ 3.73 (dd, 
2J5’-Ha,5’-Hb = 12.1 Hz, 
3J5’-Ha,4’-H = 4.8 Hz, 1H, 5’-Ha), 3.79 (dd, 
2J5’-
Hb,5’-Ha = 12.1 Hz, 
3J5’-Hb,4’-H = 3.9 Hz, 1H, 5’-Hb), 3.88 (dd, 
3J2’-H,1’-H = 6.4 Hz, 
3J2’-H,3’-H = 
5.8 Hz, 1H, 2’-H), 3.95 (ddd, 
3J4’-H,3’-H = 4.8 Hz, 
3J4’-H,5’-Ha = 4.8 Hz, 
3J4’-H,5’-Hb = 3.9 Hz, 
1H, 4’-H), 4.03 (dd, 
3J3’-H,2’-H = 5.8 Hz, 
3J3’-H,4’-H = 4.8 Hz, 1H, 3’-H), 4.69 (d, 
3J1’-H,2’-H =  
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6.4 Hz, 1H, 1’-H), 5.28 (s, 3H, OH), 7.22-7.32 (m, 3H, H-arom), 7.36-7.39 (m, 2H, 
H-arom); 
13C-NMR (100.6 MHz, CD3OD)  δ 62.66 (CH2-5’), 71.48 (CH-3’), 77.42 
(CH-2’), 84.78 (CH-4’), 84.81 (CH-1’), 126.33, 128.07, and 128.57 (CH-arom), 140.03 
(C-arom); MS (CI) m/z (%) 211 ([M+H
+], 80), 193 ([M+H
+]-H2O, 100); HRMS (CI) 
211.0972 [C11H15O4 (M+H
+) requires 211.0970]; consistent with the literature data.
144b 
D-1ohβ
O
HO
OH HO
F
 
1’-Deoxy-1’-(3-fluorophenyl)-β-D-ribofuranose (D-1ohβ). 
Complex Et3N.3HF (0.25  mL, 1.5  mmol) was added to a solution of silane D-232bhβ 
(118  mg, 0.34  mmol) in THF (4  mL) and the reaction mixture was stirred at 20  °C 
overnight, and then evaporated. Flash chromatography on a column of silica gel 
(3 × 10 cm) with ethyl acetate gave D-1ohβ (50 mg, 65%) as a white solid: mp 92-93 °C 
(ethyl acetate); [α]D -31.6 (c 0.35, MeOH); 
1H-NMR (400.1 MHz, CD3OD) δ 3.32-3.33 
(bs, 3H, OH), 3.74 (dd, 
2J5’-Ha,5’-Hb = 11.9 Hz, 
3J5’-Ha,4’-H = 4.7 Hz, 1H, 5’-Ha), 3.81 (dd, 
2J5’-Hb,5’-Ha = 11.9 Hz, 
3J5’-Hb,4’-H = 3.7 Hz, 1H, 5’-Hb), 3.85 (dd, 
3J2’-H,1’-H = 6.8 Hz, 
3J2’-H,3’-
H = 5.7 Hz, 1H, 2’-H), 4.00 (ddd, 
3J4’-H,5’-Ha = 4.7 Hz, 
3J4’-H,3’-H = 4.2 Hz, 
3J4’-H,5’-Hb = 3.7 
Hz, 1H, 4’-H), 4.05 (ddd, 
3J3’-H,2’-H = 5.7 Hz, 
3J3’-H,4’-H = 4.2 Hz, 
4J3’-H,1’-H = 0.5 Hz, 1H, 
3’-H), 4.73 (dd, 
3J1’-H,2’-H = 6.8 Hz, 
4J1’-H,3’-H = 0.5 Hz, 1H, 1’-H), 6.99 (dddd, 
3J4-H,F = 9.0 
Hz, 
3J4-H,5-H = 7.9 Hz, JHH = 2.7 Hz, JHH = 1.0 Hz, 1H, 4-H), 7.21-7.26 (m, 1H, 2-H, and 
6-H), 7.33 (ddd, 
3J5-H,6-H = 8.0 Hz, 
3J5-H,4-H = 7.9 Hz, 
4J5-H,F = 6.0 Hz, 1H, 5-H); 
13C-NMR 
(100.6 MHz, CDCl3) δ 63.35 (CH2-5’), 72.59 (CH-3’), 78.87 (CH-2’), 84.50 (d, 
4JCF = 1.6 
Hz, CH-1’), 86.20 (CH-4’), 113.66 (d, 
2JCF = 22.4 Hz, CH-2), 115.09 (d, 
2JCF = 21.5 Hz, 
CH-4), 122.77 (d, 
4JCF = 2.7 Hz, CH-6), 130.73 (d, 
3JCF = 8.3 Hz, CH-5), 142.95 (d, 
3JCF = 
6.8 Hz, C-1), 164.34 (d, 
1JCF = 244.3 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ –113.83; 
MS (CI) m/z (%) 229 ([M+H
+], 55), 211 ([M+H
+]-H2O, 100); HRMS (CI) 229.0878 
[C11H14FO4 (M+H
+) requires 229.0876]. Anal. Calcd. for C11H13FO4: C, 57.89; H, 5.74. 
Found: C, 57.61; H, 5.75.  
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D-1ohβ
O
OH HO
OH F
 
1’-Deoxy-1’-(3-fluorophenyl)-β-L-ribofuranose (L-1ohβ). 
Complex Et3N.3HF (1.5  mL, 9.2  mmol) was added to a solution of silane L-232bhβ 
(666  mg, 1.94  mmol) in THF (15  mL) and the reaction mixture was stirred at 20  °C 
overnight, and then evaporated. Flash chromatography on a column of silica gel 
(3 × 10 cm) with ethyl acetate gave L-1ohβ (276 mg, 62%) as a white solid: mp 92-93 °C 
(ethyl acetate); [α]D +27.1 (c 0.48, MeOH); 
1H-NMR (400.1 MHz, CD3OD) δ 3.32-3.33 
(bs, 3H, OH), 3.74 (dd, 
2J5’-Ha,5’-Hb = 11.9 Hz, 
3J5’-Ha,4’-H = 4.7 Hz, 1H, 5’-Ha), 3.81 (dd, 
2J5’-Hb,5’-Ha = 11.9 Hz, 
3J5’-Hb,4’-H = 3.7 Hz, 1H, 5’-Hb), 3.85 (dd, 
3J2’-H,1’-H = 6.8 Hz, 
3J2’-H,3’-
H = 5.7 Hz, 1H, 2’-H), 4.00 (ddd, 
3J4’-H,5’-Ha = 4.7 Hz, 
3J4’-H,3’-H = 4.2 Hz, 
3J4’-H,5’-Hb = 3.7 
Hz, 1H, 4’-H), 4.05 (ddd, 
3J3’-H,2’-H = 5.7 Hz, 
3J3’-H,4’-H = 4.2 Hz, 
4J3’-H,1’-H = 0.5 Hz, 1H, 
3’-H), 4.73 (dd, 
3J1’-H,2’-H = 6.8 Hz, 
4J1’-H,3’-H = 0.5 Hz, 1H, 1’-H), 6.99 (dddd, 
3J4-H,F = 9.0 
Hz, 
3J4-H,5-H = 7.9 Hz, JHH = 2.7 Hz, JHH = 1.0 Hz, 1H, 4-H), 7.21-7.26 (m, 1H, 2-H, and 
6-H), 7.33 (ddd, 
3J5-H,6-H = 8.0 Hz, 
3J5-H,4-H = 7.9 Hz, 
4J5-H,F = 6.0 Hz, 1H, 5-H); 
13C-NMR 
(100.6 MHz, CDCl3) δ 63.35 (CH2-5’), 72.59 (CH-3’), 78.87 (CH-2’), 84.50 (d, 
4JCF = 1.6 
Hz, CH-1’), 86.20 (CH-4’), 113.66 (d, 
2JCF = 22.4 Hz, CH-2), 115.09 (d, 
2JCF = 21.5 Hz, 
CH-4), 122.77 (d, 
4JCF = 2.7 Hz, CH-6), 130.73 (d, 
3JCF = 8.3 Hz, CH-5), 142.95 (d, 
3JCF = 
6.8 Hz, C-1), 164.34 (d, 
1JCF = 244.3 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ –113.83; 
IR (NaCl, neat) ν 3376 (s, OH), 2932 (s), 2883 (s), 2501 (s), 1615 (s), 1591 (s), 1488 (s), 
1450 (s) cm
-1; MS (CI) m/z (%) 229 ([M+H
+], 50), 211 ([M+H
+]-H2O, 100); HRMS (CI) 
229.0875 [C11H14FO4 (M+H
+) requires 229.0876]. 
D-232baβ
O Ph
TBSO
OH HO
 
5’-O-(tert-Butyldimethylsilyl)-1’-phenyl-β-D-ribofuranose (D-232baβ). 
Grubbs 1
st generation catalyst C1 (42.4 mg, 0.051 mmol) was added to a solution of silane 
(2S,1’R)-234ba (328 mg, 1.03 mmol) in dichloromethane (20 mL) under a stream of argon 
atmosphere and the mixture was stirred at 40 °C for 3 h, and then evaporated. The resulting 
residue was dissolved in a mixture of ethyl acetate (5 mL) and acetonitrile (5 mL), cooled 
to 0 °C, and a cold (0 °C) solution of RuCl3·H2O (30 mg, 0.12 mmol), and NaIO4 (357 mg, 
1.67  mmol) in water (4  mL) was added in one portion. After 15  s, the reaction was  
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quenched with a 50% aqueous solution of Na2S2O3 (10  mL). The aqueous layer was 
separated, and extracted with ethyl acetate (3 × 50 mL). The combined organic phase was 
dried (Na2SO4) and evaporated and the residue was chromatographed on a column of silica 
gel (3  ×  10  cm) with a mixture of hexanes and ethyl acetate (80:20) to afford silane 
D-232baβ as a colourless oil (83 mg, 24%): [α]D -10.2 (c 0.74, CHCl3); 
1H-NMR (400.1 
MHz, CDCl3) δ 0.10 (s, 3H, CH3), 0.11 (s, 3H, CH3), 0.92 (s, 9H, t-Bu), 3.28 (bs, 2H, OH), 
3.85 (dd, 
2J5’-Ha,5’-Hb = 10.8 Hz, 
3J5’-Ha,4’-H = 4.3 Hz, 1H, 5’-Ha), 3.89 (dd, 
2J5’-Hb,5’-Ha = 10.8 
Hz, 
3J5’-Hb,4’-H = 3.4 Hz, 1H, 5’-Hb), 4.00 (dd, 
3J2’-H,1’-H = 6.4 Hz, 
3J2’-H,3’-H = 5.5 Hz, 1H, 
2’-H), 4.06 (dd, 
3J4’-H,5’-Ha = 4.3 Hz, 
3J4’-H,5’-Hb = 3.4 Hz, 1H, 4’-H), 4.21 (dd, 
3J3’-H,2’-H = 
5.5 Hz, JHH = 4.0 Hz, 1H, 3’-H), 4.76 (d, 
3J1’-H,2’-H = 6.4 Hz, 1H, 1’-H), 7.28-7.37 (m, 3H, 
H-arom), 7.42-7.44 (m, 2H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ -5.53 (CH3), -5.40 
(CH3), 18.31 (C(CH3)3), 25.90 (C(CH3)3), 63.71 (CH2-5’), 72.75 (CH-3’), 77.97 (CH-2’), 
84.15 (CH-4’), 84.33 (CH-1’), 126.05, 127.82, and 128.35 (CH-arom), 140.02 (C-arom); 
IR (NaCl, neat) ν 3421, 2929 (s), 2858 (s), 2360 (s), 1255 (s) cm
-1; MS (CI) m/z (%) 325 
([M+H
+], 100); HRMS (CI) 325.1837 [C17H29O4Si (M+H
+) requires 325.1835].  
L-232baβ
O Ph
OH HO
OTBS
 
5’-O-(tert-Butyldimethylsilyl)-1’-deoxy-1’-phenyl-β-L-ribofuranose (L-232baβ). 
Silane L-233baβ (337 mg, 1.16 mmol) was dissolved in a mixture of ethyl acetate (5 mL) 
and acetonitrile (5 mL), cooled to 0 °C, and a cold (0 °C) solution of RuCl3·H2O (30 mg, 
0.12 mmol), and NaIO4 (400 mg, 1.87 mmol) in water (5 mL) was added in one portion. 
After 15 s, the reaction was quenched with 50% aqueous solution of Na2S2O3 (15 mL). The 
aqueous layer was separated, and extracted with ethyl acetate (3 × 50 mL). The combined 
organic phase was dried (Na2SO4), evaporated, and the residue was chromatographed on a 
column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl acetate (80:20) to 
afford starting silane L-233baβ (232 mg, 69% of starting mass), followed by diol L-232baβ 
(colourless oil, 103 mg, 27%, 87% based on recovered silane): [α]D +10.8 (c 0.37, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.10 (s, 3H, CH3), 0.11 (s, 3H, CH3), 0.92 (s, 9H, t-Bu), 
3.28 (bs, 2H, OH), 3.85 (dd, 
2J5’-Ha,5’-Hb = 10.8 Hz, 
3J5’-Ha,4’-H = 4.3 Hz, 1H, 5’-Ha), 3.89 
(dd, 
2J5’-Hb,5’-Ha = 10.8 Hz, 
3J5’-Hb,4’-H = 3.4 Hz, 1H, 5’-Hb), 4.00 (dd, 
3J2’-H,1’-H = 6.4 Hz, 
3J2’-H,3’-H = 5.5 Hz, 1H, 2’-H), 4.06 (dd, 
3J4’-H,5’-Ha = 4.3 Hz, 
3J4’-H,5’-Hb = 3.4 Hz, 1H, 4’-H), 
4.21 (dd, 
3J3’-H,2’-H = 5.5 Hz, JHH = 4.0 Hz, 1H, 3’-H), 4.76 (d, 
3J1’-H,2’-H = 6.4 Hz, 1H, 
1’-H), 7.28-7.37 (m, 3H, H-arom), 7.42-7.44 (m, 2H, H-arom); 
13C-NMR (100.6 MHz,  
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CDCl3) δ -5.53 (CH3), -5.40 (CH3), 18.31 (C(CH3)3), 25.90 (C(CH3)3), 63.71 (CH2-5’), 
72.75 (CH-3’), 77.97 (CH-2’), 84.15 (CH-4’), 84.33 (CH-1’), 126.05, 127.82, and 128.35 
(CH-arom), 140.02 (C-arom); IR (NaCl, neat) ν 3421, 2929 (s), 2858 (s), 2360 (s), 1255 
(s) cm
-1; MS (CI) m/z (%) 325 ([M+H
+], 100); HRMS (CI) 325.1836 [C17H29O4Si (M+H
+) 
requires 325.1835].  
L-232bfβ
O
OH HO
OTBS
Br
 
5’-O-(tert-Butyldimethylsilyl)-1’-(4-bromophenyl)-1’-deoxy-β-L-ribofuranose 
(L-232bfβ). 
Grubbs 1
st generation catalyst C1 (72.0 mg, 0.087 mmol) was added to a solution of silane 
(2R,1’S)-234bf (2.483 g, 6.25 mmol) in dichloromethane (60 mL) under a stream of argon 
atmosphere and the mixture was stirred at 40 °C for 3 h, and then evaporated. The resulting 
residue was dissolved in a mixture of ethyl acetate (30  mL) and acetonitrile (30  mL), 
cooled to 0 °C, and intensively stirred with mechanical overhead stirrer. A cold (0 °C) 
solution of RuCl3·H2O (166 mg, 0.67 mmol), and NaIO4 (1.656 g, 7.74 mmol) in water 
(25 mL) was added in one portion. After 15 s, the reaction was quenched with a 50% 
aqueous solution of Na2S2O3 (50 mL). The aqueous layer was separated, and extracted 
with dichloromethane (3 × 300 mL). The combined organic phase was dried (Na2SO4) and 
evaporated. Chromatography on a column of silica gel (3  ×  10  cm) with a mixture of 
hexanes and ethyl acetate (80:20) gave diol L-232bfβ (colourless oil, 786 mg, 31%): [α]D 
-35.1 (c 0.74, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.04 (s, 3H, CH3), 0.05 (s, 3H, 
CH3), 0.90 (s, 9H, t-Bu), 2.57 (bs, 2H, OH), 3.55-3.76 (m, 4H), 4.54-4.56 (m, 1H), 7.34 (d, 
3J2-H,3-H = 8.4 Hz, 2H, 2-H, and 6-H), 7.50 (d, 
3J3-H,2-H = 8.4 Hz, 2H, 3-H, and 5-H); 
13C-NMR (100.6 MHz, CDCl3)  δ -5.42 (CH3), -5.40 (CH3), 18.30 (C(CH3)3), 25.84 
(C(CH3)3), 65.97 (CH2-5’), 73.10 (CH-3’), 74.26 (CH-2’), 79.34 (CH-1’), 79.72 (CH-4’), 
120.14 (C-4), 129.22 (CH-2, and CH-6), 131.62 (CH-3, and CH-5), 137.36 (C-1); IR 
(NaCl, neat) ν 3420 (s, OH), 2954 (s), 2928 (s), 2857 (s), 1255 (s) cm
-1; MS (CI) m/z (%) 
403/405 ([M+H
+], 100); HRMS (CI) 403.0916/405.0774 [C17H28BrO4Si (M+H
+) requires 
403.0940/405.0922].  
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D-232bhβ
O
OH HO
TBSO F
 
5’-O-(tert-Butyldimethylsilyl)-1’-deoxy-1’-(3-fluorophenyl)-β-D-ribofuranose 
(D-232bhβ). 
Silane D-233bhβ (313 mg, 1.01 mmol) was dissolved in a mixture of ethyl acetate (5 mL) 
and acetonitrile (5 mL), cooled to 0 °C, and a cold (0 °C) solution of RuCl3·H2O (30 mg, 
0.12 mmol), and NaIO4 (320 mg, 1.50 mmol) in water (4 mL) was added in one portion. 
After 45 s, the reaction was quenched with a 50% aqueous solution of Na2S2O3 (15 mL). 
The aqueous layer was separated, and extracted with ethyl acetate (3  ×  50  mL). The 
combined organic phase was dried (Na2SO4), evaporated, and chromatographed on a 
column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl acetate (80:20) to 
afford diol D-232bhβ as a colourless oil (211  mg, 61%): [α]D  -16.7 (c 1.20, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.10 (s, 3H, CH3), 0.11 (s, 3H, CH3), 0.91 (s, 9H, t-Bu), 
2.56 (bs, 2H, OH), 3.86 (dd, 
2J5’-Ha,5’-Hb = 10.8 Hz, 
3J5’-Ha,4’-H = 4.0 Hz, 1H, 5’-Ha), 3.89 
(dd, 
2J5’-Hb,5’-Ha = 10.8 Hz, 
3J5’-Hb,4’-H = 3.2 Hz, 1H, 5’-Hb), 3.97-4.01 (m, 1H, 2’-H), 4.08 
(dd, 
3J4’-H,5’-Ha = 4.0 Hz, 
3J4’-H,5’-Hb = 3.2 Hz, 1H, 4’-H), 4.22-4.25 (m, 1H, 3’-H), 4.76 (d, 
3J1’-H,2’-H = 6.5 Hz, 1H, 1’-H), 6.97 (dddd, 
3J4-H,F = 8.4 Hz, JHH = 8.3 Hz, JHH = 2.2 Hz, JHH 
= 1.5 Hz, 1H, 4-H), 7.11-7.16 (m, 1H, 2-H), 7.18-7.21 (m, 1H, 6-H), 7.27-7.33 (m, 1H, 
5-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.56 (CH3), -5.43 (CH3), 18.30 (C(CH3)3), 25.88 
(C(CH3)3), 63.64 (CH2-5’), 72.83 (CH-3’), 78.05 (CH-2’), 83.60 (d, 
4JCF = 1.9 Hz, CH-1’), 
84.38 (CH-4’), 112.83 (d, 
2JCF = 22.3 Hz, CH-2), 114.64 (d, 
2JCF = 21.2 Hz, CH-4), 121.58 
(d, 
4JCF = 2.9 Hz, CH-6), 129.83 (d, 
3JCF = 8.2 Hz, CH-5), 143.90 (d, 
3JCF = 6.6 Hz, C-1), 
162.97 (d, 
1JCF = 246.7 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ –113.59; IR (NaCl, 
neat) ν 3398 (s, OH), 2929 (s), 2858 (s), 1617 (s), 1592 (s) cm
-1; MS (CI) m/z (%) 343 
([M+H
+], 100); HRMS (CI) 343.1740 [C17H28FO4Si (M+H
+) requires 343.1741]. Anal. 
Calcd. for C17H27FO4Si: C, 59.62; H, 7.95. Found: C, 59.47; H, 8.06.  
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L-232bhβ
O
OH HO
OTBS F
 
5’-O-(tert-Butyldimethylsilyl)-1’-deoxy-1’-(3-fluorophenyl)-β-L-ribofuranose 
(L-232bhβ). 
Grubbs 1
st generation catalyst C1 (71.0 mg, 0.090 mmol) was added to a solution of silane 
(2R,1’S)-234bh (1.951 g, 5.80 mmol) in dichloromethane (50 mL) under a stream of argon 
atmosphere and the mixture was stirred at 40 °C for 3 h, and then evaporated. The resulting 
residue was dissolved in a mixture of ethyl acetate (25  mL) and acetonitrile (25  mL), 
cooled to 0 °C, and intensively stirred with mechanical overhead stirrer. A cold (0 °C) 
solution of RuCl3·H2O (140 mg, 0.60 mmol), and NaIO4 (1.430 g, 6.69 mmol) in water 
(20 mL) was added in one portion. After 15 s, the reaction was quenched with a 50% 
aqueous solution of Na2S2O3 (50 mL), the aqueous layer was separated, and extracted with 
ethyl acetate (3 × 250 mL). The combined organic phase was dried (Na2SO4), evaporated, 
and chromatographed on a column of silica gel (3 cm × 10 cm) with a mixture of hexanes 
and ethyl acetate (80:20) to afford diol L-232bhβ as a colourless oil (667 mg, 34%): [α]D 
-15.7 (c 1.15, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.10 (s, 3H, CH3), 0.11 (s, 3H, 
CH3), 0.91 (s, 9H, t-Bu), 2.56 (bs, 2H, OH), 3.86 (dd, 
2J5’-Ha,5’-Hb = 10.8 Hz, 
3J5’-Ha,4’-H = 4.0 
Hz, 1H, 5’-Ha), 3.89 (dd, 
2J5’-Hb,5’-Ha = 10.8 Hz, 
3J5’-Hb,4’-H = 3.2 Hz, 1H, 5’-Hb), 3.97-4.01 
(m, 1H, 2’-H), 4.08 (dd, 
3J4’-H,5’-Ha = 4.0 Hz, 
3J4’-H,5’-Hb = 3.2 Hz, 1H, 4’-H), 4.22-4.25 (m, 
1H, 3’-H), 4.76 (d, 
3J1’-H,2’-H = 6.5 Hz, 1H, 1’-H), 6.97 (dddd, 
3J4-H,F = 8.4 Hz, JHH = 8.3 
Hz, JHH = 2.2 Hz, JHH = 1.5 Hz, 1H, 4-H), 7.11-7.16 (m, 1H, 2-H), 7.18-7.21 (m, 1H, 6-H), 
7.27-7.33 (m, 1H, 5-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.56 (CH3), -5.43 (CH3), 18.30 
(C(CH3)3), 25.88 (C(CH3)3), 63.64 (CH2-5’), 72.83 (CH-3’), 78.05 (CH-2’), 83.60 (d, 
4JCF 
= 1.9 Hz, CH-1’), 84.38 (CH-4’), 112.83 (d, 
2JCF = 22.3 Hz, CH-2), 114.64 (d, 
2JCF = 21.2 
Hz, CH-4), 121.58 (d, 
4JCF = 2.9 Hz, CH-6), 129.83 (d, 
3JCF = 8.2 Hz, CH-5), 143.90 (d, 
3JCF = 6.6 Hz, C-1), 162.97 (d, 
1JCF = 246.7 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ 
-113.59; IR (NaCl, neat) ν 3398 (s, OH), 2929 (s), 2858 (s), 1617 (s), 1592 (s) cm
-1; MS 
(CI) m/z (%) 343 ([M+H
+], 100); HRMS (CI) 343.1740 [C17H28FO4Si (M+H
+) requires 
343.1741]. Anal. Calcd. for C17H27FO4Si: C, 59.62; H, 7.95. Found: C, 59.47; H, 8.06. 
  
 
178
233aa
O Ph
HO
 
2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-phenyl-α/β-D/L-ribofuranose (233aa).  A solution 
of TBAF (0.5  mL, 0.5  mmol, 1.0M solution in THF) was added to a solution of the 
protected dihydrofuran 233ca (60 mg, 0.15 mmol) in THF (2 mL). The mixture was stirred 
at room temperature until no more starting material was detected by TLC. The reaction 
was quenched with brine and extracted with CHCl3. Chromatography on a column of 
neutral alumina (3 × 10 cm) with a mixture of hexanes and ethyl acetate (95:5 to 67:33) 
gave 233aa as a colourless oil (14 mg, 53%): 
1H-NMR (400.1 MHz, CDCl3, mixture of 
diastereoisomers in a 1:2.6 ratio, the minor diastereoisomer is marked with * where 
possible)  δ 3.58-4.15 (m, 2H, CH2); 4.18-4.24 and 5.00*-5.04* (m, 1H, CH2CH), 
5.06*-5.07* and 5.15-5.19 (m, 1H, PhCH), 5.81-6.16 (m, 2H, CH=CH), 7.30-7.39 (m, 5H, 
H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 68.0 and 70.8 (CH2), 75.2 and 76.8 (CH2CH), 
87.3 and 88.1 (PhCH), 126.4 and 126.5 and 132.4 and 133.4 (CH=CH), 127.2, 127.7, 
128.0, 128.2, 128.5, 128.6; MS (CI) m/z (%) 177 ([M+H
+], 80), 159 ([M+H
+]-H2O, 100); 
HRMS (CI) 177.0915 [C11H13O2 (M+H
+) requires 177.0916]. 
D-233aaα
O Ph
HO
 
2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-phenyl-α-D-ribofuranose (D-233aaα). 
Complex Et3N.3HF (1.0  mL, 6.1  mmol) was added to a solution of silane D-233baα 
(441  mg, 1.52  mmol) in THF (10  mL) and the reaction mixture was stirred at 20  °C 
overnight and then evaporated. Gradient chromatography on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (95:5 to 67:33) gave D-233aaα 
(176 mg, 66%) as a colourless oil: [α]D -332.4 (c 1.71, CHCl3); 
1H-NMR (400.1 MHz, 
CDCl3) δ 2.42 (s, 1H, OH), 3.59 (dd, 
2J5’-Ha,5’-Hb = 11.7 Hz, 
3J5’-Ha,4’-H = 5.2 Hz, 1H, 5’-Ha), 
3.74 (dd, 
2J5’-Hb,5’-Ha = 11.7 Hz, 
3J5’-Hb,4’-H = 3.2 Hz, 1H, 5’-Hb), 5.10 (m, 1H, 4’-H), 5.81 
(ddd, 
4J1’-H,4’-H = 5.7 Hz, JHH = 2.3 Hz, JHH = 1.6 Hz, 1H, 1’-H), 5.85 (ddd, 
3J3’-H,2’-H = 6.1 
Hz, JHH = 2.3 Hz, JHH = 1.6 Hz, 1H, 3’-H), 5.95 (ddd, 
3J2’-H,3’-H = 6.1 Hz, JHH = 2.3 Hz, JHH 
= 1.6 Hz, 1H, 2’-H), 7.24-7.33 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 64.95 
(CH2-5’), 87.37 (CH-4’), 87.99 (CH-1’), 126.28 (CH-arom), 126.51 (CH-3’), 127.99, and 
128.48 (CH-arom), 132.16 (CH-2’), 141.27 (C-arom); IR (NaCl, neat) ν 3406 (s, OH), 
2868 (s), 1493 (m), 1454 (m), 1065 (s) cm
-1; MS (CI) m/z (%) 177 ([M+H
+], 95), 159  
 
179
([M+H
+]-H2O, 100); HRMS (CI) 177.0917 [C11H13O2 (M+H
+) requires 177.0916]. Anal. 
Calcd. for C11H12O2: C, 74.98; H, 6.86. Found: C, 74.82; H, 6.96. 
D-233aaβ
O Ph
HO
 
2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-phenyl-β-L-ribofuranose (D-233aaβ). 
Complex Et3N.3HF (0.4  mL, 2.5  mmol) was added to a solution of silane D-233baβ 
(203 mg, 0.70 mmol) in THF (5 mL). Reaction mixture was stirred at 20 °C overnight and 
then evaporated. Gradient chromatography on a column of silica gel (3 × 10 cm) with a 
mixture of hexanes and ethyl acetate (80:20 to 60:40) gave D-233aaβ (84 mg, 68%) as a 
colourless oil: [α]D +77.5 (c 1.28, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 1.96 (t, 
3J5-OH,5-
H = 6.0 Hz, 1H, 5-OH), 3.67 (ddd, 
2J5-Ha,5-Hb = 11.6 Hz, 
3J5-Ha,5-OH = 6.1 Hz, 
3J5-Ha,4-H = 5.2 
Hz, 1H, 5-Ha), 3.78 (ddd, 
2J5-Hb,5-Ha = 11.6 Hz, 
3J5-Hb,5-OH = 5.9 Hz, 
3J5-Hb,4-H = 3.3 Hz, 1H, 
5-Hb), 5.00-5.03 (m, 1H, 4-H), 5.80-5.82 (m, 1H, 1-H), 5.94 (ddd, 
3J3-H,2-H = 6.1 Hz, JHH = 
2.4 Hz, JHH = 1.4 Hz, 1H, 3-H), 6.00 (ddd, 
3J2-H,3-H = 6.1 Hz, JHH = 2.2 Hz, JHH = 1.5 Hz, 
1H, 2-H), 7.29-7.38 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 64.99 (CH2-5), 
87.19 (CH-4), 87.85 (CH-1), 126.95 (CH-arom), 127.65 (CH-3), 128.13 (CH-arom), 
128.58 (CH-arom), 131.48 (CH-2), 141.05 (C-arom); IR (NaCl, neat) ν 3365 (m, OH), 
2929 (m), 2858 (m), 2360 (s), 1454 (m) cm
-1; MS (CI) m/z (%) 177 ([M+H
+], 80), 159 
([M+H
+]-H2O, 100); HRMS (CI) 177.0918 [C11H13O2 (M+H
+) requires 177.0916].  
L-233aaα
O
OH
Ph
 
2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-phenyl-α-L-ribofuranose (L-233aaα). 
Complex Et3N.3HF (0.8  mL, 4.9  mmol) was added to a solution of silane L-233baα 
(463  mg, 1.59  mmol) in THF (10  mL) and the reaction mixture was stirred at 20  °C 
overnight and then evaporated. Gradient chromatography on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (95:5 to 67:33) gave L-233aaα 
(199 mg, 71%) as a colourless oil: [α]D +334.6 (c 1.79, CHCl3); 
1H-NMR (400.1 MHz, 
CDCl3) δ 2.42 (s, 1H, OH), 3.59 (dd, 
2J5’-Ha,5’-Hb = 11.7 Hz, 
3J5’-Ha,4’-H = 5.2 Hz, 1H, 5’-Ha), 
3.74 (dd, 
2J5’-Hb,5’-Ha = 11.7 Hz, 
3J5’-Hb,4’-H = 3.2 Hz, 1H, 5’-Hb), 5.10 (m, 1H, 4’-H), 5.81 
(ddd, 
4J1’-H,4’-H = 5.7 Hz, JHH = 2.3 Hz, JHH = 1.6 Hz, 1H, 1’-H), 5.85 (ddd, 
3J3’-H,2’-H = 6.1 
Hz, JHH = 2.3 Hz, JHH = 1.6 Hz, 1H, 3’-H), 5.95 (ddd, 
3J2’-H,3’-H = 6.1 Hz, JHH = 2.3 Hz, JHH 
= 1.6 Hz, 1H, 2’-H), 7.24-7.33 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 64.95  
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(CH2-5’), 87.37 (CH-4’), 87.99 (CH-1’), 126.28 (CH-arom), 126.51 (CH-3’), 127.99, and 
128.48 (CH-arom), 132.16 (CH-2’), 141.27 (C-arom); IR (NaCl, neat) ν 3406 (s, OH), 
2868 (s), 1493 (m), 1454 (m), 1065 (s) cm
-1; MS (CI) m/z (%) 177 ([M+H
+], 95), 159 
([M+H
+]-H2O, 100); HRMS (CI) 177.0918 [C11H13O2 (M+H
+) requires 177.0916]. Anal. 
Calcd. for C11H12O2: C, 74.98; H, 6.86. Found: C, 74.73; H, 6.95. 
L-233aaβ
O Ph
OH
 
2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-phenyl-β-L-ribofuranose (L-233aaβ). 
Complex Et3N.3HF (0.5  mL, 3.0  mmol) was added to a solution of silane L-233baβ 
(254 mg, 0.87 mmol) in THF (5 mL). Reaction mixture was stirred at 20 °C overnight and 
then evaporated. Gradient chromatography on a column of silica gel (3 × 10 cm) with a 
mixture of hexanes and ethyl acetate (80:20 to 60:40) gave L-233aaβ (82 mg, 54%) as a 
colourless oil: [α]D -78.8 (c 1.32, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 1.96 (t, 
3J5-OH,5-
H = 6.0 Hz, 1H, 5-OH), 3.67 (ddd, 
2J5-Ha,5-Hb = 11.6 Hz, 
3J5-Ha,5-OH = 6.1 Hz, 
3J5-Ha,4-H = 5.2 
Hz, 1H, 5-Ha), 3.78 (ddd, 
2J5-Hb,5-Ha = 11.6 Hz, 
3J5-Hb,5-OH = 5.9 Hz, 
3J5-Hb,4-H = 3.3 Hz, 1H, 
5-Hb), 5.00-5.03 (m, 1H, 4-H), 5.80-5.82 (m, 1H, 1-H), 5.94 (ddd, 
3J3-H,2-H = 6.1 Hz, JHH = 
2.4 Hz, JHH = 1.4 Hz, 1H, 3-H), 6.00 (ddd, 
3J2-H,3-H = 6.1 Hz, JHH = 2.2 Hz, JHH = 1.5 Hz, 
1H, 2-H), 7.29-7.38 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 64.99 (CH2-5), 
87.19 (CH-4), 87.85 (CH-1), 126.95 (CH-arom), 127.65 (CH-3), 128.13 (CH-arom), 
128.58 (CH-arom), 131.48 (CH-2), 141.05 (C-arom); IR (NaCl, neat) ν 3365 (m, OH), 
2929 (m), 2858 (m), 2360 (s), 1454 (m) cm
-1; MS (CI) m/z (%) 177 ([M+H
+], 80), 159 
([M+H
+]-H2O, 100); HRMS (CI) 177.0918 [C11H13O2 (M+H
+) requires 177.0916]. Anal. 
Calcd. for C11H12O2: C, 74.98; H, 6.86. Found: C, 74.59; H, 6.82. 
via three-step procedure: n-Butyllithium (0.5  mL, 1.0  mmol, 2.0M solution in 
pentane) was added slowly to a solution of protected butenediol (R)-235b (211  mg, 
1.02 mmol) in THF (1 mL) and the mixture was stirred at 0 °C for 15 min. The lithium 
alkoxide thus generated was transferred (via a cannula) to a suspension of copper(I) iodide 
(200 mg, 1.05 mmol) in THF (2 mL) at room temperature. The mixture turned light yellow 
and was then stirred for 30 min.
230 The resulting mixture was cooled to 0 °C and a cold 
(0 °C) solution of [Ir(COD)Cl]2 (9.7 mg, 0.014 mmol) in THF (1 mL) and allylcarbonate 
(S)-267a (170 mg, 0.72 mmol, neat) were added, consecutively. The cooling bath was then 
removed and the reaction mixture was stirred at room temperature for 16 h. The catalyst 
was precipitated by adding hexane (5 mL) and the mixture was filtered through a pad of  
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silica (3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate 
(90:10). Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes 
and ethyl acetate (98.5:1.5) gave silane (2R,1’S)-234ba as a colourless oil (182 mg, 79%, 
as a single diastereoisomer). Silane (2R,1’S)-234ba was dissolved in CH2Cl2 (10  mL), 
Grubbs 1
st generation catalyst C1 (10.1 mg, 0.012 mmol) was added under a stream of 
argon atmosphere and the mixture was stirred at 40 °C for 5 h. The resulting solution was 
evaporated and the residue was chromatographed on a column of silica gel (3 × 10 cm) 
with a mixture of hexanes and ethyl acetate (98.5:1.5) to afford silane L-233baβ as a 
colourless oil (146 mg, 88%). Silane L-233baβ was dissolved in THF (4.5 mL), complex 
Et3N.3HF (150 µL, 0.92 mmol) was added, the reaction mixture was stirred overnight at 
20  °C, and then evaporated. Gradient chromatography on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (90:10 to 67:33) gave L-233aaβ 
(47 mg, 53%, 37% from (R)-235b over 3 steps) as a colourless oil: [α]D -78.3 (c 1.24, 
CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 1.96 (t, 
3J5-OH,5-H = 6.0 Hz, 1H, 5-OH), 3.67 (ddd, 
2J5-Ha,5-Hb = 11.6 Hz, 
3J5-Ha,5-OH = 6.1 Hz, 
3J5-Ha,4-H = 5.2 Hz, 1H, 5-Ha), 3.78 (ddd, 
2J5-Hb,5-Ha 
= 11.6 Hz, 
3J5-Hb,5-OH = 5.9 Hz, 
3J5-Hb,4-H = 3.3 Hz, 1H, 5-Hb), 5.00-5.03 (m, 1H, 4-H), 
5.80-5.82 (m, 1H, 1-H), 5.94 (ddd, 
3J3-H,2-H = 6.1 Hz, JHH = 2.4 Hz, JHH = 1.4 Hz, 1H, 3-H), 
6.00 (ddd, 
3J2-H,3-H = 6.1 Hz, JHH = 2.2 Hz, JHH = 1.5 Hz, 1H, 2-H), 7.29-7.38 (m, 5H, 
H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 64.99 (CH2-5), 87.19 (CH-4), 87.85 (CH-1), 
126.95 (CH-arom), 127.65 (CH-3), 128.13 (CH-arom), 128.58 (CH-arom), 131.48 (CH-2), 
141.05 (C-arom); MS (EI) m/z (%) 176 ([M
+], 10), 145 (100), 127 (50), 117 (95), 115 (95); 
HRMS (EI) 176.0842 [C11H12O2 (M
+) requires 176.0837]. Chiral GC (Supelco β-DEX 120 
column, oven 135  °C isothermal, t = 42.79  min) showed >99% de, >99% ee (tR = 
42.48 min  (L-233aaβ),  tR = 44.27  min (D-233aaβ),  tR = 51.25 (L-233aaα),  tR = 54.79 
(D-233aaα)).
227 
233ai
O
HO
F
 
2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-(4-fluorophenyl)-α/β-D/L-ribofuranose (233ai). 
Complex Et3N.3HF (90 µL, 0.55 mmol) was added to a solution of silane 233ci (108 mg, 
0.25 mmol) in THF (4 mL) and the mixture was stirred at room temperature for 16 h. The 
resulting solution was evaporated (40  °C) and the residue was chromatographed on a 
column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl acetate (98.5:1.5) to  
 
182
remove the non-polar compounds, followed by elution with a mixture of hexanes and ethyl 
acetate (67:33) that gave the D4 ribofuranose 233ai as a colourless oil (23 mg, 48%): 
1H-NMR (400.1 MHz, CDCl3) δ 1.83 (t, 
3JHH = 6.4 Hz, 1H, OH), 3.67 (ddd, 
2J5’-Ha,5’-Hb = 
11.4 Hz, JHH = 6.0 Hz, JHH = 4.9 Hz, 1H, 1-Ha), 3.79 (ddd, 
2J5’-Hb,5’-Ha = 11.4 Hz, JHH = 5.7 
Hz, JHH = 3.1 Hz, 1H, 1-Hb), 4.98-5.02 (m, 1H, 4’-H), 5.77-5.78 (m, 1H, 1’-H), 5.95 (d, 
3J2’-H,3’-H = 6.7 Hz, 1H, 2’-H), 5.97 (d, 
3J3’-H,2’-H = 6.7 Hz, 1H, 3’-H), 7.05 (t, 
3J3-H,2-H = 8.7 
Hz, 
3J3-H,F = 8.7 Hz, 2H, 3-H), 7.33 (dd, 
3J2-H,3-H = 8.7 Hz, 
4J2-H,F = 5.4 Hz, 2H, 2-H); 
13C-NMR (100.6 MHz, CDCl3) δ 64.95 (CH2-5’), 87.14 (CH-1’), 87.21 (CH-4’), 115.50 
(d, 
2JCF = 21.5 Hz, CH-3), 128.02 (CH-2’), 128.82 (d, 
3JCF = 8.3 Hz, CH-2), 131.48 
(CH-3’), 137.02 (d, 
4JCF = 3.1 Hz, C-1), 162.63 (d, 
1JCF = 246.5 Hz, C-4); MS (CI, 150 °C) 
m/z (%) 195 (M
+, 60), 177 (M
+-H2O, 100); HRMS (CI) 195.0822 [C11H12FO2 (M
+) 
requires 195.0821]. 
D-233ahα
O
HO F
 
2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-(3-fluorophenyl)-α-D-ribofuranose (D-233ahα). 
Complex Et3N.3HF (0.4  mL, 2.3  mmol) was added to a solution of silane D-233bhα 
(178  mg, 0.57  mmol) in THF (5  mL) and the reaction mixture was stirred at 20  °C 
overnight, and then evaporated. Gradient chromatography on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (67:33 to 60:40) gave D-233ahα 
(97  mg, 88%) as a colourless oil: [α]D  -236.8 (c 1.90, CHCl3); 
1H-NMR (400.1 MHz, 
CDCl3) δ 2.05 (bs, 1H, OH), 3.65 (dd, 
2J5’-Ha,5’-Hb = 11.7 Hz, 
3J5’-Ha,4’-H = 5.2 Hz, 1H, 
5’-Ha), 3.81 (dd, 
2J5’-Hb,5’-Ha = 11.7 Hz, 
3J5’-Hb,4’-H = 3.2 Hz, 1H, 5’-Hb), 5.14-5.18 (m, 1H, 
4’-H), 5.85 (ddd, 
3J1’-H,F = 5.8 Hz, JHH = 2.1 Hz, JHH = 2.1 Hz, 1H, 1’-H), 5.92 (ddd, 
3J2’-
H,3’-H = 6.1 Hz, JHH = 2.3 Hz, JHH = 1.5 Hz, 1H, 2’-H), 6.00 (ddd, 
3J3’-H,2’-H = 6.1 Hz, JHH = 
2.2 Hz, JHH = 1.6 Hz, 1H, 3’-H), 6.95-7.13 (m, 3H, 2-H, 4-H, and 6-H), 7.31 (ddd, 
3JHH = 
7.9 Hz, 
3JHH = 7.7 Hz, 
4J5-H,F = 5.8 Hz, 1H, 5-H); 
13C-NMR (100.6 MHz, CDCl3) δ 64.95 
(CH2-5’), 87.35 (d, 
4JCF = 1.8 Hz, CH-1’), 87.53 (CH-4’), 113.12 (d, 
2JCF = 21.9 Hz, 
CH-2), 114.71 (d, 
2JCF = 21.3 Hz, CH-4), 121.78 (d, 
4JCF = 2.9 Hz, CH-6), 126.90 (CH-2’), 
130.07 (d, 
3JCF = 8.1 Hz, CH-5), 131.84 (CH-3’), 144.06 (d, 
3JCF = 6.4 Hz, C-1), 163.00 (d, 
1JCF = 246.3 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ –113.28; IR (NaCl, neat) ν 3405 
(s, OH), 2928 (m), 2874 (m), 1615 (s), 1592 (s), 1488 (s), 1449 (s), 1264 (s) cm
-1; MS (CI) 
m/z (%) 195 ([M+H
+], 15), 177 ([M+H
+]-H2O, 100); HRMS (CI) 195.0816 [C11H12FO2 
(M+H
+) requires 195.0821].   
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D-233ahβ
O
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2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-(3-fluorophenyl)-β-D-ribofuranose (D-233ahβ). 
Complex Et3N.3HF (1.0  mL, 6.0  mmol) was added to a solution of silane D-233bhβ 
(459  mg, 1.49  mmol) in THF (10  mL) and the reaction mixture was stirred at 20  °C 
overnight, and then evaporated. Flash chromatography on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (80:20) gave D-233ahβ (176 mg, 
61%) as a colourless oil: [α]D +64.2 (c 1.90, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 2.19 
(bs, 1H, OH), 3.66 (dd, 
2J5’-Ha,5’-Hb = 11.8 Hz, 
3J5’-Ha,4’-H = 5.2 Hz, 1H, 5’-Ha), 3.78 (dd, 
2J5’-Hb,5’-Ha = 11.8 Hz, 
3J5’-Hb,4’-H = 3.4 Hz, 1H, 5’-Hb), 4.98-5.02 (m, 1H, 4’-H), 5.78 (d, 
3J1’-H,F = 5.9 Hz, 1H, 1’-H), 5.93 (ddd, 
3J2’-H,3’-H = 6.1 Hz, JHH = 2.1 Hz, JHH = 1.1 Hz, 1H, 
2’-H), 5.96 (ddd, 
3J3’-H,2’-H = 6.1 Hz, JHH = 2.1 Hz, JHH = 1.2 Hz, 1H, 3’-H), 6.99 (dddd, 
3J4-H,F = 8.4 Hz, 
3J4-H,5-H = 8.0 Hz, 
4J4-H,2-H = 2.6 Hz, 
4J4-H,6-H = 1.0 Hz, 1H, 4-H), 7.07 (ddd, 
3J2-H,F = 9.7 Hz, 
4J2-H,4-H = 2.6 Hz, 
4J2-H,6-H = 1.6 Hz, 1H, 2-H), 7.12 (dddd, 
3J6-H,5-H = 7.7 
Hz, 
4J6-H,2-H = 1.6 Hz, 
4J6-H,4-H = 1.0 Hz, 
5J6-H,F = 0.5 Hz, 1H, 6-H), 7.32 (ddd, 
3J5-H,4-H = 8.0 
Hz, 
3J5-H,6-H = 7.7 Hz, 
4J5-H,F = 5.8 Hz, 1H, 5-H); 
13C-NMR (100.6 MHz, CDCl3) δ 65.02 
(CH2-5’), 87.18 (d, 
4JCF = 1.8 Hz, CH-1’), 87.37 (CH-4’), 113.75 (d, 
2JCF = 21.8 Hz, 
CH-2), 114.98 (d, 
2JCF = 21.2 Hz, CH-4), 122.38 (d, 
4JCF = 2.9 Hz, CH-6), 127.89 (CH-2’), 
130.13 (d, 
3JCF = 8.1 Hz, CH-5), 131.17 (CH-3’), 143.78 (d, 
3JCF = 6.5 Hz, C-1), 162.95 (d, 
1JCF = 246.5 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ –113.06; IR (NaCl, neat) ν 3406 
(s, OH), 2929 (m), 2870 (m), 1615 (s), 1592 (s), 1488 (s), 1449 (s), 1263 (s) cm
-1; MS (CI) 
m/z (%) 195 ([M+H
+], 30), 177 ([M+H
+]-H2O, 100); HRMS (CI) 195.0819 [C11H12FO2 
(M+H
+) requires 195.0821]. Anal. Calcd. for C11H11FO2: C, 68.03; H, 5.71. Found: C, 
68.23; H, 5.72. 
L-233ahα
O
OH F
 
2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-(3-fluorophenyl)-α-L-ribofuranose (L-233ahα). 
Complex Et3N.3HF (1.0  mL, 6.0  mmol) was added to a solution of silane L-233bhα 
(455  mg, 1.48  mmol) in THF (10  mL) and the reaction mixture was stirred at 20  °C 
overnight, and then evaporated. Gradient chromatography on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (75:25 to 60:40) gave L-233ahα  
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(218 mg, 76%) as a colourless oil: [α]D +288.2 (c 2.04, CHCl3); 
1H-NMR (400.1 MHz, 
CDCl3) δ 2.05 (bs, 1H, OH), 3.65 (dd, 
2J5’-Ha,5’-Hb = 11.7 Hz, 
3J5’-Ha,4’-H = 5.2 Hz, 1H, 
5’-Ha), 3.81 (dd, 
2J5’-Hb,5’-Ha = 11.7 Hz, 
3J5’-Hb,4’-H = 3.2 Hz, 1H, 5’-Hb), 5.14-5.18 (m, 1H, 
4’-H), 5.85 (ddd, 
3J1’-H,F = 5.8 Hz, JHH = 2.1 Hz, JHH = 2.1 Hz, 1H, 1’-H), 5.92 (ddd, 
3J2’-
H,3’-H = 6.1 Hz, JHH = 2.3 Hz, JHH = 1.5 Hz, 1H, 2’-H), 6.00 (ddd, 
3J3’-H,2’-H = 6.1 Hz, JHH = 
2.2 Hz, JHH = 1.6 Hz, 1H, 3’-H), 6.95-7.13 (m, 3H, 2-H, 4-H, and 6-H), 7.31 (ddd, 
3JHH = 
7.9 Hz, 
3JHH = 7.7 Hz, 
4J5-H,F = 5.8 Hz, 1H, 5-H); 
13C-NMR (100.6 MHz, CDCl3) δ 64.95 
(CH2-5’), 87.35 (d, 
4JCF = 1.8 Hz, CH-1’), 87.53 (CH-4’), 113.12 (d, 
2JCF = 21.9 Hz, 
CH-2), 114.71 (d, 
2JCF = 21.3 Hz, CH-4), 121.78 (d, 
4JCF = 2.9 Hz, CH-6), 126.90 (CH-2’), 
130.07 (d, 
3JCF = 8.1 Hz, CH-5), 131.84 (CH-3’), 144.06 (d, 
3JCF = 6.4 Hz, C-1), 163.00 (d, 
1JCF = 246.3 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ –113.28; IR (NaCl, neat) ν 3405 
(s, OH), 2928 (m), 2874 (m), 1615 (s), 1592 (s), 1488 (s), 1449 (s), 1264 (s) cm
-1; MS (CI) 
m/z (%) 195 ([M+H
+], 40), 177 ([M+H
+]-H2O, 100); HRMS (CI) 195.0824 [C11H12FO2 
(M+H
+) requires 195.0821].  
L-233ahβ
O
OH F
 
2’,3’-Didehydro-1’,2’,3’-trideoxy-1’-(3-fluorophenyl)-β-L-ribofuranose (L-233ahβ). 
Complex Et3N.3HF (0.2  mL, 1.3  mmol) was added to a solution of silane L-233bhβ 
(100  mg, 0.32  mmol) in THF (5  mL) and the reaction mixture was stirred at 20  °C 
overnight, and then evaporated. Flash chromatography on a column of silica gel 
(3 × 10 cm) with a mixture of hexanes and ethyl acetate (80:20) gave L-233ahβ (42 mg, 
67%) as a colourless oil: [α]D -63.4 (c 1.90, CHCl3); HRMS (CI) 195.0820 [C11H12FO2 
(M+H
+) requires 195.0821]. Anal. Calcd. for C11H11FO2: C, 68.03; H, 5.71. Found: C, 
68.19; H, 5.77. 
D-233baα
O Ph
TBSO
 
5’-O-(tert-Butyldimethylsilyl)-2’,3’-didehydro-2’,3’-dideoxy-1’-phenyl-
α-D-ribofuranose (D-233baα). Grubbs 1
st generation catalyst C1 (6.9 mg, 0.008 mmol) 
was added to a solution of silane (2S,1’S)-234ba (266 mg, 0.83 mmol) in dichloromethane 
(10 mL) under a stream of argon atmosphere and the mixture was stirred at 40 °C for 5 h. 
The resulting solution was evaporated and the residue was chromatographed on a column  
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of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl acetate (98.5:1.5) gave silane 
D-233baα as a colourless oil (136 mg, 56%): [α]D -69.6 (c 1.02, CHCl3); 
1H-NMR (400.1 
MHz, CDCl3) δ 0.06 (s, 3H, CH3), 0.07 (s, 3H, CH3), 0.90 (s, 9H, t-Bu), 3.66 (dd, 
2J5-Ha,5-Hb 
= 10.3 Hz, 
3J5-Ha,4-H = 5.7 Hz, 1H, 5-Ha), 3.77 (dd, 
2J5-Hb,5-Ha = 10.3 Hz, 
3J5-Hb,4-H = 4.6 Hz, 
1H, 5-Hb), 5.02-5.07 (m, 1H, 4-H), 5.78-5.80 (m, 1H, 1-H), 5.92 (ddd, 
3J3-H,2-H = 6.1 Hz, 
JHH = 2.1 Hz, JHH = 1.4 Hz, 1H, 3-H), 5.97 (ddd, 
3J2-H,3-H = 6.1 Hz, JHH = 2.2 Hz, JHH = 1.5 
Hz, 1H, 2-H), 7.22-7.36 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ -5.33 (CH3), 
-5.28 (CH3), 18.37 (C(CH3)3), 25.93 (C(CH3)3), 66.03 (CH2-5), 87.24 (CH-4), 88.04 
(CH-1), 126.40, and 127.75 (CH-arom), 128.13 (CH-2), 128.44 (CH-arom), 131.28 
(CH-3), 141.85 (C-arom); IR (NaCl, neat) ν 3380 (s), 2954 (s), 2930 (s), 2858 (s), 1725 
(m), 1257 (s), 1113 (m), 836 (s) cm
-1;
228 MS (CI) m/z (%) 291 ([M+H
+], 70), 149 (100); 
HRMS (CI) 291.1776 [C17H27O2Si (M+H
+) requires 291.1780].  
D-233baβ
O Ph
TBSO
 
5’-O-(tert-Butyldimethylsilyl)-2’,3’-didehydro-2’,3’-dideoxy-1’-phenyl-
β-D-ribofuranose (D-233baβ). Grubbs 1
st generation catalyst C1 (12.5 mg, 0.015 mmol) 
was added to a solution of silane (2S,1’R)-234ba (483 mg, 1.52 mmol) in dichloromethane 
(20 mL) under a stream of argon atmosphere and the mixture was stirred at 40 °C for 5 h. 
The resulting solution was evaporated and the residue was chromatographed on a column 
of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl acetate (98.5:1.5) gave silane 
D-233baβ as a colourless oil (441 mg, 78%): [α]D -35.5 (c 1.24, CHCl3); 
1H-NMR (400.1 
MHz, CDCl3) δ 0.09 (s, 6H, CH3), 0.93 (s, 9H, t-Bu), 3.73 (dd, 
2J5-Ha,5-Hb = 10.3 Hz, 
3J5-
Ha,4-H = 5.9 Hz, 1H, 5-Ha), 3.85 (dd, 
2J5-Hb,5-Ha = 10.3 Hz, 
3J5-Hb,4-H = 4.8 Hz, 1H, 5-Hb), 
4.96 (ddddd, 
3J4-H,5-Ha = 5.9 Hz, 
3J4-H,5-Hb = 4.8 Hz, 
4J4-H,1-H = 4.0 Hz, 
3J4-H,3-H = 2.1 Hz, 
4J4-
H,2-H = 1.4 Hz, 1H, 4-H), 5.80 (ddd, 
4J1-H,4-H = 4.0 Hz, 
3J1-H,2-H = 2.4 Hz, 
4J1-H,3-H = 1.6 Hz, 
1H, 1-H), 5.92 (ddd, 
3J3-H,2-H = 6.1 Hz, 
3J3-H,4-H = 2.1 Hz, 
4J3-H,1-H = 1.6 Hz, 1H, 3-H), 6.02 
(ddd, 
3J2-H,3-H = 6.1 Hz, 
3J2-H,1-H = 2.4 Hz, 
4J2-H,4-H = 1.4 Hz, 1H, 2-H), 7.27-7.40 (m, 5H, 
H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ -5.38 (CH3), 18.37 (C(CH3)3), 25.89 (C(CH3)3), 
66.42 (CH2-5), 87.15 (CH-4), 87.95 (CH-1), 126.84, 127.77, and 128.27 (CH-arom), 
128.33 (CH-2), 130.99 (CH-3), 141.65 (C-arom); IR (NaCl, CHCl3) ν 3371 (s), 2954 (s), 
2930 (s), 2858 (s), 1726 (m), 1257 (s), 1113 (s), 836 (s) cm
-1;
228 MS (CI) m/z (%) 305 
(100), 291 ([M
+], 50); HRMS (CI) 291.1778 [C17H27O2Si (M
+) requires 291.1780].   
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O
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5’-O-(tert-Butyldimethylsilyl)-2’,3’-didehydro-2’,3’-dideoxy-1’-phenyl-
α-L-ribofuranose (L-233baα). 
Grubbs 1
st generation catalyst C1 (55.0 mg, 0.067 mmol) was added to a solution of silane 
(2R,1’R)-234ba (1.226 g, 3.85 mmol) in dichloromethane (40 mL) under a stream of argon 
atmosphere and the mixture was stirred at 40  °C for 3  h. The resulting solution was 
evaporated and the residue was chromatographed on a column of silica gel (3 × 10 cm) 
with a mixture of hexanes and ethyl acetate (98.5:1.5) to afford silane L-233baα as a 
colourless oil (1.019 g, 91%): [α]D +202.6 (c 1.90, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) 
δ 0.06 (s, 3H, CH3), 0.07 (s, 3H, CH3), 0.90 (s, 9H, t-Bu), 3.66 (dd, 
2J5-Ha,5-Hb = 10.3 Hz, 
3J5-Ha,4-H = 5.7 Hz, 1H, 5-Ha), 3.77 (dd, 
2J5-Hb,5-Ha = 10.3 Hz, 
3J5-Hb,4-H = 4.6 Hz, 1H, 5-Hb), 
5.02-5.07 (m, 1H, 4-H), 5.78-5.80 (m, 1H, 1-H), 5.92 (ddd, 
3J3-H,2-H = 6.1 Hz, JHH = 2.1 Hz, 
JHH = 1.4 Hz, 1H, 3-H), 5.97 (ddd, 
3J2-H,3-H = 6.1 Hz, JHH = 2.2 Hz, JHH = 1.5 Hz, 1H, 2-H), 
7.22-7.36 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ -5.33 (CH3), -5.28 (CH3), 
18.37 (C(CH3)3), 25.93 (C(CH3)3), 66.03 (CH2-5), 87.24 (CH-4), 88.04 (CH-1), 126.40, 
and 127.75 (CH-arom), 128.13 (CH-2), 128.44 (CH-arom), 131.28 (CH-3), 141.85 
(C-arom); IR (NaCl, neat) ν 3373 (s), 2931 (s), 2858 (s), 1730 (m), 1467 (m), 1257 (s), 
1113 (s), 837 (s) cm
-1;
228 MS (CI) m/z (%) 291 ([M+H
+], 100); HRMS (CI) 291.1779 
[C17H27O2Si (M+H
+) requires 291.1780].  
L-233baβ
O
OTBS
Ph
 
5’-O-(tert-Butyldimethylsilyl)-2’,3’-didehydro-2’,3’-dideoxy-1’-phenyl-
β-L-ribofuranose (L-233baβ). 
Grubbs 1
st generation catalyst C1 (34.1 mg, 0.041 mmol) was added to a solution of silane 
(2R,1’S)-234ba (1.129 g, 3.54 mmol) in dichloromethane (40 mL) under a stream of argon 
atmosphere and the mixture was stirred at 40  °C for 3  h. The resulting solution was 
evaporated and the residue was chromatographed on a column of silica gel (3 × 10 cm) 
with a mixture of hexanes and ethyl acetate (98.5:1.5) to give silane L-233baβ as a 
colourless oil (880 mg, 86%): [α]D -24.6 (c 1.83, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 
0.09 (s, 6H, CH3), 0.93 (s, 9H, t-Bu), 3.73 (dd, 
2J5-Ha,5-Hb = 10.3 Hz, 
3J5-Ha,4-H = 5.9 Hz, 1H, 
5-Ha), 3.85 (dd, 
2J5-Hb,5-Ha = 10.3 Hz, 
3J5-Hb,4-H = 4.8 Hz, 1H, 5-Hb), 4.96 (ddddd, 
3J4-H,5-Ha  
 
187
= 5.9 Hz, 
3J4-H,5-Hb = 4.8 Hz, 
4J4-H,1-H = 4.0 Hz, 
3J4-H,3-H = 2.1 Hz, 
4J4-H,2-H = 1.4 Hz, 1H, 
4-H), 5.80 (ddd, 
4J1-H,4-H = 4.0 Hz, 
3J1-H,2-H = 2.4 Hz, 
4J1-H,3-H = 1.6 Hz, 1H, 1-H), 5.92 
(ddd, 
3J3-H,2-H = 6.1 Hz, 
3J3-H,4-H = 2.1 Hz, 
4J3-H,1-H = 1.6 Hz, 1H, 3-H), 6.02 (ddd, 
3J2-H,3-H = 
6.1 Hz, 
3J2-H,1-H = 2.4 Hz, 
4J2-H,4-H = 1.4 Hz, 1H, 2-H), 7.27-7.40 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ -5.38 (CH3), 18.37 (C(CH3)3), 25.89 (C(CH3)3), 66.42 
(CH2-5), 87.15 (CH-4), 87.95 (CH-1), 126.84, 127.77, and 128.27 (CH-arom), 128.33 
(CH-2), 130.99 (CH-3), 141.65 (C-arom); IR (NaCl, neat) ν 3375 (s), 2954 (s), 2931 (s), 
2858 (s), 1468 (m), 1255 (s), 1103 (s), 839 (s) cm
-1; MS (CI) m/z (%) 291 ([M+H
+], 100); 
HRMS (CI) 291.1760 [C17H27O2Si (M+H
+) requires 291.1780].  
L-233bfα/β
O
TBSO
Br
 
1’-(4-Bromophenyl)-5’-O-(tert-butyldimethylsilyl)-2’,3’-didehydro-2’,3’-dideoxy-
α/β-L-ribofuranose (L-233bfα/β).  Grubbs 1
st generation catalyst C1 (20.0  mg, 
0.024  mmol) was added to a solution of silane (2R)-234bf (967  mg, 2.43  mmol) in 
dichloromethane (20 mL) under a stream of argon atmosphere and the mixture was stirred 
at 40 °C for 5 h. The resulting solution was evaporated. Chromatography on a column of 
silica gel (3 × 10 cm) with a mixture of hexanes and ethyl acetate (98.5:1.5) gave silane 
L-233bfα/β as a colourless oil (755 mg, 84%); mixture of diastereoisomers A, B: 
1H-NMR 
(400.1 MHz, CDCl3) δ 0.01 (s, 6H, CH3), 0.02 (s, 6H, CH3), 0.84 (s, 9H, t-Bu), 0.85 (s, 9H, 
t-Bu), 3.62 (dd, 
2J5’A-Ha,5’A-Hb = 10.4 Hz, 
3J5’A-Ha,4’A-H = 5.5 Hz, 1H, 5’A-Ha), 3.65 (dd, 
2J5’B-Ha,5’B-Hb = 10.5 Hz, 
3J5’B-Ha,4’B-H = 5.4 Hz, 1H, 5’B-Ha), 3.71 (dd, 
2J5’A-Hb,5’A-Ha = 10.4 
Hz, 
3J5’A-Hb,4’A-H = 4.5 Hz, 1H, 5’A-Hb), 3.75 (dd, 
2J5’B-Hb,5’B-Ha = 10.4 Hz, 
3J5’B-Hb,4’B-H = 
4.6 Hz, 1H, 5’B-Hb), 4.85-4.89 (m, 1H, 4’A-H or 4’B-H), 4.97-5.02 (m, 1H, 4’B-H or 
4’A-H), 5.65-5.67 (m, 1H, 1’A-H or 1’B-H), 5.69-5.71 (m, 1H, 1’B-H or 1’A-H), 5.80 
(ddd, 
3JHH = 6.1 Hz, JHH = 2.2 Hz, JHH = 1.6 Hz, 1H, 3’A-H or 3’B-H), 5.84 (ddd, 
3JHH = 
6.1 Hz, JHH = 2.1 Hz, JHH = 1.5 Hz, 1H, 3’B-H or 3’A-H), 5.91-5.94 (m, 2H, 2’A-H, and 
2’B-H), 7.12 (d, 
3J2-H,3-H = 8.4 Hz, 2H, 2A-H or 2B-H), 7.21 (d, 
3J2-H,3-H = 8.4 Hz, 2H, 
2B-H or 2A-H), 7.39 (d, 
3J3-H,2-H = 8.4 Hz, 2H, 3A-H or 3B-H), 7.40 (d, 
3J3-H,2-H = 8.4 Hz, 
2H, 3B-H or 3A-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.37 (CH3), -5.34 (CH3), -5.32 
(CH3), -5.30 (CH3), 18.36 (C(CH3)3), 18.40 (C(CH3)3), 25.91 (C(CH3)3), 65.88, and 66.16 
(CH2-1), 87.25, 87.35, 87.36, and 87.37 (CH-1’, and CH-4’), 121.56, and 121.65 (C-4), 
128.10, and 128.41 (CH-2’ or CH-3’), 128.59, and 128.65 (CH-2), 130.71, and 130.90 
(CH-3’ or CH-2’), 131.37, and 131.52 (CH-3), 140.88, and 140.93 (C-1); MS (CI) m/z (%)  
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369/371 ([M
+], 100), 353/355 (10), 311/313 (30), 237/239 (20), 195/197 (20); HRMS (CI) 
369.0882/371.0878 [C17H26BrO2Si (M
+) requires 369.0885/371.0867]. 
D-233bhα
O
TBSO F
 
5’-O-(tert-Butyldimethylsilyl)-2’,3’-didehydro-1’,2’,3’-trideoxy-
1’-(3-fluorophenyl)-α-D-ribofuranose (D-233bhα). 
Grubbs 1
st generation catalyst C1 (12.0 mg, 0.014 mmol) was added to a solution of silane 
(2S,1’S)-234bh (329 mg, 0.97 mmol) in dichloromethane (8 mL) under a stream of argon 
atmosphere and the mixture was stirred at 40  °C for 3  h. The resulting solution was 
evaporated and the residue was chromatographed on a column of silica gel (3 × 10 cm) 
with a mixture of hexanes and ethyl acetate (98.5:1.5) to afford silane D-233bhα as a 
colourless oil (285 mg, 95%): [α]D -154.4 (c 1.80, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) 
δ 0.09 (s, 3H, CH3), 0.10 (s, 3H, CH3), 0.93 (s, 9H, t-Bu), 3.70 (dd, 
2J5’-Ha,5’-Hb = 10.4 Hz, 
3J5’-Ha,4’-H = 5.5 Hz, 1H, 5’-Ha), 3.80 (dd, 
2J5’-Hb,5’-Ha = 10.4 Hz, 
3J5’-Hb,4’-H = 4.6 Hz, 1H, 
5’-Hb), 5.05-5.11 (m, 1H, 4’-H), 5.81-5.82 (m, 1H, 1’-H), 5.93 (ddd, 
3J3’-H,2’-H = 6.1 Hz, 
JHH = 2.0 Hz, JHH = 1.6 Hz, 1H, 3’-H), 6.01 (ddd, 
3J2’-H,3’-H = 6.1 Hz, JHH = 2.3 Hz, JHH = 
1.5 Hz, 1H, 2’-H), 6.96 (dddd, 
3J4-H,F = 9.5 Hz, 
3J4-H,5-H = 8.5 Hz, 
4J4-H,2-H = 2.6 Hz, 
4J4-H,6-H 
= 1.0 Hz, 1H, 4-H), 7.03 (ddd, 
3J2-H,F = 9.7 Hz, 
4J2-H,4-H = 2.6 Hz, 
4J2-H,6-H = 1.6 Hz, 1H, 
2-H), 7.07-7.10 (m, 1H, 6-H), 7.30 (ddd, 
3J5-H,4-H = 8.5 Hz, 
3J5-H,6-H = 7.7 Hz, 
4J5-H,F = 5.8 
Hz, 1H, 5-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.34 (CH3), -5.30 (CH3), 18.37 (C(CH3)3), 
25.92 (C(CH3)3), 65.91 (CH2-5’), 87.36 (d, 
4JCF = 1.8 Hz, CH-1’), 87.45 (CH-4’), 113.21 
(d, 
2JCF = 21.8 Hz, CH-2), 114.55 (d, 
2JCF = 21.3 Hz, CH-4), 121.84 (d, 
4JCF = 2.9 Hz, 
CH-6), 128.47 (CH-2’), 129.93 (d, 
3JCF = 8.1 Hz, CH-5), 130.87 (CH-3’), 144.69 (d, 
3JCF = 
6.5 Hz, C-1), 163.04 (d, 
1JCF = 246.1 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ –113.55; 
IR (NaCl, neat) ν 2955 (s), 2930 (s), 2858 (s), 1730 (m), 1593 (s), 1258 (s) cm
-1;
228 MS 
(CI) m/z (%) 309 ([M+H
+], 100); HRMS (CI) 309.1687 [C17H26FO2Si (M+H
+) requires 
309.1686].  
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D-233bhβ
O
TBSO F
 
5’-O-(tert-Butyldimethylsilyl)-2’,3’-didehydro-1’,2’,3’-trideoxy-
1’-(3-fluorophenyl)-β-D-ribofuranose (D-233bhβ). 
Grubbs 1
st generation catalyst C1 (40.1 mg, 0.049 mmol) was added to a solution of silane 
(2S,1’R)-234bh (1.346 g, 4.00 mmol) in dichloromethane (50 mL) under a stream of argon 
atmosphere and the mixture was stirred at 40  °C for 3  h. The resulting solution was 
evaporated and the residue was chromatographed on a column of silica gel (3 × 10 cm) 
with a mixture of hexanes and ethyl acetate (99:1) to give silane D-233bhβ as a colourless 
oil (1.185 g, 96%): [α]D +8.0 (c 2.63, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.09 (s, 6H, 
CH3), 0.93 (s, 9H, t-Bu), 3.71 (dd, 
2J5’-Ha,5’-Hb = 10.5 Hz, 
3J5’-Ha,4’-H = 5.5 Hz, 1H, 5’-Ha), 
3.77 (dd, 
2J5’-Hb,5’-Ha = 10.5 Hz, 
3J5’-Hb,4’-H = 4.9 Hz, 1H, 5’-Hb), 4.89-4.95 (m, 1H, 4’-H), 
5.73-5.75 (m, 1H, 1’-H), 5.94 (ddd, 
3J3’-H,2’-H = 6.1 Hz, JHH = 1.8 Hz, JHH = 1.2 Hz, 1H, 
3’-H), 5.97 (ddd, 
3J2’-H,3’-H = 6.1 Hz, JHH = 2.2 Hz, JHH = 1.1 Hz, 1H, 2’-H), 6.98-7.11 (m, 
3H, 2-H, 4-H, and 6-H), 7.30-7.32 (m, 1H, 5-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.36 
(CH3), 18.35 (C(CH3)3), 25.90 (C(CH3)3), 62.97 (CH2-5’), 87.19 (d, 
4JCF = 1.8 Hz, CH-1’), 
87.29 (CH-4’), 113.84 (d, 
2JCF = 21.7 Hz, CH-2), 114.82 (d, 
2JCF = 21.2 Hz, CH-4), 122.44 
(d, 
4JCF = 2.9 Hz, CH-6), 129.47 (CH-2’), 129.99 (d, 
3JCF = 8.1 Hz, CH-5), 130.20 
(CH-3’), 144.41 (d, 
3JCF = 6.6 Hz, C-1), 162.99 (d, 
1JCF = 246.3 Hz, CF-3); 
19F-NMR 
(376.5 MHz, CDCl3) δ –113.33; IR (NaCl, neat) ν 2954 (s), 2931 (s), 2858 (s), 1742 (m), 
1592 (m), 1258 (s) cm
-1;
228 MS (CI) m/z (%) 309 ([M+H
+], 100); HRMS (CI) 309.1687 
[C17H26FO2Si (M+H
+) requires 309.1686].  
L-233bhα
O
OTBS F
 
5’-O-(tert-Butyldimethylsilyl)-2’,3’-didehydro-1’,2’,3’-trideoxy-
1’-(3-fluorophenyl)-α-L-ribofuranose (L-233bhα). 
Grubbs 1
st generation catalyst C1 (20.0 mg, 0.024 mmol) was added to a solution of silane 
(2R,1’R)-234bh (650 mg, 1.93 mmol) in dichloromethane (15 mL) under a stream of argon 
atmosphere and the mixture was stirred at 40  °C for 3  h. The resulting solution was 
evaporated and the residue was chromatographed on a column of silica gel (3 × 10 cm) 
with a mixture of hexanes and ethyl acetate (98.5:1.5) to give silane L-233bhα as a  
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colourless oil (580 mg, 97%): [α]D +147.1 (c 2.40, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) 
δ 0.09 (s, 3H, CH3), 0.10 (s, 3H, CH3), 0.93 (s, 9H, t-Bu), 3.70 (dd, 
2J5’-Ha,5’-Hb = 10.4 Hz, 
3J5’-Ha,4’-H = 5.5 Hz, 1H, 5’-Ha), 3.80 (dd, 
2J5’-Hb,5’-Ha = 10.4 Hz, 
3J5’-Hb,4’-H = 4.6 Hz, 1H, 
5’-Hb), 5.05-5.11 (m, 1H, 4’-H), 5.81-5.82 (m, 1H, 1’-H), 5.93 (ddd, 
3J3’-H,2’-H = 6.1 Hz, 
JHH = 2.0 Hz, JHH = 1.6 Hz, 1H, 3’-H), 6.01 (ddd, 
3J2’-H,3’-H = 6.1 Hz, JHH = 2.3 Hz, JHH = 
1.5 Hz, 1H, 2’-H), 6.96 (dddd, 
3J4-H,F = 9.5 Hz, 
3J4-H,5-H = 8.5 Hz, 
4J4-H,2-H = 2.6 Hz, 
4J4-H,6-H 
= 1.0 Hz, 1H, 4-H), 7.03 (ddd, 
3J2-H,F = 9.7 Hz, 
4J2-H,4-H = 2.6 Hz, 
4J2-H,6-H = 1.6 Hz, 1H, 
2-H), 7.07-7.10 (m, 1H, 6-H), 7.30 (ddd, 
3J5-H,4-H = 8.5 Hz, 
3J5-H,6-H = 7.7 Hz, 
4J5-H,F = 5.8 
Hz, 1H, 5-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.34 (CH3), -5.30 (CH3), 18.37 (C(CH3)3), 
25.92 (C(CH3)3), 65.91 (CH2-5’), 87.36 (d, 
4JCF = 1.8 Hz, CH-1’), 87.45 (CH-4’), 113.21 
(d, 
2JCF = 21.8 Hz, CH-2), 114.55 (d, 
2JCF = 21.3 Hz, CH-4), 121.84 (d, 
4JCF = 2.9 Hz, 
CH-6), 128.47 (CH-2’), 129.93 (d, 
3JCF = 8.1 Hz, CH-5), 130.87 (CH-3’), 144.69 (d, 
3JCF = 
6.5 Hz, C-1), 163.04 (d, 
1JCF = 246.1 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ –113.55; 
IR (NaCl, neat) ν 2955 (s), 2930 (s), 2858 (s), 1730 (m), 1593 (s), 1258 (s) cm
-1;
228 MS 
(CI) m/z (%) 309 ([M+H
+], 100); HRMS (CI) 309.1682 [C17H26FO2Si (M+H
+) requires 
309.1686].  
L-233bhβ
O
OTBS F
 
5’-O-(tert-Butyldimethylsilyl)-2’,3’-didehydro-1’,2’,3’-trideoxy-
1’-(3-fluorophenyl)-β-L-ribofuranose (L-233bhβ). 
Grubbs 1
st generation catalyst C1 (27.1 mg, 0.033 mmol) was added to a solution of silane 
(2R,1’S)-234bh (1.088 g, 3.23 mmol) in dichloromethane (15 mL) under a stream of argon 
atmosphere and the mixture was stirred at 40 °C for 3 h. The solution was evaporated and 
chromatographed on a column of silica gel (3 × 10 cm) with a mixture of hexanes and 
ethyl acetate (99:1) to afford silane L-233bhβ as a colourless oil (946 mg, 95%): [α]D -7.7 
(c 1.14, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.09 (s, 6H, CH3), 0.93 (s, 9H, t-Bu), 
3.71 (dd, 
2J5’-Ha,5’-Hb = 10.5 Hz, 
3J5’-Ha,4’-H = 5.5 Hz, 1H, 5’-Ha), 3.77 (dd, 
2J5’-Hb,5’-Ha = 10.5 
Hz, 
3J5’-Hb,4’-H = 4.9 Hz, 1H, 5’-Hb), 4.89-4.95 (m, 1H, 4’-H), 5.73-5.75 (m, 1H, 1’-H), 
5.94 (ddd, 
3J3’-H,2’-H = 6.1 Hz, JHH = 1.8 Hz, JHH = 1.2 Hz, 1H, 3’-H), 5.97 (ddd, 
3J2’-H,3’-H = 
6.1 Hz, JHH = 2.2 Hz, JHH = 1.1 Hz, 1H, 2’-H), 6.98-7.11 (m, 3H, 2-H, 4-H, and 6-H), 
7.30-7.32 (m, 1H, 5-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.36 (CH3), 18.35 (C(CH3)3), 
25.90 (C(CH3)3), 62.97 (CH2-5’), 87.19 (d, 
4JCF = 1.8 Hz, CH-1’), 87.29 (CH-4’), 113.84 
(d, 
2JCF = 21.7 Hz, CH-2), 114.82 (d, 
2JCF = 21.2 Hz, CH-4), 122.44 (d, 
4JCF = 2.9 Hz,  
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CH-6), 129.47 (CH-2’), 129.99 (d, 
3JCF = 8.1 Hz, CH-5), 130.20 (CH-3’), 144.41 (d, 
3JCF = 
6.6 Hz, C-1), 162.99 (d, 
1JCF = 246.3 Hz, CF-3); 
19F-NMR (376.5 MHz, CDCl3) δ –113.33; 
IR (NaCl, neat) ν 2954 (s), 2931 (s), 2858 (s), 1742 (m), 1592 (m), 1258 (s) cm
-1;
228 MS 
(CI) m/z (%) 309 ([M+H
+], 100); HRMS (CI) 309.1687 [C17H26FO2Si (M+H
+) requires 
309.1686].  
233ca
O Ph
TBDPSO
 
5’-O-(tert-Butyldiphenylsilyl)-2’,3’-didehydro-1’,2’,3’-trideoxy-1’-phenyl-
α/β-D/L-ribofuranose (233ca). 
A solution of the 2
nd generation Grubbs catalyst C2 (20.0 mg, 0.024 mmol) in degassed 
dichloromethane (1 mL) was added to a solution of the diene 234ca (224 mg, 0.53 mmol) 
in degassed dichloromethane (5  mL) and the mixture was stirred at room temperature 
overnight. The solvent was then evaporated and the residue was chromatographed on a 
column of neutral alumina (3 × 5 cm) with a mixture of hexanes and Et2O (95:5) to give 
233ca as a colourless oil (217  mg, 99%): 
1H-NMR (400.1 MHz, CDCl3, mixture of 
diasteroisomers in a 1:1.30 ratio, minor diastereoisomer is marked with * where possible) δ 
1.07* and 1.09 (s, 9H, t-Bu), 3.59* (dd, J = 8.2 and 10.9 Hz, 1H, aCH2), 3.65 (dd, J = 3.6 
and 11.6Hz, 1H, aCH2), 3.84* (dd, J = 4.0 and 11.6Hz, 1H, bCH2), 3.92 (dd, J = 5.4 and 
10.9Hz, 1H, bCH2), 4.15-4.18 and 4.41*-4.46* (m, 1H, CH2CH), 5.00-5.02 and 
5.06*-5.08* (m, 1H, PhCH), 5.78-6.02 (m, 2H, CH=CH), 7.29-7.46 and 7.67-7.32 (m, 
15H, H-arom); 
13C-NMR (100.6 MHz, CDCl3)  δ 26.9 and 30.3 (t-Bu), 63.6 and 64.1 
(CH2CH), 68.4 and 68.5 (CH2), 75.6 and 76.4 (PhCH), 127.3 and 131.2 and 127.9 and 
130.2 (CH=CH), 127.6, 127.7, 128.4, 133.7, 133.9, 134.0, 135.7, 135.8, 140.4; HRMS 
(CI-NH3, 100 °C) 432.2360 [C27H34NO2Si (M+NH4
+) requires 432.2359]. 
233ci
O
TBDPSO
F
 
5’-O-(tert-Butyldiphenylsilyl)-2’,3’-didehydro-1’,2’,3’-trideoxy-1’-(4-fluorophenyl)-
α/β-D/L-ribofuranose (233ci). 
Benzylidene-bis(tricyclohexylphosphine)dichlororuthenium (C1; Grubbs 1
st generation 
catalyst; 73.4  mg, 0.089  mmol) was added to a solution of silane 234ci (278  mg,  
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0.60  mmol) in dichloromethane (15  mL) under a stream of argon atmosphere and the 
mixture was stirred at 40 °C for 5 h. The resulting solution was evaporated and the residue 
was chromatographed on a column of silica gel (3 × 10 cm) with a mixture of hexanes and 
ethyl acetate (98.5:1.5) to afford silane 233ci as a colourless oil (108 mg, 41%): 
1H-NMR 
(400.1 MHz, CDCl3) δ 1.09 (s, 9H, t-Bu), 3.80 (dd, 
2J5’-Ha,5’-Hb = 10.6 Hz, 
3J5’-Ha,4’-H = 5.2 
Hz, 1H, 5’-Ha), 3.85 (dd, 
2J5’-Hb,5’-Ha = 10.6 Hz, 
3J5’-Hb,4’-H = 4.9 Hz, 1H, 5’-Hb), 5.01 
(dddd, 
3J4’-H,5’-Ha = 5.2 Hz, 
3J4’-H,5’-Hb = 4.9 Hz, 
4J4’-H,2’-H = 2.4 Hz, 
3J4’-H,3’-H = 1.4 Hz, 1H, 
4’-H), 5.77-5.79 (m, 1H, 1’-H), 5.89 (ddd, 
3J2’-H,3’-H = 6.1 Hz, 
4J2’-H,4’-H = 2.4 Hz, 
3J2’-H,1’-H 
= 1.5 Hz, 1H, 2’-H), 6.03 (ddd, 
3J3’-H,2’-H = 6.1 Hz, 
4J3’-H,1’-H = 2.4 Hz, 
3J3’-H,4’-H = 1.4 Hz, 
1H, 3’-H), 6.95 (t, 
3JHH = 8.8 Hz, 
3JHF = 8.8 Hz, 2H, 3-H), 7.30-7.47 (m, 8H, H-arom), 
7.67-7.71 (m, 4H, H-arom); 
13C-NMR (100.6 MHz, CDCl3)  δ 19.26 (C(CH3)3), 26.85 
(C(CH3)3), 66.93 (CH2-5’), 87.15 (CH-4’), 87.32 (CH-1’), 115.11 (d, 
2JCF = 21.5 Hz, 
CH-3), 127.65 (CH-arom), 128.52 (CH-3’), 128.68 (d, 
3JCF = 8.2 Hz, CH-2), 129.64 and 
129.67 (CH-arom), 131.06 (CH-2’), 133.25 and 133.51 (C-arom), 135.59 and 135.66 
(CH-arom), 137.49 (d, 
4JCF = 3.1 Hz, C-1), 162.43 (d, 
1JCF = 245.6 Hz, C-4); MS (CI, 
150 °C)  m/z (%) 433 (M
+, 3), 375 (10), 355 (100), 257 (10); HRMS (CI) 433.2000 
[C27H30FO2Si (M
+) requires 433.1999]. 
234ba
O Ph
TBSO
Ha Hb
Hb
Ha
Hb
Ha
 
tert-Butyl(dimethyl)(2-(1’-(phenyl)allyloxy)but-3-enyloxy)silane (234ba). 
n-Butyllithium (0.5  mL, 1.0  mmol, 2.0M solution in pentane) was added slowly to a 
solution of protected butenediol (±)-235b (206 mg, 1.00 mmol) in THF (1 mL) and the 
mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated was transferred 
(via cannula) to a suspension of copper(I) iodide (200 mg, 1.05 mmol) in THF (2 mL) at 
room temperature. The mixture turned light yellow and was then stirred for 30 min.
230 The 
resulting mixture was cooled to 0  °C, a cold (0  °C) solution of [Ir(COD)Cl]2 (7.8  mg, 
0.011  mmol) and (t-BuO)2PN(iPr)2 (6.0  mg, 0.021  mmol) in THF (1  mL) and 
allylcarbonate (±)-267a (124 mg, 0.53 mmol, neat) were added consecutively. The cooling 
bath was then removed and the reaction mixture was stirred at room temperature for 16 h. 
The catalyst was precipitated by adding hexane (5  mL) and the mixture was filtered 
through a pad of silica (3 × 3 cm) and the product was eluted with a mixture of hexanes  
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and ethyl acetate (90:10). Chromatography on a column of silica gel (3 × 10 cm) with a 
mixture of hexanes and ethyl acetate (98.5:1.5) gave silane 234ba as colourless oil 
(142 mg, 84%, an equimolar mixture of diastereoisomers A, B): 
1H-NMR (400.1 MHz, 
CDCl3) δ 0.03 (s, 6H, CH3), 0.08 (s, 3H, CH3), 0.09 (s, 3H, CH3), 0.89 (s, 9H, t-Bu), 0.92 
(s, 9H, t-Bu), 3.57 (dd, 
2J1A-Ha,1A-Hb = 10.5 Hz, 
3J1A-Ha,2A-H = 5.3 Hz, 1H, 1A-Ha), 3.63 (dd, 
2J1B-Ha,1B-Hb = 10.5 Hz, 
3J1B-Ha,2B-H = 5.3 Hz, 1H, 1B-Ha), 3.70 (dd, 
2J1A-Hb,1A-Ha = 10.5 Hz, 
3J1A-Hb,2A-H = 6.6 Hz, 1H, 1A-Hb), 3.76 (dd, 
2J1B-Hb,1B-Ha = 10.5 Hz, 
3J1B-Hb,2B-H = 6.6 Hz, 
1H, 1B-Hb), 3.83 (ddddd, 
3J2-H,3-H = 6.9 Hz, 
3J2-H,1-Hb = 6.6 Hz, 
3J2-H,1-Ha = 5.3 Hz, 
4J2-H,4-Ha 
= 1.0 Hz, 
4J2-H,4-Hb = 1.0 Hz, 1H, 2A-H or 2B-H), 4.06 (ddddd, 
3J2-H,3-H = 6.9 Hz, 
3J2-H,1-Hb 
= 6.6 Hz, 
3J2-H,1-Ha = 5.3 Hz, 
4J2-H,4-Ha = 1.0 Hz, 
4J2-H,4-Hb = 1.0 Hz, 1H, 2B-H or 2A-H), 
4.95 (d, 
3J1’-H,2’-H = 7.2 Hz, 1H, 1’A-H or 1’B-H), 4.95 (d, 
3J1’-H,2’-H = 6.1 Hz, 1H, 1’B-H or 
1’A-H), 5.10-5.34 (m, 8H, 4A-H, 3’A-H, 4B-H, and 3’B-H), 5.74 (ddd, 
3J3-H,4-Ha = 17.3 
Hz, 
3J3-H,4-Hb = 10.4 Hz, 
3J3-H,2-H = 6.9 Hz, 1H, 3A-H or 3B-H), 5.77 (ddd, 
3J3-H,4-Ha = 16.2 
Hz, 
3J3-H,4-Hb = 11.5 Hz, 
3J3-H,2-H = 6.9 Hz, 1H, 3B-H or 3A-H), 5.90 (ddd, 
3J2’-H,3’-Ha = 17.3 
Hz, 
3J2’-H,3’-Hb = 10.2 Hz, 
3J2’-H,1’-H = 7.2 Hz, 1H, 2’A-H or 2’B-H), 5.98 (ddd, 
3J2’-H,3’-Ha = 
17.2 Hz, 
3J2’-H,3’-Hb = 10.3 Hz, 
3J2’-H,1’-H = 6.1 Hz, 1H, 2’B-H or 2’A-H), 7.23-7.38 (m, 10H, 
H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ -5.37 (CH3), -5.31 (CH3), -5.28 (CH3), -5.18 
(CH3), 18.35 (C(CH3)3), 25.90 (C(CH3)3), 66.24, and 66.29 (CH2-1), 78.52, and 78.75 
(CH-2), 79.90, and 80.26 (CH-1’), 115.29, 116.68, 117.85, and 118.09 (CH2-4, and 
CH2-3’), 126.73, 127.19, 127.34, 127.51, 128.25, and 128.35 (CH-arom), 136.14, and 
136.27 (CH-3), 138.78, and 139.49 (CH-2’), 140.99, and 141.52 (C-arom); IR (NaCl, neat) 
ν 2956 (s), 2929 (s), 2857 (s), 1472 (m), 1257 (s), 1087 (s), 838 (s) cm
-1; MS (CI-NH3, 
160 °C)  m/z (%) 336 ([M+NH4
+], 30), 117 (100); HRMS (CI-NH3, 100  °C) 336.2357 
[C19H34NO2Si (M+NH4
+) requires 336.2359]. Anal. Calcd. for C19H30O2Si: C, 71.64; H, 
9.49. Found: C, 71.26; H, 9.57. 
(2R,1'R)-234ba
O Ph
TBSO
Ha Hb
Hb
Ha
Hb
Ha
 
(2R,1’R)-tert-Butyl(dimethyl)(2-(1’-(phenyl)allyloxy)but-3-enyloxy)silane 
(2R,1’R)-(234ba).  n-Butyllithium (3.0  mL, 6.0  mmol, 2.0M solution in pentane) was 
added slowly to a solution of protected butenediol (R)-235b (1.236 g, 6.11 mmol) in THF 
(7 mL) and the mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated  
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was transferred (via cannula) to a suspension of copper(I) iodide (1.200 g, 6.30 mmol) in 
THF (12 mL) at room temperature. The mixture turned light yellow and was then stirred 
for 30  min.
230 The resulting mixture was cooled to 0  °C, a cold (0  °C) solution of 
[Ir(COD)Cl]2 (40.4  mg, 0.060  mmol) in THF (5.0  mL) and allylcarbonate (R)-267a 
(1.226 g, 5.23 mmol, neat) were added consecutively. The cooling bath was then removed 
and the reaction mixture was stirred at room temperature for 20  h. The catalyst was 
precipitated by adding hexane (10 mL) and the mixture was filtered through a pad of silica 
(3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate (90:10). 
Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave silane (2R,1’R)-234ba as colourless oil (1.388 g, 83%, as a single 
diastereoisomer): [α]D -10.2 (c 3.73, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.08 (s, 3H, 
CH3), 0.09 (s, 3H, CH3), 0.92 (s, 9H, t-Bu), 3.63 (dd, 
2J1-Ha,1-Hb = 10.5 Hz, 
3J1-Ha,2-H = 5.3 
Hz, 1H, 1-Ha), 3.76 (dd, 
2J1-Hb,1-Ha = 10.5 Hz, 
3J1-Hb,2-H = 6.6 Hz, 1H, 1-Hb), 4.06 (ddddd, 
3J2-H,3-H = 6.9 Hz, 
3J2-H,1-Hb = 6.6 Hz, 
3J2-H,1-Ha = 5.3 Hz, 
4J2-H,4-Ha = 0.9 Hz, 
4J2-H,4-Hb = 0.9 
Hz, 1H, 2-H), 4.95 (d, 
3J1’-H,2’-H = 7.3 Hz, 1H, 1’-H), 5.20-5.35 (m, 4H, 4-Ha, 4-Hb, 3’-Ha, 
and 3’-Hb), 5.74 (ddd, 
3J3-H,4-Ha = 17.3 Hz, 
3J3-H,4-Hb = 10.4 Hz, 
3J3-H,2-H = 6.9 Hz, 1H, 3-H), 
5.90 (ddd, 
3J2’-H,3’-Ha = 17.3 Hz, 
3J2’-H,3’-Hb = 10.2 Hz, 
3J2’-H,1’-H = 7.3 Hz, 1H, 2’-H), 
7.23-7.38 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ -5.31 (CH3), -5.18 (CH3), 
18.35 (C(CH3)3), 25.91 (C(CH3)3), 66.29 (CH2-1), 78.75 (CH-2), 80.26 (CH-1’), 116.68, 
117.84 (CH2-4, and CH2-3’), 126.73, 127.34, and 128.25 (CH-arom), 136.28 (CH-3), 
138.79 (CH-2’), 141.53 (C-arom); IR (NaCl, neat) ν 2955 (s), 2928 (s), 2857 (s), 1471 (m), 
1255 (s), 1128 (s), 1086 (s) cm
-1; MS (CI-iso, 150 °C) m/z (%) 319 ([M+H
+], 5), 117 
(100); HRMS (CI) 319.2091 [C19H31O2Si (M+H
+) requires 319.2093]. Anal. Calcd. for 
C19H30O2Si: C, 71.64; H, 9.49. Found: C, 71.45; H, 9.54. 
(2R,1'S)-234ba
O Ph
TBSO
Ha Hb
Hb
Ha
Hb
Ha
 
(2R,1’S)-tert-Butyl(dimethyl)(2-(1’-(phenyl)allyloxy)but-3-enyloxy)silane 
(2R,1’S)-(234ba).  n-Buthyllithium (3.1  mL, 6.2  mmol, 2.0M solution in pentane) was 
added slowly to a solution of protected butenediol (R)-235b (1.252 g, 6.19 mmol) in THF 
(6 mL) and the mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated 
was transferred (via cannula) to a suspension of copper(I) iodide (1.200 g, 6.30 mmol) in  
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THF (12 mL) at room temperature. The mixture turned light yellow and was then stirred 
for 30  min.
230 The resulting mixture was cooled to 0  °C, a cold (0  °C) solution of 
[Ir(COD)Cl]2 (40.0  mg, 0.060  mmol) in THF (12.0  mL) and allylcarbonate (S)-267a 
(1.180 g, 5.04 mmol, neat) were added consecutively. The cooling bath was then removed 
and the reaction mixture was stirred at room temperature for 20  h. The catalyst was 
precipitated by adding hexane (10 mL) and the mixture was filtered through a pad of silica 
(3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate (90:10). 
Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave silane (2R,1’S)-234ba as colourless oil (1.232 g, 77%, as a single 
diastereoisomer): [α]D -23.3 (c 2.62, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.04 (s, 6H, 
CH3), 0.89 (s, 9H, t-Bu), 3.58 (dd, 
2J1-Ha,1-Hb = 10.5 Hz, 
3J1-Ha,2-H = 5.3 Hz, 1H, 1-Ha), 3.71 
(dd, 
2J1-Hb,1-Ha = 10.5 Hz, 
3J1-Hb,2-H = 6.6 Hz, 1H, 1-Hb), 3.84 (ddddd, 
3J2-H,3-H = 7.0 Hz, 
3J2-
H,1-Hb = 6.6 Hz, 
3J2-H,1-Ha = 5.3 Hz, 
4J2-H,4-Ha = 0.8 Hz, 
4J2-H,4-Hb = 0.8 Hz, 1H, 2-H), 4.96 (d, 
3J1’-H,2’-H = 6.1 Hz, 1H, 1’-H), 5.12-5.28 (m, 4H, 4-H, and 3’-H), 5.78 (ddd, 
3J3-H,4-Ha = 16.2 
Hz, 
3J3-H,4-Hb = 11.4 Hz, 
3J3-H,2-H = 7.0 Hz, 1H, 3-H), 5.98 (ddd, 
3J2’-H,3’-Ha = 17.1 Hz, 
3J2’-
H,3’-Hb = 10.4 Hz, 
3J2’-H,1’-H = 6.1 Hz, 1H, 2’-H), 7.25-7.38 (m, 5H, H-arom); 
13C-NMR 
(100.6 MHz, CDCl3) δ -5.37 (CH3), -5.28 (CH3), 18.34 (C(CH3)3), 25.90 (C(CH3)3), 66.24 
(CH2-1), 78.52 (CH-2), 79.89 (CH-1’), 115.26, and 118.07 (CH2-4, and CH2-3’), 127.19, 
127.50, and 128.34 (CH-arom), 136.14 (CH-3), 139.49 (CH-2’), 140.99 (C-arom); IR 
(NaCl, neat) ν 2955 (s), 2928 (s), 2857 (s), 1471 (m), 1255 (s), 1121 (s), 1083 (s), 838 
(s) cm
-1; MS (CI-Iso, 150 °C) m/z (%) 319 ([M+H
+], 3), 185 (10), 117 (100); HRMS (CI) 
319.2092 [C19H31O2Si (M+H
+) requires 319.2093]. Anal. Calcd. for C19H30O2Si: C, 71.64; 
H, 9.49. Found: C, 71.45; H, 9.57. 
(2S,1'R)-234ba
O Ph
TBSO
Ha Hb
Hb
Ha
Hb
Ha
 
(2S,1’R)-tert-Butyl(dimethyl)(2-(1’-(phenyl)allyloxy)but-3-enyloxy)silane 
(2S,1’R)-(234ba).  n-Buthyllithium (3.0  mL, 6.0  mmol, 2.0M solution in pentane) was 
added slowly to a solution of protected butenediol (S)-235b (1.236 g, 6.11 mmol) in THF 
(6 mL) and the mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated 
was transferred (via cannula) to a suspension of copper(I) iodide (1.200 g, 6.30 mmol) in 
THF (12 mL) at room temperature. The mixture turned light yellow and was then stirred  
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for 30  min.
230 The resulting mixture was cooled to 0  °C, a cold (0  °C) solution of 
[Ir(COD)Cl]2 (40.0  mg, 0.060  mmol) in THF (3.5  mL) and allylcarbonate (R)-267a 
(1.133 g, 4.84 mmol, neat) were added consecutively. The cooling bath was then removed 
and the reaction mixture was stirred at room temperature for 16  h. The catalyst was 
precipitated by adding hexane (5 mL) and the mixture was filtered through a pad of silica 
(3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate (90:10). 
Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave silane (2S,1’R)-234ba as colourless oil (1.263 g, 82%, as a single 
diastereoisomer): [α]D +25.3 (c 1.11, MeOH); 
1H-NMR (400.1 MHz, CDCl3) δ 0.04 (s, 6H, 
CH3), 0.89 (s, 9H, t-Bu), 3.58 (dd, 
2J1-Ha,1-Hb = 10.5 Hz, 
3J1-Ha,2-H = 5.3 Hz, 1H, 1-Ha), 3.71 
(dd, 
2J1-Hb,1-Ha = 10.5 Hz, 
3J1-Hb,2-H = 6.6 Hz, 1H, 1-Hb), 3.84 (ddddd, 
3J2-H,3-H = 7.0 Hz, 
3J2-
H,1-Hb = 6.6 Hz, 
3J2-H,1-Ha = 5.3 Hz, 
4J2-H,4-Ha = 0.8 Hz, 
4J2-H,4-Hb = 0.8 Hz, 1H, 2-H), 4.96 (d, 
3J1’-H,2’-H = 6.1 Hz, 1H, 1’-H), 5.12-5.28 (m, 4H, 4-H, and 3’-H), 5.78 (ddd, 
3J3-H,4-Ha = 16.2 
Hz, 
3J3-H,4-Hb = 11.4 Hz, 
3J3-H,2-H = 7.0 Hz, 1H, 3-H), 5.98 (ddd, 
3J2’-H,3’-Ha = 17.1 Hz, 
3J2’-
H,3’-Hb = 10.4 Hz, 
3J2’-H,1’-H = 6.1 Hz, 1H, 2’-H), 7.25-7.38 (m, 5H, H-arom); 
13C-NMR 
(100.6 MHz, CDCl3) δ -5.37 (CH3), -5.28 (CH3), 18.34 (C(CH3)3), 25.90 (C(CH3)3), 66.24 
(CH2-1), 78.52 (CH-2), 79.89 (CH-1’), 115.26, and 118.07 (CH2-4, and CH2-3’), 127.19, 
127.50, and 128.34 (CH-arom), 136.14 (CH-3), 139.49 (CH-2’), 140.99 (C-arom); IR 
(NaCl, neat) ν 2955 (s), 2928 (s), 2857 (s), 1471 (m), 1255 (s), 1121 (s), 1083 (s), 838 
(s) cm
-1; MS (CI-NH3, 150 °C) m/z (%) 336 ([M+NH4
+], 100), 134 (90), 117 (60). Anal. 
Calcd. for C19H30O2Si: C, 71.64; H, 9.49. Found: C, 71.80; H, 9.52. 
(2S,1'S)-234ba
O Ph
TBSO
Ha Hb
Hb
Ha
Hb
Ha
 
(2S,1’S)-tert-Butyl(dimethyl)(2-(1’-(phenyl)allyloxy)but-3-enyloxy)silane 
(2S,1’S)-(234ba). n-Butyllithium (1.4 mL, 2.8 mmol, 2.0M solution in pentane) was added 
slowly to a solution of protected butenediol (S)-235b (556 mg, 2.74 mmol) in THF (3 mL) 
and the mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated was 
transferred (via cannula) to a suspension of copper(I) iodide (600 mg, 3.15 mmol) in THF 
(6 mL) at room temperature. The mixture turned light yellow and was then stirred for 
30 min.
230 The resulting mixture was cooled to 0  °C, a cold (0  °C) solution of 
[Ir(COD)Cl]2 (18.0  mg, 0.027  mmol) in THF (1.5  mL) and allylcarbonate (S)-267a  
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(436 mg, 1.86 mmol, neat) were added consecutively. The cooling bath was then removed 
and the reaction mixture was stirred at room temperature for 16  h. The catalyst was 
precipitated by adding hexane (5 mL) and the mixture was filtered through a pad of silica 
(3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate (90:10). 
Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave silane (2S,1’S)-234ba as a colourless oil (468 mg, 79%, as a single 
diastereoisomer): [α]D +11.5 (c 0.78, MeOH); 
1H-NMR (400.1 MHz, CDCl3) δ 0.08 (s, 3H, 
CH3), 0.09 (s, 3H, CH3), 0.92 (s, 9H, t-Bu), 3.63 (dd, 
2J1-Ha,1-Hb = 10.5 Hz, 
3J1-Ha,2-H = 5.3 
Hz, 1H, 1-Ha), 3.76 (dd, 
2J1-Hb,1-Ha = 10.5 Hz, 
3J1-Hb,2-H = 6.6 Hz, 1H, 1-Hb), 4.06 (ddddd, 
3J2-H,3-H = 6.9 Hz, 
3J2-H,1-Hb = 6.6 Hz, 
3J2-H,1-Ha = 5.3 Hz, 
4J2-H,4-Ha = 0.9 Hz, 
4J2-H,4-Hb = 0.9 
Hz, 1H, 2-H), 4.95 (d, 
3J1’-H,2’-H = 7.3 Hz, 1H, 1’-H), 5.20-5.35 (m, 4H, 4-Ha, 4-Hb, 3’-Ha, 
and 3’-Hb), 5.74 (ddd, 
3J3-H,4-Ha = 17.3 Hz, 
3J3-H,4-Hb = 10.4 Hz, 
3J3-H,2-H = 6.9 Hz, 1H, 3-H), 
5.90 (ddd, 
3J2’-H,3’-Ha = 17.3 Hz, 
3J2’-H,3’-Hb = 10.2 Hz, 
3J2’-H,1’-H = 7.3 Hz, 1H, 2’-H), 
7.23-7.38 (m, 5H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ -5.31 (CH3), -5.18 (CH3), 
18.35 (C(CH3)3), 25.91 (C(CH3)3), 66.29 (CH2-1), 78.75 (CH-2), 80.26 (CH-1’), 116.68, 
117.84 (CH2-4, and CH2-3’), 126.73, 127.34, and 128.25 (CH-arom), 136.28 (CH-3), 
138.79 (CH-2’), 141.53 (C-arom); IR (NaCl, neat) ν 2955 (s), 2928 (s), 2857 (s), 1471 (m), 
1255 (s), 1128 (s), 1086 (s) cm
-1; MS (CI-NH3, 150 °C) m/z (%) 336 ([M+NH4
+], 95), 117 
(100). Anal. Calcd. for C19H30O2Si: C, 71.64; H, 9.49. Found: C, 71.75; H, 9.57. 
(2R,1'S)-234bc
O
TBSO
Ha Hb
Hb
Ha
Hb
Ha
OMe
OMe
 
(2R,1’S)-tert-Butyl(dimethyl)(2-(1’-(3’’,4’’-dimethoxyphenyl)allyloxy)but-3-enyloxy) 
silane (2R,1’S)-(234bc). n-Butyllithium (5.0 mL, 10.0 mmol, 2.0M solution in pentane) 
was added slowly to a solution of protected butenediol (R)-235b (2.022 g, 9.99 mmol) in 
THF (8 mL) and the mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus 
generated was transferred (via cannula) to a suspension of copper(I) iodide (2.000  g, 
10.50 mmol) in THF (20 mL) at room temperature. The mixture turned light yellow and 
was then stirred for 30 min.
230 The resulting mixture was cooled to 0 °C, a cold (0 °C) 
solution of [Ir(COD)Cl]2 (62.4  mg, 0.093  mmol) in THF (5.0  mL) and allylcarbonate 
(S)-267c (2.511 g, 8.53 mmol, neat) were added consecutively. The cooling bath was then 
removed and the reaction mixture was stirred at room temperature for 20 h. The catalyst  
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was precipitated by adding hexane (10 mL) and the mixture was filtered through a pad of 
silica (3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate 
(67:33). Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes 
and ethyl acetate (98:2) gave silane (2R,1’S)-234bc as colourless oil (2.267 g, 70%): [α]D 
-20.4 (c 2.30, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ -0.04 (s, 3H, CH3), -0.01 (s, 3H, 
CH3), 0.84 (s, 9H, t-Bu), 3.54 (dd, 
2J1-Ha,1-Hb = 10.4 Hz, 
3J1-Ha,2-H = 5.6 Hz, 1H, 1-Ha), 3.66 
(dd, 
2J1-Hb,1-Ha = 10.4 Hz, 
3J1-Hb,2-H = 6.3 Hz, 1H, 1-Hb), 3.77-3.82 (m, 1H, 2-H), 3.84 (s, 
3H, CH3O), 3.85 (s, 3H, CH3O), 4.87 (d, 
3J1’-H,2’-H = 5.9 Hz, JHH = 1.3 Hz, JHH = 1.3 Hz, 
1H, 1’-H), 5.08 (ddd, 
3J3’-Hb,2’-H = 10.4 Hz, JHH = 1.7 Hz, JHH = 1.3 Hz, 1H, 3’-Hb), 
5.16-5.24 (m, 3H, 3’-Ha, 4-Ha, and 4-Hb), 5.75 (ddd, 
3J3-H,4-Ha = 16.3 Hz, 
3J3-H,4-Hb = 11.4 
Hz, 
3J3-H,2-H = 7.0 Hz, 1H, 3-H), 5.95 (ddd, 
3J2’-H,3’-Ha = 17.2 Hz, 
3J2’-H,3’-Hb = 10.4 Hz, 
3J2’-
H,1’-H = 5.9 Hz, 1H, 2’-H), 6.80 (d, 
3J5’’-H,6’’-H = 8.0 Hz, 1H, 5’’-H), 6.84 (d, 
4J2’’-H,6’’-H = 1.8 
Hz, 1H, 2’’-H), 6.86 (ddd, 
3J6’’-H,5’’-H = 8.0 Hz, 
4J6’’-H,2’’-H = 1.8 Hz, JHH = 0.4 Hz, 1H, 
6’’-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.47 (CH3), -5.40 (CH3), 18.22 (C(CH3)3), 25.76 
(C(CH3)3), 55.65, and 55.68 (2 × CH3O), 66.17 (CH2-1), 78.08 (CH-2), 79.53 (CH-1’), 
109.99 (CH-2’’), 110.70 (CH-5’’), 114.90 (CH2-3’), 117.85 (CH2-4), 119.56 (CH-6’’), 
133.36 (C-1’’), 136.21 (CH-3), 139.38 (CH-2’), 148.35, and 148.91 (C-3’’, and C-4’’); IR 
(NaCl, neat) ν 2955 (s), 2928 (s), 2858 (s), 1614 (m), 1256 (s) cm
-1; MS (EI) m/z (%) 378 
([M
+], 80), 321 (100), 265 (90), 246 (60); HRMS (CI) 378.2225 [C21H34O4Si (M
+) requires 
378.2226]. 
(2R)-234bf
O
TBSO
Ha Hb
Hb
Ha
Hb
Ha
Br
 
(2R)-(2-(1’-(4’’-Bromophenyl)allyloxy)but-3-enyloxy)(tert-butyl)dimethylsilane 
(2R)-(234bf).  n-Butyllithium (3.0  mL, 6.0  mmol, 2.0M solution in pentane) was added 
slowly to a solution of protected butenediol (R)-235b (1.227  mg, 6.06  mmol) in THF 
(6 mL) and the mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated 
was transferred (via cannula) to a suspension of copper(I) iodide (1.200 g, 6.30 mmol) in 
THF (12 mL) at room temperature. The mixture turned light yellow and was then stirred 
for 30  min.
230 The resulting mixture was cooled to 0  °C, a cold (0  °C) solution of 
[Ir(COD)Cl]2 (36.8 mg, 0.055 mmol) in THF (6 mL) and allylcarbonate (±)-267f (1.533 g, 
4.89 mmol, neat) were added consecutively. The cooling bath was then removed and the  
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reaction mixture was stirred at room temperature for 20 h. The catalyst was precipitated by 
adding hexane (5 mL) and the mixture was filtered through a pad of silica (3 × 3 cm) and 
the product was eluted with a mixture of hexanes and ethyl acetate (90:10). 
Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave silane (2R)-234bf as yellowish oil (1.464 g,  75%,  equimolar 
mixture of diastereoisomers A, B): 
1H-NMR (400.1 MHz, CDCl3) δ 0.09 (s, 6H, CH3), 
0.12 (s, 3H, CH3), 0.13 (s, 3H, CH3), 0.94 (s, 9H, t-Bu), 0.96 (s, 9H, t-Bu), 3.62 (dd, 
2J1A-
Ha,1A-Hb = 10.5 Hz, 
3J1A-Ha,2A-H = 4.9 Hz, 1H, 1A-Ha), 3.68 (dd, 
2J1B-Ha,1B-Hb = 10.6 Hz, 
3J1B-
Ha,2B-H = 5.1 Hz, 1H, 1B-Ha), 3.73 (dd, 
2J1A-Hb,1A-Ha = 10.5 Hz, 
3J1A-Hb,2A-H = 6.9 Hz, 1H, 
1A-Hb), 3.79 (dd, 
2J1B-Hb,1B-Ha = 10.6 Hz, 
3J1B-Hb,2B-H = 6.7 Hz, 1H, 1B-Hb), 3.85 (ddddd, 
3J2A-H,3A-H = 7.0 Hz, 
3J2A-H,1A-Hb = 6.9 Hz, 
3J2A-H,1A-Ha = 4.9 Hz, 
4J2A-H,4A-Ha = 1.0 Hz, 
4J2A-
H,4A-Hb = 1.0 Hz, 1H, 2A-H), 4.08 (ddddd, 
3J2B-H,3B-H = 7.0 Hz, 
3J2B-H,1B-Hb = 6.7 Hz, 
3J2B-
H,1B-Ha = 5.1 Hz, 
4J2B-H,4B-Ha = 0.9 Hz, 
4J2B-H,4B-Hb = 0.9 Hz, 1H, 2B-H), 4.95 (d, 
3J1’-H,2’-H = 
7.2 Hz, 1H, 1’A-H or 1’B-H), 4.97 (d, 
3J1’-H,2’-H = 6.1 Hz, 1H, 1’B-H or 1’A-H), 5.17-5.39 
(m, 8H, 4A-H, 3’A-H, 4B-H, and 3’B-H), 5.76 (ddd, 
3J3-H,4-Ha = 17.4 Hz, 
3J3-H,4-Hb = 10.4 
Hz, 
3J3-H,2-H = 7.0 Hz, 1H, 3A-H or 3B-H), 5.79 (ddd, 
3J3-H,4-Ha = 17.1 Hz, 
3J3-H,4-Hb = 10.6 
Hz, 
3J3-H,2-H = 7.0 Hz, 1H, 3B-H or 3A-H), 5.88 (ddd, 
3J2’-H,3’-Ha = 17.4 Hz, 
3J2’-H,3’-Hb = 
10.2 Hz, 
3J2’-H,1’-H = 7.2 Hz, 1H, 2’A-H or 2’B-H), 5.97 (ddd, 
3J2’-H,3’-Ha = 17.1 Hz, 
3J2’-H,3’-
Hb = 10.4 Hz, 
3J2’-H,1’-H = 6.1 Hz, 1H, 2’B-H or 2’A-H), 7.29 (d, 
3J2’’-H,3’’-H = 8.4 Hz, 2H, 
2’’A-H or 2’’B-H), 7.30 (d, 
3J2’’-H,3’’-H = 8.4 Hz, 2H, 2’’B-H or 2’’A-H), 7.50 (d, 
3J3’’-H,2’’-H 
= 8.4 Hz, 2H, 3’’A-H or 3’’B-H), 7.51 (d, 
3J3’’-H,2’’-H = 8.4 Hz, 2H, 3’’B-H or 3’’A-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.38 (CH3), -5.31 (CH3), -5.27 (CH3), -5.19 (CH3), 
18.34 (C(CH3)3), 19.40 (C(CH3)3), 25.89 (C(CH3)3), 66.24, and 66.28 (CH2-1), 78.81, and 
78.91 (CH-2), 79.23, and 79.57 (CH-1’), 115.71, 117.17, 118.05, and 118.28 (CH2-4, and 
CH2-3’), 121.17, and 121.34 (C-4’’), 128.45, and 128.92 (CH-2’’), 131.30, and 131.45 
(CH-3’’), 135.80, and 135.99 (CH-3), 138.30, and 139.00 (CH-2’), 140.09, and 140.61 
(C-1’’); MS (CI-NH3, 150 °C) m/z (%) 781 ([2M
+], 1), 608/610/612 (10), 580/581 (10), 
414/416 (10), 212/214 (30), 195/197 (100). Anal. Calcd. for C19H23BrO2Si: C, 57.42; H, 
7.35. Found: C, 57.37; H, 7.30. 
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(2R,1'S)-234bf
O
TBSO
Ha Hb
Hb
Ha
Hb
Ha
Br
 
(2R,1’S)-(2-(1’-(4’’-Bromophenyl)allyloxy)but-3-enyloxy)(tert-butyl)dimethylsilane 
(2R,1’S)-(234bf).  n-Butyllithium (5.0  mL, 10.0  mmol, 2.0M solution in pentane) was 
added slowly to a solution of protected butenediol (R)-235b (2.022 g, 9.99 mmol) in THF 
(8 mL) and the mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated 
was transferred (via cannula) to a suspension of copper(I) iodide (2.000 g, 10.50 mmol) in 
THF (20 mL) at room temperature. The mixture turned light yellow and was then stirred 
for 30  min.
230 The resulting mixture was cooled to 0  °C, a cold (0  °C) solution of 
[Ir(COD)Cl]2 (62.4 mg, 0.093 mmol) in THF (5 mL) and allylcarbonate (S)-267f (2.527 g, 
8.07 mmol, neat) were added consecutively. The cooling bath was then removed and the 
reaction mixture was stirred at room temperature for 20 h. The catalyst was precipitated by 
adding hexane (10 mL) and the mixture was filtered through a pad of silica (3 × 3 cm) and 
the product was eluted with a mixture of hexanes and ethyl acetate (90:10). 
Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave silane (2R,1’S)-234bf as yellowish oil (2.724 g, 85%): [α]D -18.8 (c 
2.02, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.11 (s, 6H, CH3), 0.95 (s, 9H, t-Bu), 3.63 
(dd, 
2J1-Ha,1-Hb = 10.5 Hz, 
3J1-Ha,2-H = 4.9 Hz, 1H, 1-Ha), 3.73 (dd, 
2J1-Hb,1-Ha = 10.5 Hz, 
3J1-
Hb,2-H = 6.9 Hz, 1H, 1-Hb), 3.85 (ddddd, 
3J2-H,3-H = 7.0 Hz, 
3J2-H,1-Hb = 6.9 Hz, 
3J2-H,1-Ha = 
4.9 Hz, 
4J2-H,4-Ha = 1.0 Hz, 
4J2-H,4-Hb = 1.0 Hz, 1H, 2-H), 4.97 (d, 
3J1’-H,2’-H = 6.1 Hz, 
4J1’-H,3’-
Ha = 1.2 Hz, 
4J1’-H,3’-Hb = 1.2 Hz, 1H, 1’-H), 5.19 (ddd, 
3J3’-Hb,2’-H = 10.3 Hz, JHH = 1.7 Hz, 
4J3’-Hb,1’-H = 1.2 Hz, 1H, 3’-Hb), 5.24-5.34 (m, 3H, 3’-Ha, 4-Ha, and 4-Hb), 5.79 (ddd, 
3J3-
H,4-Ha = 16.9 Hz, 
3J3-H,4-Hb = 10.8 Hz, 
3J3-H,2-H = 7.0 Hz, 1H, 3-H), 5.97 (ddd, 
3J2’-H,3’-Ha = 
17.2 Hz, 
3J2’-H,3’-Hb = 10.3 Hz, 
3J2’-H,1’-H = 6.1 Hz, 1H, 2’-H), 7.30 (d, 
3J2’’-H,3’’-H = 8.2 Hz, 
2H, 2’’-H, and 6’’-H), 7.52 (d, 
3J3’’-H,2’’-H = 8.2 Hz, 2H, 3’’-H, and 5’’-H); 
13C-NMR 
(100.6 MHz, CDCl3) δ -5.38 (CH3), -5.27 (CH3), 18.33 (C(CH3)3), 25.88 (C(CH3)3), 66.24 
(CH2-1), 78.80 (CH-2), 79.23 (CH-1’), 115.65 (CH2-3’), 118.28 (CH2-4), 121.34 (C-4’’), 
128.90 (CH-2’’, and CH-6’’), 131.44 (CH-3’’, and CH-5’’), 135.80 (CH-3), 139.01 
(CH-2’), 140.09 (C-1’’); IR (NaCl, neat) ν 3446 (s), 2954 (s), 2928 (s), 2857 (s), 1487 (m), 
1472 (m), 1255 (s), 1121 (s), 1073 (s) cm
-1; MS (CI) m/z (%) 397/399 ([M+H
+], 10), 369  
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(30), 195/197 (100); HRMS (CI) 397.1156/399.1200 [C19H30BrO2Si (M+H
+) requires 
397.1198/399.1180]. 
(2R,1'R)-234bh
O
TBSO
Ha Hb
Hb
Ha
Hb
Ha
F
 
(2R,1’R)-tert-Butyl(dimethyl)(2-(1’-(3’’-fluorophenyl)allyloxy)but-3-enyloxy)silane 
(2R,1’R)-(234bh).  n-Butyllithium (3.0  mL, 6.0  mmol, 2.0M solution in pentane) was 
added slowly to a solution of protected butenediol (R)-235b (1.209 g, 5.97 mmol) in THF 
(5 mL) and the mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated 
was transferred (via cannula) to a suspension of copper(I) iodide (1.200 g, 6.30 mmol) in 
THF (12 mL) at room temperature. The mixture turned light yellow and was then stirred 
for 30  min.
230 The resulting mixture was cooled to 0  °C, a cold (0  °C) solution of 
[Ir(COD)Cl]2 (44.1  mg, 0.065  mmol) in THF (5.0  mL) and allylcarbonate (R)-267h 
(1.208 g, 4.79 mmol, neat) were added consecutively. The cooling bath was then removed 
and the reaction mixture was stirred at room temperature for 20  h. The catalyst was 
precipitated by adding hexane (10 mL) and the mixture was filtered through a pad of silica 
(3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate (90:10). 
Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave silane (2R,1’R)-234bh as colourless oil (1.161 g, 72%): [α]D -14.7 
(c 1.84, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.10 (s, 3H, CH3), 0.11 (s, 3H, CH3), 
0.94 (s, 9H, t-Bu), 3.66 (dd, 
2J1-Ha,1-Hb = 10.5 Hz, 
3J1-Ha,2-H = 5.1 Hz, 1H, 1-Ha), 3.78 (dd, 
2J1-Hb,1-Ha = 10.5 Hz, 
3J1-Hb,2-H = 6.6 Hz, 1H, 1-Hb), 4.07 (ddddd, 
3J2-H,1-Hb = 6.6 Hz,
 3J2-H,3-H 
= 6.2 Hz, 
3J2-H,1-Ha = 5.1 Hz, 
4J2-H,4-Ha = 1.2 Hz, 
4J2-H,4-Hb = 1.0 Hz, 1H, 2-H), 4.96 (d, 
3J1’-
H,2’-H = 7.3 Hz, 1H, 1’-H), 5.25 (ddd, 
3J4-Hb,3-H = 10.4 Hz, 
2J4-Hb,4-Ha = 1.9 Hz, 
4J4-Hb,2-H = 1.0 
Hz, 1H, 4-Hb), 5.28 (ddd, 
3J3’-Hb,2’-H = 10.2 Hz, 
3J3’-Hb,3’-Ha = 1.7 Hz, JHH = 0.8 Hz, 1H, 
3’-Hb), 5.29 (ddd, 
3J4-Ha,3-H = 17.4 Hz, 
3J4-Ha,4-Hb = 1.9 Hz, 
4J4-Ha,2-H = 1.2 Hz, 1H, 4-Ha), 
5.35 (ddd, 
3J3’-Ha,2’-H = 17.4 Hz, 
3J3’-Ha,3’-Hb = 1.7 Hz, JHH = 1.1 Hz, 1H, 3’-Ha), 5.75 (ddd, 
3J3-H,4-Ha = 17.4 Hz, 
3J3-H,4-Hb = 10.4 Hz, 
3J3-H,2-H = 6.2 Hz, 1H, 3-H), 5.88 (ddd, 
3J2’-H,3’-Ha = 
17.4 Hz, 
3J2’-H,3’-Hb = 10.2 Hz, 
3J2’-H,1’-H = 7.3 Hz, 1H, 2’-H), 6.93-6.98 (m, 1H, 4’’-H), 
7.11-7.14 (m, 1H, 2’’-H), 7.14-1.16 (m, 1H, 6’’-H), 7.30 (ddd, JHH = 8.1 Hz, JHH = 8.1 Hz, 
4J5’’-H,F = 5.9 Hz, 1H, 5’’-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.31 (CH3), -5.19 (CH3), 
18.35 (C(CH3)3), 25.91 (C(CH3)3), 66.32 (CH2-1), 78.98 (CH-2), 79.59 (d, 
4JCF = 1.8 Hz,  
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CH-1’), 113.62 (d, 
2JCF = 22.1 Hz, CH-2’’), 114.12 (d, 
2JCF = 21.2 Hz, CH-4’’), 117.23 
(CH2-3’), 118.04 (CH2-4), 122.26 (d, 
4JCF = 2.9 Hz, CH-6’’), 129.64 (d, 
3JCF = 8.2 Hz, 
CH-5’’), 136.05 (CH-3), 138.31 (CH-2’), 144.31 (d, 
3JCF = 6.9 Hz, C-1’’), 162.89 (d, 
1JCF 
= 245.5 Hz, CF-3’’); 
19F-NMR (376.5 MHz, CDCl3) δ –113.78; IR (NaCl, neat) ν 2958 (s), 
2931 (s), 2858 (s), 2360 (s), 1593 (m), 1253 (s), 1128 (s) cm
-1; MS (CI) m/z (%) 337 
([M+H
+], 10), 135 (100); HRMS (CI) 337.1998 [C19H30FO2Si (M+H
+) requires 337.1999]. 
Anal. Calcd. for C19H29FO2Si: C, 67.81; H, 8.69. Found: C, 67.71; H, 8.55. 
(2R,1'S)-234bh
O
TBSO
Ha Hb
Hb
Ha
Hb
Ha
F
 
(2R,1’S)-tert-Butyl(dimethyl)(2-(1’-(3’’-fluorophenyl)allyloxy)but-3-enyloxy)silane 
(2R,1’S)-(234bh).  n-Butyllithium (5.0  mL, 10.0  mmol, 2.0M solution in pentane) was 
added slowly to a solution of protected butenediol (R)-235b (2.024 g, 10.02 mmol) in THF 
(10  mL) and the mixture was stirred at 0  °C for 15  min. The lithium alkoxide thus 
generated was transferred (via cannula) to a suspension of copper(I) iodide (2.000  g, 
10.50 mmol) in THF (20 mL) at room temperature. The mixture turned light yellow and 
was then stirred for 30 min.
230 The resulting mixture was cooled to 0 °C, a cold (0 °C) 
solution of [Ir(COD)Cl]2 (65.0  mg, 0.092  mmol) in THF (5.0  mL) and allylcarbonate 
(S)-267h (2.005 g, 7.94 mmol, neat) were added consecutively. The cooling bath was then 
removed and the reaction mixture was stirred at room temperature for 20 h. The catalyst 
was precipitated by adding hexane (10 mL) and the mixture was filtered through a pad of 
silica (3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate 
(90:10). Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes 
and ethyl acetate (98.5:1.5) gave silane (2R,1’S)-234bh as colourless oil (1.951 g, 73%): 
[α]D -18.4 (c 1.96, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.06 (s, 6H, CH3), 0.90 (s, 9H, 
t-Bu), 3.60 (dd, 
2J1-Ha,1-Hb = 10.6 Hz, 
3J1-Ha,2-H = 4.9 Hz, 1H, 1-Ha), 3.71 (dd, 
2J1-Hb,1-Ha = 
10.6 Hz, 
3J1-Hb,2-H = 6.8 Hz, 1H, 1-Hb), 3.85 (ddddd, 
3J2-H,3-H = 7.0 Hz,
 3J2-H,1-Hb = 6.8 Hz, 
3J2-H,1-Ha = 4.9 Hz, JHH = 1.0 Hz, JHH = 1.0 Hz, 1H, 2-H), 4.96 (d, 
3J1’-H,2’-H = 6.1 Hz, 1H, 
1’-H), 5.15 (ddd, JHH = 10.4 Hz, JHH = 1.4 Hz, JHH = 1.4 Hz, 1H, 3’-Ha or 3’-Hb), 
5.21-5.29 (m, 3H, 3’-Hb or 3’-Ha, 4-Ha, and 4-Hb), 5.76 (ddd, JHH = 17.4 Hz, JHH = 10.8 
Hz, 
3J3-H,2-H = 7.0 Hz, 1H, 3-H), 5.94 (ddd, JHH = 17.1 Hz, JHH = 10.3 Hz, 
3J2’-H,1’-H = 6.1 
Hz, 1H, 2’-H), 6.94-6.99 (m, 1H, 4’’-H), 7.10-7.14 (m, 2H, 2’’-H, and 6’’-H), 7.27-7.32  
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(m, 1H, 5’’-H); 
13C-NMR (100.6 MHz, CDCl3)  δ -5.39 (CH3), -5.30 (CH3), 18.36 
(C(CH3)3), 25.90 (C(CH3)3), 66.32 (CH2-1), 78.96 (CH-2), 78.38 (d, 
4JCF = 1.7 Hz, CH-1’), 
113.96 (d, 
2JCF = 21.7 Hz, CH-2’’), 114.36 (d, 
2JCF = 21.3 Hz, CH-4’’), 115.73 (CH2-3’), 
118.18 (CH2-4), 122.73 (d, 
4JCF = 2.8 Hz, CH-6’’), 129.78 (d, 
3JCF = 8.1 Hz, CH-5’’), 
136.90 (CH-3), 138.98 (CH-2’), 143.92 (d, 
3JCF = 6.6 Hz, C-1’’), 163.04 (d, 
1JCF = 245.9 
Hz, CF-3’’); 
19F-NMR (376.5 MHz, CDCl3) δ –113.56; IR (NaCl, neat) ν 2955 (s), 2929 
(s), 2858 (s), 1614 (m), 1592 (m), 1296 (s), 1126 (s), 1086 (s) cm
-1; MS (CI) m/z (%) 337 
([M+H
+], 5), 135 (100); HRMS (CI) 337.1997 [C19H30FO2Si (M+H
+) requires 337.1999]. 
Anal. Calcd. for C19H29FO2Si: C, 67.81; H, 8.69. Found: C, 67.64; H, 8.80. 
(2S,1'R)-234bh
O
TBSO
Ha Hb
Hb
Ha
Hb
Ha
F
 
(2S,1’R)-tert-Butyl(2-(1’-(3’’-fluorophenyl)allyloxy)but-3-enyloxy)dimethylsilane 
(2S,1’R)-(234bh).  n-Butyllithium (8.5  mL, 17.0  mmol, 2.0M solution in pentane) was 
added slowly to a solution of protected butenediol (S)-235b (3.440 g, 17.00 mmol) in THF 
(18  mL) and the mixture was stirred at 0  °C for 15  min. The lithium alkoxide thus 
generated was transferred (via cannula) to a suspension of copper(I) iodide (3.400  g, 
17.85 mmol) in THF (35 mL) at room temperature. The mixture turned light yellow and 
was then stirred for 30 min.
230 The resulting mixture was cooled to 0 °C, a cold (0 °C) 
solution of [Ir(COD)Cl]2 (107.9  mg, 0.161  mmol) in THF (5.0  mL) and allylcarbonate 
(R)-267h (3.605 g, 14.29 mmol, neat) were added consecutively. The cooling bath was 
then removed and the reaction mixture was stirred at room temperature for 20  h. The 
catalyst was precipitated by adding hexane (10 mL) and the mixture was filtered through a 
pad of silica (3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl 
acetate (90:10). Chromatography on a column of silica gel (3 × 10 cm) with a mixture of 
hexanes and ethyl acetate (98.5:1.5) gave silane (2S,1’R)-234bh as colourless oil (3.557 g, 
74%): [α]D +18.3 (c 3.06, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.06 (s, 6H, CH3), 0.90 
(s, 9H, t-Bu), 3.60 (dd, 
2J1-Ha,1-Hb = 10.6 Hz, 
3J1-Ha,2-H = 4.9 Hz, 1H, 1-Ha), 3.71 (dd, 
2J1-Hb,1-
Ha = 10.6 Hz, 
3J1-Hb,2-H = 6.8 Hz, 1H, 1-Hb), 3.85 (ddddd, 
3J2-H,3-H = 7.0 Hz,
 3J2-H,1-Hb = 6.8 
Hz, 
3J2-H,1-Ha = 4.9 Hz, JHH = 1.0 Hz, JHH = 1.0 Hz, 1H, 2-H), 4.96 (d, 
3J1’-H,2’-H = 6.1 Hz, 
1H, 1’-H), 5.15 (ddd, JHH = 10.4 Hz, JHH = 1.4 Hz, JHH = 1.4 Hz, 1H, 3’-Ha or 3’-Hb), 
5.21-5.29 (m, 3H, 3’-Hb or 3’-Ha, 4-Ha, and 4-Hb), 5.76 (ddd, JHH = 17.4 Hz, JHH = 10.8  
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Hz, 
3J3-H,2-H = 7.0 Hz, 1H, 3-H), 5.94 (ddd, JHH = 17.1 Hz, JHH = 10.3 Hz, 
3J2’-H,1’-H = 6.1 
Hz, 1H, 2’-H), 6.94-6.99 (m, 1H, 4’’-H), 7.10-7.14 (m, 2H, 2’’-H, and 6’’-H), 7.27-7.32 
(m, 1H, 5’’-H); 
13C-NMR (100.6 MHz, CDCl3)  δ -5.39 (CH3), -5.30 (CH3), 18.36 
(C(CH3)3), 25.90 (C(CH3)3), 66.32 (CH2-1), 78.96 (CH-2), 78.38 (d, 
4JCF = 1.7 Hz, CH-1’), 
113.96 (d, 
2JCF = 21.7 Hz, CH-2’’), 114.36 (d, 
2JCF = 21.3 Hz, CH-4’’), 115.73 (CH2-3’), 
118.18 (CH2-4), 122.73 (d, 
4JCF = 2.8 Hz, CH-6’’), 129.78 (d, 
3JCF = 8.1 Hz, CH-5’’), 
136.90 (CH-3), 138.98 (CH-2’), 143.92 (d, 
3JCF = 6.6 Hz, C-1’’), 163.04 (d, 
1JCF = 245.9 
Hz, CF-3’’); 
19F-NMR (376.5 MHz, CDCl3) δ –113.56; IR (NaCl, neat) ν 2955 (s), 2929 
(s), 2858 (s), 1614 (m), 1592 (m), 1296 (s), 1126 (s), 1086 (s) cm
-1; MS (CI) m/z (%) 337 
([M+H
+], 5), 135 (100); HRMS (CI) 337.1997 [C19H30FO2Si (M+H
+) requires 337.1999]. 
Anal. Calcd. for C19H29FO2Si: C, 67.81; H, 8.69. Found: C, 67.55; H, 8.70. 
(2S,1'S)-234bh
O
TBSO
Ha Hb
Hb
Ha
Hb
Ha
F
 
(2S,1’S)-tert-Butyl(dimethyl)(2-(1’-(3’’-fluorophenyl)allyloxy)but-3-enyloxy)silane 
(2S,1’S)-(234bh). n-Butyllithium (4.0 mL, 8.0 mmol, 2.0M solution in pentane) was added 
slowly to a solution of protected butenediol (S)-235b (1.641 g, 8.11 mmol) in THF (8 mL) 
and the mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated was 
transferred (via cannula) to a suspension of copper(I) iodide (1.600 g, 8.40 mmol) in THF 
(16 mL) at room temperature. The mixture turned light yellow and was then stirred for 
30 min.
230 The resulting mixture was cooled to 0  °C, a cold (0  °C) solution of 
[Ir(COD)Cl]2 (54.2  mg, 0.081  mmol) in THF (5.0  mL) and allylcarbonate (S)-267h 
(1.700 g, 6.73 mmol, neat) were added consecutively. The cooling bath was then removed 
and the reaction mixture was stirred at room temperature for 20  h. The catalyst was 
precipitated by adding hexane (10 mL) and the mixture was filtered through a pad of silica 
(3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate (90:10). 
Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl 
acetate (98.5:1.5) gave silane (2S,1’S)-234bh as colourless oil (1.765 g, 78%): [α]D +15.2 
(c 3.10, CHCl3); 
1H-NMR (400.1 MHz, CDCl3) δ 0.10 (s, 3H, CH3), 0.11 (s, 3H, CH3), 
0.94 (s, 9H, t-Bu), 3.66 (dd, 
2J1-Ha,1-Hb = 10.5 Hz, 
3J1-Ha,2-H = 5.1 Hz, 1H, 1-Ha), 3.78 (dd, 
2J1-Hb,1-Ha = 10.5 Hz, 
3J1-Hb,2-H = 6.6 Hz, 1H, 1-Hb), 4.07 (ddddd, 
3J2-H,1-Hb = 6.6 Hz,
 3J2-H,3-H 
= 6.2 Hz, 
3J2-H,1-Ha = 5.1 Hz, 
4J2-H,4-Ha = 1.2 Hz, 
4J2-H,4-Hb = 1.0 Hz, 1H, 2-H), 4.96 (d, 
3J1’- 
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H,2’-H = 7.3 Hz, 1H, 1’-H), 5.25 (ddd, 
3J4-Hb,3-H = 10.4 Hz, 
2J4-Hb,4-Ha = 1.9 Hz, 
4J4-Hb,2-H = 1.0 
Hz, 1H, 4-Hb), 5.28 (ddd, 
3J3’-Hb,2’-H = 10.2 Hz, 
3J3’-Hb,3’-Ha = 1.7 Hz, JHH = 0.8 Hz, 1H, 
3’-Hb), 5.29 (ddd, 
3J4-Ha,3-H = 17.4 Hz, 
3J4-Ha,4-Hb = 1.9 Hz, 
4J4-Ha,2-H = 1.2 Hz, 1H, 4-Ha), 
5.35 (ddd, 
3J3’-Ha,2’-H = 17.4 Hz, 
3J3’-Ha,3’-Hb = 1.7 Hz, JHH = 1.1 Hz, 1H, 3’-Ha), 5.75 (ddd, 
3J3-H,4-Ha = 17.4 Hz, 
3J3-H,4-Hb = 10.4 Hz, 
3J3-H,2-H = 6.2 Hz, 1H, 3-H), 5.88 (ddd, 
3J2’-H,3’-Ha = 
17.4 Hz, 
3J2’-H,3’-Hb = 10.2 Hz, 
3J2’-H,1’-H = 7.3 Hz, 1H, 2’-H), 6.93-6.98 (m, 1H, 4’’-H), 
7.11-7.14 (m, 1H, 2’’-H), 7.14-1.16 (m, 1H, 6’’-H), 7.30 (ddd, JHH = 8.1 Hz, JHH = 8.1 Hz, 
4J5’’-H,F = 5.9 Hz, 1H, 5’’-H); 
13C-NMR (100.6 MHz, CDCl3) δ -5.31 (CH3), -5.19 (CH3), 
18.35 (C(CH3)3), 25.91 (C(CH3)3), 66.32 (CH2-1), 78.98 (CH-2), 79.59 (d, 
4JCF = 1.8 Hz, 
CH-1’), 113.62 (d, 
2JCF = 22.1 Hz, CH-2’’), 114.12 (d, 
2JCF = 21.2 Hz, CH-4’’), 117.23 
(CH2-3’), 118.04 (CH2-4), 122.26 (d, 
4JCF = 2.9 Hz, CH-6’’), 129.64 (d, 
3JCF = 8.2 Hz, 
CH-5’’), 136.05 (CH-3), 138.31 (CH-2’), 144.31 (d, 
3JCF = 6.9 Hz, C-1’’), 162.89 (d, 
1JCF 
= 245.5 Hz, CF-3’’); 
19F-NMR (376.5 MHz, CDCl3) δ –113.78; IR (NaCl, neat) ν 2958 (s), 
2931 (s), 2858 (s), 2360 (s), 1593 (m), 1253 (s), 1128 (s) cm
-1; MS (CI) m/z (%) 337 
([M+H
+], 10), 135 (100); HRMS (CI) 337.1998 [C19H30FO2Si (M+H
+) requires 337.1999]. 
Anal. Calcd. for C19H29FO2Si: C, 67.81; H, 8.69. Found: C, 67.74; H, 8.79. 
234ca
O Ph
TBDPSO
 
tert-Butyl(2-(1’-(phenyl)allyloxy)but-3-enyloxy)diphenylsilane (234ca).  n-Butyllithium 
(0.4 mL, 1.0 mmol, 2.5M solution in hexanes) was added slowly to a solution of protected 
butenediol (±)-235c (326 mg, 1.00 mmol) in THF (1 mL) and the mixture was stirred at 
0 °C for 15 min. The lithium alkoxide thus generated was transferred (via cannula) to a 
suspension of copper(I) iodide (200 mg, 1.05 mmol) in THF (2 mL) at room temperature. 
The mixture turned light yellow and was then stirred for 30 min.
230 The resulting mixture 
was cooled to 0 °C, a cold (0 °C) solution of catalyst ([Ir(COD)Cl]2 (14.0 mg, 0.020 mmol) 
and ligand (Ra,Rc,Rc)-L2 (14.0 mg, 0.044 mmol) in THF (1  mL) and allylcarbonate 
(±)-236a (120 mg, 0.51 mmol, neat) were added respectively. The cooling bath was then 
removed and the reaction mixture was stirred at room temperature for 16 h. The catalyst 
was precipitated by adding hexane (5 mL) and the mixture was filtered through a pad of 
silica (3 × 3 cm) and the product was eluted with a mixture of hexanes and ethyl acetate 
(90:10). Chromatography on a column of silica gel (3 × 10 cm) with a mixture of hexanes 
and Et2O (95:5) gave 234ca as a colourless oil (198 mg, 93%): 
1H-NMR (400.1 MHz,  
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CDCl3, a mixture of diastereoisomers in a 1:1.8 ratio, the minor diastereoisomer is marked 
with * where possible) δ 1.07* 1.10 (s, 9H, t-Bu), 3.28*-3.50* 3.62-3.86 (m, 2H, CH2), 
3.92*-3.97* 4.14-4.18 (m, 1H, CH2CH), 4.98 (d, JHH = 7.2 Hz, 0.6H, PhCH), 5.06* (d, JHH 
= 7.5 Hz, 0.4H, PhCH), 5.11-5.36 (m, 4H, CH2=CH), 5.72-5.80 and 5.77*-5.84* and 
5.86-5.96 and 5.95*-6.04* (m, 2H, CH2=CH), 7.22-7.47 and 7.66-7.76 (m, 15H, Ph); 
13C-NMR (100.6 MHz, CDCl3)  δ 26.8 and 27.0 (tBu), 66.8 (CH2CH), 78.4 and 78.5 
(CH2CH), 79.7 and 80.2 (PhCH), 115.1 and 116.6 and 117.9 and 118.1 (CH2=CH), 126.7, 
127.2, 127.6, 129.5, 129.6, 133.5, 133.6, 135.6, 135.7, 135.9, 136.0, 136.1, 141.0, 141.5. 
MS (CI-NH3, 150 °C) m/z (%) 460 ([M+NH4
+], 95), 444 (5), 364 (10), 252 (30), 193 (15), 
52 (100); HRMS (CI-NH3, 100  °C) 460.2670 [C29H38NO2Si (M+NH4
+) requires 
460.2672]. 
234ci
O
TBDPSO
F Ha Hb
Hb
Ha
Hb
Ha
 
tert-Butyl(2-(1’-(4’’-fluorophenyl)allyloxy)but-3-enyloxy)diphenylsilane (234ci). 
n-Butyllithium (1.2  mL, 3.0  mmol, 2.5M solution in hexanes) was added slowly to a 
solution of protected butenediol (±)-235c (986 mg, 3.02 mmol) in THF (3 mL) and the 
mixture was stirred at 0 °C for 15 min. The lithium alkoxide thus generated was transferred 
(via cannula) to a suspension of copper(I) iodide (600 mg, 3.15 mmol) in THF (6 mL) at 
room temperature. The mixture turned light yellow and was then stirred for 30 min.
230 The 
resulting mixture was cooled to 0 °C, a cold (0 °C) solution of [Ir(COD)Cl]2 (20.7 mg, 
0.031 mmol) in THF (3 mL) and allylcarbonate (±)-267i (508 mg, 2.01 mmol, neat) were 
added consecutively. The cooling bath was then removed and the reaction mixture was 
stirred at room temperature for 16  h. The catalyst was precipitated by adding hexane 
(5 mL) and the mixture was filtered through a pad of silica (3 × 3 cm) and the product was 
eluted with a mixture of hexanes and ethyl acetate (90:10). Chromatography on a column 
of silica gel (3 × 10 cm) with a mixture of hexanes and ethyl acetate (98.5:1.5) gave silane 
234ci as a colourless oil (733 mg, 79%, mixture of diastereoisomers A, B: 
1H-NMR (400.1 
MHz, CDCl3) δ 1.06 (s, 9H, t-Bu), 1.09 (s, 9H, t-Bu), 3.63 (dd, 
2J1A-Ha,1A-Hb = 10.5 Hz, 
3J1A-Ha,2A-H = 4.7 Hz, 1H, 1A-Ha), 3.70 (dd, 
2J1B-Ha,1B-Hb = 10.5 Hz, 
3J1B-Ha,2B-H = 4.9 Hz, 
1H, 1B-Ha), 3.76 (dd, 
2J1A-Hb,1A-Ha = 10.5 Hz, 
3J1A-Hb,2A-H = 6.8 Hz, 1H, 1A-Hb), 3.83 (dd, 
2J1B-Hb,1B-Ha = 10.5 Hz, 
3J1B-Hb,2B-H = 6.6 Hz, 1H, 1B-Hb), 3.89 (dddt, 
3J2A-H,1A-Hb = 6.8 Hz,  
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3J2A-H,3A-H = 5.7 Hz, 
3J2A-H,1A-Ha = 4.7 Hz, 
4J2A-H,4A-H = 1.0 Hz, 1H, 2A-H), 4.13 (dddt, 
3J2B-
H,1B-Hb = 6.6 Hz, 
3J2B-H,3B-H = 5.9 Hz, 
3J2B-H,1B-Ha = 4.9 Hz, 
4J2B-H,4B-H = 1.1 Hz, 1H, 2B-H), 
4.93-4.96 (m, 2H, 1’A-H, and 1’B-H), 5.12-5.34 (m, 8H, 3’A-H, 3’B-H, 4A-H, and 4B-H), 
5.70-6.00 (m, 4H, 2’A-H, 2’B-H, 3A-H, and 3B-H), 6.98-7.05 (m, 4H, H-arom), 7.31-7.47 
(m, 16H, H-arom), 7.65-7.76 (m, 8H, H-arom); HRMS (CI-NH3, 100  °C) 478.2576 
[C29H37FNO2Si (M+NH4
+) requires 478.2578]. 
279a
 
(E)-Prop-1-ene-1,3-diyldibenzene (279a).
229  n-Butyllithium (0.5  mL, 1.0  mmol, 2.0M 
solution in pentane) was added slowly to a solution of protected butenediol 235c (326 mg, 
1.00 mmol) in THF (1 mL) and the mixture was stirred at 0 °C for 15 min. The lithium 
alkoxide thus generated was transferred (via cannula) to a suspension of copper(I) iodide 
(200 mg, 1.05 mmol) in THF (2 mL) at room temperature. The mixture turned light yellow 
and was then stirred for 30 min.
230 The resulting mixture was cooled to 0 °C, a cold (0 °C) 
solution of Rh(PPh)3Cl (61.1 mg, 0.066 mmol) and P(OMe)3 (25.0 mg, 0.201 mmol) in 
THF (1.0  mL) and allylcarbonate 267a (136  mg, 0.58  mmol, neat) were added 
respectively. The cooling bath was then removed and the reaction mixture was stirred at 
room temperature for 16 h. The catalyst was precipitated by adding hexane (5 mL) and the 
mixture was filtered through a pad of silica (3 × 3 cm) and the product was eluted with a 
mixture of hexanes and ethyl acetate (90:10). Chromatography on a column of silica gel 
(3 × 10 cm) with hexanes gave 279a as a colourless oil (26 mg, 46% of theory, 77% based 
on recovered carbonate). Subsequent elution with a mixture of hexanes and ethyl acetate 
(98.5:1.5) gave carbonate 267a as a colourless oil (55 mg, 40% recovered). 279a: 
1H-NMR 
(400.1 MHz, CDCl3) δ 3.47 (d, 
3J3-H,2-H = 6.6 Hz, 2H, 3-H), 6.28 (dt, 
3J2-H,1-H = 15.8 Hz, 
3J2-H,3-H = 6.6 Hz, 1H, 2-H), 6.38 (d, 
3J1-H,2-H = 15.8 Hz, 1H, 1-H), 7.10-7.29 (m, 10H, 
H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 39.34 (CH2-3), 126.10, 126.16, 127.08, 128.47, 
128.48, and 128.65 (CH-arom), 129.20 (CH-2), 131.05 (CH-1), 137.45 (C-1’), 140.14 
(C-1’’); MS (EI) m/z (%) 194 (M
+, 40), 179 (15), 115 (20), 83 (100); HRMS (EI) 194.1094 
[C15H14 (M
+) requires 194.1096]. Consistent with the literature data.
229  
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279i
F F
 
(E)-4,4’-(Prop-1-en-1,3-diyl)bis(fluorobenzen) (279i). n-Butyllithium (0.4  mL, 
1.0  mmol, 2.5M solution in hexanes) was added slowly to a solution of protected 
butenediol 235c (326 mg, 1.00 mmol) in THF (1 mL) and the mixture was stirred at 0 °C 
for 15  min. The lithium alkoxide thus generated was transferred (via cannula) to a 
suspension of copper(I) iodide (200 mg, 1.05 mmol) in THF (2 mL) at room temperature. 
The mixture turned light yellow and was then stirred for 30 min.
230 The resulting mixture 
was cooled to 0 °C, a cold (0 °C) solution of [Rh(COD)Cl]2 (10.1 mg, 0.020 mmol) in THF 
(1.0 mL) and allylcarbonate 267i (136 mg, 0.54 mmol, neat) were added respectively. The 
cooling bath was then removed and the reaction mixture was stirred at room temperature 
for 16  h. The catalyst was precipitated by adding hexane (5  mL) and the mixture was 
filtered through a pad of silica (3 × 3 cm) and the product was eluted with a mixture of 
hexanes and ethyl acetate (90:10). Chromatography on a column of silica gel (3 × 10 cm) 
with hexanes gave 279i as colourless oil (27 mg, 43%). Subsequent elution with a mixture 
of hexanes and ethyl acetate (98.5:1.5) gave diallyl ether 234ci as a colourless oil (78 mg, 
31%). 279i: 
1H-NMR (400.1 MHz, CDCl3) δ 3.45 (d, 
3J3-H,2-H = 6.8 Hz, 2H, 3-H), 6.19 (dt, 
3J2-H,1-H = 15.7 Hz, 
3J2-H,3-H = 6.8 Hz, 1H, 2-H), 6.33 (d, 
3J1-H,2-H = 15.7 Hz, 1H, 1-H), 
6.87-6.92 (m, 2H, H-arom), 7.12-7.25 (m, 6H, H-arom); 
13C-NMR (100.6 MHz, CDCl3) δ 
38.16 (CH2-3), 114.76 (d, 
2JCF = 21.7 Hz, CH-3’’), 115.29 (d, 
2JCF = 22.9 Hz, CH-3’), 
126.31 (CH-2), 130.14 (d, 
3JCF = 8.1 Hz, CH-2’), 130.31 (d, 
3JCF = 8.2 Hz, CH-2’’), 130.85 
(CH-1), 133.68 (d, 
4JCF = 1.1 Hz, C-1’), 136.83 (d, 
4JCF = 3.1 Hz, C-1’’), 160.27 (d, 
1JCF = 
249.2 Hz, CF-4’), 162.10 (d, 
1JCF = 246.1 Hz, CF-4’’); HRMS (EI) 230.0910 [C15H12F2 
(M
+) requires 230.0907]. 
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